<SEC-DOCUMENT>0001654954-25-005746.txt : 20250515
<SEC-HEADER>0001654954-25-005746.hdr.sgml : 20250515
<ACCEPTANCE-DATETIME>20250515160641
ACCESSION NUMBER:		0001654954-25-005746
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250515
DATE AS OF CHANGE:		20250515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			374Water Inc.
		CENTRAL INDEX KEY:			0000933972
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORS & GENERATORS [3621]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				880271109
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41420
		FILM NUMBER:		25952812

	BUSINESS ADDRESS:	
		STREET 1:		701 W. MAIN STREET
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27701
		BUSINESS PHONE:		440-609-9677

	MAIL ADDRESS:	
		STREET 1:		3710 SHANNON RD #51877
		STREET 2:		SUITE 410
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27717

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	POWERVERDE, INC.
		DATE OF NAME CHANGE:	20080820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VYREX CORP
		DATE OF NAME CHANGE:	19951206
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>scwo_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:scwo="http://scwo.com/20250331"><head><title>scwo_10q.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2025-01-01to2025-03-31" id="ixv-8655">0000933972</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2025-01-01to2025-03-31" format="ixt:booleanfalse" id="ixv-8656">false</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="From2025-01-01to2025-03-31" id="ixv-8657">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="From2025-01-01to2025-03-31" id="ixv-8658">Q1</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="From2025-01-01to2025-03-31" id="ixv-8659">2025</ix:nonNumeric><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8660">200000000</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-8661">0.0001</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-8662">144682963</ix:nonFraction><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8663">144301977</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" unitRef="USDPShares" decimals="INF" id="ixv-8664">0.0001</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8665">50000000</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8666">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-12-31" unitRef="Shares" decimals="0" id="ixv-8667">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-8668">0</ix:nonFraction><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-03-31" unitRef="Shares" decimals="0" id="ixv-8669">0</ix:nonFraction><ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-8670">false</ix:nonNumeric><ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-8671">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-8672">false</ix:nonNumeric><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" contextRef="From2025-01-01to2025-03-31" id="ixv-8673">false</ix:nonNumeric><ix:nonFraction name="us-gaap:InventoryRecallExpense" contextRef="From2024-01-01to2024-12-31" unitRef="USD" decimals="0" id="ixv-8674">50000</ix:nonFraction><ix:nonFraction name="us-gaap:LossContingencyAccrualProvision" contextRef="From2024-01-01to2024-12-31" unitRef="USD" decimals="0" id="ixv-8675">1000000</ix:nonFraction><ix:nonFraction name="scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" contextRef="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember" unitRef="Shares" decimals="0" id="ixv-8676">570000</ix:nonFraction><ix:nonFraction name="scwo:AnnualRevenueAchiveForFiscalYear2026" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" unitRef="USD" decimals="0" id="ixv-8677">20000000</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="scwo-20250331.xsd"/></ix:references><ix:resources><xbrli:context id="From2025-01-01to2025-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-04-30_us-gaap_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:CommitmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-01</xbrli:startDate><xbrli:endDate>2024-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_AirSCWOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:AirSCWOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_AirSCWOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:AirSCWOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_PerformanceBasedOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:PerformanceBasedOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">scwo:VestUponAchievementOfFifityPercentRevenueTargetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentTargetMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">scwo:VestUponAchievementOfFifityPercentTargetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31_scwo_TwoZeroTwoOnePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_scwo_TwoZeroTwoOnePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_keyEmployeeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:keyEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_FinancialOfficerMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">scwo:FinancialOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:FormerEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_ServiceBasedOptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:ServiceBasedOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_TwentyTwentyFiveMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">scwo:TwentyTwentyFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:ServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:EquipmentRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:EquipmentRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_ATMMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:ATMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_UnvestedRestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:UnvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_UnvestedRestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:UnvestedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_OptionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_FullScaleDemonstrationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:FullScaleDemonstrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31_scwo_ThreeCustomerMember_us-gaap_AccountsReceivableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:ThreeCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_scwo_OneCustomerMember_scwo_RevenueMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:OneCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">scwo:RevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_scwo_RevenueMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:TwoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">scwo:RevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_TreatabilityStudyServicesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">scwo:TreatabilityStudyServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_FullScaleDemonstrationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:FullScaleDemonstrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_us-gaap_AccountsReceivableMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:TwoCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_scwo_EquipmentDemoSystemMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:EquipmentDemoSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_OfficeEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_scwo_EquipmentDemoSystemMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:EquipmentDemoSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_OfficeEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_VehiclesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_VehiclesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2023-12-31_us-gaap_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="From2024-01-01to2024-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="AsOf2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-03-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="AsOf2025-05-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000933972</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES</strong><strong> </strong><strong>AND EXCHANGECOMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">Form <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentType" id="ixv-9434">10-Q</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>For</strong><strong> </strong><strong>the</strong><strong> </strong><strong>Quarterly</strong><strong> </strong><strong>Period</strong><strong> </strong><strong>ended</strong><strong> </strong><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen" id="ixv-9435">March 31, 2025</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="ixv-9436">&#9746;</ix:nonNumeric>&#160;&#160;&#160;&#160; Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="ixv-9437">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160; Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Commission</strong><strong> </strong><strong>file</strong><strong> </strong><strong>No.</strong><strong> </strong><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityFileNumber" id="ixv-9438">000-27866</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_10qimg24.jpg" alt="scwo_10qimg24.jpg"/></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityRegistrantName" id="ixv-9439">374WATER INC.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Exact name of Registrant as specified in its charter)</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="ixv-9440">Delaware</ix:nonNumeric> </strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityTaxIdentificationNumber" id="ixv-9441">88-0271109</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(State or other jurisdiction of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>incorporation or organization)</strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(IRS</strong><strong> Employer</strong><strong> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Identification</strong><strong> </strong><strong>No.)</strong></p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressAddressLine1" id="ixv-9442">100 Southcenter Court</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressAddressLine2" id="ixv-9443">Suite 200</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline"><strong><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressCityOrTown" id="ixv-9444">Morrisville</ix:nonNumeric>, <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="ixv-9445">North Carolina</ix:nonNumeric> <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityAddressPostalZipCode" id="ixv-9446">27560</ix:nonNumeric></strong>&#160;</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Address</strong><strong> </strong><strong>of</strong><strong> </strong><strong>principal</strong><strong> </strong><strong>executive</strong><strong> offices)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:CityAreaCode" id="ixv-9447">440</ix:nonNumeric>-<ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:LocalPhoneNumber" id="ixv-9448">601-9677</ix:nonNumeric></span></strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(Registrant&#8217;s</strong><strong> </strong><strong>telephone number</strong><strong> </strong><strong>including</strong><strong> </strong><strong>area</strong><strong> </strong><strong>code)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Title of each class</p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Trading Symbol(s)</p></td><td style="width:5%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.7pt; text-align:center;">Name of each exchange on which registered</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:Security12bTitle" id="ixv-9449">Common Stock, par value $0.0001</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.45pt; text-align:center;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:TradingSymbol" id="ixv-9450">SCWO</ix:nonNumeric></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 21.9pt; text-align:center;">The <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="ixv-9451">Nasdaq</ix:nonNumeric> Capital Market LLC</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityCurrentReportingStatus" id="ixv-9452">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160; &#9744; No</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &#9746; <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityInteractiveDataCurrent" id="ixv-9453">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#9744; No</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:20%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Large accelerated filer</p></td><td style="width:20%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="width:30%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accelerated filer</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9746;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="ixv-9454">Non-accelerated Filer</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="ixv-9455">&#9746;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Smaller reporting company</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="ixv-9456">&#9744;</ix:nonNumeric></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Emerging Growth Company</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 4.65pt">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <ix:nonNumeric contextRef="From2025-01-01to2025-03-31" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="ixv-9457">&#9744;</ix:nonNumeric> Yes&#160;&#160;&#160;&#160; &#9746; No</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">State the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date: At May 15, 2025, the issuer had <ix:nonFraction contextRef="AsOf2025-05-15" name="dei:EntityCommonStockSharesOutstanding" format="ixt:numdotdecimal" unitRef="Shares" decimals="INF" id="ixv-9458">144,682,963</ix:nonFraction> shares of common stock outstanding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="INDEX"><strong>Index</strong><strong> </strong><strong>to</strong><strong> </strong><strong>Form</strong><strong> </strong><strong>10-Q</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Page </strong></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#P1"><strong>PART</strong><strong> </strong><strong>I</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#P1"><strong>FINANCIAL</strong><strong> </strong><strong>INFORMATION</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#I1"><strong>Item</strong><strong> </strong><strong>1</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#I1"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong><strong> </strong><strong>(Unaudited</strong><strong>)</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>4</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#BS"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Balance</strong><strong> </strong><strong>Sheets</strong><strong> </strong><strong>at</strong><strong> </strong><strong>March</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2025</strong><strong> </strong><strong>(Unaudited)</strong><strong> </strong><strong>and</strong><strong> </strong><strong>December</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2024</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>4</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#OP"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Statements</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Operations</strong><strong> </strong><strong>for the</strong><strong> </strong><strong>three months</strong><strong> </strong><strong>ended</strong><strong> </strong><strong>March</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2025</strong><strong> </strong><strong>and</strong><strong> </strong><strong>2024</strong><strong> </strong><strong>(Unaudited</strong><strong>)</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>5</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.25pt"><a href="#EQ"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Statements</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Changes</strong><strong> </strong><strong>in</strong><strong> </strong><strong>Stockholders&#8217;</strong><strong> </strong><strong>Equity</strong><strong> </strong><strong>for</strong><strong> </strong><strong>the</strong><strong> </strong><strong>three</strong><strong> </strong><strong>months</strong><strong> </strong><strong>ended March</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2025</strong><strong> </strong><strong>and</strong><strong> </strong><strong>2024 </strong><strong>(Unaudited</strong><strong>)</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>6</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#CF"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Statements</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Cash</strong><strong> </strong><strong>Flows</strong><strong> </strong><strong>for the</strong><strong> </strong><strong>three months</strong><strong> </strong><strong>ended</strong><strong> </strong><strong>March</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2025</strong><strong> </strong><strong>and</strong><strong> </strong><strong>2024</strong><strong> </strong><strong>(Unaudited</strong><strong>)</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>7</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#NOTE"><strong>Notes</strong><strong> </strong><strong>to</strong><strong> </strong><strong>Unaudited</strong><strong> </strong><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>8</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#I2"><strong>Item</strong><strong> </strong><strong>2</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#I2"><strong>Management&#8217;s</strong><strong> </strong><strong>Discussion</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Analysis</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Condition</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Results</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Operations</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>23</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#I3"><strong>Item</strong><strong> </strong><strong>3</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#I3"><strong>Quantitative</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Qualitative</strong><strong> </strong><strong>Disclosures</strong><strong> </strong><strong>about</strong><strong> </strong><strong>Market</strong><strong> </strong><strong>Risk</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>24</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#I4"><strong>Item</strong><strong> </strong><strong>4</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#I4"><strong>Controls</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Procedures</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>25</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#P2"><strong>PART</strong><strong> </strong><strong>I</strong><strong>I</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#P2"><strong>OTHER</strong><strong> </strong><strong>INFORMATION</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT1"><strong>Item</strong><strong> </strong><strong>1</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT1"><strong>Legal</strong><strong> </strong><strong>Proceedings</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>27</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT1a"><strong>Item</strong><strong> </strong><strong>1A</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT1a"><strong>Risk</strong><strong> </strong><strong>Factors</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>27</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT2"><strong>Item</strong><strong> </strong><strong>2</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT2"><strong>Unregistered</strong><strong> </strong><strong>Sales</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Equity</strong><strong> </strong><strong>Securities</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Use</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Proceeds</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>46</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT3"><strong>Item</strong><strong> </strong><strong>3</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT3"><strong>Defaults</strong><strong> </strong><strong>upon</strong><strong> </strong><strong>Senior</strong><strong> </strong><strong>Securities</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>46</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT4"><strong>Item</strong><strong> </strong><strong>4</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT4"><strong>Mine</strong><strong> </strong><strong>Safety</strong><strong> </strong><strong>Disclosures</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>46</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT5"><strong>Item</strong><strong> </strong><strong>5</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><a href="#IT5"><strong>Other</strong><strong> Information</strong></a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>27</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="#IT6"><strong>Item</strong><strong> </strong><strong>6</strong><strong>.</strong></a></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0.15pt"><strong><a href="#IT6">Exhibits</a></strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>47</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><a href="#SIG">SIGNATURES</a></strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>48</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Cautionary Note Regarding Forward-Looking Information</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Quarterly Report on Form 10-Q (the &#8220;Form 10-Q&#8221;) contains certain statements related to future results of 374 Water, Inc. (the &#8220;Company&#8221;) that are considered &#8220;forward-looking statements'' within the meaning of the Private Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within the Company&#8217;s market; equity and fixed income market fluctuation; technological changes; changes in law; changes in fiscal, monetary, regulatory, and tax policies; monetary fluctuations as well as other risks and uncertainties detailed elsewhere in this Form 10-Q or from time-to-time in the filings of the Company with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;"><span class="atag" style="display: inline" id="P1"><strong>PART</strong><strong> </strong><strong>I</strong><strong> </strong><strong>FINANCIAL</strong><strong> </strong><strong>INFORMATION</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;"><span class="atag" style="display: inline" id="I1"><strong>Item</strong><strong> </strong><strong>1.</strong><strong> </strong><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;">&#160;</p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;"><span style="text-decoration:underline"><strong>374Water</strong><strong> </strong><strong>Inc.</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Subsidiaries</strong></span></p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 23pt; text-align:center;"><span style="text-decoration:underline"><span id="BS" class="atag" style="display:inline"><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Balance</strong><strong> </strong><strong>Sheets</strong></span></span></p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 19.7pt; text-align:center;"><span style="text-decoration:underline"><strong>March</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2025</strong><strong> </strong><strong>(Unaudited)</strong><strong> </strong><strong>and</strong><strong> </strong><strong>December</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2024</strong></span></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 10.15pt; text-align:center;"><strong>March&#160;</strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 9.9pt; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 7pt"><strong>December&#160;</strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 3.4pt"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Cash&#160;and cash equivalents</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1012" contextRef="AsOf2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,883,845</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1013" contextRef="AsOf2024-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,651,644</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accounts&#160;receivable, net&#160;of&#160;allowance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1014" contextRef="AsOf2025-03-31" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">94,103</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1015" contextRef="AsOf2024-12-31" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">269,733</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Unbilled&#160;accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1016" contextRef="AsOf2025-03-31" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,163,417</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1017" contextRef="AsOf2024-12-31" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,653,007</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other accounts&#160;receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1018" contextRef="AsOf2025-03-31" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">29,246</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1019" contextRef="AsOf2024-12-31" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">43,886</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Inventory, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1020" contextRef="AsOf2025-03-31" name="us-gaap:InventoryNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,876,554</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1021" contextRef="AsOf2024-12-31" name="us-gaap:InventoryNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,701,474</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Contract assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1022" contextRef="AsOf2025-03-31" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">197,043</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1023" contextRef="AsOf2024-12-31" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">136,651</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Prepaid&#160;expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1024" contextRef="AsOf2025-03-31" name="us-gaap:PrepaidExpenseCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">338,315</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1025" contextRef="AsOf2024-12-31" name="us-gaap:PrepaidExpenseCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">431,412</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Total Current Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1026" contextRef="AsOf2025-03-31" name="us-gaap:AssetsCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,582,523</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1027" contextRef="AsOf2024-12-31" name="us-gaap:AssetsCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,887,807</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-Term Assets:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Property, and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1028" contextRef="AsOf2025-03-31" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,719,232</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1029" contextRef="AsOf2024-12-31" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,567,571</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Intangible asset, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1030" contextRef="AsOf2025-03-31" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">998,251</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1031" contextRef="AsOf2024-12-31" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,016,594</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Right-of-use asset, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1032" contextRef="AsOf2025-03-31" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:numdotdecimal" unitRef="USD" decimals="0">662,310</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1033" contextRef="AsOf2024-12-31" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:numdotdecimal" unitRef="USD" decimals="0">691,014</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1034" contextRef="AsOf2025-03-31" name="us-gaap:OtherAssets" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,847</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1035" contextRef="AsOf2024-12-31" name="us-gaap:OtherAssets" format="ixt:numdotdecimal" unitRef="USD" decimals="0">20,847</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Total </strong><strong>Long-Term </strong><strong>Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1036" contextRef="AsOf2025-03-31" name="us-gaap:AssetsNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,395,640</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1037" contextRef="AsOf2024-12-31" name="us-gaap:AssetsNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,296,026</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total </strong><strong>Assets</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1038" contextRef="AsOf2025-03-31" name="us-gaap:Assets" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,978,163</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1039" contextRef="AsOf2024-12-31" name="us-gaap:Assets" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,183,833</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Liabilities </strong><strong>and </strong><strong>Stockholders&#8217; </strong><strong>Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Current Liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1042" contextRef="AsOf2025-03-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">819,528</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1043" contextRef="AsOf2024-12-31" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">906,394</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accrued bonuses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1044" contextRef="AsOf2025-03-31" name="us-gaap:AccruedBonusesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">380,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1045" contextRef="AsOf2024-12-31" name="us-gaap:AccruedBonusesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">570,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accrued contract loss provision</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1046" contextRef="AsOf2025-03-31" name="us-gaap:ProvisionForLossOnContracts" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1047" contextRef="AsOf2024-12-31" name="us-gaap:ProvisionForLossOnContracts" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Accrued legal settlement</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1048" contextRef="AsOf2025-03-31" name="us-gaap:SettlementLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">335,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1049" contextRef="AsOf2024-12-31" name="us-gaap:SettlementLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">335,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1050" contextRef="AsOf2025-03-31" name="us-gaap:DeferredRevenueCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">170,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1051" contextRef="AsOf2024-12-31" name="us-gaap:DeferredRevenueCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">197,683</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Operating lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1052" contextRef="AsOf2025-03-31" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">105,697</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1053" contextRef="AsOf2024-12-31" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">101,320</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Other liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1054" contextRef="AsOf2025-03-31" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">37,998</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1055" contextRef="AsOf2024-12-31" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">17,279</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Total </strong><strong>Current </strong><strong>Liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1056" contextRef="AsOf2025-03-31" name="us-gaap:LiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,848,223</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1057" contextRef="AsOf2024-12-31" name="us-gaap:LiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,127,676</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Long-Term Liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Unearned revenue, less current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1058" contextRef="AsOf2025-03-31" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1059" contextRef="AsOf2024-12-31" name="us-gaap:DeferredRevenueNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Operating lease liability, less current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1060" contextRef="AsOf2025-03-31" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">523,210</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1061" contextRef="AsOf2024-12-31" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">551,376</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"><strong>Total Long-Term Liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>553,210</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>581,376</strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total </strong><strong>Liabilities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1064" contextRef="AsOf2025-03-31" name="us-gaap:Liabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,401,433</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1065" contextRef="AsOf2024-12-31" name="us-gaap:Liabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,709,052</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Commitments and contingencies (Note 9)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stockholders&#8217; </strong><strong>Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock: <ix:nonFraction id="fid_363" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">50,000,000</ix:nonFraction> shares authorized, par value $<ix:nonFraction id="fid_91" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, nil issued and outstanding&#160;at March 31, 2025 and December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1068" contextRef="AsOf2025-03-31" name="us-gaap:PreferredStockValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1069" contextRef="AsOf2024-12-31" name="us-gaap:PreferredStockValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Common stock: <ix:nonFraction id="fid_71" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockSharesAuthorized" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000,000</ix:nonFraction> authorized, par value $<ix:nonFraction id="fid_73" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.0001</ix:nonFraction> per share, <ix:nonFraction id="fid_76" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockSharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">144,682,963</ix:nonFraction> and <ix:nonFraction id="fid_75" contextRef="AsOf2024-12-31" name="us-gaap:CommonStockSharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">144,301,977</ix:nonFraction> shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1070" contextRef="AsOf2025-03-31" name="us-gaap:CommonStockValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,467</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1071" contextRef="AsOf2024-12-31" name="us-gaap:CommonStockValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,429</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Additional paid-in capital</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonFraction id="fid_1072" contextRef="AsOf2025-03-31" name="us-gaap:AdditionalPaidInCapital" format="ixt:numdotdecimal" unitRef="USD" decimals="0">44,645,824</ix:nonFraction></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1073" contextRef="AsOf2024-12-31" name="us-gaap:AdditionalPaidInCapital" format="ixt:numdotdecimal" unitRef="USD" decimals="0">43,845,499</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accumulated deficit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(<ix:nonFraction id="fid_1074" contextRef="AsOf2025-03-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">32,086,032</ix:nonFraction></p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1075" contextRef="AsOf2024-12-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">28,387,618</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accumulated other comprehensive income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1076" contextRef="AsOf2025-03-31" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1077" contextRef="AsOf2024-12-31" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total </strong><strong>Stockholders&#8217; </strong><strong>Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1078" contextRef="AsOf2025-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,576,730</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1079" contextRef="AsOf2024-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,781</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total </strong><strong>Liabilities </strong><strong>and </strong><strong>Stockholders&#8217; </strong><strong>Equity</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1080" contextRef="AsOf2025-03-31" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,978,163</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1081" contextRef="AsOf2024-12-31" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,183,833</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">374Water</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Inc.</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Subsidiaries</span><span style="text-decoration:underline"> </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="OP"><span style="text-decoration:underline">Condensed </span><span style="text-decoration:underline">Consolidated Statements of Operations</span> </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">For</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">the</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Three</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Months</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Ended</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">March</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">31,</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">2025</span><span style="text-decoration:underline"> and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">2024</span> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(Unaudited</span>)</strong>&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three months ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1082" contextRef="From2025-01-01to2025-03-31" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">543,100</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1083" contextRef="From2024-01-01to2024-03-31" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">315,278</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1084" contextRef="From2025-01-01to2025-03-31" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:numdotdecimal" unitRef="USD" decimals="0">404,817</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1085" contextRef="From2024-01-01to2024-03-31" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:numdotdecimal" unitRef="USD" decimals="0">617,298</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Gross margin (deficit)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1086" contextRef="From2025-01-01to2025-03-31" name="us-gaap:GrossProfit" format="ixt:numdotdecimal" unitRef="USD" decimals="0">138,283</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1087" contextRef="From2024-01-01to2024-03-31" name="us-gaap:GrossProfit" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">302,020</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Operating Expenses</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1089" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">533,587</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1090" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">535,147</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Compensation and related expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1091" contextRef="From2025-01-01to2025-03-31" name="us-gaap:LaborAndRelatedExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,675,865</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1092" contextRef="From2024-01-01to2024-03-31" name="us-gaap:LaborAndRelatedExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">790,190</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1093" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ProfessionalFees" format="ixt:numdotdecimal" unitRef="USD" decimals="0">771,901</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1094" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ProfessionalFees" format="ixt:numdotdecimal" unitRef="USD" decimals="0">252,705</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1095" contextRef="From2025-01-01to2025-03-31" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">942,440</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1096" contextRef="From2024-01-01to2024-03-31" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">321,141</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total Operating Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1097" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,923,793</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1098" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OperatingExpenses" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,899,183</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Loss from Operations</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1099" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,785,510</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1100" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OperatingIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,201,203</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Other Income</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Interest income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1102" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InterestIncomeOther" format="ixt:numdotdecimal" unitRef="USD" decimals="0">89,710</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1103" contextRef="From2024-01-01to2024-03-31" name="us-gaap:InterestIncomeOther" format="ixt:numdotdecimal" unitRef="USD" decimals="0">104,620</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other income (expense)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1104" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,614</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1105" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">72,118</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Total Other Income, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1106" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NonoperatingIncomeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">87,096</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1107" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NonoperatingIncomeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">176,738</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Loss before Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1108" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1109" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,024,465</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Provision for Income Taxes</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1110" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1111" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Loss</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1112" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1113" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,024,465</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Loss per Share - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1114" contextRef="From2025-01-01to2025-03-31" name="us-gaap:EarningsPerShareDiluted" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.03</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1115" contextRef="From2024-01-01to2024-03-31" name="us-gaap:EarningsPerShareDiluted" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF" sign="-">0.02</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted Average Common Shares Outstanding - Basic and Diluted</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1116" contextRef="From2025-01-01to2025-03-31" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">144,607,438</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1117" contextRef="From2024-01-01to2024-03-31" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">132,668,777</ix:nonFraction></strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">374Water</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Inc.</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Subsidiaries</span><span style="text-decoration:underline"> </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="EQ"><span style="text-decoration:underline">Condensed</span><span style="text-decoration:underline">Consolidated</span><span style="text-decoration:underline">Changes</span><span style="text-decoration:underline">in</span><span style="text-decoration:underline">Stockholders&#8217;</span><span style="text-decoration:underline">Equity</span> </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">For the Three Months Ended March 31, 2025 </span><span style="text-decoration:underline">and 2024</span> </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">(Unaudited</span>)</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="33" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>For the Three Months Ended March 31, 2025</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="14" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Preferred Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Other</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid&#160;in</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Deficit</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Comprehensive</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Income</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders&#8217;</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balances, December 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1185" contextRef="AsOf2024-12-31_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1184" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">144,301,977</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1186" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,429</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1187" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">43,845,499</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1188" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">28,387,618</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1189" contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1190" contextRef="AsOf2024-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">15,474,781</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of shares of common stock for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1193" contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1192" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">180,986</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1194" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" unitRef="USD" decimals="0">18</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1195" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,882</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1196" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1197" contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1198" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,900</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accretion of stock-based compensation &#8211; options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1199" contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1200" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1201" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:numdotdecimal" unitRef="USD" decimals="0">460,512</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1202" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1203" contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1204" contextRef="From2025-01-01to2025-03-31" name="scwo:AccretionOfStockBasedCompensationOptionsAmount" format="ixt:numdotdecimal" unitRef="USD" decimals="0">460,512</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accretion of stock-based compensation &#8211; restricted stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1205" contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1206" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1207" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:numdotdecimal" unitRef="USD" decimals="0">248,951</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1208" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1209" contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1210" contextRef="From2025-01-01to2025-03-31" name="scwo:AccretionOfStockBasedCompensationRestrictedStockAmount" format="ixt:numdotdecimal" unitRef="USD" decimals="0">248,951</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of shares of common stock for option exercise</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1213" contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1212" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1214" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:numdotdecimal" unitRef="USD" decimals="0">20</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1215" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:numdotdecimal" unitRef="USD" decimals="0">23,980</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1216" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1217" contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1218" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1219" contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1220" contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1221" contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1222" contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1223" contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1224" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balances, March 31, 2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1227" contextRef="AsOf2025-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1226" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">144,682,963</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1228" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,467</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1229" contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">44,645,824</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1230" contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">32,086,032</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1231" contextRef="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1232" contextRef="AsOf2025-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,576,730</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160;&#160; </p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="16" style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">For the Three Months Ended March 31, 2024</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="10" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="14" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Preferred Stock </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Common Stock </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Additional</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Other</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:6%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong><strong>Shares</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Paid</strong><strong> </strong><strong>in</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Capital</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Accumulated</strong><strong> Deficit </strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Comprehensive</strong> <strong>Income</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:6%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stockholders</strong><strong>&#8217; </strong><strong>Equity</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balances,</strong><strong> </strong><strong>December</strong><strong> </strong><strong>31,</strong><strong> </strong><strong>2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1235" contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1234" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">132,667,107</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1236" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">13,266</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1237" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,684,943</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1238" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">15,953,504</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1239" contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1240" contextRef="AsOf2023-12-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">14,747,176</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issuance of shares for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1243" contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1242" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,339</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1244" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1245" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1246" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1247" contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1248" contextRef="From2024-01-01to2024-03-31" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1249" contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1250" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1251" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,200</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1252" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1253" contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1254" contextRef="From2024-01-01to2024-03-31" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,200</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1255" contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1256" contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1257" contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1258" contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,024,465</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1259" contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:NetIncomeLoss" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:6%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1260" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,024,465</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balances, March 31, 2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1263" contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember" name="us-gaap:StockholdersEquity" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1262" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" name="us-gaap:SharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">132,670,446</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1264" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">13,266</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1265" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,872,643</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1266" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">17,977,969</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1267" contextRef="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,471</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:6%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1268" contextRef="AsOf2024-03-31" name="us-gaap:StockholdersEquity" format="ixt:numdotdecimal" unitRef="USD" decimals="0">12,910,411</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="3" style="width:6%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="5" style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td colspan="33" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 91.55pt; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline"><strong>374Water</strong><strong>Inc. </strong><strong>and </strong><strong>Subsidiaries</strong></span></p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="CF"><span style="text-decoration:underline"><strong>Condensed </strong><strong>Consolidated </strong><strong>Statements </strong><strong>of </strong><strong>Cash </strong><strong>Flows</strong></span></span></p></td></tr><tr style="height:15px"><td colspan="9" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline"><strong>For the Three </strong><strong>Months </strong><strong>Ended </strong><strong>March </strong><strong>31, </strong><strong>2025 </strong><strong>and </strong><strong>2024</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span style="text-decoration:underline"><strong>(Unaudited</strong><strong>)</strong></span></p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cash Flows from Operating Activities</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1118" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1119" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,024,465</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Adjustments to reconcile net loss to net cash used in operating activities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Depreciation and amortization expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1121" contextRef="From2025-01-01to2025-03-31" name="us-gaap:DepreciationAndAmortization" format="ixt:numdotdecimal" unitRef="USD" decimals="0">164,004</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1122" contextRef="From2024-01-01to2024-03-31" name="us-gaap:DepreciationAndAmortization" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,560</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Non-cash lease expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1123" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OtherNoncashExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">28,704</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1124" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OtherNoncashExpense" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Issuance of common stock for services</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1125" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,900</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1126" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,500</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Stock-based compensation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1127" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">709,463</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1128" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,200</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Increase in inventory reserve</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1129" contextRef="From2025-01-01to2025-03-31" name="scwo:InventoryReserveIncreased" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1130" contextRef="From2024-01-01to2024-03-31" name="scwo:InventoryReserveIncreased" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Changes in operating assets and liabilities:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1132" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">175,630</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1133" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,532</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Unbilled accounts receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1134" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInUnbilledReceivables" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">14,640</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1135" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInUnbilledReceivables" format="ixt:numdotdecimal" unitRef="USD" decimals="0">277,056</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other receivables</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1136" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:numdotdecimal" unitRef="USD" decimals="0">510,410</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1137" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">5,588</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Inventory</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1138" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:numdotdecimal" unitRef="USD" decimals="0">175,080</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1139" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:numdotdecimal" unitRef="USD" decimals="0">374,981</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Contract assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1140" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:numdotdecimal" unitRef="USD" decimals="0">60,392</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1141" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Prepaid expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1142" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">93,097</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1143" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInPrepaidExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">340,280</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1144" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">5,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1145" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accounts payable and accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1146" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">86,866</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1147" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,424</ix:nonFraction> </td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accrued bonus</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1148" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">190,000</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1149" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Accrued contract loss provision</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1150" contextRef="From2025-01-01to2025-03-31" name="scwo:IncreaseDecreaseInProvisionForLossOnContracts" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1151" contextRef="From2024-01-01to2024-03-31" name="scwo:IncreaseDecreaseInProvisionForLossOnContracts" format="ixt:numdotdecimal" unitRef="USD" decimals="0">100,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1152" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">27,683</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1153" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,768</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Other liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1154" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0">20,719</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1155" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">26,379</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Operating lease liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1156" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">23,789</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1157" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Cash Used In Operating Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1158" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,494,477</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1159" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,508,653</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cash Flows from Investing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Purchases of property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1161" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:numdotdecimal" unitRef="USD" decimals="0">297,322</ix:nonFraction> </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1162" contextRef="From2024-01-01to2024-03-31" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Increase in intangible assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1163" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1164" contextRef="From2024-01-01to2024-03-31" name="us-gaap:PaymentsToAcquireIntangibleAssets" format="ixt:numdotdecimal" unitRef="USD" decimals="0">590</ix:nonFraction> </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Cash Used In Investing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1165" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">297,322</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1166" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">590</ix:nonFraction> </strong></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Cash Flows from Financing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Proceeds from the exercise of stock options</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1168" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1169" contextRef="From2024-01-01to2024-03-31" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Cash Provided by Financing Activities</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1170" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1171" contextRef="From2024-01-01to2024-03-31" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net Decrease in Cash and Cash Equivalents</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1172" contextRef="From2025-01-01to2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,767,799</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><strong>(<ix:nonFraction id="fid_1173" contextRef="From2024-01-01to2024-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">2,509,243</ix:nonFraction> </strong></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents, Beginning of the Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1174" contextRef="AsOf2024-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,651,644</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1175" contextRef="AsOf2023-12-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">10,445,404</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash and cash equivalents, End of the Period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1176" contextRef="AsOf2025-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">6,883,845</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1177" contextRef="AsOf2024-03-31" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:numdotdecimal" unitRef="USD" decimals="0">7,936,161</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>SUPPLEMENTAL CASHFLOW DISCLOSURES:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1179" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InterestPaidNet" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1180" contextRef="From2024-01-01to2024-03-31" name="us-gaap:InterestPaidNet" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash paid for taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1181" contextRef="From2025-01-01to2025-03-31" name="us-gaap:IncomeTaxesPaidNet" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1182" contextRef="From2024-01-01to2024-03-31" name="us-gaap:IncomeTaxesPaidNet" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="text-decoration:underline">374Water</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Inc.</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Subsidiaries</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><span class="atag" style="display: inline" id="NOTE"><strong>Notes</strong><strong> </strong><strong>to</strong><strong> </strong><strong>Unaudited</strong><strong> </strong><strong>Condensed</strong><strong> </strong><strong>Consolidated</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><ix:nonNumeric id="fid_366" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note</strong><strong> </strong><strong>1</strong><strong> </strong><strong>&#8211;</strong><strong> </strong><strong>Nature</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Business</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Presentation</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Description of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">the</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Company</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water Inc. (the &#8220;Company&#8221;, &#8220;374Water&#8221;, &#8220;We&#8221;, or &#8220;Our&#8221;) is a global industrial technology and services company providing innovative solutions addressing global organic waste destruction/treatment and waste management issues within the Municipal, Federal, and Industrial markets.&#160; 374Water offers our proprietary AirSCWO system, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy.&#160; Importantly, our AirSCWO system eliminates recalcitrant organic wastes without creating waste byproducts. Our AirSCWO system effectively converts solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., &#8220;per-and polyfluoroalkyl substances&#8221; or &#8220;PFAS&#8221;) into recoverable resources including water, minerals, and heat energy, by focusing on waste as a valuable resource.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In the first quarter of fiscal year 2025, 374Water continued to build on the strategic plan implemented in 2024.&#160; &#160; During the first quarter, we continued to execute our plan towards reaching critical business milestones. Our first quarter 2025 achievements to date include (i) continuing ruggedizing and optimizing our AirSCWO system to effectively and continuously process a variety of organic waste streams; (ii) preparing our first commercial scale AirSCWO system at the City of Orlando for the Iron Bridge Water Reclamation Facility bio-sludge test; (iii) completing various federal&#160; waste destruction demonstrations; (iv) secured a waste destruction services contract for aqueous film forming firefighting form (&#8220;AFFF&#8221;) with the University of North Carolina at Chapel Hill Collaboratory; and (v) strengthening our leadership team and organization.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Presentation</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Financial</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial information. It is management&#8217;s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2024 filed with the SEC on March 28, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, currently inactive, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_367" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="cont_66b175"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_394" contextRef="From2025-01-01to2025-03-31" name="us-gaap:UseOfEstimates" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of inventory reserve, equity-based compensation, revenue recognition, and accrued loss provisions on onerous contracts, useful lives of long-lived assets, and valuation allowance against deferred tax assets.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_66b175" continuedAt="cont_251299"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Receivables</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_377" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ReceivablesPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Accounts</em><em> </em><em>Receivable, Net </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivable consist of balances due from equipment and service revenues. The Company monitors accounts receivable and provides allowances when considered necessary based on historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future economic conditions to form adjustments to historical loss patterns. At March 31, 2025 and December 31, 2024, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant at March 31, 2025 and December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Unbilled Accounts Receivable</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Unbilled accounts receivable consist of balances due from&#160;revenues earned but not yet billed related to one customer contract for an equipment sale and one customer contract for a full-scale demonstration completed in January 2025.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Inventory, Net</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_379" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InventoryPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress. Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question. We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used, we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required. Once inventory has been written down, it creates a new cost basis for inventory. Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $<ix:nonFraction id="fid_1301" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InventoryRecallExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction> at both March 31, 2025 and December 31, 2024.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">9</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_251299" continuedAt="cont_36f10b"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Property</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Equipmen</span>t</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_380" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and the estimated useful life of the asset. Expenses for maintenance and repairs are charged to expense as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt">The following table presents property and equipment at March 31, 2025 and December 31, 2024:</span></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_396" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1288" contextRef="AsOf2025-03-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,977</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1283" contextRef="AsOf2024-12-31_us-gaap_ComputerEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,977</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1287" contextRef="AsOf2025-03-31_us-gaap_OfficeEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">578,352</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1286" contextRef="AsOf2024-12-31_us-gaap_OfficeEquipmentMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">366,400</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment &#8211; Demo System</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1291" contextRef="AsOf2025-03-31_scwo_EquipmentDemoSystemMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,356,041</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1290" contextRef="AsOf2024-12-31_scwo_EquipmentDemoSystemMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,298,666</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1285" contextRef="AsOf2025-03-31_us-gaap_VehiclesMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">87,300</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1284" contextRef="AsOf2024-12-31_us-gaap_VehiclesMember" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">59,306</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1278" contextRef="AsOf2025-03-31" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,041,670</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1289" contextRef="AsOf2024-12-31" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,744,349</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1280" contextRef="AsOf2025-03-31" name="us-gaap:RealEstateAccumulatedDepreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">322,438</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1279" contextRef="AsOf2024-12-31" name="us-gaap:RealEstateAccumulatedDepreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">176,778</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1282" contextRef="AsOf2025-03-31" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,719,232</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1281" contextRef="AsOf2024-12-31" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,567,571</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We completed the manufacturing and fabrication of one of our AirSCWO systems that we will be using for full-scale wastewater treatment demonstration purposes (&#8220;Demo System&#8221;). We have capitalized the material and labor costs incurred to develop this Demo System, and had previously classified these costs within inventory. In the first quarter of 2024, we executed a contract with the City of Orlando, Florida to deploy&#160;the Demo System as part of a full-scale demonstration. We began the set up and commissioning process of this Demo System in the third quarter of 2024 which was completed in October 2024.&#160; We began depreciating the Demo System over an estimated life of five years during the last calendar quarter of 2024.&#160; We expect to continue to develop and enhance this unit as we perform our demonstrations and continue progressing towards commercialization. Upgrades and enhancements that will improve the operational efficiency of the unit itself will be capitalized. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense for the three months ended March 31, 2025 and 2024 was $<ix:nonFraction id="fid_1305" contextRef="From2025-01-01to2025-03-31" name="us-gaap:Depreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">145,661</ix:nonFraction> and $<ix:nonFraction id="fid_1304" contextRef="From2024-01-01to2024-12-31" name="us-gaap:Depreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">156,002</ix:nonFraction>, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense is presented as follows on the unaudited condensed consolidated statement of operations:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.1pt; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_415" contextRef="From2025-01-01to2025-03-31" name="scwo:ScheduleOfDepreciationExpenseTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1293" contextRef="From2025-01-01to2025-03-31" name="scwo:CostOfRevenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">40,327</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1292" contextRef="From2024-01-01to2024-03-31" name="scwo:CostOfRevenues" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1295" contextRef="From2025-01-01to2025-03-31" name="scwo:GeneralAndAdministrative" format="ixt:numdotdecimal" unitRef="USD" decimals="0">105,334</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1294" contextRef="From2024-01-01to2024-03-31" name="scwo:GeneralAndAdministrative" format="ixt:numdotdecimal" unitRef="USD" decimals="0">156,002</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total depreciation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1296" contextRef="From2025-01-01to2025-03-31" name="us-gaap:Depreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">145,661</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1297" contextRef="From2024-01-01to2024-03-31" name="us-gaap:Depreciation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">156,002</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">10</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_36f10b" continuedAt="cont_52aa31"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentrations</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Credit</span><span style="text-decoration:underline"> Risk</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_384" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company&#8217;s revenues, purchases, accounts receivable and accounts payable. Two customers made up approximately <ix:nonFraction id="fid_1312" contextRef="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_scwo_RevenueMember" name="scwo:ConcentrationsOfCreditRisk" unitRef="Pure" decimals="INF" scale="-2">94</ix:nonFraction>% of total revenues for the three months ended March 31, 2025 and one customer made up&#160;<ix:nonFraction id="fid_1314" contextRef="From2024-01-01to2024-03-31_scwo_OneCustomerMember_scwo_RevenueMember" name="scwo:ConcentrationsOfCreditRisk" unitRef="Pure" decimals="INF" scale="-2">94</ix:nonFraction>% of total revenues for the three months ended March 31, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers comprised <ix:nonFraction id="fid_1306" contextRef="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_us-gaap_AccountsReceivableMember" name="scwo:ConcentrationsOfCreditRisk" unitRef="Pure" decimals="INF" scale="-2">91</ix:nonFraction>% and three customers accounted for <ix:nonFraction id="fid_1315" contextRef="From2024-01-01to2024-12-31_scwo_ThreeCustomerMember_us-gaap_AccountsReceivableMember" name="scwo:ConcentrationsOfCreditRisk" unitRef="Pure" decimals="INF" scale="-2">89</ix:nonFraction>% of our outstanding accounts receivable, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers and one customer comprised our unbilled receivables. These customers comprise the majority of our revenue. The loss of a significant customer could adversely affect the results of our operations. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (&#8220;Merrell Bros.&#8221;) (see Note 7).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 8 for a license agreement we have with Duke University for the SCWO technology used in our systems.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_385" contextRef="From2025-01-01to2025-03-31" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="cont_fd7c2e"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the revenue standards of Codification (ASC) Topic 606: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of full-scale demonstrations and treatability studies. In the case of equipment revenues, the Company&#8217;s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Services revenues related to treatability studies are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In late 2024, we deployed our Demo System to the City of Orlando&#8217;s Iron Bridge Regional Water Reclamation Facility pursuant to a contract executed in March 2024 as part of a full-scale demonstration (the &#8220;Demo Contract&#8221;). Pursuant to the Demo Contract, the Company is responsible for system design, installation, commissioning and the start-up of the AirSCWO unit at the facility. Further, the Company will operate and maintain the AirSCWO unit for a period of approximately three months and is required to treat no less than 193 metric tons of wastewater during the three month period. Lastly, the Company will decommission, disassemble and demobilize the AirSCWO unit after the contract period. The Company will receive $<ix:nonFraction id="fid_1316" contextRef="From2025-01-01to2025-03-31" name="scwo:RevenueReceiveAsConsideration" format="ixt:numdotdecimal" unitRef="USD" decimals="0">812,000</ix:nonFraction> as consideration for the full-scale demonstration. </p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">11</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_fd7c2e"><ix:continuation id="cont_52aa31" continuedAt="cont_c51982"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASC 606-10-25-21, we have concluded that the Demo Contract includes one performance obligation the full-scale demonstration. The system design, site preparation, installation, commissioning and decommissioning represent fulfillment activities versus separate performance obligations. At March 31, 2025 and December 31, 2024, we have accounted for such costs as contract costs under ASC 340-40 (see below). We will recognize revenue on this Demo Contract over the three-month period of operations and maintenance which is the point in time that the City of Orlando receives the benefit simultaneously to the Company&#8217;s performance, which will commence in 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We&#160;plan to&#160;invoice the City of Orlando in accordance with the contract terms. Invoices are due within thirty days of receipt. At March 31, 2025, we have invoiced and collected $<ix:nonFraction id="fid_1317" contextRef="AsOf2025-03-31" name="us-gaap:UnearnedPremiums" format="ixt:numdotdecimal" unitRef="USD" decimals="0">170,000</ix:nonFraction> which is included in unearned revenue. The City of Orlando has the right to cancel the Demo Contract for convenience with a twenty-day written notice but is responsible for paying the Company all amounts owed and outstanding for work performed prior to the effective termination date and costs and expenses incurred by the Company to uninstall, remove, relocate and deliver the AirSCWO&#160;system up to a limit of&#160;$<ix:nonFraction id="fid_1318" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OperatingCostsAndExpenses" format="ixt:numdotdecimal" unitRef="USD" decimals="0">68,000</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we completed a full-scale demonstration for another customer. The contract with this customer included three performance obligations: i) treatability studies, ii) full-scale demonstration and iii) a technical report summarizing the results of the full-scale demonstration.&#160; We have allocated the transaction price of approximately $<ix:nonFraction id="fid_1319" contextRef="From2025-01-01to2025-03-31" name="scwo:AllocatedTransactionPriceDuringCustomerContract" format="ixt:numdotdecimal" unitRef="USD" decimals="0">498,000</ix:nonFraction> among the performance obligations using stand-alone selling price (&#8220;SASP&#8221;) for the treatability study, cost-plus-margin for the technical report and the residual approach in the case of the full-scale demonstration. Under the residual approach, the stand-alone selling price is estimated after subtracting the sum of the observable SASP allocated to the other performance obligations within the contract. We do not have a history of selling full-scale demonstrations and a technical report separately to our customers. &#160;At March 31, 2025, the delivery of the technical report is the only remaining performance obligation which approximately $<ix:nonFraction id="fid_1320" contextRef="AsOf2025-03-31" name="scwo:DuringCustomerContractRemainingPerformanceObligation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">72,000</ix:nonFraction> of the contract transaction price has been allocated. We anticipate this performance obligation to be completed in the second quarter of 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we recognized as revenue approximately $<ix:nonFraction id="fid_1311" contextRef="From2025-01-01to2025-03-31_scwo_TreatabilityStudyServicesMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">25,000</ix:nonFraction> and $<ix:nonFraction id="fid_1310" contextRef="From2025-01-01to2025-03-31_scwo_FullScaleDemonstrationMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">376,000</ix:nonFraction> for the completion of a treatability study and the full-scale demonstration, respectively. We have not yet billed for the full-scale demonstration and therefore, our unbilled receivables include the $<ix:nonFraction id="fid_1321" contextRef="AsOf2025-03-31_scwo_FullScaleDemonstrationMember" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">376,000</ix:nonFraction> at March 31, 2025.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred. At March 31, 2025, we have capitalized an aggregate of $<ix:nonFraction id="fid_1322" contextRef="AsOf2025-03-31" name="us-gaap:CapitalizedContractCostNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">197,043</ix:nonFraction> of costs incurred to date related to the following: <ix:nonNumeric id="fid_1323" contextRef="From2025-01-01to2025-03-31" name="scwo:DescriptionOfCapitalizedCost">(i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025</ix:nonNumeric>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, contract costs were comprised of the $<ix:nonFraction id="fid_1324" contextRef="From2025-01-01to2025-03-31" name="scwo:ContractCostsOnDemoContract" format="ixt:numdotdecimal" unitRef="USD" decimals="0">136,651</ix:nonFraction>&#160;fulfillment related activities for the Demo Contract with the City of Orlando.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See further revenue related disclosures in Note 5.</p></ix:continuation></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">&#160;</span></p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">12</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_c51982" continuedAt="cont_513ad3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Accrued</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Contract</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Loss</span><span style="text-decoration:underline"> Provision and Onerous Contracts</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_386" contextRef="From2025-01-01to2025-03-31" name="scwo:AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. U.S. GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition&#8212;Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a total accrued loss provision of $<ix:nonFraction id="fid_1303" contextRef="From2025-01-01to2025-03-31" name="us-gaap:LossContingencyAccrualProvision" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,000,000</ix:nonFraction> at March 31, 2025 and December 31, 2024, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets.&#160; Any changes to the estimated loss provision are reflected within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Development</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_391" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $<ix:nonFraction id="fid_1307" contextRef="From2025-01-01to2025-03-31" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">533,587</ix:nonFraction> and $<ix:nonFraction id="fid_1313" contextRef="From2024-01-01to2024-03-31" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">535,147</ix:nonFraction> for the three months ended March 31, 2025 and 2024, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Loss</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Per</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_392" contextRef="From2025-01-01to2025-03-31" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss per share is computed in accordance with ASC Topic 260, &#8220;Earnings per Share.&#8221; Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2025 and 2024 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive. At March 31, 2025 and March 31, 2024, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for <ix:nonFraction id="fid_1308" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">16,409,062</ix:nonFraction> and <ix:nonFraction id="fid_1326" contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">10,740,250</ix:nonFraction> shares of common stock, <ix:nonFraction id="fid_1309" contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,675,244</ix:nonFraction> and <ix:nonFraction id="fid_1327" contextRef="From2024-01-01to2024-03-31_scwo_WarrantsMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,235,000</ix:nonFraction>&#160;&#160;of outstanding common stock warrants and unvested restricted stock units of <ix:nonFraction id="fid_1328" contextRef="From2025-01-01to2025-03-31_scwo_UnvestedRestrictedStockMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">5,931,576</ix:nonFraction> and <ix:nonFraction id="fid_1329" contextRef="From2024-01-01to2024-03-31_scwo_UnvestedRestrictedStockMember" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">0</ix:nonFraction>, respectively.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Reclassifications</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_1277" contextRef="From2025-01-01to2025-03-31" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have made certain reclassifications to prior period amounts presented on our consolidated statements of operations to conform to the current period presentation with no impact to net loss or loss per share. These reclassifications consisted of reclassifying $<ix:nonFraction id="fid_1486" contextRef="From2025-01-01to2025-03-31" name="scwo:OtherStockBasedCompensation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">138,586</ix:nonFraction> of stock-based compensation expense from general and administrative expenses to compensation and related expenses. </p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">13</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_513ad3"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Recent </span><span style="text-decoration:underline">Accounting</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Pronouncements</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">-</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Not</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Yet</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Adopted</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_395" contextRef="From2025-01-01to2025-03-31" name="scwo:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): </em><em>Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Effective January 1, 2025, we adopted ASU 2023-09 on a prospective basis. The adoption of ASU 2023-09 did not &#160;have a material impact on these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU 2024-03,&#160;<em>Disaggregation of Income Statement Expenses (&#8220;<strong>DISE</strong>&#8221;)</em>. In November 2024, the FASB issued a new accounting standard to improve the disclosures about an entity&#8217;s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_368" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3 &#8211; Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASU No. 2014-15 <em>Presentation of Financial Statements &#8211; Going Concern</em> (subtopic 205-40), the Company&#8217;s management evaluates whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. At March 31, 2025, the Company had working capital of $<ix:nonFraction id="fid_1333" contextRef="AsOf2025-03-31" name="us-gaap:Capital" format="ixt:numdotdecimal" unitRef="USD" decimals="0">8,734,300</ix:nonFraction> and an accumulated deficit of $<ix:nonFraction id="fid_1330" contextRef="AsOf2025-03-31" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">32,086,032</ix:nonFraction>. For the three months ended March 31, 2025, the Company incurred a net loss of $<ix:nonFraction id="fid_1331" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetIncomeLoss" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">3,698,414</ix:nonFraction> and used $<ix:nonFraction id="fid_1332" contextRef="From2025-01-01to2025-03-31" name="us-gaap:NetCashProvidedByUsedInContinuingOperations" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,494,477</ix:nonFraction> of net cash in operations for the period. These conditions raise substantial doubt regarding our ability to continue as a going concern.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Presently, the Company will need additional debt or equity financing or a combination of both to continue its operations and meet its financial obligations for at least the next twelve months from the date these unaudited condensed interim consolidated financial statements were issued and beyond. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. We expect to incur continuing losses and negative cash flows from operations for the foreseeable future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $<ix:nonFraction id="fid_1335" contextRef="AsOf2025-03-31_scwo_ATMMember" name="us-gaap:CommonStockSharesIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="-6" scale="6">100</ix:nonFraction>&#160;million of common stock, subject to applicable law. &#160; At March 31, 2025,&#160;approximately $<ix:nonFraction id="fid_1334" contextRef="From2025-01-01to2025-03-31" name="scwo:ProceedFromAtTheMarketOffering" format="ixt:numdotdecimal" unitRef="USD" decimals="0">86,154,000</ix:nonFraction> remains available to be sold in the Company&#8217;s at-the-market offerings, subject to various limitations. During the three months ended March 31, 2025 and 2024, we did not use the ATM to raise capital. &#160;The Company is evaluating strategies to obtain the required additional funding for future operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2024, we closed on an offering of shares of common stock and common stock warrants resulting in net proceeds of approximately $<ix:nonFraction id="fid_1336" contextRef="From2024-01-01to2024-12-31" name="scwo:ProceedsFromCommonStockAndWarrantsShares" format="ixt:numdotdecimal" unitRef="USD" decimals="0">11,393,000</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any additional debt or equity financing that the Company obtains may substantially dilute the ownership held by our existing stockholders. The economic dilution to our shareholders will be significant if our stock price does not materially increase, or if the effective price of any sale is below the price paid by a particular investor. The Company may be unable to access further equity or debt financing when needed or obtain additional financing under acceptable terms, if at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may decide to raise additional capital through a variety of sources in the short-term and in the long-term, including but not limited to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the public equity markets;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">private equity financings;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">collaborative arrangements;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">asset sales; and/or</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">public or private debt.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If the Company is unable to raise additional capital, there is a risk that the Company could be required to discontinue or significantly reduce the scope of its operations. These unaudited condensed interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">14</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_369" contextRef="From2025-01-01to2025-03-31" name="us-gaap:InventoryDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4 &#8211; Inventory, Net</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory, net consists of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_397" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1338" contextRef="AsOf2025-03-31" name="us-gaap:InventoryRawMaterials" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,926,554</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1337" contextRef="AsOf2024-12-31" name="us-gaap:InventoryRawMaterials" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,751,474</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work-in-process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1340" contextRef="AsOf2025-03-31" name="us-gaap:InventoryWorkInProcess" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1339" contextRef="AsOf2024-12-31" name="us-gaap:InventoryWorkInProcess" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: inventory reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1342" contextRef="AsOf2025-03-31" name="us-gaap:InventoryValuationReserves" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1341" contextRef="AsOf2024-12-31" name="us-gaap:InventoryValuationReserves" format="ixt:numdotdecimal" unitRef="USD" decimals="0">50,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1344" contextRef="AsOf2025-03-31" name="us-gaap:InventoryNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,876,554</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1343" contextRef="AsOf2024-12-31" name="us-gaap:InventoryNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,701,474</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">15</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_371" contextRef="From2025-01-01to2025-03-31" name="scwo:RevenueDisclosureTextBlock" escape="true" continuedAt="cont_e654c0"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5 &#8211; Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our revenues by type for the three months ended March 31, 2025 and March 31, 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_400" contextRef="From2025-01-01to2025-03-31" name="scwo:ScheduleOfRevenueByTypeTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1348" contextRef="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">134,410</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1352" contextRef="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember" name="scwo:RevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">25</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1347" contextRef="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">296,096</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1351" contextRef="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember" name="scwo:RevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">94</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1350" contextRef="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">408,690</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1354" contextRef="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember" name="scwo:RevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">75</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1349" contextRef="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">19,182</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1353" contextRef="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember" name="scwo:RevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">6</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1346" contextRef="From2025-01-01to2025-03-31" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">543,100</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1355" contextRef="From2025-01-01to2025-03-31" name="scwo:PremiumsRevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">100</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1345" contextRef="From2024-01-01to2024-03-31" name="us-gaap:Revenues" format="ixt:numdotdecimal" unitRef="USD" decimals="0">315,278</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1356" contextRef="From2024-01-01to2024-03-31" name="scwo:PremiumsRevenuePercentage" unitRef="Pure" decimals="INF" scale="-2">100</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned</strong><strong> </strong><strong>Revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unearned revenue activity for the three months ended March 31, 2025 and year ended December 31, 2024:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><ix:nonNumeric id="fid_401" contextRef="From2025-01-01to2025-03-31" name="scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance </strong><strong>at </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unearned revenue at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1358" contextRef="AsOf2024-12-31" name="scwo:UnearnedRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">227,683</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1357" contextRef="AsOf2023-12-31" name="scwo:UnearnedRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">130,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Billings deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1360" contextRef="From2025-01-01to2025-03-31" name="scwo:BillingsDeferredUnearnedRevenue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1359" contextRef="From2024-01-01to2024-12-31" name="scwo:BillingsDeferredUnearnedRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">197,683</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Refundable deposit returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1366" contextRef="From2025-01-01to2025-03-31" name="scwo:RefundableDepositReturned" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1365" contextRef="From2024-01-01to2024-12-31" name="scwo:RefundableDepositReturned" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">100,000</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recognition of prior unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1362" contextRef="From2025-01-01to2025-03-31" name="us-gaap:RecognitionOfDeferredRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">27,683</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1361" contextRef="From2024-01-01to2024-12-31" name="us-gaap:RecognitionOfDeferredRevenue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned revenue at end of period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1363" contextRef="AsOf2025-03-31" name="scwo:UnearnedRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">200,000</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1364" contextRef="AsOf2024-12-31" name="scwo:UnearnedRevenue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">227,683</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025 , we anticipate recognizing approximately $<ix:nonFraction id="fid_1376" contextRef="AsOf2025-03-31_scwo_TwentyTwentyFiveMember" name="us-gaap:LiabilitiesCurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">170,000</ix:nonFraction> of the unearned revenue in 2025 which has been presented as a current liability at March 31, 2025.&#160; The remaining balance of $<ix:nonFraction id="fid_1375" contextRef="AsOf2025-03-31_scwo_TwentyTwentyFiveMember" name="us-gaap:LiabilitiesNoncurrent" format="ixt:numdotdecimal" unitRef="USD" decimals="0">30,000</ix:nonFraction>&#160;has been classified as a long-term liability as the timing of revenue recognition is unknown.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">16</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_e654c0"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Unbilled Accounts Receivable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unbilled accounts receivable activity for the three months ended March 31, 2025 and the year ended December 31, 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_402" contextRef="From2025-01-01to2025-03-31" name="scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unbilled accounts receivable at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1368" contextRef="AsOf2024-12-31" name="us-gaap:AccountsReceivableNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,653,007</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1367" contextRef="AsOf2023-12-31" name="us-gaap:AccountsReceivableNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,494,553</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services performed but not yet billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1370" contextRef="From2025-01-01to2025-03-31" name="scwo:ServicesPerformedButUnbilled" format="ixt:numdotdecimal" unitRef="USD" decimals="0">510,410</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1369" contextRef="From2024-01-01to2024-12-31" name="scwo:ServicesPerformedButUnbilled" format="ixt:numdotdecimal" unitRef="USD" decimals="0">217,666</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1372" contextRef="From2025-01-01to2025-03-31" name="scwo:ServicesBilled" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1371" contextRef="From2024-01-01to2024-12-31" name="scwo:ServicesBilled" format="ixt:numdotdecimal" unitRef="USD" decimals="0" sign="-">59,212</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unbilled accounts receivable at end of the period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1373" contextRef="AsOf2025-03-31" name="us-gaap:AccountsReceivableNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,163,417</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong><ix:nonFraction id="fid_1374" contextRef="AsOf2024-12-31" name="us-gaap:AccountsReceivableNet" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,653,007</ix:nonFraction></strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to contractual terms with our customers, we anticipate billing the unbilled accounts receivable during our 2025 fiscal year. </p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_372" contextRef="From2025-01-01to2025-03-31" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="cont_e0cd9f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Issuance of Stock for Services</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we issued <ix:nonFraction id="fid_1430" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">180,986</ix:nonFraction> fully vested shares of common stock to service providers with a fair value of $<ix:nonFraction id="fid_1438" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember" name="us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" format="ixt:numdotdecimal" unitRef="USD" decimals="0">66,900</ix:nonFraction> based on the market price of our common stock on date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, we issued <ix:nonFraction id="fid_1453" contextRef="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,339</ix:nonFraction> fully vested shares of common stock to a service provider with a fair value of $<ix:nonFraction id="fid_1452" contextRef="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember" name="us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" format="ixt:numdotdecimal" unitRef="USD" decimals="0">4,500</ix:nonFraction> based on the market price of our common stock on date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock for Stock Option Exercises</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we issued an aggregate of <ix:nonFraction id="fid_1444" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000</ix:nonFraction> shares of common stock for stock option exercises that resulted in cash proceeds of $<ix:nonFraction id="fid_1445" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember" name="us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction>.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">17</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_e0cd9f" continuedAt="cont_8990b0"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock-based</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2021 Plan</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has reserved <ix:nonFraction id="fid_1447" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="scwo:IssuanceOfShares" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">24,000,000</ix:nonFraction> shares of common stock or common stock equivalents to be issued under our 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) to the Company&#8217;s employees and non-employee services providers. &#160;At March 31, 2025, the Company has issued a total of&#160;&#160;<ix:nonFraction id="fid_1446" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">18,114,133</ix:nonFraction> stock options and restricted stock units under the 2021 Plan with&#160;<ix:nonFraction id="fid_1463" contextRef="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="scwo:CommonSharesForIssuanceRemaining" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">5,885,867</ix:nonFraction>&#160;reserved shares remaining for issuance.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, and 2024, the Company recorded stock-based compensation of $<ix:nonFraction id="fid_1464" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">460,512</ix:nonFraction> and $<ix:nonFraction id="fid_1465" contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ShareBasedCompensation" format="ixt:numdotdecimal" unitRef="USD" decimals="0">183,200</ix:nonFraction>, respectively, related to granted options to employees and various consultants expected to vest. During the three months ended March 31, 2025, $<ix:nonFraction id="fid_1466" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">428,678</ix:nonFraction> was charged as&#160;compensation and related expenses and $<ix:nonFraction id="fid_1467" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">31,834</ix:nonFraction> as research and development expenses in the accompanying unaudited condensed consolidated statements of operations. During the three months ended March 31, 2024, $<ix:nonFraction id="fid_1468" contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">138,586</ix:nonFraction> was charged as&#160;compensation and&#160;related expenses and $<ix:nonFraction id="fid_1469" contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">44,614</ix:nonFraction> as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stock</strong><strong> </strong><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock option activity for the three months ended March 31, 2025 is summarized as follows:&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_403" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"/><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>December 31, </strong><strong>2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1379" contextRef="AsOf2024-12-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">15,843,116</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1377" contextRef="AsOf2024-12-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.94</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1395" contextRef="AsOf2024-12-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,324,000</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1391" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">5.95</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1378" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">908,659</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1384" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.66</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1380" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000</ix:nonFraction></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1385" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.12</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1394" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(<ix:nonFraction id="fid_1381" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">142,713</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1387" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">2.96</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1382" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">16,409,062</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1386" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.92</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1389" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,274,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1392" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" format="ixt-sec:duryear">5.98</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>Exercisable </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1383" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">8,150,185</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1388" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.60</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1390" contextRef="AsOf2025-03-31_scwo_OptionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:numdotdecimal" unitRef="USD" decimals="0">1,274,000</ix:nonFraction></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1393" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear">2.74</ix:nonNumeric></td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">*At March 31, 2025 and December 31, 2024, the options outstanding and exercisable include 5,700,00 and <ix:nonFraction id="fid_1471" contextRef="AsOf2024-12-31_scwo_TwoZeroTwoOnePlanMember" name="scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">5,900,000</ix:nonFraction> granted in connection with a merger that occurred in 2021, respectively, which were not granted under the 2021 Plan &#160;and include <ix:nonFraction id="fid_1472" contextRef="From2024-01-01to2024-12-31_scwo_TwoZeroTwoOnePlanMember" name="scwo:OptionsGranted" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">275,000</ix:nonFraction> of options granted in 2024 pursuant to a legal settlement and were not granted under the 2021 Plan. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, the options granted were primarily to our Chief Financial Officer and key employees. The weighted average grant-date fair value of the granted options was $<ix:nonFraction id="fid_1454" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember" name="scwo:AverageGrantDateFairValue" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.33</ix:nonFraction>.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Of the total&#160;options outstanding at March 31, 2025,&#160;<ix:nonFraction id="fid_1455" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember" name="scwo:NumberOfOptionIncludePerformanceConditions" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,708,288</ix:nonFraction>&#160;of the options include performance conditions. The performance-based options vest as follows:&#160;<ix:nonFraction id="fid_1456" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentTargetMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="Pure" decimals="INF" scale="-2">50</ix:nonFraction>% vest upon the achievement of operating profit, as defined in the employment agreements, and&#160;<ix:nonFraction id="fid_1457" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="Pure" decimals="INF" scale="-2">50</ix:nonFraction>% upon the achievement of a revenue target of $<ix:nonFraction id="fid_1458" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" name="scwo:RevenueTarget" format="ixt:numdotdecimal" unitRef="USD" decimals="-6" scale="6">100</ix:nonFraction>&#160;million by the end of fiscal year 2028. The performance-based options with the revenue target begin vesting once the Company achieves $<ix:nonFraction id="fid_1459" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" name="scwo:AchiveRevenueTarget" format="ixt:numdotdecimal" unitRef="USD" decimals="-6" scale="6">15</ix:nonFraction>&#160;million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of options that vest is based on the proportionate percentage of each fiscal year&#8217;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20&#160;million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, total unrecognized compensation expense for service based and performance-based options was $<ix:nonFraction id="fid_1462" contextRef="AsOf2025-03-31" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" unitRef="USD" decimals="0">3,315,257</ix:nonFraction>&#160;and $<ix:nonFraction id="fid_1450" contextRef="AsOf2025-03-31_scwo_PerformanceBasedOptionMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,821,770</ix:nonFraction>, respectively. The unrecognized service-based expense will be recognized over a weighted-average period of&#160;<ix:nonNumeric id="fid_1461" contextRef="From2025-01-01to2025-03-31_scwo_ServiceBasedOptionsMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear">2.89</ix:nonNumeric>&#160;years. The unrecognized expense associated with the performance-based options will be expensed when it becomes probable that the performance obligations will be met.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, intrinsic value is computed based on the difference between options exercise price and the market price of our common stock at March 31, 2025 of $<ix:nonFraction id="fid_1494" contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember" name="scwo:MarketPriceAndExercisePriceDifference" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.34</ix:nonFraction> per share multiplied by the total common stock options outstanding or exercisable whose market price exceeds the exercise price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, <ix:nonFraction id="fid_1473" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="scwo:StockOptionsIssued" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">200,000</ix:nonFraction> stock options issued outside of the 2021 Plan were exercised with an exercise price of $<ix:nonFraction id="fid_1448" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:StockOptionExercisePriceIncrease" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.12</ix:nonFraction> for total proceeds to the Company of $<ix:nonFraction id="fid_1449" contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:numdotdecimal" unitRef="USD" decimals="0">24,000</ix:nonFraction>.</p></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">18</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_8990b0" continuedAt="cont_97148f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_404" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1400" contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="Pure" decimals="INF" scale="-2">67.81</ix:nonFraction> &#8211; <ix:nonFraction id="fid_1401" contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="Pure" decimals="INF" scale="-2">69.25</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1398" contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="Pure" decimals="INF" scale="-2">26.36</ix:nonFraction> &#8211; <ix:nonFraction id="fid_1399" contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="Pure" decimals="INF" scale="-2">26.38</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term (years)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1407" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">6.25</ix:nonNumeric> Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="fid_1406" contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear">6.25</ix:nonNumeric> Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free rate</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1404" contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="Pure" decimals="INF" scale="-2">4.14</ix:nonFraction> - <ix:nonFraction id="fid_1405" contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="Pure" decimals="INF" scale="-2">4.51</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1402" contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="Pure" decimals="INF" scale="-2">4.09</ix:nonFraction> &#8211; <ix:nonFraction id="fid_1403" contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="Pure" decimals="INF" scale="-2">4.31</ix:nonFraction>%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1397" contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2">0.00</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"/><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td/><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonFraction id="fid_1396" contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="Pure" decimals="INF" scale="-2">0.00</ix:nonFraction>%</p></td><td style="width:1%;white-space: nowrap;"/></tr></tbody></table></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Restricted Stock Units</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, the Company granted an aggregate of&#160;<ix:nonFraction id="fid_1433" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,382,284</ix:nonFraction>&#160;unvested restricted stock units under the 2021 Plan as follows:&#160;<ix:nonFraction id="fid_1431" contextRef="From2025-01-01to2025-03-31_scwo_FinancialOfficerMember" name="scwo:OptionsGranted" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">617,284</ix:nonFraction> to&#160;our Chief Financial Officer (&#8220;CFO&#8221;) pursuant to an employment agreement and <ix:nonFraction id="fid_1432" contextRef="From2025-01-01to2025-03-31_scwo_keyEmployeeMember" name="scwo:OptionsGranted" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,765,000</ix:nonFraction>&#160;to non-executive key employees of the Company. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The unvested restricted stock units granted to our CFO consist of&#160;<ix:nonFraction id="fid_1439" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">308,642</ix:nonFraction> units with time-based vesting provisions and&#160;<ix:nonFraction id="fid_1440" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="scwo:PerformanceBasedRestrictedStockUnits" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">308,642</ix:nonFraction> units with performance-based vesting provisions. <ix:nonNumeric id="fid_1441" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="scwo:PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription">The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year&#8217;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027. The 1,765,000 restricted stock units granted to non-executive key employees are all time-based vesting and vest as follows: 50% on the one-year grant-date anniversary with the remaining vesting ratably over a period of thirty-six months</ix:nonNumeric>. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The grant-date fair value of the restricted stock units was determined using the market price of our common stock on the date of grant which ranged from $<ix:nonFraction id="fid_1436" contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_BottomMember" name="scwo:GrantDateFairValueOfRestrictedStock" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.62</ix:nonFraction>&#160;to $<ix:nonFraction id="fid_1437" contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_TopMember" name="scwo:GrantDateFairValueOfRestrictedStock" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.63</ix:nonFraction>.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A summary of our outstanding nonvested restricted stock units is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_414" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1408" contextRef="AsOf2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">3,549,292</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1412" contextRef="AsOf2024-12-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.23</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1409" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">2,382,284</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1410" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.62</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, end of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1411" contextRef="AsOf2025-03-31" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">5,931,576</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1413" contextRef="AsOf2025-03-31" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.98</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">19</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:continuation id="cont_97148f"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, we have $<ix:nonFraction id="fid_1435" contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,524,952</ix:nonFraction> of unrecognized stock-based compensation associated with the restricted stock units with a performance condition which will be recognized when the performance conditions are probable of being met. At March 31, 2025, the Company had $<ix:nonFraction id="fid_1434" contextRef="AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:numdotdecimal" unitRef="USD" decimals="0">2,749,402</ix:nonFraction>&#160;of unrecognized stock-based compensation associated with the time vesting restricted stock units which will be recognized over a weighted-average period of approximately&#160;<ix:nonNumeric id="fid_1442" contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember" name="scwo:VestingRestrictedStockUnitsRecognizedPeriod" format="ixt-sec:duryear">3.43</ix:nonNumeric>&#160;years. During the three months ended March 31, 2025, our stock based compensation associated with the time-based restricted stock units totaled $<ix:nonFraction id="fid_1474" contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">248,951</ix:nonFraction>, of which $<ix:nonFraction id="fid_1487" contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember" name="scwo:OtherLaborAndRelatedExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">216,982</ix:nonFraction> was charged as compensation and related expenses, and $<ix:nonFraction id="fid_1488" contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember" name="us-gaap:OtherResearchAndDevelopmentExpense" format="ixt:numdotdecimal" unitRef="USD" decimals="0">31,969</ix:nonFraction> as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock</strong><strong> Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, there were <ix:nonFraction id="fid_1476" contextRef="AsOf2025-03-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,675,244</ix:nonFraction> warrants outstanding which relate to and offering completed in November 2024, where investors were offered one and a half warrants for every one common share purchased in the offering at an exercise price of $<ix:nonFraction id="fid_1475" contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember" name="us-gaap:StockOptionExercisePriceIncrease" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.125</ix:nonFraction> per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025 and 2024, no warrants were issued or exercised. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A summary of warrant activity for the three months &#160;ended &#160;March 31, 2025, is as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><ix:nonNumeric id="fid_405" contextRef="From2025-01-01to2025-03-31" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exercise</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Intrinsic</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Contractual</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1414" contextRef="AsOf2024-12-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,675,244</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1422" contextRef="AsOf2024-12-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.13</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1423" contextRef="AsOf2024-12-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1416" contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear">4.88</ix:nonNumeric></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1419" contextRef="AsOf2025-03-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">14,675,244</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1418" contextRef="AsOf2025-03-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">1.13</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonFraction id="fid_1417" contextRef="AsOf2025-03-31_scwo_WarrantsMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:zerodash" unitRef="USD" decimals="0">-</ix:nonFraction></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><ix:nonNumeric id="fid_1415" contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember" name="scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" format="ixt-sec:duryear">4.63</ix:nonNumeric></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table></ix:nonNumeric></ix:continuation><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">20</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_373" contextRef="From2025-01-01to2025-03-31" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 7, 2021, we entered into a manufacturing and services agreement (the &#8220;M&amp;S Agreement&#8221;) to fabricate and manufacture the AirSCWO systems with Merrell Bros. Fabrication, LLC (&#8220;Merrell Bros.&#8221;). As part of the agreement, the Company appointed Terry Merrell, one of the owners of Merrell Bros., to its board of directors. On December 18, 2024, Mr. Merrell notified the Company of his intention to resign from the Company's Board of Directors effective December 31, 2024, to allow him to focus more on his core business responsibilities at Merrell Bros. &#160;The M&amp;S Agreement terminated on its original expiration date of July 7, 2024.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 27, 2024, we executed a supplemental manufacturing and services agreement (the &#8220;Supplemental M&amp;S Agreement&#8221;) with Merrell Bros. as Merrell Bros. indicated to us their intent to not renew the Original M&amp;S Agreement and we indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations (see Note 9). The Supplemental M&amp;S Agreement became effective on July 7, 2024 and replaced the Original M&amp;S Agreement. Under the Supplemental M&amp;S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders. The term of the Supplemental M&amp;S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension. Either party may terminate this Supplement M&amp;S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.&#160;The Supplemental M&amp;S Agreement terminated during the year ended December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025 and 2024, the Company incurred $<ix:nonFraction id="fid_1479" contextRef="From2025-01-01to2025-03-31_scwo_AirSCWOMember" name="scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" format="ixt:numdotdecimal" unitRef="USD" decimals="0">0</ix:nonFraction> and $<ix:nonFraction id="fid_1478" contextRef="From2024-01-01to2024-03-31_scwo_AirSCWOMember" name="scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" format="ixt:numdotdecimal" unitRef="USD" decimals="0">130,321</ix:nonFraction>, respectively,&#160;in related party expenses related to the manufacturing of our AirSCWO systems.&#160;At March 31, 2025 and December 31, 2024, we did not have any outstanding obligations owed to Merrell Bros. for these services. </p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">21</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_374" contextRef="From2025-01-01to2025-03-31" name="us-gaap:CommitmentsDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note</strong><strong> </strong><strong>8</strong><strong> </strong><strong>&#8211;</strong><strong> </strong><strong>Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>License Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. At March 31, 2025, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; written notice.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Legal Settlement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 4, 2024, our former Chief Executive Officer and Chairman of the Board filed a complaint against the Company alleging unpaid wages and a bonus. Management and the board of directors, in consultation with its attorneys, have estimated a potential loss associated with this complaint of approximately $<ix:nonFraction id="fid_1480" contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember" name="scwo:PotentialLossesAssociatedWithComplaints" format="ixt:numdotdecimal" unitRef="USD" decimals="0">335,000</ix:nonFraction>.&#160; At December 31, 2024, we established an accrual for legal settlement of this amount as presented on the consolidated balance sheet.&#160; This legal matter was officially settled on April 2, 2025 for the amount accrued. We have agreed to pay $<ix:nonFraction id="fid_1481" contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember" name="scwo:PaymentOfLegalSettlementAmount" format="ixt:numdotdecimal" unitRef="USD" decimals="0">110,000</ix:nonFraction> of the settlement within ten calendar days of certain conditions being met by the plaintiff, as defined in the settlement agreement, with the remaining settlement being paid in equal statements through December 31, 2025. As of the date of this filling, we have paid the agreed upon $<ix:nonFraction id="fid_1498" contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember" name="us-gaap:PaymentsForLegalSettlements" format="ixt:numdotdecimal" unitRef="USD" decimals="0">110,000</ix:nonFraction> as all plaintiff conditions were met.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable. We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above. However, there is inherent uncertainty regarding such matters.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_407" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9 - &#160;&#160;Segment Reporting</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly provided to the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s Chief Executive Officer, Chief Operating Officer and Chief Financial Officer comprise the Company&#8217;s CODMs. The CODMs review financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.&#160; The CODMs use consolidated net income (loss) to assess performance, evaluate cost optimization, and allocate resources, including personnel-related and financial or capital resources, in the annual budget and forecasting process, as well as budget-to-actual variances on a monthly basis. As such, the Company has determined that it operates as&#160;one&#160;operating and reportable segment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The significant expenses regularly reviewed by the CODMs are consistent with those reported on the Company's unaudited condensed consolidated statement of operations and expenses are not regularly reviewed on a more disaggregated basis for assessing segment performance and deciding how to allocate resources. The CODMs do not regularly review total assets for our single reportable segment as total assets are not used to assess performance or allocate resources.</p></ix:nonNumeric><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><ix:nonNumeric id="fid_375" contextRef="From2025-01-01to2025-03-31" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;<strong>Note 10 - Subsequent Events </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 13, 2025, the Company appointed Stephen Jones to the Company&#8217;s Board of Directors, effective April 14, 2025. Mr. Jones, age 63, is being appointed to the Board of Directors to fill the vacancy on the Board of Directors. From March 2015 through October 2020, Mr. Jones was President, Chief Executive Officer and a director of Covanta Holding Corporation (formerly NYSE: CVA, now owned by private equity) (&#8220;Covanta&#8221;), a leading global provider of sustainable waste and energy solutions. Prior to joining Covanta in January 2015, Mr. Jones was employed from 1992 through September 2014 by Air Products and Chemicals, Inc. (&#8220;Air Products&#8221;), a global supplier of industrial gases and equipment. Mr. Jones held a variety of senior-level management positions at Air Products including in the company&#8217;s tonnage gases, equipment, energy and industrial chemicals businesses, culminating with his role as Air Products&#8217; China president based at the company&#8217;s office in Shanghai. Mr. Jones is a director of Tronox Holdings plc, an industrial and chemical company (NYSE: TROX), and chairman of the board of directors of Badger Infrastructure Solutions Ltd., a Canadian infrastructure solutions company specializing in nondestructive excavation services (TSE: BDGI). Mr. Jones also serves as a special advisor to the supervisory board of Hitachi Zosen Inova AG, a global cleantech company. Prior to joining Air Products in 1992, Mr. Jones practiced corporate law at Dechert LLP in Philadelphia, PA, primarily in the area of mergers and acquisitions.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Pursuant to an employment agreement executed with our Chief Technology Officer on March 31, 2025, our board of directors approved the following equity compensation grant under our 2021 Plan on April 30, 2025: </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><ix:nonFraction id="fid_1483" contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember" name="scwo:ShareBasedRestrictedStockUnitsGranted" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,515,152</ix:nonFraction> restricted stock units and <ix:nonFraction id="fid_1482" contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:numdotdecimal" unitRef="Shares" decimals="0">1,515,152</ix:nonFraction> stock options vesting as follows: <ix:nonNumeric id="fid_1484" contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember" name="scwo:DescriptionOfBoardOfDirectorsEquityCompensation">(a) with respect to 757,576 restricted stock and 757,576 shares subject to stock options, 25% vest on the first anniversary of the CTO&#8217;s employment agreement, and the remaining 75% vest in equal increments on the last day of every month thereafter over the following 36 months, subject to the CTO&#8217;s continued employment with the Company on each vesting date: and (b) with respect to the remaining 757,576 restricted stock and 757,576 stock options, each vest in accordance with a performance based milestone set forth by the Company and defined in the CTO&#8217;s employment agreement. See Note 6 for further disclosures on the performance-related milestones</ix:nonNumeric>. The stock options have an exercise price of $<ix:nonFraction id="fid_1485" contextRef="AsOf2025-04-30_us-gaap_SubsequentEventMember" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" format="ixt:numdotdecimal" unitRef="USDPShares" decimals="INF">0.33</ix:nonFraction> and a ten-year contractual term. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></ix:nonNumeric><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">22</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="I2">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#160;&#160;&#160;</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Forward Looking Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be &#8220;forward-looking statements&#8221; that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;project&#8221; and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 2024 Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 28, 2025 (the &#8220;2024 Form 10-K&#8221;), or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward- looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Critical Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In preparing the condensed consolidated financial statements, we have made estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenues, costs, and expenses, and the disclosure of contingent assets and liabilities as in our condensed consolidated financial statements. Actual results may differ from these estimates. A summary of our critical accounting estimates and policies is included in our 2024 Form 10-K under "Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations." During the three months ended March 31, 2025, there have been no significant changes to these estimates and policies previously disclosed in our 2024 Form 10-K. For disclosure regarding recent accounting pronouncements and the anticipated impact they will have on our operations, please refer to Note 2 of the unaudited condensed consolidated financial statements included in this Form 10-Q.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Overview</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water Inc. (the &#8220;Company&#8221;, &#8220;374Water&#8221;, &#8220;We&#8221;, or &#8220;Our&#8221;) is a global industrial technology and services company providing innovative solutions addressing global organic waste destruction/treatment and waste management issues within the Municipal, Federal, and Industrial markets.&#160; 374Water offers our proprietary AirSCWO system, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy.&#160; Importantly, our AirSCWO system eliminates recalcitrant organic wastes without creating waste byproducts. Our AirSCWO system effectively converts solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., &#8220;per-and polyfluoroalkyl substances&#8221; or &#8220;PFAS&#8221;) into recoverable resources including water, minerals, and heat energy, by focusing on waste as a valuable resource.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the first quarter of fiscal year 2025, 374Water continued to build on the strategic plan implemented in 2024.&#160; &#160; During the first quarter, we continued to execute our plan towards reaching critical business milestones. Our first quarter 2025 achievements to date include (i) continuing ruggedizing and optimizing our AirSCWO system to effectively and continuously process a variety of organic waste streams; (ii) preparing our first commercial scale AirSCWO system at the City of Orlando for the Iron Bridge Water Reclamation Facility bio-sludge test; (iii) completing various federal&#160; waste destruction demonstrations; (iv) secured a waste destruction services contract for aqueous film forming firefighting form (&#8220;AFFF&#8221;) with the University of North Carolina at Chapel Hill Collaboratory; and (v) strengthening our leadership team and organization.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water has a robust plan to scale revenue, operations, and capitalize our business. During 2025, we expected to complete our commercial-scale demonstration under our contract with the City of Orlando; mobilize an AS system to Detroit, MI in partnership with the Defense Innovation Unit to demonstrate AirSCWO&#8217;s waste destruction effectiveness for specific U.S. Department of Defense applications; deploy an AirSCWO system to the Orange County Sanitation District (&#8220;OC San&#8221;) in Fountain Valley, CA; further scale our manufacturing capacity to meet client demand for AirSCWO systems of various sizes; continue to improve our AirSCWO technology; and begin accepting third party waste streams for our initial Waste Destruction Services (&#8220;WDS&#8221;) hub(s) at partner Treatment, Storage, and Disposal Facilities (&#8220;TSDF&#8221;).</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">23</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Results of Operations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table sets forth, for the periods presented, the consolidated statements of operations data, which is derived from the accompanying unaudited condensed consolidated financial statements:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Three Months Ended March 31, 2025, as Compared to the Three Months Ended March 31, 2024</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="14"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Three Months Ended March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>$ Change</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>% Change</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">543,100</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">315,278</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">227,822</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">404,817</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">617,298</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(212,481 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(34 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Gross margin</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">138,283</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(302,020 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">440,303</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(146 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Operating expenses:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Research and development</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">533,587</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">535,147</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,560 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Compensation and related expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,675,865</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">790,190</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">885,675</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">112</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Professional fees</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">771,901</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">252,705</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">519,196</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">205</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">942,440</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">321,141</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">621,299</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">193</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total operating expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,923,793</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,899,183</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,024,610</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">107</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss from operations</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,785,510 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,201,203 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,584,307 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">72</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other income, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">87,096</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">176,738</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(89,642 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(51 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss before income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(3,698,414 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(2,024,465 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,673,949 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">83</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Provision for income taxes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">&#8212;</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">0</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net loss</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>(3,698,414 </strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>(2,024,465 </strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>(1,673,949 </strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>)</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>83</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business has been focused on the development and commercialization of our supercritical water oxidation (SCWO) systems. We generated $543,100 and $315,278 in revenue from equipment manufacturing services and services, specifically a full-scale demonstration and treatability studies during the three months ending March 31, 2025 and March 31, 2024, respectively. During the three months ended March 31, 2025, we completed a full-scale demonstration for a customer resulting in an increase in our service revenues of $376,000, offset by a decrease in equipment manufacturing revenue of approximately $162,000. &#160;Costs associated with our sold unit have started to decline as we reach the end of our fabrication and testing, which have had a direct correlation to the reduced revenue recognized this period on equipment manufacturing services. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our general and administrative expenses increased to $942,440 during the three months ended March 31, 2025, as compared to $321,141 in the same period of 2024, primarily because of increased &#160;costs incurred related to relocating to our own short-term manufacturing facility in Florida of approximately $131,000, an increase in depreciation expense of $98,000 due to the capitalization of&#160; our owned unit in the fourth quarter 2024, and an increase in travel and related expenses of $70,000 due to our increased headcount, increase of $73,000 of investor relation expenses and $249,000 of general expenses due to increased headcount and expenses associated with our physical locations. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our compensation and related expenses increased to $1,675,865 during the three months ended March 31, 2025, as compared to $790,190 in the same period of 2024, primarily because of increased payroll and fringe benefit expenses due to increase in headcount and our executive team and an increase in our stock based compensation of approximately $538,000. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our professional fees increased to $771,901 during the three months ended March 31, 2025, as compared to $252,705 in the same period of 2024, primarily because of increased legal fees as a result of a litigation settlement and recruiting fees related to the increase in our headcount.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our research and development expenses decreased to $533,587 during the three months ended March 31, 2025, as compared to $535,147 in the same period of 2024, primarily due to a temporary reduction in personal in this department during the current period, offset by an increase in stock based compensation of approximately $49,000.&#160; We anticipate our research and development expenses to increase as we build up our resources to continue our efforts to commercializing our systems. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">24</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASU No. 2014-15 Presentation of Financial Statements &#8211; Going Concern (subtopic 205-40), the Company&#8217;s management evaluates whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. At March 31, 2025, the Company had working capital of $8,734,300 and an accumulated deficit of $32,086,032. For the three months ended March 31, 2025, the Company incurred a net loss of $3,698,414 and used $3,494,477 of net cash in operations for the period. These conditions raise substantial doubt regarding our ability to continue as a going concern.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Presently, the Company will need additional debt or equity financing or a combination of both to continue its operations and meet its financial obligations for at least the next twelve months from the date these unaudited condensed interim consolidated financial statements were issued and beyond. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. We expect to incur continuing losses and negative cash flows from operations for the foreseeable future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100&#160;million of common stock, subject to applicable law. During the three months ended March 31, 2025 and 2024, we did not use the ATM to raise capital. &#160;The Company is evaluating strategies to obtain the required additional funding for future operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 18, 2024, we closed on an offering of shares of common stock and common stock warrants resulting in net proceeds of approximately $11,393,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any additional debt or equity financing that the Company obtains may substantially dilute the ownership held by our existing stockholders. The economic dilution to our shareholders will be significant if our stock price does not materially increase, or if the effective price of any sale is below the price paid by a particular investor. The Company may be unable to access further equity or debt financing when needed or obtain additional financing under acceptable terms, if at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may decide to raise additional capital through a variety of sources in the short-term and in the long-term, including but not limited to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:8%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the public equity markets;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">private equity financings;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">collaborative arrangements;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">asset sales; and/or</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">public or private debt.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If the Company is unable to raise additional capital, there is a risk that the Company could be required to discontinue or significantly reduce the scope of its operations. These unaudited condensed interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong><em>Cash Flows</em></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We used $3,494,477 of cash in operating activities for the three months ended March 31, 2025 compared to $2,508,653 of cash used in operating activities for the corresponding period in 2024 an increase of $985,824. The increase in cash used in operating activities was primarily due to the increase in our net loss of $1,673,949, offset by an increase in noncash expenses of $706,811 and increase in operating cash outflows from operating assets and liabilities of $18,686. &#160;The cash used in operations was primarily to fund operations as well as our working capital requirements.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We used $297,322 of cash in investing activities for the three months ended March 31, 2025 compared to receiving $590 of cash used in financing activities for the corresponding period in 2024 an increase of $296,732. The increase in cash used by investing activities for the three months ended March 31, 2025 was primarily due a $297,322 increase in purchases of property and equipment, offset by a decrease of $590 in purchases of intangible assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We received $24,000 of cash from financing activities for the three months ended March 31, 2025 compared to $0 cash provided by financing activities for the corresponding period in 2024 an increase of $24,000 This increase was from proceeds received from the exercise of a stock option during the three months ended March 31, 2025. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="I3">Item 3. Quantitative and Qualitative Disclosures about Market Risk.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Not applicable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="I4">Item 4. Controls and Procedures. Disclosure Controls and Procedures</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company, under the supervision and with the participation of the Company&#8217;s management, including our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the design and operation of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as defined in Rule 13a-15I under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were not effective due to the identified material weakness in the Company&#8217;s internal controls over financial reporting caused by the lack of full-time resources in our finance and accounting department. As a result of the identified material weaknesses, we are working to establish a remediation plan, which includes additional full-time personnel with the necessary skills and expertise to enhance the Company&#8217;s financial and accounting resources and control environment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">25</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance of such reliability and may not prevent or detect misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Management&#8217;s Annual Report on Internal Control Over Financial Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company&#8217;s disclosure controls and procedures were ineffective due to material weaknesses in our financial reporting caused by the lack of full-time resources in our finance and accounting department. As a result of the identified material weaknesses, we are working to establish a remediation plan focused on strengthening our internal controls &#160;and hiring full-time personnel with the necessary skills and expertise to enhance the Company&#8217;s financial and accounting resources and control environment. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Changes in Internal Control Over Financial Reporting</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There have been no other changes in our internal control over financial reporting during the first three months of 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">26</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="P2">PART II OTHER INFORMATION</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span class="atag" style="display: inline" id="IT1"><strong>Item</strong><strong> </strong><strong>1.</strong><strong> </strong><strong>Legal</strong><strong> </strong><strong>Proceedings.</strong></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The information set forth under the &#8220;Legal Settlement&#8221; section in Note 8 &#8211; Commitments and Contingencies, in the notes to the unaudited condensed consolidated financial statements in Item 1 of Part I of this Form 10-Q, is incorporated herein by reference.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT1a">Item 1A. Risk Factors.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">You should carefully consider the following risks. These risks could materially affect our business, results of operations or financial condition, cause the trading price of our common stock to decline materially or cause our actual results to differ materially from those expected or those expressed in any forward-looking statements made by us or on our behalf. These risks are not exclusive, and additional risks to which we are subject include, but are not limited to, the factors mentioned under &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; and the risks of our businesses described elsewhere in our Form 10-K Report filed with the SEC on March 28, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Summary of Risk Factors </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Risks Related to Our Business and General Economic Conditions</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A sustainable market for our products may never develop.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to treat hazardous wastes on a commercially viable basis is unproven, which could have a detrimental effect on our ability to generate or sustain revenues.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have a limited operating history with no material revenues.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our products may have defects, which could damage our reputation, decrease market acceptance of our products, cause us to lose customers and revenue and result in costly litigation or liability.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our management team may not be able to successfully implement our business strategies.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to generate revenue will depend in part on government contracts which expose us to the uncertainties of governmental budgetary and funding constraints and local, national and international political conditions and events. </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">We have identified material weaknesses in our internal control over financial reporting.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant disruptions of our information technology systems or breaches of our data security could adversely affect our business.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may be unable to obtain required licenses from third parties for product development.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If we fail to manage growth or to prepare for product scalability effectively, it could have an adverse effect on our employee efficiency, product quality, working capital levels and results of operations.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may be adversely affected by the effects of inflation.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We face competition in our industry, and we may be unable to attract customers and maintain a viable business.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are required to obtain permits in different areas of the world in order to utilize our products in such regions. Our need to apply for and receive permits could substantially limit our ability to operate and grow our business.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have in the past and may in the future be involved in litigation matters or other legal proceedings that are expensive and time consuming.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Developments in, and compliance with, current and future environmental and climate change laws and regulations could impact our business, financial condition or results of operations.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If we become subject to claims relating to handling, storage, release or disposal of hazardous materials, we could incur significant cost and time to comply.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Failure to effectively treat emerging contaminants could result in material liabilities.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Wastewater operations entail significant risks that may impose significant costs.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees, which could reduce our profitability.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We enter into various contracts in the normal course of our business, some or all of which may require us to indemnify the other party to the contract. In the event we have to perform under these indemnification provisions, it could have an adverse effect on our business, financial condition and results of operation.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Natural disasters and other catastrophic events beyond our control could adversely affect our business operations and financial performance.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">United States trade policies and other factors beyond the Company&#8217;s control, including the imposition of tariffs and retaliatory tariffs, may adversely impact our business, financial condition and results of operations.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">27</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Risks Related to Our Financial Position and Capital Requirements</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We will require and may have difficulty or be unsuccessful in raising needed capital in the future to continue to operate as a going concern.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our financial results depend on successful project execution and may be adversely affected by cost overruns, failure to meet customer schedules or other execution issues.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have inadequate capital and need for additional financing to accomplish our business and strategic plans. Terms of subsequent financing, if any, may adversely impact your investment.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our research and development expenses may increase in the future.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Risks Related to Our Intellectual Property</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may have difficulty in protecting our intellectual property and may incur substantial costs to defend ourselves in patent infringement litigation.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may become subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from developing our products, require us to obtain licenses from third parties or to develop non-infringing alternatives and subject us to substantial monetary damages.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may need to depend on certain technologies that are licensed to us. We would not control these technologies and any loss of our rights to them could prevent us from selling our products.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Risks Related to our Reliance on Third Parties</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our suppliers may fail to deliver materials and parts according to schedules, prices, quality and volumes that are acceptable to us, or we may be unable to manage these materials and parts effectively.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Failure by third parties to supply or manufacture components of our products or to deploy our systems timely or properly could adversely affect our business, financial condition and results of operations.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Risks Related to our Common Stock and Capital Structure</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The market price of our common stock historically has been highly volatile and is likely to continue to be volatile, and you could lose all or part of your investment.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">If we cannot maintain full compliance with Nasdaq listing standards, or if we cannot cure any violations within the time afforded under the Nasdaq listing standards, then we may face penalties that could significantly impact our stock price, including delisting of our stock from Nasdaq.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The interests of our principal stockholders, officers and directors, who collectively beneficially own a significant amount of our common stock, may not coincide with yours and such stockholders will have the ability to control decisions with which you may disagree.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Because we are a &#8220;smaller reporting company,&#8221; we may take advantage of certain scaled disclosures available to us, resulting in holders of our securities receiving less Company information than they would receive from a public company that is not a smaller reporting company.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not intend to pay dividends on our common stock for the foreseeable future.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If securities or industry analysts do not publish research about our business, or publish negative reports about our business, our share price and trading volume could decline.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Future sales or potential sales of our common stock in the public market could cause our share price to decline.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The market price of our common shares has been, and may continue to be, particularly volatile, and our shareholders may be unable to resell their shares at a profit.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We incur costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Provisions in our Amended and Restated Certificate of Incorporation and Bylaws and of Delaware law may prevent or delay an acquisition of the Company, which could decrease the trading price of our common stock.</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may not regain compliance with the continued listing requirements of The Nasdaq Capital Market.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">28</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>RISK FACTORS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risks Related to Our Business and General Economic Conditions</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>A sustainable market for our products may never develop.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A sustainable market for our products may never develop or may take longer to develop than we anticipate which would adversely affect our results of operations. Our products represent an emerging market, and we do not know whether our targeted customers will accept our technology or will purchase our products in sufficient quantities to allow our business to grow. To succeed, demand for our products must increase significantly in existing markets, and there must be strong demand for products that we introduce in the future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our ability to treat hazardous wastes on a commercially viable basis is unproven, which could have a detrimental effect on our ability to generate or sustain revenues.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The technologies we use to treat sludge, biosolids and wastewater, have never been utilized on a full-scale commercial basis. Our AirSCWO technology and systems remain in a research and development status. All of the tests conducted to date by us with respect to the technology have been performed in a limited scale or small commercial scale environment and the same or similar results may not be obtainable at competitive costs on a large-scale commercial basis. We have never employed our technology under the conditions or in the volumes that will be required for us to be profitable and we cannot predict all of the difficulties that may arise. Accordingly, our technology may not perform successfully on a commercial basis and we may never generate any revenues or be profitable. Even if we are able to fully commercialize our products, we may not be able to grow our business at scale. Due to the uncertainties and potential difficulties to level up our technology to be deployed on a large-scale commercial basis, there is no guarantee that the costs of operating commercial-scale products will not exceed the revenues we earn. If we cannot grow our business at scale, then our business, results of operations, financial condition and stock price could be significantly impacted.&#160; If we are unable to sell additional AirSCWO systems or are unable to deliver on existing or future contracts, such failure could adversely affect our results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We have a limited operating history with no material revenues.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our limited operating history makes evaluating the business and future prospects difficult and may increase the risk of your investment. We have yet to generate material revenues from our business and we have so far deployed our AirSCWO technology only in the City of Orlando, Florida. Therefore, the commercial value of our systems is uncertain. There can be no assurance that we will ever generate significant revenues or become profitable. Further, we are subject to all the risks inherent in a new business, including, but not limited to: intense competition&#894; lack of sufficient capital&#894; loss of protection of proprietary technology and trade secrets&#894; difficulties in commercializing our products, managing growth and hiring and retaining key employees&#894; adverse changes in costs and general business and economic conditions&#894; and the need to achieve product acceptance, to enter and develop new markets and to develop and maintain successful relationships with customers, third party suppliers and contractors.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our business and results of operations may be adversely affected if we are unable to recruit and retain qualified management.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our success depends, in large part, on our ability to hire and retain highly qualified people and if we are unable to do so, our business and operations may be impaired or disrupted. Competition for highly qualified people is intense and there is no assurance that we will be successful in attracting or retaining replacements to fill vacant positions, successors to fill retirements or employees moving to new positions, or other highly qualified personnel. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">29</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our products may have defects, which could damage our reputation, decrease market acceptance of our products, cause us to lose customers and revenue and result in costly litigation or liability.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our products may contain defects for many reasons, including defective design or manufacture, defective material or software interoperability issues. Products as complex as those we offer, frequently develop or contain undetected defects or errors. Defects or errors may arise in our existing or new products, which could result in loss of revenue, market share, failure to achieve market acceptance, diversion of development resources, injury to our reputation, and increased service and maintenance costs. Such defects or errors in our products and solutions might discourage customers from purchasing future products. Often, these defects are not detected until after the products have been installed. If any of our products contain defects or perceived defects or have reliability, quality or compatibility problems or perceived problems, our reputation might be damaged significantly, we could lose or experience a delay in market acceptance of the affected product or products and might be unable to retain existing customers or attract new customers. In addition, these defects could interrupt or delay sales. In the event of an actual or perceived defect or other problem, we may need to invest significant capital, technical, managerial and other resources to investigate and correct the potential defect or problem and potentially divert these resources from other development efforts. If we are unable to provide a solution to the potential defect or problem that is acceptable to our customers, we may be required to incur substantial product recall, repair and replacement and even litigation costs. These costs could have a material adverse effect on our business and operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furthermore, if there are defects in the design, production or testing of our products and systems, we could face substantial repair, replacement or service costs, potential liability and damage to our reputation. Defects or malfunctioning of our products, if they were to occur, would likely result in significant damage and loss of life. These events could also lead to product recalls, safety or security alerts, or result in the removal of a product from the market, warranty or liability claims or contractual damages against us. We may not be able to obtain product liability or other insurance to fully cover such risks, and our efforts to implement appropriate design, testing and manufacturing processes for our products or systems may not be sufficient to prevent such occurrences, which could have a material adverse effect on our business, results of operations and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our management team may not be able to successfully implement our business strategies.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If our management team is unable to execute on its business strategies, then our development, including the establishment of revenues and our sales and marketing activities would be materially and adversely affected. As described in &#8220;Item 1. Business&#8221; above, our management team has a number of business strategies intended to grow our operations, increase our customer base and footprint across various markets, and develop a full-scale commercialization of our AirSCWO systems. However, we currently have no demonstrated operating history of such full-scale commercialization, and our ability to execute on such strategies successfully and on the timelines we expect (or at all) is subject to significant uncertainties and risks. As our management team moves forward with its business strategies, unexpected setbacks, obstacles and challenges may occur, resulting in delays, changes in strategy, abandonment of certain projects and plans, and the creation of new strategies and plans that may look very different from our current business strategies. Even if we do not change or reverse our current business strategies, there is no guarantee that we will be able to scale our business on the timelines we expect or at all, or that we will be able to successfully compete with other providers in the market to capitalize on the demand that we have identified to exist. There is also no guarantee that we will be able to effectively manage the costs of maintaining the AirSCWO systems we provide to customers in a way that would allow us to turn a profit at some point in the future. Additionally, all of our management team&#8217;s business strategies require significant financing to execute, and there is no guarantee that we will have sufficient capital at any given time to do so. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, even if we manage to grow our business in the ways we plan, we may encounter difficulties in effectively managing the budgeting, forecasting and other process control issues presented by any future growth. Our historical financial information may not be reflective of our future financial performance, and the costs and expenses that we have incurred in the past is likely not indicative of the volume of costs and expenses that we will incur in the future as we try to scale and fully commercialize our business. We expect there to be a period of time, during which we need to increase our costs and expenses to invest in our future commercialization success as a company. However, we may be stuck in such a period of time indefinitely if we cannot recognize revenue quickly enough and we cannot manage our costs efficiently during the time it takes us to ramp up production and development, negotiate and win new contracts and streamline the maintenance and continued work required on our AirSCWO systems. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since our business is still in its nascent stages, there is no historical basis upon which to evaluate our ability to successfully execute on our business strategies, achieve our business goals and objectives, and recognize revenue and turn a profit over time. If we are not able to deliver the results we expect, or if our business strategies do not result in the successes we intend, our business, operations and financial condition will be materially and adversely impacted. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">30</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Furthermore, we may seek to augment or replace members of our management team. For example, we have recently hired a new Chief Executive Officer and Chief Financial Officer and have made other key senior management hires. In addition, we may lose key members of our management team, and we may not be able to attract new management talent with sufficient skill and experience. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our ability to generate revenue will depend in part on government contracts</em> <em>which expose us to the uncertainties of governmental budgetary and funding constraints and local, national and international political conditions and events.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We expect to derive a significant portion of our future revenues directly or indirectly from government agencies. The funding of government programs could be reduced or eliminated due to numerous factors, including changes in administration, governmental budget constraints, changes in funding priorities and policies, and developments in geopolitical events and macroeconomic conditions that are beyond our control. Reduction or elimination of government spending under our contracts would imperil the sales of our products and may cause a negative effect on our revenues, results of operations, cash flow and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We have identified material weaknesses in our internal control over financial reporting,<strong> </strong>which may have a material adverse effect on our results of operations and financial condition for future periods.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and to effectively prevent fraud. Any inability to provide reliable financial reports or to prevent fraud could harm our business. The Sarbanes-Oxley Act requires management to evaluate and assess the effectiveness of our internal controls over financial reporting. In order to comply with the requirements of the Sarbanes-Oxley Act, we are required to continuously evaluate and, where appropriate, enhance our policies, procedures and internal controls. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. While we continue the process of reviewing and improving our internal controls and procedures for compliance with applicable law, implementing any appropriate changes to our internal controls requires significant attention from our officers and employees, entail substantial costs to modify our existing processes and take significant time to complete.&#160;However, our efforts do not always result in maintaining effective internal controls, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and harm our business. In addition, investors&#8217; perceptions that our internal controls are inadequate or that we are unable to produce accurate and complete financial statements on a timely basis may harm the trading price of our ordinary shares&#160;and make it more difficult for us to effectively market and sell our service to new and existing customers. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Give the early-stage of our Company, we have limited full-time accounting and financial reporting personnel and other resources with which to address our internal controls and related procedures. We just recently hired a full-time Chief Financial Officer. For the fiscal year ended December 31, 2024, we and our independent registered public accounting firm have identified material weaknesses in our internal controls over financial reporting related due to our ongoing personnel limitations. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. While we are still working to further expand our financial reporting and related personal to support our Chief Financial Officer and internal controls processes, there is no assurance that the actions we are taking or plan to take will give us the results we expect, that our remediation plan will be effective, or that our remediation plan will be completed on the timelines that we expect. See Part I, Item 4 &#8220;Controls and Procedures&#8221; for further discussion about the material weakness and our remediation activities.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If we are unable to remedy our material weaknesses in a timely manner, we may be unable to produce timely and accurate financial statements, and we may again discover additional material weaknesses and conclude that our internal control over financial reporting is not effective in future periods, which could adversely impact our investors&#8217; confidence and our stock price. If we continue to fail to maintain the adequacy of our internal controls over financial reporting, we could be subject to litigation or regulatory scrutiny. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">31</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Significant disruptions of our information technology systems or breaches of our data security could adversely affect our business.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A significant invasion, interruption, destruction or breakdown of our information technology systems and/or infrastructure by persons with authorized or unauthorized access could negatively impact our business and operations. We could also experience business interruption, information theft and/or reputational damage from cyberattacks, which may compromise our systems and lead to data leakage either internally or at our third-party providers. Our systems have been, and are expected to continue to be, the target of malware and other cyberattacks. The measures we have undertaken to reduce these risks may not be successful in preventing compromise and/or disruption of our information technology systems and related data. As a technology company, our business depends on our ability to protect our propriety intellectual property. We also maintain records of sensitive and/or confidential information about our customers, including various governmental agencies. If we are not able to prevent access to our systems and a bad actor gains access to such proprietary, sensitive or confidential information, then our business, financial condition and reputation could be significantly impacted. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may be unable to obtain required licenses from third parties for product development.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may be required to obtain licenses to patents or other proprietary rights from third parties. If we do not obtain required licenses, we could encounter delays in product development or find that the development, manufacture or sale of products requiring these licenses could be prevented in the U.S. or abroad.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>If we fail to manage growth or to prepare for product scalability effectively, it could have an adverse effect on our employee efficiency, product quality, working capital levels and results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any significant growth in the market for our products or our entry into new markets may require an expansion of our employee base for managerial, operational, financial, and other purposes. During any period of growth, we may face problems related to our operational and financial systems and controls, including quality control and delivery and service capacities. We would also need to continue to expand, train and manage our employee base. Continued future growth will impose significant added responsibilities upon the members of management to identify, recruit, maintain, integrate, and motivate new employees. Aside from increased difficulties in the management of human resources, we may also encounter working capital issues, as we will need increased liquidity to finance the development of new products and the hiring of additional employees. For effective growth management, we will be required to continue improving our operations, management, and financial systems and controls. Our failure to manage growth effectively may lead to operational and financial inefficiencies that will have a negative effect on our profitability. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may be adversely affected by the effects of inflation.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inflation has the potential to adversely affect our business, results of operations, financial position and liquidity by increasing our overall cost structure, particularly if we are unable to achieve commensurate increases in the prices we expect to charge our customers. The existence of inflation in the economy has the potential to result in higher interest rates and capital costs, supply shortages, increased costs of labor and other similar effects. As a result of inflation, we have experienced and may continue to experience, increases in our costs associated with operating our business including labor, equipment and other inputs. If we are unable to take measures to mitigate the impact of inflation through pricing actions upon commercialization of our product and efficiency gains, then our business, results of operations, financial position and liquidity could be materially adversely affected. Even if such measures are effective, there could be a difference between the timing of when these beneficial actions impact our results of operations and when the cost inflation is incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We face competition in our industry, and we may be unable to attract customers and maintain a viable business.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The markets for our products and services are highly competitive, with companies offering a variety of competitive products and services. We expect competition in our markets to intensify in the future as new and existing competitors introduce new or enhanced products and services that are potentially more competitive than our products and services. &#160;We compete with direct competitors in the SCWO Field.&#160;&#160;Additionally, several other technologies are in competition with SCWO, depending on the market sector, including but not limited to: anaerobic digestion, landfilling, drying and incineration, lagoon and spray-fields, and lime stabilization. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">32</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We believe many of our competitors and potential competitors have significant competitive advantages, including longer operating histories, greater ability to leverage their sales efforts and marketing expenditures across a broader portfolio of products and services, larger and broader customer bases, more established relationships with a larger number of suppliers, contract manufacturers, and channel partners, greater brand recognition, and greater financial, research and development, marketing, distribution, and other resources than we do and the ability to offer financing for projects. Our competitors and potential competitors may also be able to develop products or services that are equal or superior to ours, achieve greater market acceptance of their products and services, and increase sales by utilizing different distribution channels than we do. Some of our competitors may aggressively discount their products and services in order to gain market share, which could result in pricing pressures, reduced profit margins, lost market share, or a failure to grow market share for us once we attain commercialization. If we are not able to compete effectively against our current or potential competitors, our prospects, operating results, and financial condition could be adversely affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to commercialize our systems and grow and achieve profitability in accordance with our business plan will depend on our ability to satisfy our customers and withstand increasing competition by providing superior waste treatment at reasonable cost. There can be no assurance that we will be able to achieve or maintain a successful competitive position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We are required to obtain permits in different areas of the world in order to utilize our products in such regions. Our need to apply for and receive permits could substantially limit our ability to operate and grow our business.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to continue with our current scope of operations and expand our operations and business across the globe is subject, in certain cases, to our receiving a permit for different purposes, including the use of land. It may be difficult to receive the required permits, which may require our management team to divert its attention from other aspects of our business, or it may be more capital intensive or a more time-consuming process than expected to receive permits, either of which could increase costs and delay the launch of our products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We have in the past and may in the future be involved in litigation matters or other legal proceedings that are expensive and time consuming.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have in the past and may in the future become involved in litigation matters, including class action lawsuits and lawsuits relating to intellectual property and product liability. Any lawsuit to which we are a party, with or without merit, may result in an unfavorable judgment. Any such negative outcome could result in payments of substantial damages or fines, damage to our reputation, loss of rights, or adverse changes to our offerings or business practices. Any of these results could adversely affect our business. In addition, defending claims is costly and can impose a significant burden on our management.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If any of our current or future products and services that we make or sell (including items that we source from third parties) are defectively designed or manufactured, contain defective components, are misused, have safety or quality issues, have inadequate operating guidelines, malfunctions or if someone claims any of the foregoing, whether or not meritorious, we may become subject to substantial and costly litigation. Misuse of our products by us or other operating parties or services or failing to adhere to the operating guidelines could cause significant harm to the public and the environment. The foregoing events could lead to recalls or safety alerts, result in the removal of a product or service from the market and result in product liability or similar claims being brought against us.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any product liability claims brought against us could divert management&#8217;s attention from our core business, be expensive to defend and result in sizable damage awards against us. We may not have sufficient product insurance coverage for all future claims. Any product liability claims brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing continuing coverage, could harm our reputation in the industry and could reduce revenue, if any. Product and services liability claims in excess of our insurance coverage would be paid out of cash reserves, harming our financial condition and adversely affecting our results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">33</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, if we expand into additional geographic markets, we may then be exposed to different and changing regulations regarding, for example, environmental impact and damages, which entail risks for compensation obligation, which may mean that we would need to update our existing insurance policy or obtain additional policies for specific geographical markets. If we do not have sufficient insurance coverage or the cost of obtaining the appropriate insurance coverage is costly, this could have a material adverse effect on our business, results of operations and financial position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Moreover, in the past companies that have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management&#8217;s attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant liabilities. For further information on our legal proceedings, see Part II, Item 3. &#8220;Legal Proceedings.&#8221;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Developments in, and compliance with, current and future environmental and climate change laws and regulations could impact our business, financial condition or results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business, operations, and product and service offerings are subject to and affected by many federal, state, local and foreign environmental laws and regulations, including those enacted in response to climate change concerns.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Increasing public and governmental awareness and concern regarding the effects of climate change has led to significant legislative and regulatory efforts to limit greenhouse gas emissions and will likely result in further environmental and climate change laws and regulations. Compliance with existing laws and regulations currently requires, and compliance with future laws is expected to continue to require, increasing operating and capital expenditures, including with respect to the design or re-design of our products in order to conform to changing environmental standards and regulations, which could impact our business, financial condition and results of operations. Furthermore, environmental laws and regulations may authorize substantial fines and criminal sanctions as well as facility shutdowns to address violations, and may require the installation of costly pollution control equipment or operational changes to limit emissions or discharges. We also incur, and expect to continue to incur, costs to comply with current environmental laws and regulations. Developments such as the adoption of new environmental laws and regulations, stricter enforcement of existing laws and regulations, violations by us of such laws and regulations, discovery of previously unknown or more extensive contamination, litigation involving environmental impacts, our inability to recover costs associated with any such developments, or financial insolvency of other responsible parties could in the future have a material adverse effect on our financial condition and results of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>If we become subject to claims relating to handling, storage, release or disposal of hazardous materials, we could incur significant cost and time to comply.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business activities, including our manufacturing processes and waste recycling and treatment processes, currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes. These activities create a risk of significant environmental liabilities and reputational damage. Under applicable environmental laws and regulations, we could be strictly, jointly and severally liable for releases of regulated substances by us at our current or former properties or the properties of others or by other businesses that previously owned or used our current or former properties, including if such releases result in contamination of air, water or soil, or cause harm to individuals. We could also be liable or incur reputational damage if we merely generate hazardous materials or wastes, or arrange for their transportation, disposal or treatment, or we transport such materials, and they are subsequently released or cause harm.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business activities also create a risk of contamination or injury to our employees, customers or third parties, from the use, treatment, storage, transfer, handling and/or disposal of these materials.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the event that our business activities result in environmental liabilities, such as those described above, we could incur significant costs or reputational damage in connection with the investigation and remediation of environmental contamination, and we could be liable for any resulting damages including natural resource damages. Such liabilities could exceed our available cash or any applicable insurance coverage we may have. Additionally, we are subject to, on an ongoing basis, federal, state and local laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. The cost of compliance with these laws and regulations may become significant and could have a material adverse effect on our business, financial condition, results of operations or prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">34</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Further, we may incur costs to defend our position even if we are not liable for consequences arising out of a release of or exposure to a hazardous substance or waste, or other environmental damage. Our insurance policies may not be sufficient to cover the costs of such claims.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Failure to effectively treat emerging contaminants could result in material liabilities.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A number of emerging contaminants might be found in water that we treat, including PFAS, 1,4-dioxane, dinitrotoluene, perchlorate, in addition to other pathogens and hazardous substances that have the potential to cause any number of illnesses, including cholera, typhoid fever, cancer, giardiasis, cryptosporidiosis, amoebiasis and free-living amoebic infections. There is a risk that workers may be exposed to these contaminants and pathogens before material is treated, the unit may not be operated properly and waste not fully treated during the process, or there is a malfunction and waste is not properly treated, creating a risk of third-party exposure to contaminants in byproducts that are generated. The potential impact of a failure to adequately treat is difficult to predict and could lead to an increased risk of exposure to property damage, natural resource damage, personal injury or even product liability claims, increased scrutiny by federal and state regulatory agencies and negative publicity. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Wastewater operations entail significant risks that may impose significant costs.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Wastewater treatment involves various unique risks. If our treatment systems fail or do not operate properly, or if there is a spill, untreated or partially treated wastewater could discharge onto property or into nearby streams and rivers, causing various damages and injuries, including environmental damage. Liabilities resulting from such damages and injuries could materially adversely affect our business, financial condition, results of operations or prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These risks could be increased by the potential physical impacts of climate change on our operations. The physical impacts of climate change are highly uncertain and vary depending on geographical location, but could include changing temperatures, water shortages, changes in weather and rainfall patterns and changing storm patterns and intensities. Many climate change predictions, if true, present several potential challenges to water and wastewater service providers, such as increased precipitation and flooding, potential degradation of water quality and changes in demand for water services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees, which could reduce our profitability.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We anticipate that our customers may require product warranties as to the proper operation and conformance to specifications of the products we manufacture or install and performance guarantees as to any effluent produced by our equipment and services. Failure of our products to operate properly or to meet specifications of our customers or our failure to meet our performance guarantees may increase costs by requiring additional engineering resources and services, replacement of parts and equipment and frequent replacement of consumables or monetary reimbursement to a customer or could otherwise result in liability to our customers. There are significant uncertainties and judgments involved in estimating warranty and performance guarantee obligations, including changing product designs, differences in customer installation processes and failure to identify or disclaim certain variables in a customer&#8217;s influent. To the extent that we incur substantial warranty or performance guarantee claims in any period, our reputation, earnings and ability to obtain future business could be materially adversely affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">35</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We enter into various contracts in the normal course of our business, some or all of which may require us to indemnify the other party to the contract. In the event we have to perform under these indemnification provisions, it could have an adverse effect on our business, financial condition and results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the normal course of business, we may enter into agreements that contain indemnification provisions which require us to indemnify the other parties against adverse events occurring as a result of our operations. Should our obligation under an indemnification provision exceed applicable insurance coverage or if we were denied insurance coverage, our business, financial condition and results of operations could be adversely affected. Similarly, if we are relying on a third party to indemnify us and the party is denied insurance coverage, or the indemnification obligation exceeds the applicable insurance coverage and does not have other assets available to indemnify us, our business, financial condition and results of operations could be adversely affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Natural disasters and other catastrophic events beyond our control could adversely affect our business operations and financial performance.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The occurrence of one or more natural disasters, such as fires, hurricanes, tornados, tsunamis, floods and earthquakes&#894; geo-political events, such as civil unrest in a country in which our suppliers are located or terrorist or military activities disrupting transportation, communication or utility systems&#894; or other highly disruptive events, such as nuclear accidents, pandemics, unusual weather conditions or cyber-attacks, could adversely affect our operations and financial performance. Such events could result, among other things, in operational disruptions, physical damage to or destruction or disruption of one or more of our properties or properties used by third parties in connection with the supply of products or services to us, the lack of an adequate workforce in parts or all of our operations and communications and transportation disruptions. These factors could also cause consumer confidence and spending to decrease or result in increased volatility in the United States and global financial markets and economy. Such occurrences could have a material adverse effect on us and could also have indirect consequences such as increases in the costs of insurance if they result in significant loss of property or other insurable damage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>United States trade policies and other factors beyond the Company&#8217;s control, including the imposition of&#160;tariffs&#160;and retaliatory&#160;tariffs, may adversely impact our business, financial condition, and results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In February 2025, President Trump issued executive orders announcing sweeping tariffs on products originating from Canada, Mexico and China. Effective February 4, 2025, all products of Chinese origin became subject to an additional 10% tariff pursuant to these executive orders, and effective March 4, all products of Chinese origin were subject to an additional 10% tariff, raising the tariff rate to 20%. While most of the tariffs on Mexican- and Canadian-origin products have been delayed until April 2, 2025, certain tariffs are already effective and there is no guarantee that the tariffs will be further delayed or negated. Additionally, these tariffs are in addition to existing duties and other tariffs, including the existing and upcoming additional tariffs on steel and aluminum. Our products contain materials and parts purchased globally from hundreds of suppliers, including single-source direct suppliers, which exposes us to potential component shortages or delays. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition to the impacts to our business stemming from the tariffs imposed by the Trump administration, we may also be materially impacted by retaliatory&#160;tariffs and other penalties that may be imposed by such countries against the United States. For example, Canada has already retaliated, imposing 25% tariffs on $30 billion worth of U.S.-origin products immediately, and there are plans to expand these tariffs with additional retaliatory tariffs, pending the current delay in the effectiveness of the tariffs against Canadian-origin products. China has also retaliated with tariffs on U.S.-origin farm products and trade and investment restrictions on certain U.S. companies. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">There continues to be significant uncertainties regarding these recent changes in U.S. trade policies, legislation, treaties, and&#160;tariffs, and potential future developments. If maintained, the newly announced&#160;tariffs&#160;and the potential escalation of trade disputes, a trade war or other governmental action related to&#160;tariffs&#160;or international trade agreements or policies, have the potential to negatively impact our and/or our clients&#8217; costs, demand for our clients&#8217; products, and/or the U.S. economy or certain sectors thereof and, thus, adversely affect our business, financial condition, and results of operations. These tariffs and changes in trade policies may result in significant increases in our cost of doing business, including increases in costs to our R&amp;D and increases in costs of materials in our supply chain. If we are not able to find cheaper alternative sources, or if we are unable to obtain supplies at all, we could experience material harm to our business, results of operations and financial condition. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See &#8220;Risks Related to our Reliance on Third Parties&#8212;Our suppliers may fail to deliver materials and parts according to schedules, prices, quality and volumes that are acceptable to us, or we may be unable to manage these materials and parts effectively.&#8221; for more information about risks related to our ability to source materials and parts from our suppliers</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">36</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Related to Our Financial Position and Capital Requirements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We will require and may have difficulty or be unsuccessful in raising needed capital in the future to continue to operate as a going concern.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our business currently does not generate sufficient revenues to meet our capital requirements and we do not expect that it will do so in the near future. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Presently, we do not have sufficient cash resources to meet our plans for the next twelve months from the issuance of the financial statements included herein. Our recurring losses from operations, negative cash flows and need for additional capital raise substantial doubt about our ability to continue as a going concern. We will require additional financing to fund our operations or we will have to significantly curtail or discontinue our operations to conserve our capital resources. Additional funds may not be available on acceptable terms, if at all, and such availability will depend on a number of factors, some of which are outside of our control, including general capital markets conditions and investors&#8217; view of our prospects and valuation. In addition, our ability to raise capital in the public capital markets, including through our at-the-market equity offerings, may in the future be limited by, among other things, SEC rules and regulations impacting the eligibility of smaller companies to use Form S-3 for primary offerings of securities. In general, under the &#8220;baby shelf&#8221; rules if our public float is less than $75 million at the time we file our annual report of Form 10-K to update our Form S-3 and our public float remains less than $75 million, we may not sell more than the equivalent of one-third of our public float during any 12 consecutive months pursuant to the baby shelf rules. Alternative public and private transaction structures may require additional time and cost, may impose operational restrictions on us, and may not be available on attractive terms. Further, investors&#8217; perception of our ability to continue as a going concern may make it more difficult for us to obtain financing, or necessitate that we obtain financing on terms that are more favorable to investors, and could result in the loss of confidence by investors, suppliers and employees. Our continued operations are contingent on our ability to raise additional capital or deploy or otherwise monetize our technology. If we do not acquire sufficient additional funding or alternative sources of capital to meet our working capital needs, we will have to substantially curtail or discontinue our operations, resulting in delays in the development and deployment of our technology and in generating revenue.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our actual capital requirements will depend on many factors, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">continued progress and cost of our research and development programs;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the time and costs involved in obtaining regulatory approvals and permitting, if any;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">regulatory actions with respect to our technology;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing intellectual property rights;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">costs of developing sales, marketing and distribution channels and our ability to sell our products;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">competing technological and market developments;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">market acceptance of our products;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">costs for recruiting and retaining employees and consultants; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">unexpected legal, accounting and other costs and liabilities related to our business.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">37</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our financial results depend on successful project execution and may be adversely affected by cost overruns, failure to meet customer schedules or other execution issues. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A significant portion of our revenue will be derived from large projects that are technically complex and may occur over multiple years. These projects are subject to a number of significant risks, including project delays, cost overruns, changes in scope, unanticipated site conditions, design and engineering issues, incorrect cost assumptions, increases in the cost of materials and labor, safety hazards, third party performance issues, weather issues and changes in laws or permitting requirements. If we are unable to manage these risks, we may incur higher costs, liquidated damages and other liabilities to our customers, which may decrease our profitability and harm our reputation. Our continued growth will depend in part on executing a higher volume of large projects, which will require us to expand and retain our project management and execution personnel and resources.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We have inadequate capital and need for additional financing to accomplish our business and strategic plans. Terms of subsequent financing, if any, may adversely impact your investment in our securities. </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We will need to raise substantial additional funds in order to execute our business plan. Our ability to secure additional financing depends on a variety of different factors, including but not limited to our ability to meet major milestones in our technology R&amp;D pursuits, our ability to attract new customers and grow our business, our ability to attract new investors who believe in our business strategy and our potential for future growth, our ability to successfully convert financing into tangible business successes, our stock price and the marketability (or perceived marketability) of our securities, among others. There is no guarantee that we will be able to secure financing on terms that are favorable to us, or at all. If the cost of securing financing is too high, or if the obligations to which we are subject pursuant to the terms of the financing we secure are too burdensome, we may not be able to realize the full benefits of the financing we receive. If we cannot secure financing at all, we may have to cease operations or scale back our activities. Our ultimate success may depend on our ability to raise additional capital. In the absence of additional financing or significant revenues and profits, we will have to approach our business plan from a much different and much more restricted direction, attempting to secure additional funding sources to fund our growth, borrowing money from lenders or elsewhere or to take other actions to attempt to provide funding.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may have to engage in common equity, debt, or preferred stock financings in the future. Your rights and the value of your investment in the common stock could be reduced by the dilution caused by future equity issuances. Interest on debt securities could increase costs and negatively impact operating results and debt issuances may subject us to restrictive covenants which may limit our flexibility. In the event we issue preferred stock pursuant to the terms of our certificate of incorporation, preferred stock could be issued in series from time to time with such designation, rights, preferences, and limitations as needed to raise capital. The terms of preferred stock would be more advantageous to those investors than to the holders of common stock. In addition, if we need to raise more equity capital from the sale of common stock, institutional or other investors may negotiate terms possibly less favorable to us, and thereby cause our stock price to fall. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our research and development expenses may increase in the future.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our research and development expenses primarily relate to our efforts to increase the output, durability and commercial viability of our technology. The results of such research and development can be unforeseen and undesirable and therefore our forecasted costs related to such research and development are associated with great uncertainty. We expect that our research and development expenses will increase in the future. Unforeseen research and development results could require us to undertake supplementary research and development at significant costs or cause us to pause or stop research and development efforts. A delay or non-existent launch of our technology or an insufficient investment (or overspend on such expenditure) could have a material adverse effect on our business, results of operations and financial position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">38</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Related to Our Intellectual Property</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may have difficulty in protecting our intellectual property and may incur substantial costs to defend ourselves in patent infringement litigation.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At this time, we rely primarily on a combination of patents, trade secrets, copyright and trademark laws, and confidentiality procedures to protect our proprietary technology, which is our principal asset.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our ability to compete effectively will depend to a large extent on our success in protecting our proprietary technology, both in the United States and abroad. There can be no assurance that (i) any patents that we apply for will be issued, (ii) we will ever obtain the rights to any patents covering the technology on which our current systems are based, (iii) any patents issued will not be challenged, invalidated, or circumvented, (iv) we will have the financial resources to enforce any such patents, (v) our confidentiality and invention agreements will be honored or that we will be able to protect our rights to our non-patented trade secrets and know-how effectively, (vi) our competitors will not independently develop equivalent or superior proprietary information and techniques or otherwise gain access to our trade secrets and know-how, and (vi) any patent rights granted will provide any competitive advantage. We could incur substantial costs in obtaining patent coverage and defending any patent infringement suits or in asserting our patent rights, including those granted by third parties, and we might not be able to afford such expenditures.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not know whether any of our current or future patent applications, if any, will result in the issuance of any patents. Even issued patents may be challenged, invalidated or circumvented. Patents may not provide a competitive advantage or afford protection against competitors with similar technology. Competitors or potential competitors may have filed applications for, or may have received patents and may obtain additional and proprietary rights to, compounds or processes used by or competitive with ours. Both the patent application process and the process of managing patent disputes can be time-consuming and expensive. Competitors may be able to design around our patents or develop products which provide outcomes which are comparable or may even be superior to ours.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the event a competitor infringes upon our intellectual property rights, enforcing those rights may be costly, uncertain, difficult and time consuming. Even if successful, litigation to enforce our intellectual property rights or to defend our patents against challenge could be expensive and time consuming and could divert our management&#8217;s attention. We may not have sufficient resources to enforce our intellectual property rights or to defend our patent rights against a challenge. The failure to obtain patents and/or protect our intellectual property rights could have a material and adverse effect on our business, results of operations and financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, we have taken steps to protect our intellectual property and proprietary technology, including entering into confidentiality agreements and intellectual property assignment agreements with our executive officers, employees, consultants and advisors; however, such agreements may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements. Furthermore, the laws of foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States. Moreover, the following can limit our ability to protect our intellectual property and technology:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">intellectual property laws in certain jurisdictions may be relatively ineffective&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">detecting infringements and enforcing proprietary rights may divert management&#8217;s attention and company resources&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">contractual measures such as non-disclosure agreements and confidentiality provisions may afford only limited protection&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any patents we may receive will expire, thus providing competitors access to the applicable technology&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">competitors may independently develop products that are substantially equivalent or superior to our products or circumvent our intellectual property rights&#894; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">competitors may register patents in technologies relevant to our business areas.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, various parties may assert infringement claims against us. The cost of defending against infringement claims could be significant, regardless of whether the claims are valid. If we are not successful in defending such claims, we may be prevented from the use or sale of certain of our products, or liable for damages and required to obtain licenses, which may not be available on reasonable terms, any of which may have a material adverse impact on our business, results of operation or financial condition.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">39</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may become subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from developing our products, require us to obtain licenses from third parties or to develop non-infringing alternatives and subject us to substantial monetary damages.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Third parties could, in the future, assert infringement or misappropriation claims against us with respect to products we develop. Whether a product infringes a patent or misappropriates other intellectual property involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of others. Our potential competitors may assert that some aspect of our product infringes their patents. Because patent applications may take years to issue, there also may be applications now pending of which we are unaware that may later result in issued patents upon which our products could infringe. There also may be existing patents or pending patent applications of which we are unaware upon which our products may inadvertently infringe.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. If the relevant patents in such a claim were upheld as valid and enforceable and we were found to infringe them, we could be prohibited from selling any product that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain such a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. A court could also order us to pay compensatory damages for such infringement, plus prejudgment interest and could, in addition, treble the compensatory damages and award attorney fees. These damages could be substantial and could harm our reputation, business, financial condition and operating results. A court also could enter orders that temporarily, preliminarily or permanently enjoin us and our customers from making, using, or selling products, and could enter an order mandating that we undertake certain remedial activities. Depending on the nature of the relief ordered by the court, we could become liable for additional damages to third parties.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We also employ individuals who were previously employed at other companies in our industry, including our competitors or potential competitors. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of any of our employee&#8217;s former employer or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could adversely impact our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patents or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of consultants or others who are involved in developing our products. Litigation may be necessary to defend against these and other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We employ individuals or hire consultants who are employed by or otherwise affiliated with universities and have commitments or obligations under employment agreements, policies, and other contracts with those universities. Failure by these employees and consultants to comply with their commitments or obligations to any university may result in disputes over our intellectual property or technology. The resolution of any dispute that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, which could adversely impact our business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">40</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may need to depend on certain technologies that are licensed to us. We would not control these technologies and any loss of our rights to them could prevent us from selling our products.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have entered into license agreements with third parties for certain licensed technologies that are not currently utilized in the systems we market but may be in the future. In addition, we may in the future elect to license third-party intellectual property to further our business objectives and/or as needed for freedom to operate our systems. We do not and will not own the patents or patent applications that are a subject of these licenses. Our rights to use these technologies and employ the inventions claimed in the licensed patents and patent applications are or will be subject to the continuation of and compliance with the terms of those licenses.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In some cases, we do not or may not control the prosecution, maintenance, or filing of the patents or patent applications to which we hold licenses, or the enforcement of these patents against third parties. As a result, we cannot be certain that drafting or prosecution of the licensed patents and patent applications by the licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents and other intellectual property rights.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Moreover, disputes may arise regarding intellectual property subject to a licensing agreement, including:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the scope of rights granted under the license agreement and other interpretation-related issues&#894;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the extent to which our products, technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement&#894;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations&#894;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners&#894; and</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the priority of invention of patented technology.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected products, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Related to our Reliance on Third Parties</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Our suppliers may fail to deliver materials and parts according to schedules, prices, quality and volumes that are acceptable to us, or we may be unable to manage these materials and parts effectively.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our products contain materials and parts purchased globally from numerous &#160;suppliers, including single-source direct suppliers, which exposes us to potential component shortages or delays. Unexpected changes in business conditions, materials pricing, labor issues, natural disasters, health epidemics, trade and shipping disruptions, port congestions and other factors beyond our or our suppliers&#8217; control could also affect these suppliers&#8217; ability to deliver components to us or to remain solvent and operational. Additionally, if our suppliers do not accurately forecast and effectively allocate production or if they are not willing to allocate sufficient production to us, it may reduce our access to components and require us to search for new suppliers. The unavailability of any component or supplier could result in production delays, idle manufacturing facilities, product design changes and loss of access to important technology and tools for producing and supporting our products, as well as impact the capacity of our AirSCWO systems. Product design changes by us may also require us to procure additional components in a short amount of time. Our suppliers may not be willing or able to sustainably meet our timelines or our cost, quality and volume needs, or to do so may cost us more, which may require us to replace them with other sources. There is no assurance that we will be able to secure additional or alternate sources for our components quickly or at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">41</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As we scale production of our AirSCWO systems, we will also need to accurately forecast, purchase, warehouse and transport components at high volumes to our manufacturing facilities. If we are unable to accurately match the timing and quantities of component purchases to our actual needs or successfully implement automation, inventory management and other systems to accommodate the increased complexity in our supply chain and parts management, we may incur unexpected production disruption, storage, transportation and write- off costs, which may harm our business and operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Failure by third parties to supply or manufacture components of our products or to deploy our systems timely or properly could adversely affect our business, financial condition and results of operations.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have been and expect to continue to be dependent on third parties to supply and manufacture components of our technology. If, for any reason, our third-party manufacturers or vendors are not willing or able to provide us with components or supplies in a timely fashion, or at all, our ability to manufacture and sell many of our products could be impaired, which, in turn, could have a material adverse effect on our business, results of operations and financial position.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We do not have long-term contracts with all of our third-party suppliers and manufacturers or vendors. Therefore, if we do not develop ongoing relationships with those vendors located in different regions, we may not be successful at controlling unit costs as our manufacturing volume increases. We may not be able to negotiate new arrangements with these third parties on acceptable terms, or at all. In addition, we rely on third parties, under our oversight, for the deployment and installation of our AirSCWO systems. For example, the manufacture, assembly and installation of the hydraulic, control and automation and electrical sub-systems of our AirSCWO systems are performed by third-party suppliers. The mechanical sub-system is installed (moored) at the relevant project site by third-party engineering service providers. If these third parties do not properly manufacture, assemble, and install our AirSCWO technology and systems, or otherwise do not perform adequately, or if we fail to recruit and retain third parties to deploy our systems in particular geographic areas, our business, financial condition and results of operations could be adversely affected. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Risks Related to our Common Stock and Capital Structure</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>The market price of our common stock historically has been highly volatile and is likely to continue to be volatile, and you could lose all or part of your investment.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The market price of our common stock has been volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this Annual Report, these factors include:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inability to obtain additional capital&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Failure to meet or exceed financial or operational projections we may provide to the public&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Failure to meet or exceed the financial or operational projections of the investment community&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant acquisitions, strategic partnerships, joint ventures or capital commitments by us or our competitors&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additions or departures of key management personnel&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant lawsuits, including shareholder litigation&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If securities or industry analysts issue an adverse or misleading opinion regarding our common stock&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in market valuations of similar companies&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">General market or macroeconomic conditions&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Sales of shares of our common stock by us or our shareholders in the future&#894; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trading volume of our common stock.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">42</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, companies trading in the stock market in general, and on the Nasdaq Capital Market, have experienced extreme price and volume fluctuations, and we have in the past experienced volatility that has been unrelated or disproportionate to our operating performance. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Further, on some occasions, our share price may be, or may be purported to be, subject to &#8220;short squeeze&#8221; activity. A &#8220;short squeeze&#8221; is a technical market condition that occurs when the price of a stock increases substantially, forcing market participants who had taken a position that its price would fall (i.e., who had sold the stock &#8220;short&#8221;), to buy it, which in turn may create a significant, short-term demand for the stock not for fundamental reasons, but rather due to the need for such market participants to acquire the stock in order to forestall the risk of even greater losses. A &#8220;short squeeze&#8221; condition in the market for a stock can lead to short-term conditions involving very high volatility and trading that may or may not track fundamental valuation models.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In addition, in the past, class action litigation has often been instituted against companies whose securities experienced periods of volatility in market price. Securities litigation brought against us following volatility in the price of our common stock, regardless of the merit or ultimate results of such litigation, could result in substantial costs, which would hurt our financial condition and operating results and divert management&#8217;s attention and resources from our business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>The interests of our principal stockholders, officers and directors, who collectively beneficially own a significant amount of our common stock, may not coincide with yours and such stockholders will have the ability to control decisions with which you may disagree.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, our principal stockholders, officers and directors beneficially owned approximately 43.5% of our common stock. As a result, our principal stockholders, officers and directors will have the ability to control matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. In addition, this concentration of ownership may delay or prevent a change in control of the Company and make some future transactions more difficult or impossible without the support of our controlling stockholders. The interests of such stockholders may not coincide with your interests or the interests of other stockholders.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Because we are a &#8220;smaller reporting company,&#8221; we may take advantage of certain scaled disclosures available to us, resulting in holders of our securities receiving less Company information than they would receive from a public company that is not a smaller reporting company.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We are a &#8220;smaller reporting company&#8221; as defined under Rule 12b-2 of the Exchange Act. As a smaller reporting company, we may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) our Common Stock held by non-affiliates is less than $250 million measured on the last business day of our second fiscal quarter, or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and our Common Stock held by non-affiliates is less than $700 million measured on the last business day of our second fiscal quarter. Based on the closing price of our common stock on June 30, 2024, we will remain a smaller reporting company through at least the end of fiscal year 2025.&#160; To the extent we take advantage of any reduced disclosure obligations, it may make it harder for investors to analyze the Company&#8217;s results of operations and financial prospectus in comparison with other public companies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a smaller reporting company, we are permitted to comply with scaled-back disclosure obligations in our SEC filings compared to other issuers, including with respect to disclosure obligations regarding executive compensation in our periodic reports and proxy statements. We have elected to adopt the accommodations available to smaller reporting companies. Until we cease to be a smaller reporting company, the scaled-back disclosure in our SEC filings will result in less information about our company being available than for other public companies.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If investors consider our Common Stock less attractive as a result of our election to use the scaled-back disclosure permitted for smaller reporting companies, there may be a less active trading market for our Common Stock and our share price may be more volatile.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">43</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We do not intend to pay dividends on our common stock for the foreseeable future.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We currently intend to retain our future earnings to finance the development and expansion of our business and, therefore, do not intend to pay cash dividends on our common stock for the foreseeable future. The timing, declaration, amount and payment of future dividends to stockholders will fall within the discretion of our Board of Directors. Our Board of Directors&#8217; decisions regarding the payment of future dividends will depend on many factors, including our financial condition, earnings, capital requirements of our business and covenants associated with debt obligations, as well as legal requirements, regulatory constraints, industry practice and other factors that our Board of Directors deem relevant. There can be no assurance that we will pay a dividend in the future or continue to pay any dividend if we do commence paying dividends.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>If securities or industry analysts do not publish research about our business, or publish negative reports about our business, our share price and trading volume could decline.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The trading market for our common stock may, depend on the research and reports that securities or industry analysts publish about our business. We do not have any control over these analysts. If one or more of the analysts elect to cover us and downgrade our shares or lower their opinion of our shares, our share price would likely decline. If one or more of these analysts elect to cover us and subsequently cease coverage of the Company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additionally, there may be risks associated with us becoming public through a merger. Securities analysts of major brokerage firms and securities institutions may not provide coverage of us because there were no broker-dealers who sold our stock in a public offering that would be incentivized to follow or recommend the purchase of our common stock. The absence of such research coverage could limit investor interest in our common stock, resulting in decreased liquidity. No assurance can be given that established brokerage firms will, in the future, want to cover our securities or conduct any secondary offerings or other financings on our behalf.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Future sales or potential sales of our common stock in the public market could cause our share price to decline.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If the existing holders of our common stock, particularly our directors and officers, sell a large number of shares, they could adversely affect the market price for our common stock. We have an at-the-market equity offering pursuant to which, we can issue up to an aggregate of $100 million of common stock, subject to applicable law and our previous at-the-market equity offering sales. Sales of substantial amounts of our common stock in the public market, or the perception that these sales could occur, could cause the market price of our common stock to decline.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The market price of our common stock has been, and may continue to be, particularly volatile, and our shareholders may be unable to resell their shares at a profit. The market price of our common shares has significantly declined over the past twelve months, and may continue to fluctuate or decline in the future. Between January&#160;1, 2022 and December 31, 2024, the closing price per share of our common shares has ranged from a high of $4.94 (on April 3, 2023) to a low of $0.67 (on December 30, 2024). We believe that one of the reasons for the continual decline in our common stock market price is due to the significant supply that far exceeds demand, as a result of the large volume of sales of our common stock by a single significant stockholder of the Company. Sales by such significant stockholder are out of our control, and there is no assurance that such stockholder will not continue to engage in such sales.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If we cannot find ways to successfully manage our stock price, our business and financial condition may be negatively impacted. We may not be able to attract new investors and other stakeholders, and we may not be able to secure financing or otherwise acquire capital in the market (either on favorable terms or at all). If our share price is volatile, we may also become the target of securities litigation, which could result in substantial costs and divert our management&#8217;s attention and resources from our business. Since our stock price has been trading below $1.00 per share, we are also subject to delisting from the Nasdaq stock exchange if we cannot improve our stock price and regain full compliance with the Nasdaq listing standards.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">44</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We incur costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As a public reporting company, we incur significant legal, accounting and other expenses. The Sarbanes-Oxley Act and rules subsequently implemented by the SEC, have imposed various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will entail significant legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept low policy limits and coverage.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Provisions in our Amended and Restated Certificate of Incorporation and Bylaws and of Delaware law may prevent or delay an acquisition of the Company, which could decrease the trading price of our common stock.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Several provisions of our Amended and Restated Certificate of Incorporation, Bylaws and Delaware law may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable. These include, but are not limited to, provisions that:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Only our board of directors may fill board vacancies;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Permit us to issue blank check preferred stock&#894;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Prevent stockholders from calling special meetings;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Maintain a plurality voting standard for our board of directors;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Does not include an opt out of Delaware anti-takeover law;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Require stockholders to follow certain advance notice and disclosure requirements in order to propose business or nominate directors at an annual or special meeting&#894; and</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Limit our ability to enter into business combination transactions with certain stockholders.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">These and other provisions of our Amended and Restated Certificate of Incorporation, Bylaws and Delaware law may discourage, delay or prevent certain types of transactions involving an actual or a threatened acquisition or change in control of us, including unsolicited takeover attempts, even though the transaction may offer our stockholders the opportunity to sell their shares of our common stock at a price above the prevailing market price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>We may not regain compliance with the continued listing requirements of The Nasdaq Capital Market.</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As previously reported on our Current Report on Form 8-K filed on January 15, 2025, the Company received a deficiency letter from the Nasdaq Listing Qualifications Department (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company&#8217;s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the &#8220;Minimum Bid Price Requirement&#8221;). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been given 180 calendar days, or until July 14, 2025, to regain compliance with the Minimum Bid Price Requirement. If at any time before July 14, 2025, the bid price of the Company&#8217;s common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Staff will provide written confirmation that the Company has achieved compliance.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement, including initiating a reverse stock split. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement or will otherwise be in compliance with other Nasdaq Listing Rules.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Further, &#160;as previously reported on our Current Report on Form 8-K filed on March 13, 2025, the Company notified the Staff of Nasdaq that the Company no longer complies with Nasdaq&#8217;s independent director requirement (&#8220;Independent Director Requirement&#8221;)&#160;as set forth in Nasdaq Listing Rule 5605(b)(1), which requires a majority of the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) to be comprised of Independent Directors as defined in Nasdaq Listing Rule 5605(a)(2). On that same date, the Company received a letter from Nasdaq confirming the foregoing (the &#8220;Letter&#8221;).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">45</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Consistent with Nasdaq Listing Rule 5605(b)(1)(A), the Letter provides that the Company is eligible for a cure period in which to regain compliance with Nasdaq Listing Rule 5605(b)(1). This cure period will expire at the earlier of the Company&#8217;s next annual meeting of stockholders or March 9, 2026; or if the Company&#8217;s next annual meeting is held before September 8, 2025, then the Company must evidence compliance no later than September 8, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company intends to elect an additional Independent Director to the Board as soon as practicable and prior to the expiration of this cure period. However, there can be no assurance that the Company will successfully regain compliance with Nasdaq Listing Rule 5605(b)(1) within the applicable cure period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Minimum Bid Price Requirement and Independent Director Requirement deficiencies have no immediate effect on the listing or trading of the Company&#8217;s common stock, which will continue to be listed and traded on The Nasdaq Capital Market under the symbol &#8220;SCWO,&#8221; subject to the Company&#8217;s compliance with the other Nasdaq listing requirements.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT2">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">None</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT3">Item 3. Defaults Upon Senior Securities.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">None.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT4">Item 4. Mine Safety Disclosures.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">Not applicable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT5">Item 5. Other Information.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">(a) None.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">(b) None.</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 45px">(c) During the fiscal quarter ended March 31, 2025, none of our directors or officers informed us of the adoption, modification or termination of a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement,&#8221; as those terms are defined in Item 408(a) of Regulation S-K.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 45px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">46</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span class="atag" style="display: inline" id="IT6">Item 6. Exhibits.</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(a)</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exhibits</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160; </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="width:8%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex101.htm">10.1&#160;</a></p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex101.htm">Amendment No. 1 to the License Agreement dated as of April 16, 2021 between 374Water Inc. and Duke University</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex102.htm">10.2</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex102.htm">Employment Agreement dated as of March 31, 2025 &#160;between 374Water Inc. and Rajesh Melkote.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex311.htm">31.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex312.htm">31.2</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex321.htm">32.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex321.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex322.htm">32.2</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="scwo_ex322.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.INS</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL INSTANCE DOCUMENT</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.SCH</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL TAXONOMYEXTENSION SCHEMA</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.CAL</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL TAXONOMYEXTENSION CALCULATION LINKBASE</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.DEF</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL TAXONOMYEXTENSION DEFINITION LINKBASE</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.LAB</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL TAXONOMYEXTENSION LABEL LINKBASE</p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">101.PRE</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">XBRL TAXONOMYEXTENSION PRESENTATION LINKBASE</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">47</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span class="atag" style="display: inline" id="SIG">SIGNATURES</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td>&#160;</td><td colspan="2"><strong>374WATER INC</strong></td><td/></tr><tr style="height:15px"><td style="width:50%;">&#160;</td><td style="width:3%;">&#160;</td><td style="width:35%;">&#160;</td><td style="width:12%;">&#160;</td></tr><tr style="height:15px"><td>Dated: May 15, 2025</td><td>By:</td><td style="BORDER-BOTTOM: black 1px solid;">/s/ Christian Gannon</td><td/></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td>Christian Gannon</td><td>&#160;</td></tr><tr style="height:15px"><td>&#160;</td><td>&#160;</td><td>Chief Executive Officer</td><td>&#160;</td></tr><tr style="height:15px"><td>&#160;</td><td>&#160;</td><td>&#160;</td><td>&#160;</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Dated: May 15, 2025</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">By:</p></td><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="font-size:10pt;font-family:times new roman;margin:0px">/s/ Russell Kline</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Russell Kline</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">48</td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td><em><a href="#INDEX">Table of Contents</a></em></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exhibit Index</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">49</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>scwo_ex101.htm
<DESCRIPTION>LICENSE AGREEMENT
<TEXT>
<html><head><title>scwo_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_ex101img1.jpg">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="scwo_ex101img2.jpg">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-ALIGN: center; TEXT-INDENT: 0px;">2</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>scwo_ex102.htm
<DESCRIPTION>EMPLOYMENT AGREEMENT
<TEXT>
<html><head><title>scwo_ex102.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>EMPLOYMENT AGREEMENT</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">THIS EMPLOYMENT AGREEMENT (&#8220;<u>Agreement</u>&#8221;) is made and entered into as of March 31, 2025 (the &#8220;<u>Effective Date</u>&#8221;), between 374WATER INC., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and <strong>RAJESH MELKOTE</strong>, an individual (the &#8220;<u>Executive</u>&#8221;).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><u>BACKGROUND</u></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"></td> <td style="width:3%;vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">A.</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">The Executive possesses knowledge and skills which the Company believes will be of substantial benefit to its operations and success, and the Company desires to employ the Executive on the terms and conditions set forth below.</p></td></tr> <tr style="height:15px"> <td></td> <td></td> <td></td></tr> <tr style="height:15px"> <td></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">B.</p></td> <td style="vertical-align:top;"> <p style="text-align:justify;margin:0px 0px 0px 0in">The Executive is willing to make the Executive&#8217;s services available to the Company on the terms and conditions set forth below.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><u></u>&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><u>AGREEMENT</u><strong><u></u></strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">NOW, THEREFORE, in consideration of the premises and mutual covenants set forth herein, the parties agree as follows:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Employment</u>. The Company hereby agrees to employ the Executive and the Executive hereby agrees to serve the Company on the terms and conditions set forth herein.&nbsp;&nbsp; Subject to any pre-employment requirements, the Executive&#8217;s employment will commence on March 31, 2025, or such other date as the Executive and the Company may agree (the &#8220;<u>Start Date</u>&#8221;).&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Duties of Executive; Place of Performance</u>. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) <em>Title and Duties</em>. During the Employment Period (as defined in Section 3, below), the Executive shall serve as Chief Technology Officer of the Company. The Executive shall diligently perform all services reasonably required of the Executive in the Executive&#8217;s capacity as Chief Technology Officer. Executive will have all of the duties, responsibilities and authority commensurate with the position of Chief Technology Officer of a comparable company, consistent with applicable law and the authorizations and instructions given from time to time by the Company&#8217;s Preident and Chief Executive Officer (&#8220;CEO&#8221;).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) <em>Outside Activities</em>. During the Employment Period, the Executive will be expected to devote Executive&#8217;s full working time and attention to the business of the Company, and Executive will not render services to any other business without the prior approval of the CEO. Notwithstanding the foregoing, Executive may manage personal investments, participate in civic, charitable, and academic activities (if in a limited, non-leadership capacity unless a larger role is approved by the CEO), and, subject to prior approval by the CEO, serve on the board of directors (and any committees) and/or as an advisor of other for-profit companies, provided that such activities do not at the time the activity or activities commence or thereafter (a) create an actual or potential business or fiduciary conflict of interest or (b) individually or in the aggregate, interfere materially with the performance of Executive&#8217;s duties to the Company.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">1</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(c) <em>Additional Conditions</em>. In addition, the Executive shall act in accordance with (i) standing instructions for the position which may be issued by the CEO from time to time; (ii) all reasonable and lawful requests, directions and/or restrictions imposed by the CEO; and (iii) all policies of the Company as prescribed from time to time. Upon termination of employment, the Executive shall return all Company equipment and other Company property in the Executive&#8217;s possession, custody or control.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(d) <em>Executive&#8217;s Location</em>. During the Employment Period, the Executive&#8217;s location of employment will be Executive&#8217;s home office in Massachusetts unless otherwise agreed by the Executive and the Company. The Executive acknowledges that the position of Chief Technology Officer requires domestic and international travel.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Employment Period</u>. The Executive shall be employed by the Company commencing on the Start Date. The Executive&#8217;s employment by the Company shall continue until this Agreement and the Executive&#8217;s employment are terminated pursuant to Section 7 below (the &#8220;<u>Employment Period</u>&#8221;). For all purposes of the Agreement, no termination of the Executive&#8217;s employment shall be deemed to have occurred if the Executive is transferred during the Employment Period to any business entity which is an Affiliate of the Company. As used in this Agreement, the term &#8220;<u>Affiliate</u>&#8221; means, with respect to any specified person or entity (&#8220;<u>Person</u>&#8221;), any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Compensation; Benefits</u>. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) <em><u>Base Salary</u></em>. The Executive shall receive a base salary (the &#8220;<u>Base Salary</u>&#8221;) of $300,000 per year, subject to applicable deductions, withholding and other taxes as shall be required by applicable law. The Base Salary shall be payable biweekly in accordance with the Company&#8217;s standard payroll schedule and procedures, and will be pro-rated for the current year, as well as any other partial year of employment. Thereafter, Executive&#8217;s Base Salary shall be periodically reviewed as a part of the Company&#8217;s regular review of compensation, and will be determined by either the CEO or the Compensation Committee (the &#8220;<u>Compensation Committee</u>&#8221;) of the Board of Directors (the &#8220;<u>Board</u>&#8221;). Any increased base salary shall thereafter constitute the Base Salary for purposes hereof.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) <em><u>Target Bonus</u></em>. Executive will be eligible for an annual bonus (the &#8220;<u>Annual Bonus</u>&#8221;) with a target amount equal to 50% of Executive&#8217;s then-current annual Base Salary (the &#8220;<u>Target Bonus</u>&#8221;). The Annual Bonus objectives and performance criteria shall be determined in consultation between Executive and the CEO on an annual basis.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(c) <em><u>Benefits &amp; Vacation</u></em>. Executive will be entitled to participate in all employee retirement (401(k)), insurance, benefit and paid time off programs of the Company, including, but not limited to, any long-term incentive program, as are in effect from time to time and in which other executive officers of the Company are eligible to participate, on terms no less favorable than any other executive officer.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Equity</u>.&nbsp; Pursuant to the terms of the Company&#8217;s 2021 Equity Incentive Plan, as amended (the &#8220;<u>Equity&nbsp;Plan</u>&#8221;) and subject to the vesting schedules set forth herein, Executive will receive the following Awards (as defined in the Equity Plan):&nbsp; (i) Restricted Stock Units (as defined in the Equity Plan) for up to 1,515,151 &nbsp;shares of Common Stock (as defined in the Equity Plan) and (ii) Options (as defined in the Equity Plan) to purchase up to 1,515,152 shares of the Company&#8217;s Common Stock (collectively, the &#8220;<u>Executive Awards</u>&#8221;).&nbsp;&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">2</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">The Executive Awards will be subject to Award Agreements (as defined in the Equity Plan) and vest as follows: (i) Restricted Stock Units for up to 757,576 shares of Common Stock and Options for up to 757,576 shares of Common Stock will vest over time in accordance with the terms set forth on <u>Exhibit A</u> attached hereto and (ii) Restricted Stock for up to 757,575 shares of Common Stock and Options for up to 757,576 shares of Common Stock will vest in accordance with the performance objective terms set forth on <u>Exhibit A</u> attached hereto.&nbsp; The per share exercise price of the Options will be the Fair Market Value (as defined in the Equity Plan) of the Common Stock determined as of the grant date of the Options.&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Expense Reimbursement</u>. Subject to such reasonable rules and guidelines as the Company may from time to time adopt for its executives generally, the Company will, in accordance with applicable Company policies and guidelines, reimburse Executive for all reasonable and necessary expenses incurred by Executive in connection with Executive&#8217;s performance of services on behalf of the Company during Executive&#8217;s employment with the Company, on terms no less favorable than for any other executive officer of the Company. Subject to the preceding, the reimbursement for all such expenses shall be paid pursuant to the Company&#8217;s policies and practices, following Executive&#8217;s submission of proper documentation for such expenses.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Termination</u>.&nbsp;&nbsp;&nbsp; Executive's employment may be terminated in any one of the following ways:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) <em><u>Death</u></em>. The Executive&#8217;s employment shall terminate upon the Executive&#8217;s death.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) <em><u>Disability</u></em>. The Company shall have the right to terminate the Executive&#8217;s employment as a result of the Executive&#8217;s Disability (as defined below). &#8220;<u>Disability</u>&#8221; shall mean (i) the Executive&#8217;s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for not less than three (3) months over any 12-month period; (ii) the Executive is, by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for not less than three (3) months over any 12-month period, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering the Executive; or (iii) the Executive is determined to be totally disabled by the Social Security Administration.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(c) <em><u>Termination by the Company For Cause</u></em>. The Company may terminate the employment upon written notice to Executive for &#8220;<u>Cause</u>&#8221;. For purposes hereof, &#8220;<u>Cause</u>&#8221; shall mean the occurrence of one or more of the following: (i) the conviction of, or plea of guilty or no contest to, a felony or a crime involving moral turpitude or any other action or inaction involving willful malfeasance or material fiduciary breach with respect to the Company or an affiliate; (ii) gross negligence or willful misconduct with respect to the Company or an affiliate; (iii) any act or acts of intentional dishonesty or willful misrepresentation (including by omission) of a material nature; (iv) material violation of the Company&#8217;s written policies or codes of conduct, including written policies related to discrimination, harassment, performance of illegal or unethical activities, and ethical misconduct; (v) Executive&#8217;s refusal to perform the material duties and responsibilities lawfully and ethically required to be performed by Executive under the terms of the definitive employment agreements; or (vi) a material breach by Executive of the definitive employment agreements or any other agreement to which Executive and the Company or its affiliates are parties (provided, however, failure alone to achieve any performance milestones will not be deemed a breach of this Agreement or a reason for Cause termination).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">Any event described in (iv) through (vi) above shall not constitute Cause unless the Company delivers to Executive a written notice of termination for Cause describing the applicable circumstances within ninety (90) days after the Company first learns of the existence of the applicable circumstances giving rise to Cause, and within thirty (30) days following delivery of such notice, Executive has failed to cure the circumstances giving rise to Cause to the extent such circumstances may be cured.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">3</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">In the event of a termination for Cause, as enumerated above, Executive shall have no right to any Separation Benefits (as defined in Subsection 6(e) below) or other compensation accruing after the effective date of termination (the &#8220;<u>Separation Date</u>&#8221;), and no right to bonus not yet due and payable at the time of termination.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(d) <em><u>Termination Without Cause</u></em>. At any time after the Start Date, the Company may terminate the Executive&#8217;s employment without Cause.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(e) <em><u>Resignation for Good Reason</u></em>. At any time after the Start Date, Executive may resign Executive&#8217;s employment with or without Good Reason. For purposes hereof, &#8220;<u>Good Reason</u>&#8221; means the occurrence of one or more of the following without Executive&#8217;s express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt of a written notice from Executive describing the applicable circumstances (which notice must be provided by Executive within ninety (90) days of Executive&#8217;s knowledge of the applicable circumstances): (i) any adverse change in Executive&#8217;s duties, responsibilities, authority, title, status or reporting structure; (ii) a reduction in Executive&#8217;s Base Salary or bonus opportunity unless a reduction is part of an overall cost reduction program that affects all senior executives of the Company and does not disproportionately affect Executive and does not reduce Executive&#8217;s Base Salary or bonus opportunity by more than ten percent (10%); (iii) a mandated geographical relocation of Executive&#8217;s principal current home office location by more than twenty-five (25) miles; or (iv) a breach by the Company of a material provision of this Agreement or any other agreement to which Executive and the Company or its Affiliates are parties.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">8<em>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><u>Effect of Termination</u>. </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) <em><u>Resignation from All Positions</u></em>. Effective as of the Separation Date, the Executive will be automatically deemed to resign from all Company-related positions, including as an officer and director of the Company and the Affiliates, as applicable, and shall execute all documentation necessary to effectuate such resignation(s).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) <em><u>Payment Through Termination</u></em>. Executive shall be entitled to receive all of the Base Salary earned and all reimbursements due through the Separation Date. Additional compensation subsequent to termination, if any, will be due and payable to Executive only to the extent and in the manner expressly provided in this Section 8. All other rights and obligations of the Company and Executive under this Agreement shall cease as of the Separation Date, except as otherwise provided in the Confidentiality Agreement (as defined in Section 12 of this Agreement) or any termination notice or separation and release agreement between the Executive and the Company.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(c) <em><u>Separation Benefits</u></em>. In the event the Company terminates Executive&#8217;s employment without Cause or Executive resigns for Good Reason, the Company shall, subject to the provisions of Subsection 8(d), provide Executive with the following benefits:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (i) the Company shall pay an amount equal to six (6) months of Executive&#8217;s then-current Base Salary, which shall be paid out in substantially equal installments in accordance with the Company&#8217;s payroll practice, as in effect at the time of Executive&#8217;s termination, over a six (6) month period following the Separation Date; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (ii) the Company will provide substantially similar coverage under the Company&#8217;s then current medical, health, and vision insurance plans to Executive and his eligible dependents for a period of six (6) months provided that Executive continues to make any required employee contribution; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">4</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iii) any earned but unpaid Annual Bonus with respect to any completed performance period or milestone; and </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (iv) if such separation occurs on the day of Executive&#8217;s first year anniversary of employment or after the first anniversary of the Start Date, (x) a pro-rated Annual Bonus for the fiscal year in which the employment is terminated equal to the pro-rated Annual Bonus that Executive would have received based on actual performance for such fiscal year if Executive had remained in the employ of the Company, to be paid at the same time annual bonuses are paid by the Company to other executives of the Company for the fiscal year in which Executive&#8217;s employment terminated, but no later than March 15<sup style="vertical-align:super">th</sup> of the calendar year following the calendar year in which Executive terminated employment, and (y) accelerated vesting with respect to the Executive Awards as if Executive had remained in the employ of the Company through the six month anniversary of the Separation Date.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (d)&nbsp;Notwithstanding anything to the contrary in this letter agreement, Executive shall not be entitled to any Separation Benefits unless, within twenty-one (21) or forty-five (45) days, as applicable, following the Separation Date, Executive executes and does not revoke a separation and release agreement in a form acceptable to the Company, which shall include a release against the Company, the Affiliates, and related persons and entities.&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">9. <u>Indemnification</u>. Promptly following the Start Date, the Executive and the Company will enter into an indemnification agreement in substantially the same form provided to other similarly situated officers and directors of the Company (the &#8220;<u>Indemnification Agreement</u>&#8221;). In addition, the Company shall maintain directors' and officers&#8217; liability insurance providing coverage to the Executive on terms that are no less favorable than the coverage provided to other similarly situated officers and directors of the Company.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;"><strong>10. <u>Governing Law</u>. This Agreement is to be construed and enforced according to the laws of the State of North Carolina. The Parties agree that any litigation arising out of or related to this Agreement will be brought exclusively in any state or federal court in North Carolina. Each Party (a) consents to the personal jurisdiction of said courts, (b) waives any defense or objection to any proceeding maintained in such courts based on venue or inconvenient forum, and (c) except as expressly permitted above, agrees not to bring any proceeding arising out of or relating to this Agreement in any other court.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">11. <u>Employee Confidentiality, Invention Assignment and Certain Covenants Agreement</u>. As a material inducement to the Company to enter into this Agreement, and as a condition to employment with the Company, the Executive will execute, deliver and comply with the Employee Confidentiality, Invention Assignment and Certain Covenants Agreement delivered to the Executive under separation cover (the &#8220;<u>Confidentiality Agreement</u>&#8221;).</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0.5in; text-align:justify;">12. <u>General Provisions</u>.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(a) <em><u>Entire Agreement</u></em>. This Agreement, together with the Confidentiality Agreement, the Indemnification Agreement and the equity grant agreements, reflects the entire agreement between the parties hereto with respect to the subject matter hereof and, upon its effectiveness, shall supersede all prior agreements, understandings and arrangements, both oral and written, between the Executive and the Company (or any of its Affiliates) with respect to such subject matter.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(b) <em><u>Notices</u></em>. All notices required or permitted to be given hereunder shall be in writing and shall be personally delivered by courier, sent by registered or certified mail, return receipt requested or sent by email addressed as set forth herein. All notices shall be deemed given on the date of delivery. Notice shall be sent:</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">5</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(i) if to the Company, addressed to: </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.85pt; text-align:justify;">374Water Inc. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.85pt; text-align:justify;">100 Southcenter Court, Suite 200</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.85pt; text-align:justify;">Morrisville, North Carolina 27560 </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.85pt; text-align:justify;">Attention: Legal Department&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 33.85pt; text-align:justify;">e-mail:&nbsp; &nbsp;&nbsp; legal@374water.com </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">(ii) if to the Executive, to the Executive's address as reflected on the payroll records of the Company or to such other address as either party hereto may from time to time give notice of to the other.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(c) <em><u>Binding Effect</u></em>. This Agreement shall be for the benefit of and binding upon the parties hereto and their respective heirs, personal representatives, legal representatives, successors and, where applicable, assigns, including, without limitation, any successor to the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(d) <em><u>Severability</u></em>. The invalidity of any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof, all of which are inserted conditionally on their being valid in law.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(e) <em><u>Waivers</u></em>. The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or violation.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(f) <em><u>Representation</u></em>. Executive confirms that he has been individually represented by legal counsel of his own choosing in negotiating the terms of this Agreement and the Confidentiality Agreement.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(g) <em><u>Section 409A</u></em>. The intent of the parties is that payments and benefits under this Agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended, and the guidance issued thereunder (&#8220;<u>Section 409A</u>&#8221;) and, accordingly, to the maximum extent permitted, all provisions of this Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A. Executive is hereby advised to seek independent advice from Executive&#8217;s tax advisor(s) with respect to any payments or benefits under this Agreement. Notwithstanding the foregoing, the Company does not guarantee the tax treatment of any payments or benefits provided under this Agreement, whether pursuant to the Code, federal, state, local or foreign tax laws and regulations.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(h) <em><u>Section Headings</u></em>. The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(i) <em><u>Employment Eligibility Verification</u></em>. In accordance with federal law, Executive will be required to provide to the Company documentary evidence of Executive&#8217;s identity and eligibility for employment in the United States. Such documentation must be provided to the Company within three (3) business days of the Start Date.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 90px; text-align:justify;">(j) <em><u>Execution</u></em>. This Agreement may be executed in separate counterparts, which taken together will constitute one agreement. Signatures to this Agreement transmitted via electronic mail, Docusign or similar platforms shall be valid and effective to bind the party so signing.</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">[<em>Signatures Begin on Following Page.</em>]</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">6</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the Effective Date.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td>&nbsp;</td> <td colspan="2"><strong>374WATER INC.</strong></td> <td></td></tr> <tr style="height:15px"> <td style="width:47%;">&nbsp;</td> <td style="width:3%;">&nbsp;</td> <td style="width:30%;">&nbsp;</td> <td style="width:15%;">&nbsp;</td></tr> <tr style="height:15px"> <td></td> <td>By:</td> <td style="BORDER-BOTTOM: black 1px solid;">/s/ Christian Gannon</td> <td></td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td> <td>Name: Christian Gannon <p style="margin:0px">Title: President and Chief Executive Officer</p></td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td>&nbsp;</td> <td>&nbsp;</td> <td></td> <td>&nbsp;</td></tr> <tr style="height:15px"> <td><strong>EXECUTIVE</strong> <p style="margin:0px">&nbsp;</p> <p style="margin:0px">/s/ Rajesh Melkote____________________</p></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">7</td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>EXHIBIT A</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Equity Award Time and Performance-Based Vesting Terms</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font-size:10pt;border-right:#000000 1px solid;border-bottom:#000000 1px solid;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:18%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Number</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:28%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Vested Amount</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:32%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Vesting Schedule/Milestone</strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:19%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Due Date</strong></p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:18%;"> <p style="margin:0px 0px 0px 0in">Time Vesting</p> <p style="margin:0px">&nbsp;</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:28%;"> <p style="text-align:center;margin:0px 0px 0px 0in">Restricted Stock Units:</p> <p style="text-align:center;margin:0px 0px 0px 0in">757,576 shares</p> <p style="text-align:center;margin:0px">&nbsp;</p> <p style="text-align:center;margin:0px 0px 0px 0in">Options:</p> <p style="text-align:center;margin:0px 0px 0px 0in">757,576 shares</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:32%;vertical-align:bottom;"> <p style="margin:0px 0px 0px 0in">(a) 25% vesting on the first annual anniversary of Executive&#8217;s Start Date of employment and (b) the balance vesting equally on the last day of every month thereafter over the following 36 months.</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:19%;vertical-align:bottom;"> <p style="text-align:right;margin:0px 0px 0px 0in">N/A</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:18%;"> <p style="margin:0px 0px 0px 0in">Milestone 1</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:28%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in">Restricted Stock Units:</p> <p style="text-align:center;margin:0px 0px 0px 0in">378,788 shares</p> <p style="text-align:center;margin:0px">&nbsp;</p> <p style="text-align:center;margin:0px 0px 0px 0in">Options:</p> <p style="text-align:center;margin:0px 0px 0px 0in">378,788 shares</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:32%;vertical-align:bottom;"> <p style="margin:0px 0px 0px 0in">Fiscal year end completed with operational profit<sup style="vertical-align:super">1</sup> (cash based).</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:19%;vertical-align:bottom;"> <p style="text-align:right;margin:0px 0px 0px 0in">None</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:18%;"> <p style="margin:0px 0px 0px 0in">Milestone 2</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:28%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in">Restricted Stock Units:</p> <p style="text-align:center;margin:0px 0px 0px 0in">378,787 shares</p> <p style="text-align:center;margin:0px">&nbsp;</p> <p style="text-align:center;margin:0px 0px 0px 0in">Options:</p> <p style="text-align:center;margin:0px 0px 0px 0in">378,788 shares </p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:32%;vertical-align:bottom;"> <p style="margin:0px 0px 0px 0in">Equal to or greater than $100M annual revenue, with linear interpolation applying between $0M annual revenue (no vesting) and $100M annual revenue (100% vesting), so long as annual revenue is at least $15M. </p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:19%;vertical-align:bottom;"> <p style="text-align:right;margin:0px 0px 0px 0in">12/31/2028</p> <p style="text-align:right;margin:0px 0px 0px 0in">(1)</p></td></tr> <tr style="height:15px"> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:18%;"> <p style="margin:0px 0px 0px 0in"><strong>Total Time and Performance-Based Equity Grants </strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:28%;vertical-align:bottom;"> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Restricted Stock Units:</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>1,515,151 shares</strong></p> <p style="text-align:center;margin:0px">&nbsp;</p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>Options:</strong></p> <p style="text-align:center;margin:0px 0px 0px 0in"><strong>1,515,152 shares </strong></p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:32%;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td> <td style="BORDER-TOP: #000000 1px solid; BORDER-LEFT: #000000 1px solid;width:19%;"> <p style="text-align:center;margin:0px 0px 0px 0in">-</p></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">(1)&nbsp; For purposes of illustration, linear interpolation will be calculated as follows:&nbsp; If annual revenue equaled $13 million, no vesting would occur.&nbsp; If annual revenue equaled $20 million, 20% vesting would occur.&nbsp; If annual revenue equaled $20 million the next year, no additional vesting would occur.&nbsp;&nbsp; If annual revenue instead equaled $30 million the next year, an additional 10% vesting would.&nbsp; If annual revenue equaled $60 million the year after that, an additional 30% vesting would occur.&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><sup style="vertical-align:super"><sup style="vertical-align:super">[1]</sup></sup> &#8220;Operating profit&#8221; means an amount equal to the remainder of (i) consolidated net income for such period, inclusive (i.e., without deduction with respect to) of (a) non-operating consolidated interest expense (excluding interest expense relating to the acquisition of non-RDE equipment), (b) income tax expense determined on a consolidated basis in accordance with GAAP, (c) research, development and engineering (RDE) (RDE will not be included as part of the &#8220;operating profit&#8221; calculation prior to the calculation for the fiscal year ended December 31, 2026), (d) any unusual or infrequently items as determined in accordance with GAAP resulting in losses and charges or other non-recurring items for such period, (e) all non-cash expenses related to Board, employee, or consultant compensation, (f) all other non-cash charges for such period (excluding any non-cash charge in respect of an item that was included in consolidated net income in a prior period and any non-cash charge that relates to the write-down or write-off of inventory and non-cash employee or vendor stock compensation), and (g) other costs to which the Board agrees, determined on a consolidated basis in accordance with GAAP, in each case for such period; <em>less</em> (ii) to the extent included in determining consolidated net income for such period, and without duplication, (a) unusual gains and (b) non-cash gains, excluding any non-cash gains that represent the reversal of any accrual of, or cash reserve for, anticipated cash items in any prior period (other than any such accruals or cash reserves that have been added back to consolidated net income in calculating operational profit in accordance with this definition).&nbsp; </p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;text-align:center;">8</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>scwo_ex311.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>scwo_ex311.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;"><strong>EXHIBIT 31.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATION </strong><strong>OF PRINCIPAL </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>EXECUTIVEOFFICER</strong><strong> </strong><strong>RULE13a-14(a)/15d-14(a)</strong><strong> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATIONS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I, Christian Gannon, certify that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I have reviewed this Form 10-Q of 374Water Inc. for the quarterly period ending March 31, 2025;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table>&nbsp; <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">c)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">d)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting;</p></td></tr></table>&nbsp; <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">5.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function):</p></td></tr></table>&nbsp; <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: May 15, 2025</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: </p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Christian Gannon</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">(Principal Executive Officer)</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>scwo_ex312.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>scwo_ex312.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 31.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATION OF PRINCIPAL FINANCIAL </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>OFFICER RULE13a-14(a)/15d-14(a) </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATIONS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="MARGIN: 0px; text-align:justify;">I, Russell Kline, certify that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">I have reviewed this Form 10-Qof 374Water Inc. for the quarterly period ending March 31, 2025;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">4.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">c)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">d)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">5.</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function):</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin:0px">&nbsp; </p> <p style="margin:0px"> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">a)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">b)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date: May 15, 2025</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: </p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Russell Kline</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>scwo_ex321.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>scwo_ex321.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 32.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATION OF PRINCIPAL EXECUTIVEOFFICER AND PRINCIPAL FINANCIAL OFFICER</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PURSUANT</strong><strong> </strong><strong>TO</strong><strong> </strong><strong>18</strong><strong> </strong><strong>U.S.C.</strong><strong> </strong><strong>SECTION</strong><strong> </strong><strong>1350,</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with the Form 10-Q of 374Water Inc. for 374Water Inc., (the &#8220;Company&#8221;) for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), <em>Christian Gannon </em>, Interim Chief Executive Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: May 15, 2025</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: </p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Christian Gannon</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Executive Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>scwo_ex322.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<html><head><title>scwo_ex322.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 32.2</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CERTIFICATION OF PRINCIPAL EXECUTIVEOFFICER AND PRINCIPAL FINANCIAL OFFICER</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>PURSUANT</strong><strong> </strong><strong>TO</strong><strong> </strong><strong>18</strong><strong> </strong><strong>U.S.C.</strong><strong> </strong><strong>SECTION</strong><strong> </strong><strong>1350,</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with the Form 10-Q of 374Water Inc. for 374Water Inc., (the &#8220;Company&#8221;) for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), Adrienne Anderson, Chief Financial Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(1)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</p></td></tr> <tr style="height:15px"> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td> <td> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">(2)</p></td> <td style="vertical-align:top;"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: May 15, 2025</p></td></tr></table> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp; <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:3%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">By: </p></td> <td style="BORDER-BOTTOM: #000000 1px solid;width:35%;"> <p style="font-size:10pt;font-family:times new roman;margin:0px"><em>/s/ Russell Kline</em></p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">Chief Financial Officer</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr></table></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>scwo-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/15/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:scwo="http://scwo.com/20250331" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://scwo.com/20250331">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://scwo.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
        <link:definition>110200 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
        <link:definition>110201 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" id="CondensedConsolidatedStatementsOfOperationsUnaudited">
        <link:definition>124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" id="CondensedConsolidatedChangesInStockholdersEquityUnaudited">
        <link:definition>148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" id="CondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/InsiderTradingArragements" id="InsiderTradingArragements">
        <link:definition>995445 - Disclosure - Insider Trading Arragements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" id="NatureOfBusinessAndPresentationOfFinancialStatements">
        <link:definition>995446 - Disclosure - Nature of Business and Presentation of Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>995447 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" id="LiquidityCapitalResourcesAndGoingConcern">
        <link:definition>995448 - Disclosure - Liquidity Capital Resources and Going Concern</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/InventoryNet" id="InventoryNet">
        <link:definition>995449 - Disclosure - Inventory, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/Revenue" id="Revenue">
        <link:definition>995450 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquity" id="StockholderEquity">
        <link:definition>995451 - Disclosure - Stockholder Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>995452 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995453 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SegmentReporting" id="SegmentReporting">
        <link:definition>995454 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995455 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995456 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995457 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/InventoryTables" id="InventoryTables">
        <link:definition>995458 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RevenueTables" id="RevenueTables">
        <link:definition>995459 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityTables" id="StockholderEquityTables">
        <link:definition>995460 - Disclosure - Stockholder Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
        <link:definition>995461 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" id="SummaryOfSignificantAccountingPoliciesDetails1">
        <link:definition>995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
        <link:definition>995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" id="LiquidityCapitalResourcesAndGoingConcernDetailsNarrative">
        <link:definition>995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/InventoryDetails" id="InventoryDetails">
        <link:definition>995465 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RevenueDetails" id="RevenueDetails">
        <link:definition>995466 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RevenueDetails1" id="RevenueDetails1">
        <link:definition>995467 - Disclosure - Revenue (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RevenueDetails2" id="RevenueDetails2">
        <link:definition>995468 - Disclosure - Revenue (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RevenueDetailsNarrative" id="RevenueDetailsNarrative">
        <link:definition>995469 - Disclosure - Revenue (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityDetails" id="StockholderEquityDetails">
        <link:definition>995470 - Disclosure - Stockholder Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityDetails1" id="StockholderEquityDetails1">
        <link:definition>995471 - Disclosure - Stockholder Equity (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityDetails2" id="StockholderEquityDetails2">
        <link:definition>995472 - Disclosure - Stockholder Equity (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityDetails3" id="StockholderEquityDetails3">
        <link:definition>995473 - Disclosure - Stockholder Equity (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/StockholderEquityDetailsNarrative" id="StockholderEquityDetailsNarrative">
        <link:definition>995474 - Disclosure - Stockholder Equity (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
        <link:definition>995475 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
        <link:definition>995476 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://scwo.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
        <link:definition>995477 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="scwo-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
  <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
  <element id="scwo_AccretionOfStockBasedCompensationOptionsAmount" name="AccretionOfStockBasedCompensationOptionsAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" name="AccretionOfStockBasedCompensationRestrictedStockAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_InventoryReserveIncreased" name="InventoryReserveIncreased" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IncreaseDecreaseInProvisionForLossOnContracts" name="IncreaseDecreaseInProvisionForLossOnContracts" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenueDisclosureTextBlock" name="RevenueDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" name="AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" name="NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ScheduleOfDepreciationExpenseTableTextBlock" name="ScheduleOfDepreciationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ScheduleOfRevenueByTypeTableTextBlock" name="ScheduleOfRevenueByTypeTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock" name="ScheduleOfUnearnedRevenueActivityTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock" name="ScheduleOfUnbilledAccountsReceivableTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_CostOfRevenues" name="CostOfRevenues" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_GeneralAndAdministrative" name="GeneralAndAdministrative" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_OtherStockBasedCompensation" name="OtherStockBasedCompensation" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenueReceiveAsConsideration" name="RevenueReceiveAsConsideration" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AllocatedTransactionPriceDuringCustomerContract" name="AllocatedTransactionPriceDuringCustomerContract" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DuringCustomerContractRemainingPerformanceObligation" name="DuringCustomerContractRemainingPerformanceObligation" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DescriptionOfCapitalizedCost" name="DescriptionOfCapitalizedCost" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ContractCostsOnDemoContract" name="ContractCostsOnDemoContract" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ConcentrationsOfCreditRisk" name="ConcentrationsOfCreditRisk" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ProceedFromAtTheMarketOffering" name="ProceedFromAtTheMarketOffering" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ProceedsFromCommonStockAndWarrantsShares" name="ProceedsFromCommonStockAndWarrantsShares" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenuePercentage" name="RevenuePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PremiumsRevenuePercentage" name="PremiumsRevenuePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_UnearnedRevenue" name="UnearnedRevenue" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_BillingsDeferredUnearnedRevenue" name="BillingsDeferredUnearnedRevenue" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RefundableDepositReturned" name="RefundableDepositReturned" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ServicesPerformedButUnbilled" name="ServicesPerformedButUnbilled" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ServicesBilled" name="ServicesBilled" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PerformanceBasedRestrictedStockUnits" name="PerformanceBasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_VestingRestrictedStockUnitsRecognizedPeriod" name="VestingRestrictedStockUnitsRecognizedPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_OtherLaborAndRelatedExpense" name="OtherLaborAndRelatedExpense" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_GrantDateFairValueOfRestrictedStock" name="GrantDateFairValueOfRestrictedStock" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" name="PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_OptionsGranted" name="OptionsGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_IssuanceOfShares" name="IssuanceOfShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_StockOptionsIssued" name="StockOptionsIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_CommonSharesForIssuanceRemaining" name="CommonSharesForIssuanceRemaining" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_MarketPriceAndExercisePriceDifference" name="MarketPriceAndExercisePriceDifference" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AverageGrantDateFairValue" name="AverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_NumberOfOptionIncludePerformanceConditions" name="NumberOfOptionIncludePerformanceConditions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenueTarget" name="RevenueTarget" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AchiveRevenueTarget" name="AchiveRevenueTarget" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_AnnualRevenueAchiveForFiscalYear2026" name="AnnualRevenueAchiveForFiscalYear2026" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" name="RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PaymentOfLegalSettlementAmount" name="PaymentOfLegalSettlementAmount" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_PotentialLossesAssociatedWithComplaints" name="PotentialLossesAssociatedWithComplaints" nillable="true" xbrli:balance="debit" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_DescriptionOfBoardOfDirectorsEquityCompensation" name="DescriptionOfBoardOfDirectorsEquityCompensation" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_ShareBasedRestrictedStockUnitsGranted" name="ShareBasedRestrictedStockUnitsGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
  <element id="scwo_RevenueAbstract" name="RevenueAbstract" nillable="true" abstract="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
  <element name="TwoCustomerMember" id="scwo_TwoCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RevenueMember" id="scwo_RevenueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OptionsMember" id="scwo_OptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="UnvestedRestrictedStockMember" id="scwo_UnvestedRestrictedStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="OneCustomerMember" id="scwo_OneCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ATMMember" id="scwo_ATMMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="EquipmentRevenuesMember" id="scwo_EquipmentRevenuesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ServiceRevenueMember" id="scwo_ServiceRevenueMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FullScaleDemonstrationMember" id="scwo_FullScaleDemonstrationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FinancialOfficerMember" id="scwo_FinancialOfficerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="keyEmployeeMember" id="scwo_keyEmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="RestrictedStockUnitsMember" id="scwo_RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="FormerEmployeesMember" id="scwo_FormerEmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwoZeroTwoOnePlanMember" id="scwo_TwoZeroTwoOnePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="EquipmentDemoSystemMember" id="scwo_EquipmentDemoSystemMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ThreeCustomerMember" id="scwo_ThreeCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="AirSCWOMember" id="scwo_AirSCWOMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TreatabilityStudyServicesMember" id="scwo_TreatabilityStudyServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TwentyTwentyFiveMember" id="scwo_TwentyTwentyFiveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="WarrantsMember" id="scwo_WarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="BottomMember" id="scwo_BottomMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="TopMember" id="scwo_TopMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="VestUponAchievementOfFifityPercentTargetMember" id="scwo_VestUponAchievementOfFifityPercentTargetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="VestUponAchievementOfFifityPercentRevenueTargetMember" id="scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="ServiceBasedOptionsMember" id="scwo_ServiceBasedOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="PerformanceBasedOptionMember" id="scwo_PerformanceBasedOptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>scwo-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/15/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address Address Line 2</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl_65fea3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl_65fea3" xml:lang="en-US">Condensed Consolidated Balance Sheets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl_b94497" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl_b94497" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl_e47a8b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl_e47a8b" xml:lang="en-US">Current Assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_071fc7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_071fc7" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl_ba5bc1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl_ba5bc1" xml:lang="en-US">Accounts receivable, net of allowance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="us-gaap_UnbilledReceivablesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledReceivablesCurrent" xlink:to="us-gaap_UnbilledReceivablesCurrent_lbl_afd61c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl_afd61c" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl_f64c0f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl_f64c0f" xml:lang="en-US">Other accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl_df6c2e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl_df6c2e" xml:lang="en-US">Inventory, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="us-gaap_ContractWithCustomerAssetNetCurrent_lbl_077a1d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerAssetNetCurrent_lbl_077a1d" xml:lang="en-US">Contract assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl_b4f3b7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl_b4f3b7" xml:lang="en-US">Prepaid expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_f9abbe" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl_f9abbe" xml:lang="en-US">Total Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl_11" xml:lang="en-US">[Assets, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl_06e71a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl_06e71a" xml:lang="en-US">Long-Term Assets:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl_ae4216" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl_ae4216" xml:lang="en-US">Property, and equipment, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_45cc1c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl_45cc1c" xml:lang="en-US">Intangible asset, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl_e40de4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl_e40de4" xml:lang="en-US">Right-of-use asset, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl_be6d48" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl_be6d48" xml:lang="en-US">Other assets</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl_50dfb8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl_50dfb8" xml:lang="en-US">Total Long-Term Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl_17" xml:lang="en-US">[Assets, Noncurrent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_6d488e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl_6d488e" xml:lang="en-US">Total Assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl_18" xml:lang="en-US">[Assets]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_2a681f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl_2a681f" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl_2d0781" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl_2d0781" xml:lang="en-US">Current Liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_8e1811" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl_8e1811" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="us-gaap_AccruedBonusesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedBonusesCurrent" xlink:to="us-gaap_AccruedBonusesCurrent_lbl_8516e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedBonusesCurrent_lbl_8516e8" xml:lang="en-US">Accrued bonuses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLossOnContracts" xlink:label="us-gaap_ProvisionForLossOnContracts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForLossOnContracts" xlink:to="us-gaap_ProvisionForLossOnContracts_lbl_443295" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForLossOnContracts_lbl_443295" xml:lang="en-US">Accrued contract loss provision</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="us-gaap_SettlementLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SettlementLiabilitiesCurrent" xlink:to="us-gaap_SettlementLiabilitiesCurrent_lbl_4327eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SettlementLiabilitiesCurrent_lbl_4327eb" xml:lang="en-US">Accrued legal settlement</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl_2bf744" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl_2bf744" xml:lang="en-US">Unearned revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl_d1b301" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl_d1b301" xml:lang="en-US">Operating lease liability</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl_70703f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl_70703f" xml:lang="en-US">Other liabilities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_1615da" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_1615da" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl_28" xml:lang="en-US">[Liabilities, Current]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl_f10d45" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl_f10d45" xml:lang="en-US">Long-Term Liabilities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl_ef260b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl_ef260b" xml:lang="en-US">Unearned revenue, less current portion</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl_cc29b5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl_cc29b5" xml:lang="en-US">Operating lease liability, less current portion</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl_284269" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl_284269" xml:lang="en-US">Total Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl_32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl_32" xml:lang="en-US">[Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_c9a10e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl_c9a10e" xml:lang="en-US">Commitments and contingencies (Note 9)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl_b04f5c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl_b04f5c" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl_356a20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl_356a20" xml:lang="en-US">Preferred stock: 50,000,000 shares authorized, par value $0.0001 per share, nil issued and outstanding at March 31, 2025 and December 31, 2024</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl_af3c3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl_af3c3a" xml:lang="en-US">Common stock: 200,000,000 authorized, par value $0.0001 per share, 144,682,963 and 144,301,977 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl_5ba5d1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl_5ba5d1" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_8849ec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_8849ec" xml:lang="en-US">Accumulated deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl_99db5d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl_99db5d" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_a101bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl_a101bc" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_40" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl_40" xml:lang="en-US">[Equity, Attributable to Parent]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_856a18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_856a18" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl_41" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl_41" xml:lang="en-US">[Liabilities and Equity]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl_368a2a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl_368a2a" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4e6fd9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl_4e6fd9" xml:lang="en-US">Common Stock, Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_97ebe2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl_97ebe2" xml:lang="en-US">Common Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl_a3b581" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl_a3b581" xml:lang="en-US">Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl_b86bb4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl_b86bb4" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_1a1aeb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl_1a1aeb" xml:lang="en-US">Preferred Stock, Par Value</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl_f88f5a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl_f88f5a" xml:lang="en-US">Preferred Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl_4ff0d5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl_4ff0d5" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl_081ac1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl_081ac1" xml:lang="en-US">Condensed Consolidated Statements of Operations (Unaudited)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_954ba2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl_954ba2" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl_e44b16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl_e44b16" xml:lang="en-US">Cost of revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl_af48e3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl_af48e3" xml:lang="en-US">Gross margin (deficit)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl_4" xml:lang="en-US">[Gross Profit]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl_3e4bf4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl_3e4bf4" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_c5f18e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_c5f18e" xml:lang="en-US">Research and development</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl_9164fb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl_9164fb" xml:lang="en-US">Compensation and related expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl_c6e132" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl_c6e132" xml:lang="en-US">Professional fees</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_7a492b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_7a492b" xml:lang="en-US">General and administrative</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_0ca199" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl_0ca199" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl_10" xml:lang="en-US">[Operating Expenses]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_82796d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl_82796d" xml:lang="en-US">Loss from Operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl_11" xml:lang="en-US">[Operating Income (Loss)]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl_9e38e6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl_9e38e6" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl_82e720" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeOther_lbl_82e720" xml:lang="en-US">Interest income</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl_f97cbc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl_f97cbc" xml:lang="en-US">Other income (expense)</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl_f236c9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl_f236c9" xml:lang="en-US">Total Other Income, net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl_15" xml:lang="en-US">[Nonoperating Income (Expense)]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_c01675" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_c01675" xml:lang="en-US">Net Loss before Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl_16" xml:lang="en-US">[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl_cc08ad" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl_cc08ad" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_dc701b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_dc701b" xml:lang="en-US">Net Loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl_18" xml:lang="en-US">[Net Income (Loss) Attributable to Parent]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl_5dfdf8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl_5dfdf8" xml:lang="en-US">Net Loss per Share - Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_61392e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl_61392e" xml:lang="en-US">Weighted Average Common Shares Outstanding - Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl_4c8d8c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl_4c8d8c" xml:lang="en-US">Condensed Consolidated Changes in Stockholders Equity (Unaudited)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl_0cf435" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl_0cf435" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl_3604d8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl_3604d8" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl_5dc974" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl_5dc974" xml:lang="en-US">Statement Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl_c8a908" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl_c8a908" xml:lang="en-US">Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl_7f8cc2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl_7f8cc2" xml:lang="en-US">Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl_9e3003" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl_9e3003" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl_9d1275" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl_9d1275" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl_3ac362" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl_3ac362" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_a642cc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesIssued_lbl_a642cc" xml:lang="en-US">Balance, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl_2" xml:lang="en-US">[Shares, Issued]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_524407" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl_524407" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_81880e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_81880e" xml:lang="en-US">Issuance of shares for services, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_07568d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl_07568d" xml:lang="en-US">Issuance of shares for services, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_c85f04" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl_c85f04" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_b2c0dd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_b2c0dd" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationOptionsAmount" xlink:label="scwo_AccretionOfStockBasedCompensationOptionsAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AccretionOfStockBasedCompensationOptionsAmount" xlink:to="scwo_AccretionOfStockBasedCompensationOptionsAmount_lbl_037fc1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AccretionOfStockBasedCompensationOptionsAmount_lbl_037fc1" xml:lang="en-US">Accretion of stock-based compensation - options</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" xlink:label="scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" xlink:to="scwo_AccretionOfStockBasedCompensationRestrictedStockAmount_lbl_f0044a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AccretionOfStockBasedCompensationRestrictedStockAmount_lbl_f0044a" xml:lang="en-US">Accretion of stock-based compensation - restricted stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_58a77b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_58a77b" xml:lang="en-US">Issuance of shares of common stock for option exercise, shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl_84451a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl_84451a" xml:lang="en-US">Issuance of shares of common stock for option exercise, amount</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl_847491" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesIssued_lbl_847491" xml:lang="en-US">Balance, shares</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl_f7fddb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl_f7fddb" xml:lang="en-US">Balance, amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl_2fc5b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl_2fc5b2" xml:lang="en-US">Condensed Consolidated Statements of Cash Flows (Unaudited)</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_e27c93" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl_e27c93" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl_5f698f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl_5f698f" xml:lang="en-US">Net loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_709de4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl_709de4" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl_99619d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl_99619d" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="us-gaap_OtherNoncashExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashExpense" xlink:to="us-gaap_OtherNoncashExpense_lbl_0d90e9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashExpense_lbl_0d90e9" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl_f05abd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl_f05abd" xml:lang="en-US">Issuance of common stock for services</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_937dca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_937dca" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl_8" xml:lang="en-US">[Share-Based Payment Arrangement, Noncash Expense]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_InventoryReserveIncreased" xlink:label="scwo_InventoryReserveIncreased" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_InventoryReserveIncreased" xlink:to="scwo_InventoryReserveIncreased_lbl_676169" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_InventoryReserveIncreased_lbl_676169" xml:lang="en-US">Increase in inventory reserve</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_d4ceff" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl_d4ceff" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_67731b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_67731b" xml:lang="en-US">Accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_11" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl_11" xml:lang="en-US">[Increase (Decrease) in Accounts Receivable]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:to="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl_8df723" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl_8df723" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:to="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl_12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInUnbilledReceivables_lbl_12" xml:lang="en-US">[Increase (Decrease) in Unbilled Receivables]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl_f3206f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl_f3206f" xml:lang="en-US">Other receivables</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl_13" xml:lang="en-US">[Increase (Decrease) in Other Receivables]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl_faa419" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl_faa419" xml:lang="en-US">Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl_14" xml:lang="en-US">[Increase (Decrease) in Inventories]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl_3da15f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl_3da15f" xml:lang="en-US">Contract assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl_15" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerAsset_lbl_15" xml:lang="en-US">[Increase (Decrease) in Contract with Customer, Asset]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_e280c6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_e280c6" xml:lang="en-US">Prepaid expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl_16" xml:lang="en-US">[Increase (Decrease) in Prepaid Expense]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl_48070f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl_48070f" xml:lang="en-US">Other assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl_17" xml:lang="en-US">[Increase (Decrease) in Other Operating Assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_1d5055" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_1d5055" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_18" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl_18" xml:lang="en-US">[Increase (Decrease) in Accounts Payable and Accrued Liabilities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl_86a5bd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl_86a5bd" xml:lang="en-US">Accrued bonus</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncreaseDecreaseInProvisionForLossOnContracts" xlink:to="scwo_IncreaseDecreaseInProvisionForLossOnContracts_lbl_fe09b8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_IncreaseDecreaseInProvisionForLossOnContracts_lbl_fe09b8" xml:lang="en-US">Accrued contract loss provision</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IncreaseDecreaseInProvisionForLossOnContracts" xlink:label="scwo_IncreaseDecreaseInProvisionForLossOnContracts" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IncreaseDecreaseInProvisionForLossOnContracts" xlink:to="scwo_IncreaseDecreaseInProvisionForLossOnContracts_lbl_20" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IncreaseDecreaseInProvisionForLossOnContracts_lbl_20" xml:lang="en-US">[Accrued contract loss provision]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_1cfbfb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_1cfbfb" xml:lang="en-US">Unearned revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_21" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl_21" xml:lang="en-US">[Increase (Decrease) in Deferred Revenue]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl_424b95" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl_424b95" xml:lang="en-US">Other liabilities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl_22" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl_22" xml:lang="en-US">[Increase (Decrease) in Other Operating Liabilities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl_1323e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl_1323e2" xml:lang="en-US">Operating lease liability</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl_23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl_23" xml:lang="en-US">[Increase (Decrease) in Operating Lease Liability]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_e2ed48" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_e2ed48" xml:lang="en-US">Net Cash Used In Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_24" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl_24" xml:lang="en-US">[Net Cash Provided by (Used in) Operating Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_f05168" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl_f05168" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_20576f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_20576f" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl_26" xml:lang="en-US">[Payments to Acquire Property, Plant, and Equipment]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_a5c3d6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_a5c3d6" xml:lang="en-US">Increase in intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_27" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl_27" xml:lang="en-US">[Payments to Acquire Intangible Assets]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_82ed92" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_82ed92" xml:lang="en-US">Net Cash Used In Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_28" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl_28" xml:lang="en-US">[Net Cash Provided by (Used in) Investing Activities]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_f722fa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl_f722fa" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl_59aec9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl_59aec9" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_5d61a1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_5d61a1" xml:lang="en-US">Net Cash Provided by Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_31" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl_31" xml:lang="en-US">[Net Cash Provided by (Used in) Financing Activities]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_1070a3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_1070a3" xml:lang="en-US">Net Decrease in Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_32" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl_32" xml:lang="en-US">[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_757a34" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_757a34" xml:lang="en-US">Cash and cash equivalents, Beginning of the Period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_5feb1f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl_5feb1f" xml:lang="en-US">Cash and cash equivalents, End of the Period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl_6b0088" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl_6b0088" xml:lang="en-US">SUPPLEMENTAL CASHFLOW DISCLOSURES:</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl_7f9886" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl_7f9886" xml:lang="en-US">Cash paid for interest</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl_24845b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl_24845b" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl_51f24a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl_51f24a" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl_e8ff34" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl_e8ff34" xml:lang="en-US">Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl_5de0ec" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl_5de0ec" xml:lang="en-US">Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl_52a28e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl_52a28e" xml:lang="en-US">Non Rule 10b5-1 Arragement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl_c0a201" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl_c0a201" xml:lang="en-US">Non Rule 10b5-1 Arragement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl_0272d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl_0272d0" xml:lang="en-US">Nature of Business and Presentation of Financial Statements</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_e6396f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_e6396f" xml:lang="en-US">Nature of Business and Presentation of Financial Statements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl_2" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl_94158c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl_94158c" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl_058a7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl_058a7f" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl_2" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl_7c10d2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl_7c10d2" xml:lang="en-US">Liquidity Capital Resources and Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl_cfc397" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl_cfc397" xml:lang="en-US">Liquidity, Capital Resources and Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl_4cf708" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl_4cf708" xml:lang="en-US">Inventory, Net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl_925982" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl_925982" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl_2" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="scwo_RevenueAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueAbstract" xlink:to="scwo_RevenueAbstract_lbl_5da9c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueAbstract_lbl_5da9c4" xml:lang="en-US">Revenue</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueDisclosureTextBlock" xlink:to="scwo_RevenueDisclosureTextBlock_lbl_db97da" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_RevenueDisclosureTextBlock_lbl_db97da" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueDisclosureTextBlock" xlink:label="scwo_RevenueDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueDisclosureTextBlock" xlink:to="scwo_RevenueDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueDisclosureTextBlock_lbl_2" xml:lang="en-US">[Revenue]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl_2eac39" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl_2eac39" xml:lang="en-US">Stockholder Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_23c19b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl_23c19b" xml:lang="en-US">Stockholder' Equity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl_cec316" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl_cec316" xml:lang="en-US">Related Party Transactions</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_0304e8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_0304e8" xml:lang="en-US">Related Party Transactions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl_2" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl_1d6c26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl_1d6c26" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl_2" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:to="us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_lbl_a634d2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_lbl_a634d2" xml:lang="en-US">Segment Reporting</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_b8609c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_b8609c" xml:lang="en-US">Segment Reporting</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl_2" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl_89bd52" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl_89bd52" xml:lang="en-US">Subsequent Events</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_0f9957" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_0f9957" xml:lang="en-US">Subsequent Events</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl_2" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl_5a0c29" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl_5a0c29" xml:lang="en-US">Use Of Estimates</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="us-gaap_ReceivablesPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl_d054d8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl_d054d8" xml:lang="en-US">Receivables</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl_ec4f0c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl_ec4f0c" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl_4" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl_d58abc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl_d58abc" xml:lang="en-US">Property and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl_2a6d92" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl_2a6d92" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl_6873b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl_6873b2" xml:lang="en-US">Revenue Recognition</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" xlink:label="scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" xlink:to="scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock_lbl_48a2ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock_lbl_48a2ca" xml:lang="en-US">Accrued Contract Loss Provision and Onerous Contracts</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl_123243" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl_123243" xml:lang="en-US">Research And Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl_cdfac0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl_cdfac0" xml:lang="en-US">Loss Per Share</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl_bb93aa" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl_bb93aa" xml:lang="en-US">Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl_417c8a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl_417c8a" xml:lang="en-US">Recent Accounting Pronouncements - Not Yet Adopted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl_0ecc3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl_0ecc3a" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfDepreciationExpenseTableTextBlock" xlink:label="scwo_ScheduleOfDepreciationExpenseTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ScheduleOfDepreciationExpenseTableTextBlock" xlink:to="scwo_ScheduleOfDepreciationExpenseTableTextBlock_lbl_79be7a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ScheduleOfDepreciationExpenseTableTextBlock_lbl_79be7a" xml:lang="en-US">Schedule of depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl_457483" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl_457483" xml:lang="en-US">Schedule Of Inventory</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfRevenueByTypeTableTextBlock" xlink:label="scwo_ScheduleOfRevenueByTypeTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ScheduleOfRevenueByTypeTableTextBlock" xlink:to="scwo_ScheduleOfRevenueByTypeTableTextBlock_lbl_365665" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ScheduleOfRevenueByTypeTableTextBlock_lbl_365665" xml:lang="en-US">Schedule Of revenue by type</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock" xlink:label="scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock" xlink:to="scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock_lbl_7ff90b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock_lbl_7ff90b" xml:lang="en-US">Schedule Of unearned revenue activity</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock" xlink:label="scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock" xlink:to="scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock_lbl_ea61a4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock_lbl_ea61a4" xml:lang="en-US">Schedule Of unbilled accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_80b699" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl_80b699" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl_b22a1a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl_b22a1a" xml:lang="en-US">Schedule of stock option assumtion</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl_6cc11b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl_6cc11b" xml:lang="en-US">Schedule of outstanding nonvested restricted stock</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl_e3d5eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl_e3d5eb" xml:lang="en-US">Schedule of warrant activity</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl_f85edb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl_f85edb" xml:lang="en-US">Property Plant And Equipment By Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl_849689" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl_849689" xml:lang="en-US">Computers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl_3c1e3d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl_3c1e3d" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="us-gaap_OfficeEquipmentMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficeEquipmentMember" xlink:to="us-gaap_OfficeEquipmentMember_lbl_8a0e1b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficeEquipmentMember_lbl_8a0e1b" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentDemoSystemMember" xlink:label="scwo_EquipmentDemoSystemMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_EquipmentDemoSystemMember" xlink:to="scwo_EquipmentDemoSystemMember_lbl_b50eb4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_EquipmentDemoSystemMember_lbl_b50eb4" xml:lang="en-US">Equipment - Demo System [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl_49f78a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl_49f78a" xml:lang="en-US">Total Property Plant And Equipment</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealEstateAccumulatedDepreciation" xlink:to="us-gaap_RealEstateAccumulatedDepreciation_lbl_24cc35" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RealEstateAccumulatedDepreciation_lbl_24cc35" xml:lang="en-US">Less: accumulated depreciations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAccumulatedDepreciation" xlink:label="us-gaap_RealEstateAccumulatedDepreciation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealEstateAccumulatedDepreciation" xlink:to="us-gaap_RealEstateAccumulatedDepreciation_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealEstateAccumulatedDepreciation_lbl_3" xml:lang="en-US">[SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl_9f02cd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl_9f02cd" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_CostOfRevenues" xlink:to="scwo_CostOfRevenues_lbl_d5de14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_CostOfRevenues_lbl_d5de14" xml:lang="en-US">Cost of revenues</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_CostOfRevenues" xlink:label="scwo_CostOfRevenues" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_CostOfRevenues" xlink:to="scwo_CostOfRevenues_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_CostOfRevenues_lbl_2" xml:lang="en-US">[Cost of revenues]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_GeneralAndAdministrative" xlink:to="scwo_GeneralAndAdministrative_lbl_d30d2f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_GeneralAndAdministrative_lbl_d30d2f" xml:lang="en-US">General and administrative</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_GeneralAndAdministrative" xlink:label="scwo_GeneralAndAdministrative" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_GeneralAndAdministrative" xlink:to="scwo_GeneralAndAdministrative_lbl_3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_GeneralAndAdministrative_lbl_3" xml:lang="en-US">[General and administrative]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl_07e5eb" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl_07e5eb" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl_daea62" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl_daea62" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl_05c9a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl_05c9a9" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl_b88804" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl_b88804" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl_26641b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl_26641b" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl_2bb9d7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl_2bb9d7" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoCustomerMember" xlink:label="scwo_TwoCustomerMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TwoCustomerMember" xlink:to="scwo_TwoCustomerMember_lbl_9b55e1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_TwoCustomerMember_lbl_9b55e1" xml:lang="en-US">Two Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueMember" xlink:label="scwo_RevenueMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueMember" xlink:to="scwo_RevenueMember_lbl_4235f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueMember_lbl_4235f5" xml:lang="en-US">Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="scwo_OptionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OptionsMember" xlink:to="scwo_OptionsMember_lbl_ad247c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OptionsMember_lbl_ad247c" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnvestedRestrictedStockMember" xlink:label="scwo_UnvestedRestrictedStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_UnvestedRestrictedStockMember" xlink:to="scwo_UnvestedRestrictedStockMember_lbl_1bf5d2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_UnvestedRestrictedStockMember_lbl_1bf5d2" xml:lang="en-US">Unvested Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OneCustomerMember" xlink:label="scwo_OneCustomerMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OneCustomerMember" xlink:to="scwo_OneCustomerMember_lbl_36f5f2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OneCustomerMember_lbl_36f5f2" xml:lang="en-US">One Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl_c60e85" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl_c60e85" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FullScaleDemonstrationMember" xlink:label="scwo_FullScaleDemonstrationMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_FullScaleDemonstrationMember" xlink:to="scwo_FullScaleDemonstrationMember_lbl_fa0475" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_FullScaleDemonstrationMember_lbl_fa0475" xml:lang="en-US">Full-scale demonstration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ThreeCustomerMember" xlink:label="scwo_ThreeCustomerMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ThreeCustomerMember" xlink:to="scwo_ThreeCustomerMember_lbl_2fd7ba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ThreeCustomerMember_lbl_2fd7ba" xml:lang="en-US">Three Customer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TreatabilityStudyServicesMember" xlink:label="scwo_TreatabilityStudyServicesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TreatabilityStudyServicesMember" xlink:to="scwo_TreatabilityStudyServicesMember_lbl_19c0e5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_TreatabilityStudyServicesMember_lbl_19c0e5" xml:lang="en-US">Treatability study services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="scwo_WarrantsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_WarrantsMember" xlink:to="scwo_WarrantsMember_lbl_1fe0f7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_WarrantsMember_lbl_1fe0f7" xml:lang="en-US">Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl_05d960" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl_05d960" xml:lang="en-US">Research and Development Cost</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherStockBasedCompensation" xlink:label="scwo_OtherStockBasedCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OtherStockBasedCompensation" xlink:to="scwo_OtherStockBasedCompensation_lbl_220072" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OtherStockBasedCompensation_lbl_220072" xml:lang="en-US">Stock based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl_063343" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Depreciation_lbl_063343" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueReceiveAsConsideration" xlink:label="scwo_RevenueReceiveAsConsideration" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueReceiveAsConsideration" xlink:to="scwo_RevenueReceiveAsConsideration_lbl_68f826" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueReceiveAsConsideration_lbl_68f826" xml:lang="en-US">Revenue receive as consideration</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnearnedPremiums" xlink:to="us-gaap_UnearnedPremiums_lbl_1cc01c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnearnedPremiums_lbl_1cc01c" xml:lang="en-US">Unearned revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnearnedPremiums" xlink:label="us-gaap_UnearnedPremiums" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnearnedPremiums" xlink:to="us-gaap_UnearnedPremiums_lbl_6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnearnedPremiums_lbl_6" xml:lang="en-US">[Unearned Premiums]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl_bf3922" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl_bf3922" xml:lang="en-US">Costs and expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AllocatedTransactionPriceDuringCustomerContract" xlink:label="scwo_AllocatedTransactionPriceDuringCustomerContract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AllocatedTransactionPriceDuringCustomerContract" xlink:to="scwo_AllocatedTransactionPriceDuringCustomerContract_lbl_e78fd2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AllocatedTransactionPriceDuringCustomerContract_lbl_e78fd2" xml:lang="en-US">Allocated transaction price</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DuringCustomerContractRemainingPerformanceObligation" xlink:label="scwo_DuringCustomerContractRemainingPerformanceObligation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DuringCustomerContractRemainingPerformanceObligation" xlink:to="scwo_DuringCustomerContractRemainingPerformanceObligation_lbl_994318" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DuringCustomerContractRemainingPerformanceObligation_lbl_994318" xml:lang="en-US">Remaining performance obligation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="us-gaap_CapitalizedContractCostNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalizedContractCostNet" xlink:to="us-gaap_CapitalizedContractCostNet_lbl_207c16" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalizedContractCostNet_lbl_207c16" xml:lang="en-US">Capitalized costs</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfCapitalizedCost" xlink:label="scwo_DescriptionOfCapitalizedCost" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DescriptionOfCapitalizedCost" xlink:to="scwo_DescriptionOfCapitalizedCost_lbl_ce6ee4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DescriptionOfCapitalizedCost_lbl_ce6ee4" xml:lang="en-US">Capitalized cost description</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ContractCostsOnDemoContract" xlink:label="scwo_ContractCostsOnDemoContract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ContractCostsOnDemoContract" xlink:to="scwo_ContractCostsOnDemoContract_lbl_9b2ddd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ContractCostsOnDemoContract_lbl_9b2ddd" xml:lang="en-US">Contract costs</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRecallExpense" xlink:label="us-gaap_InventoryRecallExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRecallExpense" xlink:to="us-gaap_InventoryRecallExpense_lbl_96d249" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRecallExpense_lbl_96d249" xml:lang="en-US">Inventory allowance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConcentrationsOfCreditRisk" xlink:to="scwo_ConcentrationsOfCreditRisk_lbl_800638" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_ConcentrationsOfCreditRisk_lbl_800638" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ConcentrationsOfCreditRisk" xlink:label="scwo_ConcentrationsOfCreditRisk" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ConcentrationsOfCreditRisk" xlink:to="scwo_ConcentrationsOfCreditRisk_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ConcentrationsOfCreditRisk_lbl_14" xml:lang="en-US">[Concentrations of Credit Risk]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_e61b65" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl_e61b65" xml:lang="en-US">Revenues</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnbilledReceivablesCurrent" xlink:to="us-gaap_UnbilledReceivablesCurrent_lbl_2c485e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_UnbilledReceivablesCurrent_lbl_2c485e" xml:lang="en-US">Unbilled receivables</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision" xlink:label="us-gaap_LossContingencyAccrualProvision" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualProvision" xlink:to="us-gaap_LossContingencyAccrualProvision_lbl_e2b0d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyAccrualProvision_lbl_e2b0d0" xml:lang="en-US">Contract loss provision</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl_440604" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl_440604" xml:lang="en-US">Antidilutive Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl_e598e7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl_e598e7" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ATMMember" xlink:label="scwo_ATMMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ATMMember" xlink:to="scwo_ATMMember_lbl_8296b5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ATMMember_lbl_8296b5" xml:lang="en-US">ATM [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_003b12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl_003b12" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInContinuingOperations_lbl_3c997b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInContinuingOperations_lbl_3c997b" xml:lang="en-US">Net Cash Used In Operations</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="us-gaap_Capital" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Capital" xlink:to="us-gaap_Capital_lbl_1c851a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Capital_lbl_1c851a" xml:lang="en-US">Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedFromAtTheMarketOffering" xlink:label="scwo_ProceedFromAtTheMarketOffering" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ProceedFromAtTheMarketOffering" xlink:to="scwo_ProceedFromAtTheMarketOffering_lbl_361981" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ProceedFromAtTheMarketOffering_lbl_361981" xml:lang="en-US">Net proceeds from ATM</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedsFromCommonStockAndWarrantsShares" xlink:label="scwo_ProceedsFromCommonStockAndWarrantsShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ProceedsFromCommonStockAndWarrantsShares" xlink:to="scwo_ProceedsFromCommonStockAndWarrantsShares_lbl_65234b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ProceedsFromCommonStockAndWarrantsShares_lbl_65234b" xml:lang="en-US">Net proceeds from common stock and warrants</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl_b82bcd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl_b82bcd" xml:lang="en-US">Common Stock, Shares issued</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl_1243ad" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl_1243ad" xml:lang="en-US">Raw materials</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl_080d52" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl_080d52" xml:lang="en-US">Work-in-process</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl_ffba76" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl_ffba76" xml:lang="en-US">Less: inventory reserves</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_lbl_4" xml:lang="en-US">[Inventory Valuation Reserves]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl_0b72df" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryNet_lbl_0b72df" xml:lang="en-US">Total</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis_lbl_c62b1e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis_lbl_c62b1e" xml:lang="en-US">Accounts Notes Loans And Financing Receivables By Billing Status Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentRevenuesMember" xlink:label="scwo_EquipmentRevenuesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_EquipmentRevenuesMember" xlink:to="scwo_EquipmentRevenuesMember_lbl_4eb50e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_EquipmentRevenuesMember_lbl_4eb50e" xml:lang="en-US">Equipment revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceRevenueMember" xlink:label="scwo_ServiceRevenueMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ServiceRevenueMember" xlink:to="scwo_ServiceRevenueMember_lbl_65bdf9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ServiceRevenueMember_lbl_65bdf9" xml:lang="en-US">Service revenue [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl_5b75ae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl_5b75ae" xml:lang="en-US">Revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenuePercentage" xlink:label="scwo_RevenuePercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenuePercentage" xlink:to="scwo_RevenuePercentage_lbl_fd9b45" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenuePercentage_lbl_fd9b45" xml:lang="en-US">Revenue percentage</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PremiumsRevenuePercentage" xlink:to="scwo_PremiumsRevenuePercentage_lbl_2a21ed" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_PremiumsRevenuePercentage_lbl_2a21ed" xml:lang="en-US">Revenue percentage</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PremiumsRevenuePercentage" xlink:label="scwo_PremiumsRevenuePercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PremiumsRevenuePercentage" xlink:to="scwo_PremiumsRevenuePercentage_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PremiumsRevenuePercentage_lbl_4" xml:lang="en-US">[Revenue percentage]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_UnearnedRevenue" xlink:to="scwo_UnearnedRevenue_lbl_3cf2df" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="scwo_UnearnedRevenue_lbl_3cf2df" xml:lang="en-US">Unearned revenue at beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnearnedRevenue" xlink:label="scwo_UnearnedRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_UnearnedRevenue" xlink:to="scwo_UnearnedRevenue_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_UnearnedRevenue_lbl_2" xml:lang="en-US">[Unearned revenue at beginning of the period]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BillingsDeferredUnearnedRevenue" xlink:label="scwo_BillingsDeferredUnearnedRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_BillingsDeferredUnearnedRevenue" xlink:to="scwo_BillingsDeferredUnearnedRevenue_lbl_033ca0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_BillingsDeferredUnearnedRevenue_lbl_033ca0" xml:lang="en-US">Billings deferred</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RefundableDepositReturned" xlink:label="scwo_RefundableDepositReturned" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RefundableDepositReturned" xlink:to="scwo_RefundableDepositReturned_lbl_c45e0b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RefundableDepositReturned_lbl_c45e0b" xml:lang="en-US">Refundable deposit returned</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecognitionOfDeferredRevenue" xlink:to="us-gaap_RecognitionOfDeferredRevenue_lbl_8197fd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RecognitionOfDeferredRevenue_lbl_8197fd" xml:lang="en-US">Recognition of prior unearned revenue</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="us-gaap_RecognitionOfDeferredRevenue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RecognitionOfDeferredRevenue" xlink:to="us-gaap_RecognitionOfDeferredRevenue_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RecognitionOfDeferredRevenue_lbl_5" xml:lang="en-US">[Recognition of Deferred Revenue]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_UnearnedRevenue" xlink:to="scwo_UnearnedRevenue_lbl_d63262" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="scwo_UnearnedRevenue_lbl_d63262" xml:lang="en-US">Unearned revenue at end of period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl_126b44" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl_126b44" xml:lang="en-US">Unbilled accounts receivable at beginning of year</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl_2" xml:lang="en-US">[Accounts Receivable, after Allowance for Credit Loss]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServicesPerformedButUnbilled" xlink:label="scwo_ServicesPerformedButUnbilled" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ServicesPerformedButUnbilled" xlink:to="scwo_ServicesPerformedButUnbilled_lbl_443599" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ServicesPerformedButUnbilled_lbl_443599" xml:lang="en-US">Services performed but unbilled</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServicesBilled" xlink:label="scwo_ServicesBilled" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ServicesBilled" xlink:to="scwo_ServicesBilled_lbl_528b36" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ServicesBilled_lbl_528b36" xml:lang="en-US">Services billed</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl_775746" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl_775746" xml:lang="en-US">Unbilled accounts receivable at end of year</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl_934f3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl_934f3a" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwentyTwentyFiveMember" xlink:label="scwo_TwentyTwentyFiveMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TwentyTwentyFiveMember" xlink:to="scwo_TwentyTwentyFiveMember_lbl_524115" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_TwentyTwentyFiveMember_lbl_524115" xml:lang="en-US">2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl_de840e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl_de840e" xml:lang="en-US">Long term liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl_3286d8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl_3286d8" xml:lang="en-US">Current liability</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_ffa985" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_ffa985" xml:lang="en-US">Options Outstanding, beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_2" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_e0cf19" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_e0cf19" xml:lang="en-US">Granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_6d406d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl_6d406d" xml:lang="en-US">Exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_cb28f1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_cb28f1" xml:lang="en-US">Expired/forfeited</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl_5" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_7aa7c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl_7aa7c4" xml:lang="en-US">Options Outstanding, ending balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_742418" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_742418" xml:lang="en-US">Option Exercisable, ending balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl_7" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8bdfb5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8bdfb5" xml:lang="en-US">Weighted Average Exercise Price, beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_8" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_131863" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl_131863" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_bc7792" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl_bc7792" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl_f58b60" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl_f58b60" xml:lang="en-US">Weighted Average Exercise Price, Expired/forfeit</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_499458" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl_499458" xml:lang="en-US">Weighted Average Exercise Price, ending balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_440df8" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_440df8" xml:lang="en-US">Weighted Average Exercise Price, Exercisable, ending balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl_13" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_93e2af" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_93e2af" xml:lang="en-US">Aggregate Intrinsic Value, beginning balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_14" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl_92d411" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl_92d411" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_024915" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl_024915" xml:lang="en-US">Aggregate Intrinsic Value, ending balance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl_f054a2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl_f054a2" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable, ending balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl_17" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl_17" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_5b2ff0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_5b2ff0" xml:lang="en-US">Weighted Average Remaining Contractual Life (years) Beginning</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:label="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:to="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_lbl_ffcee1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_lbl_ffcee1" xml:lang="en-US">Weighted Average Remaining Contractual Life (years) Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl_9c65a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl_9c65a9" xml:lang="en-US">Weighted Average Remaining Contractual Life (years), Exercisable at June 30, 2024</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl_112e7f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OptionMember_lbl_112e7f" xml:lang="en-US">Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember" xlink:label="us-gaap_OptionMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionMember" xlink:to="us-gaap_OptionMember_lbl_23" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionMember_lbl_23" xml:lang="en-US">Options Held [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BottomMember" xlink:label="scwo_BottomMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_BottomMember" xlink:to="scwo_BottomMember_lbl_be0771" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_BottomMember_lbl_be0771" xml:lang="en-US">Bottom [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TopMember" xlink:label="scwo_TopMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TopMember" xlink:to="scwo_TopMember_lbl_a929d0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_TopMember_lbl_a929d0" xml:lang="en-US">Top [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_527a8b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl_527a8b" xml:lang="en-US">Dividend Yield</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_e63ec5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl_e63ec5" xml:lang="en-US">Expected Life</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_0ba803" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl_0ba803" xml:lang="en-US">Expected Volatility</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_41cf4d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl_41cf4d" xml:lang="en-US">Risk-free Interest Rate</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_f6ecae" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_f6ecae" xml:lang="en-US">Nonvested, beginning of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_2" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d243d7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_d243d7" xml:lang="en-US">Shares Granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_3e0ddd" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl_3e0ddd" xml:lang="en-US">Vested</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_4c1c82" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl_4c1c82" xml:lang="en-US">Forfeited</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_b2206a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_b2206a" xml:lang="en-US">Nonvested,end of the period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_30d50e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl_30d50e" xml:lang="en-US">Weighted Average Exercise Price granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_3814a9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_3814a9" xml:lang="en-US">Weighted Average Exercise Price, ending balance</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl_9" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl_091f26" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl_091f26" xml:lang="en-US">Issued</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" xlink:to="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_lbl_b760c1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_lbl_b760c1" xml:lang="en-US">Exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" xlink:to="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_lbl_4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_lbl_4" xml:lang="en-US">[Exercised]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_215629" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl_215629" xml:lang="en-US">Warrants Weighted Average Remaining Contractual Life (years) Beginning</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:to="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_lbl_70d324" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_lbl_70d324" xml:lang="en-US">Warrants Weighted Average Remaining Contractual Life (years) Ending</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl_ce8f1b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl_ce8f1b" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_f5271f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl_f5271f" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl_5c25d1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl_5c25d1" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl_1d3624" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl_1d3624" xml:lang="en-US">Restricted Stock Member</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FinancialOfficerMember" xlink:label="scwo_FinancialOfficerMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_FinancialOfficerMember" xlink:to="scwo_FinancialOfficerMember_lbl_90d5da" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_FinancialOfficerMember_lbl_90d5da" xml:lang="en-US">Financial Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_keyEmployeeMember" xlink:label="scwo_keyEmployeeMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_keyEmployeeMember" xlink:to="scwo_keyEmployeeMember_lbl_4a921f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_keyEmployeeMember_lbl_4a921f" xml:lang="en-US">key employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl_fa7583" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl_fa7583" xml:lang="en-US">Restricted Stock Units RSU Member</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl_652238" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl_652238" xml:lang="en-US">Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RestrictedStockUnitsMember" xlink:label="scwo_RestrictedStockUnitsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RestrictedStockUnitsMember" xlink:to="scwo_RestrictedStockUnitsMember_lbl_2b75ca" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RestrictedStockUnitsMember_lbl_2b75ca" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FormerEmployeesMember" xlink:label="scwo_FormerEmployeesMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_FormerEmployeesMember" xlink:to="scwo_FormerEmployeesMember_lbl_be6471" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_FormerEmployeesMember_lbl_be6471" xml:lang="en-US">Former employees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoZeroTwoOnePlanMember" xlink:label="scwo_TwoZeroTwoOnePlanMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TwoZeroTwoOnePlanMember" xlink:to="scwo_TwoZeroTwoOnePlanMember_lbl_6531b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_TwoZeroTwoOnePlanMember_lbl_6531b2" xml:lang="en-US">2021 Plan [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_BottomMember" xlink:to="scwo_BottomMember_lbl_6d0629" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_BottomMember_lbl_6d0629" xml:lang="en-US">Bottom [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_TopMember" xlink:to="scwo_TopMember_lbl_dc3329" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_TopMember_lbl_dc3329" xml:lang="en-US">Top [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentTargetMember" xlink:label="scwo_VestUponAchievementOfFifityPercentTargetMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_VestUponAchievementOfFifityPercentTargetMember" xlink:to="scwo_VestUponAchievementOfFifityPercentTargetMember_lbl_7275bc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_VestUponAchievementOfFifityPercentTargetMember_lbl_7275bc" xml:lang="en-US">Vest Upon Achievement Of 50% Target [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" xlink:label="scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" xlink:to="scwo_VestUponAchievementOfFifityPercentRevenueTargetMember_lbl_b021ba" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_VestUponAchievementOfFifityPercentRevenueTargetMember_lbl_b021ba" xml:lang="en-US">Vest Upon Achievement Of 50% Revenue Target [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceBasedOptionsMember" xlink:label="scwo_ServiceBasedOptionsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ServiceBasedOptionsMember" xlink:to="scwo_ServiceBasedOptionsMember_lbl_3e2690" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ServiceBasedOptionsMember_lbl_3e2690" xml:lang="en-US">Service Based Options [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedOptionMember" xlink:label="scwo_PerformanceBasedOptionMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PerformanceBasedOptionMember" xlink:to="scwo_PerformanceBasedOptionMember_lbl_816000" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PerformanceBasedOptionMember_lbl_816000" xml:lang="en-US">Performance Based Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl_d2cb08" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl_d2cb08" xml:lang="en-US">Weighted-average period</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_cbb597" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl_cbb597" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_61dcfc" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl_61dcfc" xml:lang="en-US">Common stock issued for services</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_663fe3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl_663fe3" xml:lang="en-US">Restricted stock units granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_lbl_d5ef27" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_lbl_d5ef27" xml:lang="en-US">Fair value of common share</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" xlink:to="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU_lbl_4ea350" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU_lbl_4ea350" xml:lang="en-US">Unvested restricted stock units</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedRestrictedStockUnits" xlink:label="scwo_PerformanceBasedRestrictedStockUnits" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PerformanceBasedRestrictedStockUnits" xlink:to="scwo_PerformanceBasedRestrictedStockUnits_lbl_62cf3c" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PerformanceBasedRestrictedStockUnits_lbl_62cf3c" xml:lang="en-US">Performance based restricted stock units</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestingRestrictedStockUnitsRecognizedPeriod" xlink:label="scwo_VestingRestrictedStockUnitsRecognizedPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_VestingRestrictedStockUnitsRecognizedPeriod" xlink:to="scwo_VestingRestrictedStockUnitsRecognizedPeriod_lbl_9dac7d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_VestingRestrictedStockUnitsRecognizedPeriod_lbl_9dac7d" xml:lang="en-US">Vesting restricted stock units recognized period</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OtherLaborAndRelatedExpense" xlink:to="scwo_OtherLaborAndRelatedExpense_lbl_4f45e2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_OtherLaborAndRelatedExpense_lbl_4f45e2" xml:lang="en-US">Compensation and related expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherLaborAndRelatedExpense" xlink:label="scwo_OtherLaborAndRelatedExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OtherLaborAndRelatedExpense" xlink:to="scwo_OtherLaborAndRelatedExpense_lbl_10" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OtherLaborAndRelatedExpense_lbl_10" xml:lang="en-US">[Compensation and related expenses]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_GrantDateFairValueOfRestrictedStock" xlink:label="scwo_GrantDateFairValueOfRestrictedStock" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_GrantDateFairValueOfRestrictedStock" xlink:to="scwo_GrantDateFairValueOfRestrictedStock_lbl_959774" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_GrantDateFairValueOfRestrictedStock_lbl_959774" xml:lang="en-US">Grant-date fair value of the restricted stock</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" xlink:label="scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" xlink:to="scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription_lbl_53fd12" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription_lbl_53fd12" xml:lang="en-US">Performance-based vesting conditions for restricted stock units</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_015e3a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_015e3a" xml:lang="en-US">Stock-based compensation</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl_13" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl_13" xml:lang="en-US">[Share-Based Payment Arrangement, Expense]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl_113d5b" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl_113d5b" xml:lang="en-US">Research and Development Expense</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_aa5388" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl_aa5388" xml:lang="en-US">Warrants outstanding</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsGranted" xlink:label="scwo_OptionsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_OptionsGranted" xlink:to="scwo_OptionsGranted_lbl_f4efe0" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_OptionsGranted_lbl_f4efe0" xml:lang="en-US">Options granted</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_93dabf" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl_93dabf" xml:lang="en-US">Options exercised</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IssuanceOfShares" xlink:label="scwo_IssuanceOfShares" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_IssuanceOfShares" xlink:to="scwo_IssuanceOfShares_lbl_f33fda" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_IssuanceOfShares_lbl_f33fda" xml:lang="en-US">Issuance of common shares</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="us-gaap_StockOptionExercisePriceIncrease" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl_1726b7" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl_1726b7" xml:lang="en-US">Exercise price</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" xlink:to="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable_lbl_2ff589" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable_lbl_2ff589" xml:lang="en-US">Options outstanding and exercisable</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_StockOptionsIssued" xlink:label="scwo_StockOptionsIssued" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_StockOptionsIssued" xlink:to="scwo_StockOptionsIssued_lbl_4eaa8d" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_StockOptionsIssued_lbl_4eaa8d" xml:lang="en-US">Issuance of stock options</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_CommonSharesForIssuanceRemaining" xlink:label="scwo_CommonSharesForIssuanceRemaining" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_CommonSharesForIssuanceRemaining" xlink:to="scwo_CommonSharesForIssuanceRemaining_lbl_f57b14" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_CommonSharesForIssuanceRemaining_lbl_f57b14" xml:lang="en-US">Remaining common shares for issuance</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl_38772a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl_38772a" xml:lang="en-US">Stock-based compensation</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl_e498d9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl_e498d9" xml:lang="en-US">General and administrative expenses</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl_1bc1c4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl_1bc1c4" xml:lang="en-US">Research and development expenses</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_MarketPriceAndExercisePriceDifference" xlink:label="scwo_MarketPriceAndExercisePriceDifference" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_MarketPriceAndExercisePriceDifference" xlink:to="scwo_MarketPriceAndExercisePriceDifference_lbl_d7a343" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_MarketPriceAndExercisePriceDifference_lbl_d7a343" xml:lang="en-US">Difference in market price and exercise price</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AverageGrantDateFairValue" xlink:label="scwo_AverageGrantDateFairValue" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AverageGrantDateFairValue" xlink:to="scwo_AverageGrantDateFairValue_lbl_2a829a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AverageGrantDateFairValue_lbl_2a829a" xml:lang="en-US">Average grant-date fair value</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_NumberOfOptionIncludePerformanceConditions" xlink:label="scwo_NumberOfOptionIncludePerformanceConditions" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_NumberOfOptionIncludePerformanceConditions" xlink:to="scwo_NumberOfOptionIncludePerformanceConditions_lbl_951cd4" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_NumberOfOptionIncludePerformanceConditions_lbl_951cd4" xml:lang="en-US">Number of option include performance conditions</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl_60f7be" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl_60f7be" xml:lang="en-US">Vested percentage</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueTarget" xlink:label="scwo_RevenueTarget" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RevenueTarget" xlink:to="scwo_RevenueTarget_lbl_600762" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RevenueTarget_lbl_600762" xml:lang="en-US">Revenue Target</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AchiveRevenueTarget" xlink:label="scwo_AchiveRevenueTarget" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AchiveRevenueTarget" xlink:to="scwo_AchiveRevenueTarget_lbl_5313f5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AchiveRevenueTarget_lbl_5313f5" xml:lang="en-US">Achive revenue target</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AnnualRevenueAchiveForFiscalYear2026" xlink:label="scwo_AnnualRevenueAchiveForFiscalYear2026" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AnnualRevenueAchiveForFiscalYear2026" xlink:to="scwo_AnnualRevenueAchiveForFiscalYear2026_lbl_4d80b3" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AnnualRevenueAchiveForFiscalYear2026_lbl_4d80b3" xml:lang="en-US">Annual revenue achive for fiscal year 2026</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl_9b98ac" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl_9b98ac" xml:lang="en-US">Gross proceeds</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AirSCWOMember" xlink:label="scwo_AirSCWOMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_AirSCWOMember" xlink:to="scwo_AirSCWOMember_lbl_ecdbd5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_AirSCWOMember_lbl_ecdbd5" xml:lang="en-US">AirSCWO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:label="scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:to="scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl_40e1b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty_lbl_40e1b2" xml:lang="en-US">Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="us-gaap_FairValueByLiabilityClassAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl_4015c5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl_4015c5" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsMember" xlink:label="us-gaap_CommitmentsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsMember" xlink:to="us-gaap_CommitmentsMember_lbl_a2716e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsMember_lbl_a2716e" xml:lang="en-US">Legal Settlement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PaymentOfLegalSettlementAmount" xlink:label="scwo_PaymentOfLegalSettlementAmount" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PaymentOfLegalSettlementAmount" xlink:to="scwo_PaymentOfLegalSettlementAmount_lbl_ae14a6" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PaymentOfLegalSettlementAmount_lbl_ae14a6" xml:lang="en-US">Legal settlement amount</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PotentialLossesAssociatedWithComplaints" xlink:label="scwo_PotentialLossesAssociatedWithComplaints" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_PotentialLossesAssociatedWithComplaints" xlink:to="scwo_PotentialLossesAssociatedWithComplaints_lbl_8369e5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_PotentialLossesAssociatedWithComplaints_lbl_8369e5" xml:lang="en-US">Potential loss</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl_46c18a" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl_46c18a" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl_eaa813" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl_eaa813" xml:lang="en-US">Subsequent Event Type Axis</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl_824342" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl_824342" xml:lang="en-US">Subsequent Events [Member]</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl_f0a087" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl_f0a087" xml:lang="en-US">Exercise price</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl_2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl_2" xml:lang="en-US">[Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price]</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfBoardOfDirectorsEquityCompensation" xlink:label="scwo_DescriptionOfBoardOfDirectorsEquityCompensation" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_DescriptionOfBoardOfDirectorsEquityCompensation" xlink:to="scwo_DescriptionOfBoardOfDirectorsEquityCompensation_lbl_38c523" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_DescriptionOfBoardOfDirectorsEquityCompensation_lbl_38c523" xml:lang="en-US">Board of directors equity compensation description</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_1ad2b2" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl_1ad2b2" xml:lang="en-US">Stock options granted</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedRestrictedStockUnitsGranted" xlink:to="scwo_ShareBasedRestrictedStockUnitsGranted_lbl_275ca9" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="scwo_ShareBasedRestrictedStockUnitsGranted_lbl_275ca9" xml:lang="en-US">Restricted stock units granted</link:label>
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedRestrictedStockUnitsGranted" xlink:label="scwo_ShareBasedRestrictedStockUnitsGranted" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="scwo_ShareBasedRestrictedStockUnitsGranted" xlink:to="scwo_ShareBasedRestrictedStockUnitsGranted_lbl_5" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="scwo_ShareBasedRestrictedStockUnitsGranted_lbl_5" xml:lang="en-US">[Restricted stock units granted]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>scwo-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/15/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20250331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20250331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryNet" xlink:href="scwo-20250331.xsd#InventoryNet" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/Revenue" xlink:href="scwo-20250331.xsd#Revenue" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquity" xlink:href="scwo-20250331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactions" xlink:href="scwo-20250331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingencies" xlink:href="scwo-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SegmentReporting" xlink:href="scwo-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEvents" xlink:href="scwo-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryTables" xlink:href="scwo-20250331.xsd#InventoryTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueTables" xlink:href="scwo-20250331.xsd#RevenueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityTables" xlink:href="scwo-20250331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryDetails" xlink:href="scwo-20250331.xsd#InventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails" xlink:href="scwo-20250331.xsd#RevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails1" xlink:href="scwo-20250331.xsd#RevenueDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails2" xlink:href="scwo-20250331.xsd#RevenueDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetailsNarrative" xlink:href="scwo-20250331.xsd#RevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails" xlink:href="scwo-20250331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails1" xlink:href="scwo-20250331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails2" xlink:href="scwo-20250331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails3" xlink:href="scwo-20250331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20250331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20250331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="scwo-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - Condensed Consolidated Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaapUnbilledReceivablesCurrent" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapUnbilledReceivablesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetNetCurrent" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapContractWithCustomerAssetNetCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedBonusesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLossOnContracts" xlink:label="loc_us-gaapProvisionForLossOnContracts" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapProvisionForLossOnContracts" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="loc_us-gaapSettlementLiabilitiesCurrent" />
    <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapSettlementLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
    <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
    <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
    <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
    <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
    <link:calculationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    <link:calculationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - Consolidated Balance Sheets (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:title="124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeOther" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:title="148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherNoncashExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_InventoryReserveIncreased" xlink:label="loc_scwoInventoryReserveIncreased" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_scwoInventoryReserveIncreased" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInUnbilledReceivables" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInUnbilledReceivables" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IncreaseDecreaseInProvisionForLossOnContracts" xlink:label="loc_scwoIncreaseDecreaseInProvisionForLossOnContracts" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_scwoIncreaseDecreaseInProvisionForLossOnContracts" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
    <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
    <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
    <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
    <link:calculationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
    <link:calculationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    <link:calculationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="995446 - Disclosure - Nature of Business and Presentation of Financial Statements" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995447 - Disclosure - Summary of Significant Accounting Policies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="995448 - Disclosure - Liquidity Capital Resources and Going Concern" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryNet" xlink:title="995449 - Disclosure - Inventory, Net" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/Revenue" xlink:title="995450 - Disclosure - Revenue" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquity" xlink:title="995451 - Disclosure - Stockholder Equity" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactions" xlink:title="995452 - Disclosure - Related Party Transactions" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingencies" xlink:title="995453 - Disclosure - Commitments and Contingencies" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SegmentReporting" xlink:title="995454 - Disclosure - Segment Reporting" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEvents" xlink:title="995455 - Disclosure - Subsequent Events" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995456 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995457 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryTables" xlink:title="995458 - Disclosure - Inventory (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueTables" xlink:title="995459 - Disclosure - Revenue (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityTables" xlink:title="995460 - Disclosure - Stockholder Equity (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="995461 - Disclosure - Summary of Significant Accounting Policies (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryDetails" xlink:title="995465 - Disclosure - Inventory (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails" xlink:title="995466 - Disclosure - Revenue (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails1" xlink:title="995467 - Disclosure - Revenue (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails2" xlink:title="995468 - Disclosure - Revenue (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetailsNarrative" xlink:title="995469 - Disclosure - Revenue (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails" xlink:title="995470 - Disclosure - Stockholder Equity (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails1" xlink:title="995471 - Disclosure - Stockholder Equity (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails2" xlink:title="995472 - Disclosure - Stockholder Equity (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails3" xlink:title="995473 - Disclosure - Stockholder Equity (Details 3)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:title="995474 - Disclosure - Stockholder Equity (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995475 - Disclosure - Related Party Transactions (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995476 - Disclosure - Commitments and Contingencies (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:title="995477 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>scwo-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/15/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20250331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20250331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryNet" xlink:href="scwo-20250331.xsd#InventoryNet" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/Revenue" xlink:href="scwo-20250331.xsd#Revenue" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquity" xlink:href="scwo-20250331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactions" xlink:href="scwo-20250331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingencies" xlink:href="scwo-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SegmentReporting" xlink:href="scwo-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEvents" xlink:href="scwo-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryTables" xlink:href="scwo-20250331.xsd#InventoryTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueTables" xlink:href="scwo-20250331.xsd#RevenueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityTables" xlink:href="scwo-20250331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryDetails" xlink:href="scwo-20250331.xsd#InventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails" xlink:href="scwo-20250331.xsd#RevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails1" xlink:href="scwo-20250331.xsd#RevenueDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails2" xlink:href="scwo-20250331.xsd#RevenueDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetailsNarrative" xlink:href="scwo-20250331.xsd#RevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails" xlink:href="scwo-20250331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails1" xlink:href="scwo-20250331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails2" xlink:href="scwo-20250331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails3" xlink:href="scwo-20250331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20250331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20250331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="scwo-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - Condensed Consolidated Balance Sheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_ce49ae" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssetsAbstract_ce49ae" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_bc02e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssetsCurrentAbstract_bc02e8" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca8372" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ca8372" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_00eac4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_00eac4" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaapUnbilledReceivablesCurrent_5c1c7b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapUnbilledReceivablesCurrent_5c1c7b" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent_268c73" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent_268c73" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_056ea8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapInventoryNet_056ea8" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent" xlink:label="loc_us-gaapContractWithCustomerAssetNetCurrent_67602e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapContractWithCustomerAssetNetCurrent_67602e" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent_09f22d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapPrepaidExpenseCurrent_09f22d" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_26914f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssetsCurrent_26914f" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_da40ff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_da40ff" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_9e2fc7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_9e2fc7" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_381be8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_381be8" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_16f30e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_16f30e" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_3c4b52" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapOtherAssets_3c4b52" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_53864b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssetsNoncurrent_53864b" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_905c8d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAssets_905c8d" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_076c37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_076c37" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_e2e952" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_e2e952" order="19" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_f3d649" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_e2e952" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_f3d649" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedBonusesCurrent" xlink:label="loc_us-gaapAccruedBonusesCurrent_885e6f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapAccruedBonusesCurrent_885e6f" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForLossOnContracts" xlink:label="loc_us-gaapProvisionForLossOnContracts_2bd14e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapProvisionForLossOnContracts_2bd14e" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SettlementLiabilitiesCurrent" xlink:label="loc_us-gaapSettlementLiabilitiesCurrent_2cc087" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapSettlementLiabilitiesCurrent_2cc087" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_3f4c68" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapDeferredRevenueCurrent_3f4c68" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_da3754" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_da3754" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_fd70a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_fd70a3" order="26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_816952" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilitiesCurrent_816952" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_cd0ef6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_cd0ef6" order="28" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_5ab32f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_cd0ef6" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_5ab32f" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_afd1ee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_cd0ef6" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_afd1ee" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_4a00af" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilities_4a00af" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_8637db" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_8637db" order="32" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_9ccb4e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapStockholdersEquityAbstract_9ccb4e" order="33" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_16151c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapPreferredStockValue_16151c" order="34" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_2a3311" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapCommonStockValue_2a3311" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_da17b5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapAdditionalPaidInCapital_da17b5" order="36" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_ee1056" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_ee1056" order="37" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2bb64a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax_2bb64a" order="38" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_1237a3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract_9ccb4e" xlink:to="loc_us-gaapStockholdersEquity_1237a3" order="39" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_4102f9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_5dd561" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_4102f9" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - Consolidated Balance Sheets (Parenthetical)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_8ab9e8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapCommonStockSharesAuthorized_8ab9e8" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_67864f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_67864f" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_ea1019" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapCommonStockSharesIssued_ea1019" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_b5a037" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapCommonStockSharesOutstanding_b5a037" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_abc42a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_abc42a" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_3f7566" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_3f7566" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_fa9734" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapPreferredStockSharesIssued_fa9734" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_fc82d9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract_200a9d" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_fc82d9" order="8" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:title="124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract_5b8ec7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_06ff04" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapRevenues_06ff04" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold_21ae1e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold_21ae1e" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_9c8beb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapGrossProfit_9c8beb" order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract_82ae03" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapOperatingExpensesAbstract_82ae03" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_1023ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_1023ca" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense_c7d43e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapLaborAndRelatedExpense_c7d43e" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_a9ad89" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapProfessionalFees_a9ad89" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_3865b1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_3865b1" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses_269e30" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapOperatingExpenses_269e30" order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss_b891e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapOperatingIncomeLoss_b891e1" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract_3a5c13" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract_82ae03" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract_3a5c13" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOther" xlink:label="loc_us-gaapInterestIncomeOther_b23f67" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapInterestIncomeOther_b23f67" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_d3cd48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_d3cd48" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_86a444" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapNonoperatingIncomeExpense_86a444" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_036e21" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_036e21" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_599f19" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_599f19" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_c0e9e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapNetIncomeLoss_c0e9e9" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_968b9c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapEarningsPerShareDiluted_968b9c" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_4efe6d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract_5b8ec7" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_4efe6d" order="19" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:title="148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract_b1413e" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_d81aec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract_b1413e" xlink:to="loc_us-gaapStatementTable_d81aec" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_686e51" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_d81aec" xlink:to="loc_us-gaapStatementLineItems_686e51" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis_de2305" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_d81aec" xlink:to="loc_us-gaapStatementEquityComponentsAxis_de2305" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_3ddde1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis_de2305" xlink:to="loc_us-gaapEquityComponentDomain_3ddde1" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_8bf3c2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_3ddde1" xlink:to="loc_us-gaapPreferredStockMember_8bf3c2" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_dea261" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_3ddde1" xlink:to="loc_us-gaapCommonStockMember_dea261" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_7075ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_3ddde1" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_7075ab" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_93da62" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_3ddde1" xlink:to="loc_us-gaapRetainedEarningsMember_93da62" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_cbcf90" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain_3ddde1" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_cbcf90" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_7fd5d6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapSharesIssued_7fd5d6" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_f3ac44" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockholdersEquity_f3ac44" order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_f12b78" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_f12b78" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_239b4e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_239b4e" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_89d3ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_89d3ab" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_8bd0c9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapNetIncomeLoss_8bd0c9" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationOptionsAmount" xlink:label="loc_scwoAccretionOfStockBasedCompensationOptionsAmount_47be83" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_scwoAccretionOfStockBasedCompensationOptionsAmount_47be83" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" xlink:label="loc_scwoAccretionOfStockBasedCompensationRestrictedStockAmount_15a0e4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_scwoAccretionOfStockBasedCompensationRestrictedStockAmount_15a0e4" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_789014" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_789014" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_7cecfc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_7cecfc" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_c1199a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapSharesIssued_c1199a" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_be99e0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_686e51" xlink:to="loc_us-gaapStockholdersEquity_be99e0" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract_12f290" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_95d38d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract_95d38d" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_1f876c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapNetIncomeLoss_1f876c" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization_6b882a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_us-gaapDepreciationAndAmortization_6b882a" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaapOtherNoncashExpense_4317d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_us-gaapOtherNoncashExpense_4317d1" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims_a6f3ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims_a6f3ab" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_894345" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_us-gaapShareBasedCompensation_894345" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_InventoryReserveIncreased" xlink:label="loc_scwoInventoryReserveIncreased_5bf879" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_scwoInventoryReserveIncreased_5bf879" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_5b6135" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0c323b" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_5b6135" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable_185283" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract_5b6135" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable_185283" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInUnbilledReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInUnbilledReceivables_33eea3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInUnbilledReceivables_33eea3" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables_2f5db2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables_2f5db2" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories_d92da6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInInventories_d92da6" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset_083d5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerAsset_083d5e" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense_6a522f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense_6a522f" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets_13c88e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets_13c88e" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8c826d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8c826d" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities_6ad5bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInEmployeeRelatedLiabilities_6ad5bb" order="18" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IncreaseDecreaseInProvisionForLossOnContracts" xlink:label="loc_scwoIncreaseDecreaseInProvisionForLossOnContracts_6763f3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_scwoIncreaseDecreaseInProvisionForLossOnContracts_6763f3" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue_d62656" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue_d62656" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities_249f24" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities_249f24" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_edffa5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability_edffa5" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_c8019f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities_c8019f" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ba04ab" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ba04ab" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_45dd37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ba04ab" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment_45dd37" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_837b9f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ba04ab" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_837b9f" order="26" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_330fed" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract_ba04ab" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities_330fed" order="27" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2774df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2774df" order="28" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_7cdae8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2774df" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_7cdae8" order="29" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_dc6a48" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract_2774df" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities_dc6a48" order="30" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_de58f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_de58f1" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_433af3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_433af3" order="32" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0916b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0916b" order="33" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract_63aabb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract_63aabb" order="34" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet_be0aa6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract_63aabb" xlink:to="loc_us-gaapInterestPaidNet_be0aa6" order="35" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet_02a349" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract_12f290" xlink:to="loc_us-gaapIncomeTaxesPaidNet_02a349" order="36" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arragements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems_5a3116" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag_e3e4f1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_5a3116" xlink:to="loc_ecdRule10b51ArrAdoptedFlag_e3e4f1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag_ad617f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_5a3116" xlink:to="loc_ecdRule10b51ArrTrmntdFlag_ad617f" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag_145ee7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_5a3116" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag_145ee7" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag_17c634" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems_5a3116" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag_17c634" order="5" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="995446 - Disclosure - Nature of Business and Presentation of Financial Statements">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f37c3a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eff9c2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f37c3a" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_eff9c2" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995447 - Disclosure - Summary of Significant Accounting Policies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_48d386" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock_a625bb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_48d386" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock_a625bb" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="995448 - Disclosure - Liquidity Capital Resources and Going Concern">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract_acb7bd" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_feaf5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract_acb7bd" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock_feaf5e" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryNet" xlink:title="995449 - Disclosure - Inventory, Net">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract_86ac0a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock_f63a59" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_86ac0a" xlink:to="loc_us-gaapInventoryDisclosureTextBlock_f63a59" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/Revenue" xlink:title="995450 - Disclosure - Revenue">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_cbfeb8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueDisclosureTextBlock" xlink:label="loc_scwoRevenueDisclosureTextBlock_b20cb2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_cbfeb8" xlink:to="loc_scwoRevenueDisclosureTextBlock_b20cb2" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquity" xlink:title="995451 - Disclosure - Stockholder Equity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_931a50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_55753d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_931a50" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock_55753d" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactions" xlink:title="995452 - Disclosure - Related Party Transactions">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract_bf49ea" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_7fc9cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_bf49ea" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock_7fc9cc" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingencies" xlink:title="995453 - Disclosure - Commitments and Contingencies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_99796a" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock_945ad0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_99796a" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock_945ad0" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SegmentReporting" xlink:title="995454 - Disclosure - Segment Reporting">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments" xlink:label="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_9beebc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock_288538" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments_9beebc" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock_288538" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEvents" xlink:title="995455 - Disclosure - Subsequent Events">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_6c1b26" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock_4ff8a7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_6c1b26" xlink:to="loc_us-gaapSubsequentEventsTextBlock_4ff8a7" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995456 - Disclosure - Summary of Significant Accounting Policies (Policies)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_f438b9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates_40560c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapUseOfEstimates_40560c" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaapReceivablesPolicyTextBlock_3efcc1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapReceivablesPolicyTextBlock_3efcc1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock_8ff1ac" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapInventoryPolicyTextBlock_8ff1ac" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_949907" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock_949907" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk_5e611d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapConcentrationRiskCreditRisk_5e611d" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock_0d6535" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock_0d6535" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock" xlink:label="loc_scwoAccruedContractLossProvisionAndOnerousContractsPolicyTextBlock_0f6c73" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_scwoAccruedContractLossProvisionAndOnerousContractsPolicyTextBlock_0f6c73" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy_ff90dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy_ff90dd" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock_63c860" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock_63c860" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_ade1f4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription_ade1f4" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="loc_scwoNewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_2834d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_f438b9" xlink:to="loc_scwoNewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_2834d7" order="11" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995457 - Disclosure - Summary of Significant Accounting Policies (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_a99ab0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock_c3f39d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_a99ab0" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock_c3f39d" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfDepreciationExpenseTableTextBlock" xlink:label="loc_scwoScheduleOfDepreciationExpenseTableTextBlock_649795" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_a99ab0" xlink:to="loc_scwoScheduleOfDepreciationExpenseTableTextBlock_649795" order="2" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryTables" xlink:title="995458 - Disclosure - Inventory (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract_2b72ec" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock_949855" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_2b72ec" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock_949855" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueTables" xlink:title="995459 - Disclosure - Revenue (Tables)">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_a1b1ce" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfRevenueByTypeTableTextBlock" xlink:label="loc_scwoScheduleOfRevenueByTypeTableTextBlock_acecd4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_a1b1ce" xlink:to="loc_scwoScheduleOfRevenueByTypeTableTextBlock_acecd4" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock" xlink:label="loc_scwoScheduleOfUnearnedRevenueActivityTableTextBlock_11fe5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_a1b1ce" xlink:to="loc_scwoScheduleOfUnearnedRevenueActivityTableTextBlock_11fe5e" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock" xlink:label="loc_scwoScheduleOfUnbilledAccountsReceivableTableTextBlock_3a515e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_a1b1ce" xlink:to="loc_scwoScheduleOfUnbilledAccountsReceivableTableTextBlock_3a515e" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityTables" xlink:title="995460 - Disclosure - Stockholder Equity (Tables)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_e9d3a0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_494866" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e9d3a0" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_494866" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_affd16" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e9d3a0" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_affd16" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_d84b5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e9d3a0" xlink:to="loc_us-gaapScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_d84b5c" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_39b967" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_e9d3a0" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_39b967" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="995461 - Disclosure - Summary of Significant Accounting Policies (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_47b6ba" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_ae6c20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_47b6ba" xlink:to="loc_us-gaapStatementTable_ae6c20" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_11bf0d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ae6c20" xlink:to="loc_us-gaapStatementLineItems_11bf0d" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_0dd6ca" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_ae6c20" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_0dd6ca" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_0dd6ca" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_28d7b8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" xlink:to="loc_us-gaapComputerEquipmentMember_28d7b8" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_8ebbd6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" xlink:to="loc_us-gaapVehiclesMember_8ebbd6" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember_4e5b29" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" xlink:to="loc_us-gaapOfficeEquipmentMember_4e5b29" order="23" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentDemoSystemMember" xlink:label="loc_scwoEquipmentDemoSystemMember_e854f3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_7c4332" xlink:to="loc_scwoEquipmentDemoSystemMember_e854f3" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_d0f8c4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_11bf0d" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_d0f8c4" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAccumulatedDepreciation" xlink:label="loc_us-gaapRealEstateAccumulatedDepreciation_1d4745" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_47b6ba" xlink:to="loc_us-gaapRealEstateAccumulatedDepreciation_1d4745" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_393e63" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_47b6ba" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_393e63" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_4f205d" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_CostOfRevenues" xlink:label="loc_scwoCostOfRevenues_ae4f31" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_4f205d" xlink:to="loc_scwoCostOfRevenues_ae4f31" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_GeneralAndAdministrative" xlink:label="loc_scwoGeneralAndAdministrative_11d642" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_4f205d" xlink:to="loc_scwoGeneralAndAdministrative_11d642" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_38b37b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_4f205d" xlink:to="loc_us-gaapDepreciation_38b37b" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract_0adb8f" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_5190c9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract_0adb8f" xlink:to="loc_us-gaapStatementTable_5190c9" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_0e0cf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_us-gaapStatementLineItems_0e0cf1" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis_b00414" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_srtMajorCustomersAxis_b00414" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_1f5ac1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis_b00414" xlink:to="loc_srtNameOfMajorCustomerDomain_1f5ac1" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis_5fca87" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis_5fca87" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_899cac" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis_5fca87" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_899cac" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_704507" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_us-gaapFinancialInstrumentAxis_704507" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c8d9b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_704507" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c8d9b" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_0c8c92" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_us-gaapAwardTypeAxis_0c8c92" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd95dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_0c8c92" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd95dc" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_9db44b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_9db44b" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_5aa1e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_9db44b" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_5aa1e9" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis_6a0145" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_5190c9" xlink:to="loc_srtProductOrServiceAxis_6a0145" order="110" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_8ef35e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis_6a0145" xlink:to="loc_srtProductsAndServicesDomain_8ef35e" order="110" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoCustomerMember" xlink:label="loc_scwoTwoCustomerMember_e342ba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain_1f5ac1" xlink:to="loc_scwoTwoCustomerMember_e342ba" order="111" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueMember" xlink:label="loc_scwoRevenueMember_d6cfc5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_899cac" xlink:to="loc_scwoRevenueMember_d6cfc5" order="112" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_761773" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9c8d9b" xlink:to="loc_scwoOptionsMember_761773" order="113" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnvestedRestrictedStockMember" xlink:label="loc_scwoUnvestedRestrictedStockMember_77e181" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd95dc" xlink:to="loc_scwoUnvestedRestrictedStockMember_77e181" order="114" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OneCustomerMember" xlink:label="loc_scwoOneCustomerMember_0da4da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain_1f5ac1" xlink:to="loc_scwoOneCustomerMember_0da4da" order="115" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_02f248" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain_899cac" xlink:to="loc_us-gaapAccountsReceivableMember_02f248" order="116" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FullScaleDemonstrationMember" xlink:label="loc_scwoFullScaleDemonstrationMember_d87bd1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_5aa1e9" xlink:to="loc_scwoFullScaleDemonstrationMember_d87bd1" order="117" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ThreeCustomerMember" xlink:label="loc_scwoThreeCustomerMember_3904d5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain_1f5ac1" xlink:to="loc_scwoThreeCustomerMember_3904d5" order="118" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TreatabilityStudyServicesMember" xlink:label="loc_scwoTreatabilityStudyServicesMember_21ce5c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain_8ef35e" xlink:to="loc_scwoTreatabilityStudyServicesMember_21ce5c" order="119" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_07ef8c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd95dc" xlink:to="loc_scwoWarrantsMember_07ef8c" order="120" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_da5540" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_da5540" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherStockBasedCompensation" xlink:label="loc_scwoOtherStockBasedCompensation_d546eb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoOtherStockBasedCompensation_d546eb" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_48ef7d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapDepreciation_48ef7d" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueReceiveAsConsideration" xlink:label="loc_scwoRevenueReceiveAsConsideration_bedac3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoRevenueReceiveAsConsideration_bedac3" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnearnedPremiums" xlink:label="loc_us-gaapUnearnedPremiums_568b2c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapUnearnedPremiums_568b2c" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses_00e693" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapOperatingCostsAndExpenses_00e693" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AllocatedTransactionPriceDuringCustomerContract" xlink:label="loc_scwoAllocatedTransactionPriceDuringCustomerContract_07cdbf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoAllocatedTransactionPriceDuringCustomerContract_07cdbf" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DuringCustomerContractRemainingPerformanceObligation" xlink:label="loc_scwoDuringCustomerContractRemainingPerformanceObligation_91b800" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoDuringCustomerContractRemainingPerformanceObligation_91b800" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="loc_us-gaapCapitalizedContractCostNet_e61bdc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapCapitalizedContractCostNet_e61bdc" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfCapitalizedCost" xlink:label="loc_scwoDescriptionOfCapitalizedCost_d52e1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoDescriptionOfCapitalizedCost_d52e1b" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ContractCostsOnDemoContract" xlink:label="loc_scwoContractCostsOnDemoContract_4228db" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoContractCostsOnDemoContract_4228db" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaapInventoryRecallExpense_50a91d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapInventoryRecallExpense_50a91d" order="12" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ConcentrationsOfCreditRisk" xlink:label="loc_scwoConcentrationsOfCreditRisk_a86488" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_scwoConcentrationsOfCreditRisk_a86488" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_e1daf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapRevenues_e1daf1" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaapUnbilledReceivablesCurrent_fda243" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapUnbilledReceivablesCurrent_fda243" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision" xlink:label="loc_us-gaapLossContingencyAccrualProvision_1d07da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapLossContingencyAccrualProvision_1d07da" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_de343a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_0e0cf1" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_de343a" order="17" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract_c279d1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_fe7361" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract_c279d1" xlink:to="loc_us-gaapStatementTable_fe7361" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_4fe1f5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fe7361" xlink:to="loc_us-gaapStatementLineItems_4fe1f5" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_31597a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fe7361" xlink:to="loc_us-gaapPlanNameAxis_31597a" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_44e8eb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_31597a" xlink:to="loc_us-gaapPlanNameDomain_44e8eb" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ATMMember" xlink:label="loc_scwoATMMember_86b5a6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_44e8eb" xlink:to="loc_scwoATMMember_86b5a6" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_2fc854" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_2fc854" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_0aa0ce" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_us-gaapNetIncomeLoss_0aa0ce" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInContinuingOperations_ee9ed8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_us-gaapNetCashProvidedByUsedInContinuingOperations_ee9ed8" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital_7c2320" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_us-gaapCapital_7c2320" order="4" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedFromAtTheMarketOffering" xlink:label="loc_scwoProceedFromAtTheMarketOffering_ef8020" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_scwoProceedFromAtTheMarketOffering_ef8020" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedsFromCommonStockAndWarrantsShares" xlink:label="loc_scwoProceedsFromCommonStockAndWarrantsShares_efdce4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_scwoProceedsFromCommonStockAndWarrantsShares_efdce4" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_68d46f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_4fe1f5" xlink:to="loc_us-gaapCommonStockSharesIssued_68d46f" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryDetails" xlink:title="995465 - Disclosure - Inventory (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract_2751dc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials_b3f755" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_2751dc" xlink:to="loc_us-gaapInventoryRawMaterials_b3f755" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess_e41a07" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_2751dc" xlink:to="loc_us-gaapInventoryWorkInProcess_e41a07" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves_b2e284" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_2751dc" xlink:to="loc_us-gaapInventoryValuationReserves_b2e284" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_0d4811" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract_2751dc" xlink:to="loc_us-gaapInventoryNet_0d4811" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails" xlink:title="995466 - Disclosure - Revenue (Details)">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_1e802f" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_7d1cb2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_1e802f" xlink:to="loc_us-gaapStatementTable_7d1cb2" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_2273e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_7d1cb2" xlink:to="loc_us-gaapStatementLineItems_2273e9" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis_d1d3cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_7d1cb2" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis_d1d3cb" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesBillingStatusDomain" xlink:label="loc_us-gaapReceivablesBillingStatusDomain_1ceca5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis_d1d3cb" xlink:to="loc_us-gaapReceivablesBillingStatusDomain_1ceca5" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentRevenuesMember" xlink:label="loc_scwoEquipmentRevenuesMember_65c883" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesBillingStatusDomain_1ceca5" xlink:to="loc_scwoEquipmentRevenuesMember_65c883" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceRevenueMember" xlink:label="loc_scwoServiceRevenueMember_264949" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesBillingStatusDomain_1ceca5" xlink:to="loc_scwoServiceRevenueMember_264949" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_183730" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2273e9" xlink:to="loc_us-gaapRevenues_183730" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenuePercentage" xlink:label="loc_scwoRevenuePercentage_11de55" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2273e9" xlink:to="loc_scwoRevenuePercentage_11de55" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PremiumsRevenuePercentage" xlink:label="loc_scwoPremiumsRevenuePercentage_efe67b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2273e9" xlink:to="loc_scwoPremiumsRevenuePercentage_efe67b" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails1" xlink:title="995467 - Disclosure - Revenue (Details 1)">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_934c0b" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnearnedRevenue" xlink:label="loc_scwoUnearnedRevenue_b8930d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_934c0b" xlink:to="loc_scwoUnearnedRevenue_b8930d" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BillingsDeferredUnearnedRevenue" xlink:label="loc_scwoBillingsDeferredUnearnedRevenue_7737d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_934c0b" xlink:to="loc_scwoBillingsDeferredUnearnedRevenue_7737d7" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RefundableDepositReturned" xlink:label="loc_scwoRefundableDepositReturned_e20abf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_934c0b" xlink:to="loc_scwoRefundableDepositReturned_e20abf" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecognitionOfDeferredRevenue" xlink:label="loc_us-gaapRecognitionOfDeferredRevenue_fe7400" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_934c0b" xlink:to="loc_us-gaapRecognitionOfDeferredRevenue_fe7400" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnearnedRevenue" xlink:label="loc_scwoUnearnedRevenue_72c28f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_934c0b" xlink:to="loc_scwoUnearnedRevenue_72c28f" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails2" xlink:title="995468 - Disclosure - Revenue (Details 2)">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_6fd212" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_920edc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_6fd212" xlink:to="loc_us-gaapAccountsReceivableNet_920edc" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServicesPerformedButUnbilled" xlink:label="loc_scwoServicesPerformedButUnbilled_689177" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_6fd212" xlink:to="loc_scwoServicesPerformedButUnbilled_689177" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServicesBilled" xlink:label="loc_scwoServicesBilled_c9b2e9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_6fd212" xlink:to="loc_scwoServicesBilled_c9b2e9" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_0c206b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_6fd212" xlink:to="loc_us-gaapAccountsReceivableNet_0c206b" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetailsNarrative" xlink:title="995469 - Disclosure - Revenue (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueAbstract" xlink:label="loc_scwoRevenueAbstract_0d7acf" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_f185b1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_scwoRevenueAbstract_0d7acf" xlink:to="loc_us-gaapStatementTable_f185b1" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_13de42" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_f185b1" xlink:to="loc_us-gaapStatementLineItems_13de42" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis_d22dc1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_f185b1" xlink:to="loc_us-gaapAwardDateAxis_d22dc1" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_badd0f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis_d22dc1" xlink:to="loc_us-gaapAwardDateDomain_badd0f" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwentyTwentyFiveMember" xlink:label="loc_scwoTwentyTwentyFiveMember_924e20" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain_badd0f" xlink:to="loc_scwoTwentyTwentyFiveMember_924e20" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_5a6bc0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_13de42" xlink:to="loc_us-gaapLiabilitiesNoncurrent_5a6bc0" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_329e18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_13de42" xlink:to="loc_us-gaapLiabilitiesCurrent_329e18" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails" xlink:title="995470 - Disclosure - Stockholder Equity (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_50a299" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_eb0e64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_50a299" xlink:to="loc_us-gaapStatementTable_eb0e64" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_9d111b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_eb0e64" xlink:to="loc_us-gaapStatementLineItems_9d111b" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_716ce2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_eb0e64" xlink:to="loc_us-gaapFinancialInstrumentAxis_716ce2" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c4eb96" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_716ce2" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c4eb96" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_8565d8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c4eb96" xlink:to="loc_scwoOptionsMember_8565d8" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0b6d0a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0b6d0a" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_03d4e1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_03d4e1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_390a49" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_390a49" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_468dfa" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_468dfa" order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4da7ff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4da7ff" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dff6a5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dff6a5" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6082ad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6082ad" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d250e2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d250e2" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5d48ec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5d48ec" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1982b7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1982b7" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06e33d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_06e33d" order="11" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_73869b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_73869b" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2451da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2451da" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d2961d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_d2961d" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b2e31c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_b2e31c" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_935609" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_935609" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8fe15c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8fe15c" order="17" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:label="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_261fa6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_261fa6" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ef3dff" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_9d111b" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_ef3dff" order="19" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails1" xlink:title="995471 - Disclosure - Stockholder Equity (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_057332" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_463278" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_057332" xlink:to="loc_us-gaapStatementTable_463278" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_2dd919" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_463278" xlink:to="loc_us-gaapStatementLineItems_2dd919" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_936f37" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_463278" xlink:to="loc_us-gaapFinancialInstrumentAxis_936f37" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acc96b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_936f37" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acc96b" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_37d6fe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_463278" xlink:to="loc_us-gaapPlanNameAxis_37d6fe" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_cf8ff5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_37d6fe" xlink:to="loc_us-gaapPlanNameDomain_cf8ff5" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember_2b4559" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acc96b" xlink:to="loc_scwoOptionsMember_2b4559" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember_2bb6cb" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_acc96b" xlink:to="loc_us-gaapOptionMember_2bb6cb" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BottomMember" xlink:label="loc_scwoBottomMember_cb75ec" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_cf8ff5" xlink:to="loc_scwoBottomMember_cb75ec" order="23" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TopMember" xlink:label="loc_scwoTopMember_e55bb7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_cf8ff5" xlink:to="loc_scwoTopMember_e55bb7" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2e53a9" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2dd919" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2e53a9" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_046d3c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2dd919" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_046d3c" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ed1d1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2dd919" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1ed1d1" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5318b2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_2dd919" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5318b2" order="4" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails2" xlink:title="995472 - Disclosure - Stockholder Equity (Details 2)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_98d9d2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e9c79d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e9c79d" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b3fea1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b3fea1" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d15c83" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d15c83" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b0e662" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b0e662" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5322d4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5322d4" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3575f5" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3575f5" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a542b0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a542b0" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_33141c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_98d9d2" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_33141c" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails3" xlink:title="995473 - Disclosure - Stockholder Equity (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_51dbaf" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_498a1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_51dbaf" xlink:to="loc_us-gaapStatementTable_498a1b" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_364fb6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_498a1b" xlink:to="loc_us-gaapStatementLineItems_364fb6" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_b78286" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_498a1b" xlink:to="loc_us-gaapAwardTypeAxis_b78286" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9db302" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_b78286" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9db302" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_1e1191" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9db302" xlink:to="loc_scwoWarrantsMember_1e1191" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a1fd7f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a1fd7f" order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ffdc64" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_ffdc64" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_4a1ec8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod_4a1ec8" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62f88d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62f88d" order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd5bd7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd5bd7" order="5" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_562657" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_562657" order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b1d57" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1b1d57" order="7" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7fa5c8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7fa5c8" order="8" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b276bf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b276bf" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:label="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_8c44df" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_364fb6" xlink:to="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance_8c44df" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:title="995474 - Disclosure - Stockholder Equity (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract_1aa6c4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_fb545c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract_1aa6c4" xlink:to="loc_us-gaapStatementTable_fb545c" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_bba5da" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapStatementLineItems_bba5da" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis_e26be4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapAwardTypeAxis_e26be4" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis_e26be4" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis_2a72cc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_srtTitleOfIndividualAxis_2a72cc" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_a5e103" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis_2a72cc" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_a5e103" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_f4256c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_f4256c" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_80777d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_f4256c" xlink:to="loc_us-gaapRelatedPartyDomain_80777d" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis_5b44db" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapFinancialInstrumentAxis_5b44db" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76619c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFinancialInstrumentAxis_5b44db" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76619c" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis_43259e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapPlanNameAxis_43259e" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_34efba" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis_43259e" xlink:to="loc_us-gaapPlanNameDomain_34efba" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis_8e6969" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_fb545c" xlink:to="loc_us-gaapVestingAxis_8e6969" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_51f6f0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingAxis_8e6969" xlink:to="loc_us-gaapVestingDomain_51f6f0" order="90" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember_ca426e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" xlink:to="loc_scwoWarrantsMember_ca426e" order="91" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_c8db4a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" xlink:to="loc_us-gaapRestrictedStockMember_c8db4a" order="92" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FinancialOfficerMember" xlink:label="loc_scwoFinancialOfficerMember_17e266" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_a5e103" xlink:to="loc_scwoFinancialOfficerMember_17e266" order="93" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_keyEmployeeMember" xlink:label="loc_scwokeyEmployeeMember_6792a8" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_80777d" xlink:to="loc_scwokeyEmployeeMember_6792a8" order="94" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_887977" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_887977" order="95" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_37bbb2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76619c" xlink:to="loc_us-gaapStockOptionMember_37bbb2" order="96" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RestrictedStockUnitsMember" xlink:label="loc_scwoRestrictedStockUnitsMember_4a1a66" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_76619c" xlink:to="loc_scwoRestrictedStockUnitsMember_4a1a66" order="97" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FormerEmployeesMember" xlink:label="loc_scwoFormerEmployeesMember_3f8a5e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain_80777d" xlink:to="loc_scwoFormerEmployeesMember_3f8a5e" order="98" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoZeroTwoOnePlanMember" xlink:label="loc_scwoTwoZeroTwoOnePlanMember_6c9b31" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_34efba" xlink:to="loc_scwoTwoZeroTwoOnePlanMember_6c9b31" order="99" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BottomMember" xlink:label="loc_scwoBottomMember_cbe44a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_34efba" xlink:to="loc_scwoBottomMember_cbe44a" order="100" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TopMember" xlink:label="loc_scwoTopMember_14db74" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain_34efba" xlink:to="loc_scwoTopMember_14db74" order="101" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentTargetMember" xlink:label="loc_scwoVestUponAchievementOfFifityPercentTargetMember_68122f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain_51f6f0" xlink:to="loc_scwoVestUponAchievementOfFifityPercentTargetMember_68122f" order="102" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" xlink:label="loc_scwoVestUponAchievementOfFifityPercentRevenueTargetMember_dbdffc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapVestingDomain_51f6f0" xlink:to="loc_scwoVestUponAchievementOfFifityPercentRevenueTargetMember_dbdffc" order="103" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceBasedOptionsMember" xlink:label="loc_scwoServiceBasedOptionsMember_1fdff1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" xlink:to="loc_scwoServiceBasedOptionsMember_1fdff1" order="104" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedOptionMember" xlink:label="loc_scwoPerformanceBasedOptionMember_d9aff4" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65a22a" xlink:to="loc_scwoPerformanceBasedOptionMember_d9aff4" order="105" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f55f18" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_f55f18" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8d5577" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8d5577" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_e8374a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_e8374a" order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60bc56" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60bc56" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_3d872d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued_3d872d" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU_17dc0f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU_17dc0f" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedRestrictedStockUnits" xlink:label="loc_scwoPerformanceBasedRestrictedStockUnits_1fe5c3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoPerformanceBasedRestrictedStockUnits_1fe5c3" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestingRestrictedStockUnitsRecognizedPeriod" xlink:label="loc_scwoVestingRestrictedStockUnitsRecognizedPeriod_1d8e92" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoVestingRestrictedStockUnitsRecognizedPeriod_1d8e92" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherLaborAndRelatedExpense" xlink:label="loc_scwoOtherLaborAndRelatedExpense_e6ebf1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoOtherLaborAndRelatedExpense_e6ebf1" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_GrantDateFairValueOfRestrictedStock" xlink:label="loc_scwoGrantDateFairValueOfRestrictedStock_61c145" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoGrantDateFairValueOfRestrictedStock_61c145" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" xlink:label="loc_scwoPerformanceBasedVestingConditionsForRestrictedStockUnitsDescription_9633dc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoPerformanceBasedVestingConditionsForRestrictedStockUnitsDescription_9633dc" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_a770a6" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_a770a6" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense_ab9a03" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense_ab9a03" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee907e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ee907e" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsGranted" xlink:label="loc_scwoOptionsGranted_16c731" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoOptionsGranted_16c731" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_b6b97a" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_b6b97a" order="16" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IssuanceOfShares" xlink:label="loc_scwoIssuanceOfShares_9ee118" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoIssuanceOfShares_9ee118" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="loc_us-gaapStockOptionExercisePriceIncrease_a23d9e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapStockOptionExercisePriceIncrease_a23d9e" order="18" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable_cd1f2d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable_cd1f2d" order="19" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_StockOptionsIssued" xlink:label="loc_scwoStockOptionsIssued_e0b1bc" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoStockOptionsIssued_e0b1bc" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_CommonSharesForIssuanceRemaining" xlink:label="loc_scwoCommonSharesForIssuanceRemaining_e39a6f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoCommonSharesForIssuanceRemaining_e39a6f" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_50e50e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapShareBasedCompensation_50e50e" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense_8f55d2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense_8f55d2" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_12ae71" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_12ae71" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_MarketPriceAndExercisePriceDifference" xlink:label="loc_scwoMarketPriceAndExercisePriceDifference_8d703c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoMarketPriceAndExercisePriceDifference_8d703c" order="25" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AverageGrantDateFairValue" xlink:label="loc_scwoAverageGrantDateFairValue_d938dd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoAverageGrantDateFairValue_d938dd" order="26" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_NumberOfOptionIncludePerformanceConditions" xlink:label="loc_scwoNumberOfOptionIncludePerformanceConditions_1a2604" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoNumberOfOptionIncludePerformanceConditions_1a2604" order="27" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4f9bd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4f9bd" order="28" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueTarget" xlink:label="loc_scwoRevenueTarget_64ee87" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoRevenueTarget_64ee87" order="29" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AchiveRevenueTarget" xlink:label="loc_scwoAchiveRevenueTarget_0becea" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoAchiveRevenueTarget_0becea" order="30" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AnnualRevenueAchiveForFiscalYear2026" xlink:label="loc_scwoAnnualRevenueAchiveForFiscalYear2026_d94af7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_scwoAnnualRevenueAchiveForFiscalYear2026_d94af7" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_290279" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bba5da" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_290279" order="32" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995475 - Disclosure - Related Party Transactions (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract_d7e5e5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_3e07ad" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract_d7e5e5" xlink:to="loc_us-gaapStatementTable_3e07ad" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_97b24e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_3e07ad" xlink:to="loc_us-gaapStatementLineItems_97b24e" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_e81e1b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_3e07ad" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_e81e1b" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_099bfe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis_e81e1b" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_099bfe" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AirSCWOMember" xlink:label="loc_scwoAirSCWOMember_0fd01d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_099bfe" xlink:to="loc_scwoAirSCWOMember_0fd01d" order="11" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:label="loc_scwoRelatedPartyTransactionExpensesFromTransactionWithRelatedParty_b1070b" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_97b24e" xlink:to="loc_scwoRelatedPartyTransactionExpensesFromTransactionWithRelatedParty_b1070b" order="1" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995476 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_040909" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_368581" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract_040909" xlink:to="loc_us-gaapStatementTable_368581" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_f71ffe" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_368581" xlink:to="loc_us-gaapStatementLineItems_f71ffe" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis_1a695c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_368581" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis_1a695c" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dea97c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis_1a695c" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dea97c" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsMember" xlink:label="loc_us-gaapCommitmentsMember_201d44" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_dea97c" xlink:to="loc_us-gaapCommitmentsMember_201d44" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PaymentOfLegalSettlementAmount" xlink:label="loc_scwoPaymentOfLegalSettlementAmount_1150d7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_f71ffe" xlink:to="loc_scwoPaymentOfLegalSettlementAmount_1150d7" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PotentialLossesAssociatedWithComplaints" xlink:label="loc_scwoPotentialLossesAssociatedWithComplaints_e430bf" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_f71ffe" xlink:to="loc_scwoPotentialLossesAssociatedWithComplaints_e430bf" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements_d6eda7" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_f71ffe" xlink:to="loc_us-gaapPaymentsForLegalSettlements_d6eda7" order="3" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:title="995477 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract_6d5b67" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable_e132ac" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract_6d5b67" xlink:to="loc_us-gaapStatementTable_e132ac" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems_bd8cb1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e132ac" xlink:to="loc_us-gaapStatementLineItems_bd8cb1" order="2000" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis_d4a598" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable_e132ac" xlink:to="loc_us-gaapSubsequentEventTypeAxis_d4a598" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_db6f73" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis_d4a598" xlink:to="loc_us-gaapSubsequentEventTypeDomain_db6f73" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_07ee1d" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain_db6f73" xlink:to="loc_us-gaapSubsequentEventMember_07ee1d" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e28ccd" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bd8cb1" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_e28ccd" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfBoardOfDirectorsEquityCompensation" xlink:label="loc_scwoDescriptionOfBoardOfDirectorsEquityCompensation_70d21c" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bd8cb1" xlink:to="loc_scwoDescriptionOfBoardOfDirectorsEquityCompensation_70d21c" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_72b3a0" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bd8cb1" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_72b3a0" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedRestrictedStockUnitsGranted" xlink:label="loc_scwoShareBasedRestrictedStockUnitsGranted_f73b60" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems_bd8cb1" xlink:to="loc_scwoShareBasedRestrictedStockUnitsGranted_f73b60" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>scwo-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/15/2025-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2025 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://scwo.com/role/Cover" xlink:href="scwo-20250331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:href="scwo-20250331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="scwo-20250331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="scwo-20250331.xsd#CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:href="scwo-20250331.xsd#NatureOfBusinessAndPresentationOfFinancialStatements" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryNet" xlink:href="scwo-20250331.xsd#InventoryNet" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/Revenue" xlink:href="scwo-20250331.xsd#Revenue" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquity" xlink:href="scwo-20250331.xsd#StockholderEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactions" xlink:href="scwo-20250331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingencies" xlink:href="scwo-20250331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SegmentReporting" xlink:href="scwo-20250331.xsd#SegmentReporting" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEvents" xlink:href="scwo-20250331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryTables" xlink:href="scwo-20250331.xsd#InventoryTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueTables" xlink:href="scwo-20250331.xsd#RevenueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityTables" xlink:href="scwo-20250331.xsd#StockholderEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="scwo-20250331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:href="scwo-20250331.xsd#LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/InventoryDetails" xlink:href="scwo-20250331.xsd#InventoryDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails" xlink:href="scwo-20250331.xsd#RevenueDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails1" xlink:href="scwo-20250331.xsd#RevenueDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetails2" xlink:href="scwo-20250331.xsd#RevenueDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RevenueDetailsNarrative" xlink:href="scwo-20250331.xsd#RevenueDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails" xlink:href="scwo-20250331.xsd#StockholderEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails1" xlink:href="scwo-20250331.xsd#StockholderEquityDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails2" xlink:href="scwo-20250331.xsd#StockholderEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetails3" xlink:href="scwo-20250331.xsd#StockholderEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:href="scwo-20250331.xsd#StockholderEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="scwo-20250331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="scwo-20250331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:href="scwo-20250331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedBalanceSheets" xlink:title="110200 - Statement - Condensed Consolidated Balance Sheets" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="110201 - Statement - Consolidated Balance Sheets (Parenthetical)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited" xlink:title="124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited" xlink:title="148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" order="25" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssued" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationOptionsAmount" xlink:label="loc_scwoAccretionOfStockBasedCompensationOptionsAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAccretionOfStockBasedCompensationOptionsAmount" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AccretionOfStockBasedCompensationRestrictedStockAmount" xlink:label="loc_scwoAccretionOfStockBasedCompensationRestrictedStockAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAccretionOfStockBasedCompensationRestrictedStockAmount" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" order="10" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements" xlink:title="995446 - Disclosure - Nature of Business and Presentation of Financial Statements" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="995447 - Disclosure - Summary of Significant Accounting Policies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern" xlink:title="995448 - Disclosure - Liquidity Capital Resources and Going Concern" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryNet" xlink:title="995449 - Disclosure - Inventory, Net" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/Revenue" xlink:title="995450 - Disclosure - Revenue" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquity" xlink:title="995451 - Disclosure - Stockholder Equity" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactions" xlink:title="995452 - Disclosure - Related Party Transactions" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingencies" xlink:title="995453 - Disclosure - Commitments and Contingencies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SegmentReporting" xlink:title="995454 - Disclosure - Segment Reporting" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEvents" xlink:title="995455 - Disclosure - Subsequent Events" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="995456 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="995457 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryTables" xlink:title="995458 - Disclosure - Inventory (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueTables" xlink:title="995459 - Disclosure - Revenue (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityTables" xlink:title="995460 - Disclosure - Stockholder Equity (Tables)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="995461 - Disclosure - Summary of Significant Accounting Policies (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember" xlink:label="loc_us-gaapOfficeEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapOfficeEquipmentMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentDemoSystemMember" xlink:label="loc_scwoEquipmentDemoSystemMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_scwoEquipmentDemoSystemMember" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstateAccumulatedDepreciation" xlink:label="loc_us-gaapRealEstateAccumulatedDepreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRealEstateAccumulatedDepreciation" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" order="3" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1" xlink:title="995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" order="60" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="80" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="100" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" order="110" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="110" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="120" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" order="130" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoCustomerMember" xlink:label="loc_scwoTwoCustomerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_scwoTwoCustomerMember" order="111" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueMember" xlink:label="loc_scwoRevenueMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_scwoRevenueMember" order="112" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_scwoOptionsMember" order="113" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_UnvestedRestrictedStockMember" xlink:label="loc_scwoUnvestedRestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoUnvestedRestrictedStockMember" order="114" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OneCustomerMember" xlink:label="loc_scwoOneCustomerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_scwoOneCustomerMember" order="115" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" order="116" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FullScaleDemonstrationMember" xlink:label="loc_scwoFullScaleDemonstrationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_scwoFullScaleDemonstrationMember" order="117" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ThreeCustomerMember" xlink:label="loc_scwoThreeCustomerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_scwoThreeCustomerMember" order="118" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TreatabilityStudyServicesMember" xlink:label="loc_scwoTreatabilityStudyServicesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_scwoTreatabilityStudyServicesMember" order="119" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="120" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherStockBasedCompensation" xlink:label="loc_scwoOtherStockBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoOtherStockBasedCompensation" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueReceiveAsConsideration" xlink:label="loc_scwoRevenueReceiveAsConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRevenueReceiveAsConsideration" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnearnedPremiums" xlink:label="loc_us-gaapUnearnedPremiums" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnearnedPremiums" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingCostsAndExpenses" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AllocatedTransactionPriceDuringCustomerContract" xlink:label="loc_scwoAllocatedTransactionPriceDuringCustomerContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAllocatedTransactionPriceDuringCustomerContract" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DuringCustomerContractRemainingPerformanceObligation" xlink:label="loc_scwoDuringCustomerContractRemainingPerformanceObligation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoDuringCustomerContractRemainingPerformanceObligation" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet" xlink:label="loc_us-gaapCapitalizedContractCostNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalizedContractCostNet" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfCapitalizedCost" xlink:label="loc_scwoDescriptionOfCapitalizedCost" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoDescriptionOfCapitalizedCost" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ContractCostsOnDemoContract" xlink:label="loc_scwoContractCostsOnDemoContract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoContractCostsOnDemoContract" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRecallExpense" xlink:label="loc_us-gaapInventoryRecallExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryRecallExpense" order="12" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ConcentrationsOfCreditRisk" xlink:label="loc_scwoConcentrationsOfCreditRisk" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoConcentrationsOfCreditRisk" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent" xlink:label="loc_us-gaapUnbilledReceivablesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnbilledReceivablesCurrent" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyAccrualProvision" xlink:label="loc_us-gaapLossContingencyAccrualProvision" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyAccrualProvision" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="17" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative" xlink:title="995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ATMMember" xlink:label="loc_scwoATMMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoATMMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInContinuingOperations" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetCashProvidedByUsedInContinuingOperations" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapital" order="4" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedFromAtTheMarketOffering" xlink:label="loc_scwoProceedFromAtTheMarketOffering" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoProceedFromAtTheMarketOffering" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ProceedsFromCommonStockAndWarrantsShares" xlink:label="loc_scwoProceedsFromCommonStockAndWarrantsShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoProceedsFromCommonStockAndWarrantsShares" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" order="7" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/InventoryDetails" xlink:title="995465 - Disclosure - Inventory (Details)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails" xlink:title="995466 - Disclosure - Revenue (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesBillingStatusDomain" xlink:label="loc_us-gaapReceivablesBillingStatusDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:to="loc_us-gaapReceivablesBillingStatusDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesBillingStatusDomain" xlink:label="loc_us-gaapReceivablesBillingStatusDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis" xlink:to="loc_us-gaapReceivablesBillingStatusDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_EquipmentRevenuesMember" xlink:label="loc_scwoEquipmentRevenuesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivablesBillingStatusDomain" xlink:to="loc_scwoEquipmentRevenuesMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceRevenueMember" xlink:label="loc_scwoServiceRevenueMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivablesBillingStatusDomain" xlink:to="loc_scwoServiceRevenueMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenuePercentage" xlink:label="loc_scwoRevenuePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRevenuePercentage" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PremiumsRevenuePercentage" xlink:label="loc_scwoPremiumsRevenuePercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPremiumsRevenuePercentage" order="3" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails1" xlink:title="995467 - Disclosure - Revenue (Details 1)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetails2" xlink:title="995468 - Disclosure - Revenue (Details 2)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RevenueDetailsNarrative" xlink:title="995469 - Disclosure - Revenue (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwentyTwentyFiveMember" xlink:label="loc_scwoTwentyTwentyFiveMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_scwoTwentyTwentyFiveMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" order="2" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails" xlink:title="995470 - Disclosure - Stockholder Equity (Details)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_scwoOptionsMember" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="14" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="16" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="17" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:label="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" order="18" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="19" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails1" xlink:title="995471 - Disclosure - Stockholder Equity (Details 1)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsMember" xlink:label="loc_scwoOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_scwoOptionsMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionMember" xlink:label="loc_us-gaapOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapOptionMember" order="22" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BottomMember" xlink:label="loc_scwoBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoBottomMember" order="23" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TopMember" xlink:label="loc_scwoTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoTopMember" order="24" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails2" xlink:title="995472 - Disclosure - Stockholder Equity (Details 2)" />
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetails3" xlink:title="995473 - Disclosure - Stockholder Equity (Details 3)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="2" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="5" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="7" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" xlink:label="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance" order="10" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/StockholderEquityDetailsNarrative" xlink:title="995474 - Disclosure - Stockholder Equity (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" order="70" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaapFinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFinancialInstrumentAxis" order="60" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFinancialInstrumentAxis" xlink:to="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_10" order="80" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="70" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="80" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" order="90" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingAxis" xlink:label="loc_us-gaapVestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapVestingAxis" order="90" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain" order="100" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VestingDomain" xlink:label="loc_us-gaapVestingDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapVestingAxis" xlink:to="loc_us-gaapVestingDomain_10" order="110" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_WarrantsMember" xlink:label="loc_scwoWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoWarrantsMember" order="91" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" order="92" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FinancialOfficerMember" xlink:label="loc_scwoFinancialOfficerMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_scwoFinancialOfficerMember" order="93" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_keyEmployeeMember" xlink:label="loc_scwokeyEmployeeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_scwokeyEmployeeMember" order="94" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" order="95" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_us-gaapStockOptionMember" order="96" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RestrictedStockUnitsMember" xlink:label="loc_scwoRestrictedStockUnitsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="loc_scwoRestrictedStockUnitsMember" order="97" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_FormerEmployeesMember" xlink:label="loc_scwoFormerEmployeesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_scwoFormerEmployeesMember" order="98" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TwoZeroTwoOnePlanMember" xlink:label="loc_scwoTwoZeroTwoOnePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoTwoZeroTwoOnePlanMember" order="99" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_BottomMember" xlink:label="loc_scwoBottomMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoBottomMember" order="100" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_TopMember" xlink:label="loc_scwoTopMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_scwoTopMember" order="101" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentTargetMember" xlink:label="loc_scwoVestUponAchievementOfFifityPercentTargetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_scwoVestUponAchievementOfFifityPercentTargetMember" order="102" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestUponAchievementOfFifityPercentRevenueTargetMember" xlink:label="loc_scwoVestUponAchievementOfFifityPercentRevenueTargetMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapVestingDomain" xlink:to="loc_scwoVestUponAchievementOfFifityPercentRevenueTargetMember" order="103" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ServiceBasedOptionsMember" xlink:label="loc_scwoServiceBasedOptionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoServiceBasedOptionsMember" order="104" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedOptionMember" xlink:label="loc_scwoPerformanceBasedOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_scwoPerformanceBasedOptionMember" order="105" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" order="3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="4" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualFairValueOfSharesIssued" order="5" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU" order="6" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedRestrictedStockUnits" xlink:label="loc_scwoPerformanceBasedRestrictedStockUnits" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPerformanceBasedRestrictedStockUnits" order="7" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_VestingRestrictedStockUnitsRecognizedPeriod" xlink:label="loc_scwoVestingRestrictedStockUnitsRecognizedPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoVestingRestrictedStockUnitsRecognizedPeriod" order="8" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OtherLaborAndRelatedExpense" xlink:label="loc_scwoOtherLaborAndRelatedExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoOtherLaborAndRelatedExpense" order="9" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_GrantDateFairValueOfRestrictedStock" xlink:label="loc_scwoGrantDateFairValueOfRestrictedStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoGrantDateFairValueOfRestrictedStock" order="10" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" xlink:label="loc_scwoPerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPerformanceBasedVestingConditionsForRestrictedStockUnitsDescription" order="11" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" order="12" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="loc_us-gaapOtherResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherResearchAndDevelopmentExpense" order="13" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="14" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_OptionsGranted" xlink:label="loc_scwoOptionsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoOptionsGranted" order="15" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="16" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_IssuanceOfShares" xlink:label="loc_scwoIssuanceOfShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoIssuanceOfShares" order="17" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionExercisePriceIncrease" xlink:label="loc_us-gaapStockOptionExercisePriceIncrease" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionExercisePriceIncrease" order="18" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" xlink:label="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable" order="19" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_StockOptionsIssued" xlink:label="loc_scwoStockOptionsIssued" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoStockOptionsIssued" order="20" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_CommonSharesForIssuanceRemaining" xlink:label="loc_scwoCommonSharesForIssuanceRemaining" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoCommonSharesForIssuanceRemaining" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensation" order="22" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" order="23" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" order="24" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_MarketPriceAndExercisePriceDifference" xlink:label="loc_scwoMarketPriceAndExercisePriceDifference" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoMarketPriceAndExercisePriceDifference" order="25" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AverageGrantDateFairValue" xlink:label="loc_scwoAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAverageGrantDateFairValue" order="26" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_NumberOfOptionIncludePerformanceConditions" xlink:label="loc_scwoNumberOfOptionIncludePerformanceConditions" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoNumberOfOptionIncludePerformanceConditions" order="27" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="28" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RevenueTarget" xlink:label="loc_scwoRevenueTarget" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRevenueTarget" order="29" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AchiveRevenueTarget" xlink:label="loc_scwoAchiveRevenueTarget" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAchiveRevenueTarget" order="30" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AnnualRevenueAchiveForFiscalYear2026" xlink:label="loc_scwoAnnualRevenueAchiveForFiscalYear2026" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoAnnualRevenueAchiveForFiscalYear2026" order="31" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" order="32" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="995475 - Disclosure - Related Party Transactions (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" order="30" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_AirSCWOMember" xlink:label="loc_scwoAirSCWOMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_scwoAirSCWOMember" order="11" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty" xlink:label="loc_scwoRelatedPartyTransactionExpensesFromTransactionWithRelatedParty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoRelatedPartyTransactionExpensesFromTransactionWithRelatedParty" order="1" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="995476 - Disclosure - Commitments and Contingencies (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByLiabilityClassAxis" xlink:label="loc_us-gaapFairValueByLiabilityClassAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByLiabilityClassAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:label="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapFairValueByLiabilityClassAxis" xlink:to="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsMember" xlink:label="loc_us-gaapCommitmentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="loc_us-gaapCommitmentsMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PaymentOfLegalSettlementAmount" xlink:label="loc_scwoPaymentOfLegalSettlementAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPaymentOfLegalSettlementAmount" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_PotentialLossesAssociatedWithComplaints" xlink:label="loc_scwoPotentialLossesAssociatedWithComplaints" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoPotentialLossesAssociatedWithComplaints" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="loc_us-gaapPaymentsForLegalSettlements" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForLegalSettlements" order="3" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://scwo.com/role/SubsequentEventsDetailsNarrative" xlink:title="995477 - Disclosure - Subsequent Events (Details Narrative)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" order="2000" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" order="40" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" order="21" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="1" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_DescriptionOfBoardOfDirectorsEquityCompensation" xlink:label="loc_scwoDescriptionOfBoardOfDirectorsEquityCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoDescriptionOfBoardOfDirectorsEquityCompensation" order="2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="3" />
    <link:loc xlink:type="locator" xlink:href="scwo-20250331.xsd#scwo_ShareBasedRestrictedStockUnitsGranted" xlink:label="loc_scwoShareBasedRestrictedStockUnitsGranted" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_scwoShareBasedRestrictedStockUnitsGranted" order="4" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>scwo_ex101img1.jpg
<TEXT>
begin 644 scwo_ex101img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[+HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#Q+]H;4K.;X=7WA/_A*=/T"^U.TFN$:\
MNHX#.D.&\E2[#EW*+QVW50\+ZIH?QH_9GL;KQ!9P:A,J);WBS(&:*YC8(9%.
M/E8J=P(Z!\>M>GZ=X6FT_P 4ZOKS>*-8NVU.,1FUN/(,-L%)V>7MB##;N; +
M$'<203S7"Z#\#;'PZFKQZ%X^\66,.KW'VN\BC:Q\MY=V[<JFU(3G^X " !T&
M*FVC7?\ ,+ZI]C@?@UJ>H:+HWB?X%ZG>$:OI.IFULV8D,]E*2[NO7&(Q(X]W
M45YKX1\,^';C]D+XB:M<:!ITNHVNIS+!>/;(TT(7RMH5R-R@;FQ@_P 1]37U
M@WPUTE?&%WXRAU*^MO$=WI::6^HQB N%4@^:%:(IYAP 3MVX  45Q]G^SYH.
MG^!-5\#V?C3Q3'H>JS?:+JW$EF3(YQGY_LVX [5R ?X?<Y>K7G;\0OJK;)WM
MY6.?^#7A3PKK6@>'KR^^&]KH=[HVF6%Q#J9MX$DU-IH)$D=FC)#QL.SG=DG(
M!XKDM:T'6/@SKEU\5O!-C]I\*76H7=IXAT"! L4<*W,B+)&@&U0% '3Y3_LL
M<>VZ;\+O[-T_0]+C\?>*+C2]%:$VMA(]FD1$6/+5S';*[@8!PS'D#-='X>\*
MKH.D7FFWFN:AX@@O)I9I!J:VYQYK%I% BBC!5F9C@@]<# XIWO+F_IBZ69\M
M?&+0_ $W[.FB^)O"GAW3+6WO]>,D-U;V*0R-"\LWRYVA@-JH-O3Y0.PKK/'%
ME8_#/X^?#^W\&V,&G:7XL=M/U;1+>,+9W"%D0N81\H;#]0/X.>ISZ/XD^!OA
MCQ%X+TWP0=8UG2_#VFS-<065C) !O+NRDM)$[_+O8  @8QG)&:U[/X8Z3#XM
M7Q;JFL:MKGB&*W:VM-1U!H2UBA!!\F..)(E/)Y*$GG.032V?E=NWE;8-6OE;
MYGANCQZ?\%?VCK6\C6/3/!_C!;NV9%&V&VN(9W"@ < #" =AYI]*L:/X:TW5
MOVR+F/Q1I-GJ3WGATW\T%[;K,J2.XP,,",HA" ^BU[+>?"70]8T33--\2:MJ
MNOIINK#6+>6^^SB02;BQC/E1(#&Q9B01GG&0  *\GPBM6^)ES\0H?&_B6WUV
M>!K7>@LC'' 3D1JC6Q&!Q@G+<<D\TUTOKO\ \ ??SM]Z/G_X/^'?"^I>*O%G
MAW5/AK9:QI]WXHNK'^TI;6%DTZ$1RLL:'/F1DE !M 49ZYP*]#^)'P?;5-=M
MM4^'TPTGQ?X=TV&XL+N((CWC1L8]DS #>2B!06XXP?E)KLO#OP2MO"::M'X>
M^(?BVQ&L3M=7K*]BSRRMG+AFM25//\)%=-H/@7^P=:LKZV\5:W<PVEC'IXL[
MDV[Q/&BX#,PA$A<MERV_EB>WRT/6VMFD#>KTW/*?AQ>>"_C4^KWWB+PC:6_B
M6"TM['789+4)*)5D;<-Q&[:XC (SD ;2>!7/>'/A_P"!]3_:T^(/AB]\)Z3)
MHT6D0&&S%E&L<#,D.6C 'R-\Q^9<'D\U]%Z?X4T/2_%FK^)K&U%OJ&L1PQWK
M)PLQBW;7(_O8<@GN /2N7T?X4V&B_%'4/B)%XJUZXU?44\N[BF-J8)HP %CV
MK " NU<%2&^7DG)R:<R?2WXBZ/7M87XE^"?#WB/X<0>'=4L4N+=+BSM(9G16
MF@#SQ1%HV(^5MI(R*\2T.:3PUKEE\!?BYI<&OVT=_:R^&=2O;<3)<0^>@,1W
M X(3</8;D/!7/TEXG\.3>)M-AL5U[4M&2.XCN#+IP@WNT;!T!\V*08#*IX S
MC!XR"W7?".B^(FT>;6(FNKO1[N*]L[DX66.5".<@8PV,,,8.>V!A7L_4?2W8
M\+\%V]O\3/VA/'\?CJQAU.P\+RI8Z5HUY&'M8$)=?-$+?*6(0'<0?O\ '08N
M_"J\O/#O[1OCSX9Z7+(_A6SMTOK2V+ETT]V$1,:9Y53YA^4<#:,=Z].U3X9:
M/=^,F\9:3J6I>&_$$L7D7%]I31 W:#HLL<T<D;XP,,5W<#G@5#IOPKT'1_#N
MN:=I>I:O9ZCK[>9J&O176W49I,YWB7;A3UP%4*,G YIQTMY*WJ^XGK?U5O([
M>\M([VSGLYC*(ID,;&*9HG (P=KH0RGW!!':O$_V<X5M5^(]I&TKQ6WBFY@C
M\R1I&"(JJH+,2QP !R2>*]D73IHO#ZZ5#J=['(D @6_+))< A<>82ZLK/WRR
MD$]17)> _AI9_#_4]6N=-\2ZWJ"ZQ<27EW!J!MF1[AR"TH\N%&!XQ@';STZ4
MEHWZ ]4O4\^_:0\&^&8_A%XR\7-HUI/KLRVF+^:%7FA"S1(%C8C*#&<XZY.:
MY#XB06WPW_9KTCQ5X#TV'0=9UNPL--OKW3HEA;RWCWM(=H'[PD%=_7YSSG!'
MO_Q \!V/Q%\*R^&=6U34M/TVY96N$L3$K3!6#*K&2-\ , ?EP>.N.*='X T2
MX^'2> M<DG\1:.D"VI_M#R_,,:XV#,2( 5 && #< YSS4VLGZI_+L5?;YGBW
MQ<\#^&OA_P# J+Q;X,MXM&\1Z*UM-!K-I\ES=,\J*_FR#F4-N)(<D?A7H_B.
M1?&'[-MWJ7B'2X)9KWP\;Z2">,.L<WV?S 0"."K<@]00*6;X,Z%?6&F:/K_B
M+Q!X@T'3)%DM=(U"XB-NI7[@<I$LDH4< 2.PQUS79^)O#\?B3PQ?>'WU*\TV
M"]B-O)+8B,2"-AAE'F(ZC(R,[<C/!!YIRU3MU>GD*.C7EN>4?LLZ;86OP!T6
M^MK&"&YO'G:YFCC"O.5N)%4NPY;   ST%<7;Z+H.D_MG>+;RU\.V4ILO#K:K
M# D"X%T/*)D48^5R2?F'.6)[FO4-'^#,'A_P2O@W2?B%XLL]# =1;1/9*VUV
M+,/-%MY@R2>C#KBKFG_">QT[XJS_ !'B\6:_-K-S']GFCE:U,#P#&(=H@!"C
M:O((;CELDDU+5Z.PHKE3ZZ_J>>? /1-)^)GA"Y^(7CRS@\3:]?7TRB2_03)8
M(K#;' C9$6.N5 /(YXK"_:&\&Z+X>T#P-Y=C_;%R?$@B\VZ"S7,UN[R2?9C+
M(<N@+;0';'3/<U[+IOPGTOP_JU]>>#_$6M^%K;4)?/NM.T^2!K620]6"312>
M63T/EE>V,8%0^,/@WHGC*/1;:\\1:]86VC3"ZMH+.:$@W&XL9W:6)W=R2<Y8
MCVY.1VNGVL--J]W>]S TOP5X+U'P9K_B&3X;Z?X;GNK6\L9M):SA5&6&9C&T
MD:@H9 8PP9<CG@G ->3S0S? \7?@WQ5;G7/A5XL@9K&2ZC\X:;=,FX(P(/&[
M!_ ..0V?H2;X;75]/<W6H?$;Q5>3SV;V2-(UFJP([*79(TME3>0NW<RD@$XP
M<$:FH^!-)USX?'P3XBGN-;L7A\EY[ORQ.V/NOF-%4.O&"%'09SSDO9W_  #L
M>)^-M!U3PCXO77H?AU9^-_ UOI\-JFGV:KY^@.@W.\$0'RLV[>64!NGS+@$\
ME\6O^$.U[X7_  N\3Z'9MKD5SK4=LMQ>QJUY<0[Y"UO*\A^8[L@[FVDY.><U
M])7G@6*35=0U/2?$FMZ%=ZAL%U)8S1,LH2-8U'ES1R(IPH^95#_[6, <QKWP
M)\+ZYH_A_1(=:UK1]*\/N+BSM+&2#:+C<6,[M)$[.Y+'.6Q[<G)V]1+3UM8O
M_#GPWX=ADE\6:=X'@\&:G.;C3Y=/@ACAS''.0A=8_D+X3.Y21ANK#!KD_P!I
M#5[:7X?7WA6/Q18:%J,EJVIJMS=1PO="%U*0H&8$L[#(QG_5X[UZ3H_@VXT_
MQ2FO:EXRU_7KA+5[6.&_:V2"(,RL6$<$,8W_ "@;CGC(J;3/"<VFZSKFJ-XK
MUB\?5NL=U]F9+3 (7RL0@@*#PK%EY)()))F2O:W0J.C;/%_%GQBUJ\_9"@\?
M>&Y3%K-S'%9W-Q&,FTEW>7*X]#D'![;U-:%UH/PB\#_"K2M4\4PS65S?6D;/
MXIM[6YFOO.=%/FM=PHSH2S# 9@#T (XKKO"?P1\-^$](UO0EU75M:T+6MQN]
M*U-H&MB[$9D18XD*-Q_"0.G&0"([CX):+?>&8_"-]XH\17OA2)T9-&GN(&B5
M4.402^3Y^U2!@>;VQTJM[^8NWE<\5^(UOX5E^-WPLUB#PFWB:SO=-F>>V_LU
M4GU-8HBJ,\5QLW$*H(#\X QGC.K\-]%T'Q)\/?BAXDT];)_"&IK,UCX7DC\P
M:7+$C-N=&&V*0DA@$R!QAN!CU[6OA#I.M>.M%\8?\)-KMC>Z'&(=.AM3:^5:
MIMVE0)(&9LC.=[,>>,<8JW7P/T%/$7B36=#\2>(/#I\2QM'J5GIDMN+>;<,,
MP26%]K'+'<"""QP1FE]EQ74+ZIGD'[/_ (8\+^)? 7AJRUCX>P020PSZFGB5
MH(5EFFAO1L5)5)?"@X(DQD 8!'-4O$VFZ%I/[5OC!H/AS8^)H$T!;O\ LX6=
MN\22LT1:X='QGJ2Q0,YW'CDD>U:/\$K?0O!D/@W3/B!XM@T")F/V))+-=RLQ
M9E,@MA)M8DY&[H2*F_X4[#'\2+_X@6OCSQ+:Z]?0_9I)H_L+(L.1B-4>V90!
MM7!QGCDDDDTVKI]$2KJZ[G/_ !"^"O@_5OAW;^$]$TFUMIOM=RVGN$7=:2R0
MRR[$;JL9<*=N<8QZ"N!TWQA-XZ_9.U#0KZ1O[3T+3+R'5HI,EL6T1$6[W+-"
MWOY;^E>YV?PWFLVM77Q]XFDFAOWU&669K21KF5D$>'W6YP@3*A4V@ ^H!%2Y
M^#OAN2P\66.G:CJ6ECQ=<M<:I+:&$O(&0JT2F2)PJ'<S=-V6.& XJ-7?S15]
MO)_@?+WB[PUX;M?V1OAQK5KX>L4U.YU*$37,5M&L]P&\[<K/@%L[5ZG'RCTK
MZ*\+^"O!.IVVL:Q/\,['PQ.5N-*ETI[.!5FA5DD4RQIF-VR@8%21@]3P:@O_
M -GO0=2\#Z3X-O/&GBB31-'F$]G;B2S4QN,[26%MN;&YL9)^\?;'4-\/[^?4
M?[0OOB-XIN[A+>2" R?8E2#?@&18TME0OC(#,&P&-'?S>@=O(^>;6";X'I9V
M/B"W;7/A'XOMHVECN8_/73+IXPQRI!RI//3D#(RR<]/\8?AWX'TG]FK6-<TW
MPOID&I&SL3'<K;)O@'F1*1&<90'+$XY8LQ.<U[C_ ,(/I=Y\/#X'UV:YUW3&
MM_LK/?\ E^:Z#[N3&B+N7 PP4'Y0<D\U3\8_#?3O&G@1/!>H:UJECI&U(Y5L
MFA#W"I@J&:2-\8*@_+MY'IQ3>J:\T"=I)^MS/^%?@SPOHGA70O$&B:+:Z9?W
MVBVD=T]K"L0N/D5]SA0 7R3\W4YYSQ7IW6N?\+Z"OAKPY8:#'JEYJ45C&L$4
MUYY?F^6HPJGRT13@ #.W/'))YKH*IN[N2DUN+1112*"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?9\YBP1C EY!XQU&B?&#PKK_ (GTK1[&WU)(=;%P=*U&:)$M[_R/]9Y?S^8
M.<%D4-@X)KG[KX()"?B;_8FK"Q'C&WVVR8.RSD=3Y_ _AD8)G'.!CL*I:?\
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M:3RHBY.>Z# XYZUY;/\ "OXB2>,-,\47,FA:OJ>EZY-J$=S=ZE<K)/:LKJD
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MYQ7':O\ ##Q)//X7N/#GA/P9X?33-:AU>ZL]/G>!',2LH4.EJ/,+!R=S*NW
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M_6JTU]1=;+8VZ***!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.:^:I-7F\-ZQJ7CSP[I_AW3)?%5[?%=2O;8S220VX"0Q16\+I+*TSH\C,N[
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MAE)!Y!'X5XAJNFW\?Q^L?!-G+I47A.V\)S,FD/IIDB$#31I)'CS "[;!AR"
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MM4'1OL?8N.:45XEX@^('CKP]J-AX3F;3+GQ)+ILFI7%Q9^']0O;9 &"1PK#
M[R<MNS*S   ?+DXKT3P+KVI^)O VE:UK6A7.@ZC<Q9N-/NHVC>!P2I&U@& .
M,C(Z$46TN*YU5%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8D#S.">",G/7^+/'6D>"[C18M5M[Z5M9OXM.MS;6Y=%ED8*N]^%0<YY.2 <
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5&R[E*\X(QP<&I** ,;1=#TK
MP]I<>EZ-9K:6JLS[5)8LS'+,S$EF8DY+$DD]36S110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ3*L8P'*;ER%92"'8?.K$XI=O.X;7^1]&Z?<W5U;"6XT^XL'W,ODW#1E\!B
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M+**X,8/4+O4XS@=/2DU#P?X3U2VLK75?"^EZA!8@+:1W5E%*ML   (PRD)@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\.^$QJ]GI%[!9:E=G4$@D@:1 Y>.-EQ(J*R[OG5LG"AJ6[L!Z-1113 ****
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MDGN;59 \BHC0J25.YE8DJ.H.2*]A;1;=O$D>NS2S2W$,#6\$;,/+@5BI<J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA2:7J$[W=FPCE9$0, LY9E_=YR!G##C.0+2U\B7>WF>^R21Q(TDC!44$LQX
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M51%:5"%  3[H ;IE?FKDO#G@_P"(>F>%_A)I=UX U 3^%-1FN-1(O+$KL?>
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI<]#[4=JP/#WB31?%VA1:UX?OOM=C*SQAS&\;!D8JRLC@,I!!!! -8]W\3?
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M+YEK=1+/"^TKN1@"IP<$<$=:>HC2HHHH&%%%% !1110 4444 %%%% !1110
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MVS(!O5'1G. %!W<#UQ@]5\-?"=MI.L^+O%$-A<V*>(]2-Q;P7*-&\<('4QL
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M[BH+!'4-CD<G.9J_P3TO6]0\4W=QXP\1P)XHCC@U"WA^QK&8H^(XTS;DJ%'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<D<PN#M.3NXR#C QN*1_"7XEQ^#=$T-H/#+RZ;XI;Q%(_P#:MP%D0NS^4/\
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M'+@85B&=%5@IP37+77@/XI:OXZ\*^)=;D\/7 TR^O+FZ@CU*X"I%/$(!#"#
M>$C4/D[=SLW"_>.KX/\  ?C#0_ 4WPUU2;2KCPXD,]G#J<,THNVMI-V$: QA
M%<!B-XD(X'RFEK;S'U\BQ-\;O#-GAM2TC7[&"XT^35-/EDL@_P#:5NG+-"L;
MLXPI#$2*A"G<<#FFVGQR\*O;P7=_I6M:39W6CR:W;7%[;QJMS!& 7"!9&;>-
MPX( /4$@@GF=.^$FN:7X(N=#MO!O@&+6(]/EL(-;MHS!/=AXVAWR8MBT3;6W
M,5:3<05^4-N$$'PQ^)$=UX&:33O"5S%X;T*;19X;K4+B6.[$B+&6*_9A\NU
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M1I<\DNGWMEJDD,K00P%,AY;5U!^=$9/*DWCLN"1*VMUO<KK?I8[V7X^>#_\
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M!H%];W/V99;:3S%+QX\THS2)D*P;;R267 SWWCCQ1I?ACX<7WB#Q%8ZNEBD
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M=.WBS3[7P0?&.M0W.AV$=K]LFCOE42P)C.&5&8;L8^4$G) Z\5YCXX^'Z_\
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MU_E_P2-7;YG64444%!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZBCD22T:*W195+GRFEV)Q*$V@B-E3<6X(Q78T44-W$E8****!A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/O&/A_P7X4U3Q!XOU9-$U/4;R+5O$46G6LDFG+'(T<**BP;%5RO+LCG.<8R
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MR_*"!W)OL![K\M'%>1_!/4-7O/#_ (IBUC6K[5YK+Q)?6<=S?2;Y/+C954<
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MPVTY U[7XM:+-:ZEYVDZO::KI^H1Z6^D2QQ-=2W$B[XT39(T9W+DYW@  DD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:?:WD[Q73L?];=3>0I8+R0HC.=JC(ZU[:S+&I9B%4#))Z"LC1_$OAWQ%Y_\
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M]\*_B-H2_#*'R/#<\?@Q[PR$:E<(;D3[E^4?9CMVJV>2<GCCK7T/12V20?\
M!_$\R^%?A+Q3X1LO$=OXDBTL'5-7GU6%M/NI)]OG-EHVWQ1XVX&",YR>!CGB
M_%'PE\;:EIOCSP]H]UHD>E^*=2AU1+JZEF\Z%E,1>,QJFW&8\AM_MCG*_0-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M749VJ_%;0=:\.Z+<>';76=3OO$-K+<6MEI\4/VN"-#MDD?S7$:;&^7YF(+<
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MC,D.FW,EVUTV,<M)%'Y:@\X 8G ^8#(+6VNX/?3M^)YO_P 5]<_&/6O EO\
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MVD,1'YA4$$XK@K7X!^)!I_A:>]\16TFMZ=<&QU"Y0OMN-'V"+[,N5R6V(IY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.<D$Y*UZ)1WI6 X:W^&OA6W1X_+U>[0V[VH6\UR^N5CC<;6$8EF81G QN7#
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MV#97/IWC-%>"_P#"YDTG0==UJQ^&,EO<Q^*!HMW!%=6\;R3D1KYTK#@N=P4
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MO!X?\4RW-[9:C:KN%OYZYFA<X.QE?+*2-K!L9R,5['2=ZG1AJK6/*+'P7?\
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MG.T3KR@5MN-H^?D' KTS0?$&D^*-%M-=T.\6[TV[7?#.JLNX D'A@""""""
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M<R[].<8YXR>[^'_@>\\!66IZ>VN'4[*YOIKRWB^RB$P>;(SL&;<Q<Y;&?E&
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M7M/TFR\?^!-<NII-<LFQ%J&G/&FR38SC$BH%RJXR,#&.6-I-2U"X^/GAK5/
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M\F01HC'^$/P/_K5[-XZ^#&F>*%O=0\.ZO>>%M8OF#7CV$TD=MJ6/X;J%'42
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB#88V<\ G;R<U]0> =#CMOA1IGA_5M5_X2JV6W>V:[N[78+V'<P7*,S94K@
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M65UCY1L?*55OF/!'-/:_X$]OQ/8_ ?CJW^('AN+Q#IF@:GINFW'-M)J @!G
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M-HHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .5\:>&;GQ9X9;2K36I-(N!/%<1
MSK"LR%HW#JLD;<.A(&5R,^M0Z7X?UC^VH->\3:Q:ZGJ%K#)!;"PL#9Q1HY4N
M2K2RLS'8HSOQ@<+GFNOH[TEH&XM%%%, JE=V[W5G-;QW4UHTBE1/!MWI[C<"
M,_4&KM% &7I.FV>C:1:Z7I\1BMK2)88T+%B%48&2>2?<\FM2BBC< HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ."UKPGXDF
M\;IXJ\.>*K;3Y?L0L9+34=--[!MWE]R;98G1B2,_,0VU<C@5O:#HJ:%831><
MUU<W5P]U=7#*$\V5S\Q"CA1P !Z 9).2=^BEMH#U"BBBF!SGB#PSI_BBVMK/
M5Y)Y-/BF$TMDCA8KO'*K*,99 <';D XY!'%=$!@8' I:* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP3^+>I75]-=Z/\/F:_A6VNE36M?C2:)?NQLJS!2@[+C ]*^K:*0'S9J'P_\
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M>!]:\7:]X7U#3_$5II4>@7PU!8I].:Y,TH!4 L)DPNUCQC.><]J:>H=+>3/
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M;4R@RL0 &8D*N<\ G)P< X-=G7BOQ\DO$LOA^=/6!KS_ (3"P,*W#E8V?$F
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M2H=0V/UJK"N:5%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M],"C=OLT"T2[K4\'MM<N_!=SIL"^,-6L=/O?AT;^:2:5KQ;6X0(J30P,P56
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M10 45F2:IIL.JP:5-J-LFH7"-)#:O,HEE5?O,J9R0.Y XK3H **** "BBB@
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M;5 8$=!W (E7LK]+AO<]+T_QIXPTOXFZ+X-\80Z5=1>(+&6ZLKO2X9(/)EB
M:2&19)'W#:1AP5S_ '1VS/C%JFHMXD\ >#8;J>RTKQ)JI@U&:WE:)Y(D4-Y
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M-%QXML_%,?PH\06VH6=G+9PE?%VDNH67F1CYELQ+,WS=< @  +\M3K8I[O\
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MG%;H\&WJV\:_\)UXD-^C<WY>V\QEVLH4Q^1Y) W$_P"KSG!).!3>E[!U//\
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M$;5-LD^X-YK#&"^X [CSD YJK?>"_".IZO\ VUJ/A71[W5-H7[;<6,4DV ,
M;V4MC''7I5&S^(W@N_O=2M8=:2*33;;[=.;F&6W3[-DCST>1562/@_.A9??F
MLF?XS?#6UT^_OM0\3#3X[$Q^?'>VD]O,OF#,96*1 [A@"054@@4 =+:^#O"-
MG;W]M9^%='MH-2&+R.*QB1;K_KH N'ZGKFKNCZ#H?AZQ^P^']'LM(M-Q;[/8
MVZ01[CU.U !FO./%WQN\*Z'X-\1:MH\EUJ>H:3#&_P!E^P7" F7(AD)9%!A8
MC_6 [2.AR1GI8_B3X4W10S75\EPT,<TJ'2;L&V5V*IYV8OW.X@[1)M)'(R.:
MH6FA;;X>^ 9)9))O!.@,\DQN&9M-A):4Y!<G;RQR>>O)IT'P_P# =M8OIMMX
M)T&"RDE6X>WCTR%8VD7[KE0N"PYP>HK1UK6]+\-Z3/K&M7R6=C#C?*^3R3@
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M\BLK5?B9X(T7Q)_PC^I:PT-^DT-O)BUF>&&67F)))E0QQLPY 9@2*HVOQ?\
MAK=Z_)I-MXNMI+J*:2"0K')Y2.D9D8-+M\L856.2V#M;'(-(K4U?^%;?#O\
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MIH<\UYX>TZZN&WSS6T<DC<#<Q4$G XZT+J#TL:]%%%, HHHH **** "BBB@
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MMR"9CMR6)().<=CKVGPH\1VMW\.Y6\9Z>Z>"(6@B7^Q7!NU9/*.X_:?E/E@
M8!^;+<@[12T^]$.[NO)_B=%XH\>ZEI?BB3POX7\-_P#"0ZS;Z<VJ7$,EY]E1
M(=Q5%5MCEI'8$*N ..6'%94GQ4U2^FN;3PQX'FOM0TW2H-4U*SU*\^PRVOFJ
M62W"^6^Z;"DE6V*./FR<5KZ]X%U*X^(%OXY\,^(H](U46?\ 9]U%=V)O+>[@
M#%URBR1LK*Q)#!O;%5+CX=ZQ;^*-2\2>'?%D=AJ.MV<=IJSW>FBY6<Q@A)8P
MLD?ENJL5&=ZX RI()*UMYE=?+0Y^Q^.5UXBUBTL?"/@N6^CO=#;7(+B^U!+5
M&17".A"K(P(;<F<?> XVG>,K0_BMXN\6?%'P]-H>AP2:'>^%I-773CJ#1RR,
M9D1LYCV-(K(41254ABQ=<X&U8_!?4=!\16FH>%_%%GI]E8Z"WA^VM;K2GN&$
M;-O:5Y!<)N<R9;A5&#C'>HO"?P5U[PG>:#J&G^.+=[S1](ET97?1_DFA:;SD
M)7SS@AN&P?F7@;#\U/J(HZ'\8O\ BF_!3>'_ (;BU7Q3J%U:QV\5Y###;2I)
M)N+%5R68J78A,<GECP=*Q^-%]=:AHMC<>$8(9+SQ'/X:O=FIE_LEQ%SO3]R/
M-0J,Y.P@\8[UGZ+\#_$^CV?A"Q3QYIL]OX6U";4+?=H+JTS2EBRN1=8Q\[8P
M!VSG',]M\$]=MX99V\;6C:FOB8^*+>X71F$<4[@K)$T9N"7C((QAE(P>3G@Z
M@#?'6*UDU#3M8TC2M*U>VUJ71XEO-:$5FYCB$CS/</$I1<,!@(Q)(&.>.L\$
M_$VW\=?#F_\ %.EZ2TMW82SVTVGV]U'*'FBYVQS$JCJP*D/P"#7+6GP1U:P\
M0W?BFR^($R^('U1]4MYGTV,V\321^7-&T08,ZNH4??&-H(YR3Z;'I^O?\(_>
M6MQK5O/K%PK8NS9L+>)BNT;8?,W;!C.TR$DD_-Z+HQ]CRCP]\7&DTKP!9^&?
MANEK#XMCNC:01WL4%M:M$9"RG:F?X=S$(,!SC>1BN^\"^-+CQGX0NM7CTF.R
MU.VN;FQEL9+DM&MQ"Y4KYH3)4D [MF0#T.*X7P_\%?$V@CP*L7CS39XO!K7)
MLP^A2!IA."'$A%UV#'& ,=\UV/@'P/K7@?0-:TV;Q%9ZI<ZA?7&H0SC36@2&
M68[F#)YS%U#8( 93CC/<#MK;Y"=]/Q/$O#.L7FDRVWQ$\0^"],U/4Y_%MQI(
MU>+6IDNX3+.8=A3R LL* 856;' (52>-3XR>*[GQ%X2\=^&]0TDZ=<^%=3TL
MQ3VVI22)=+<2C!90B?P'E&W@$\?=!KL(/@SK7_"#7GAF]\96<DO]LKKME>1:
M.R&WN?/,S;T-PPD0DX RI SDFJ'B+X%^(O$-SXHNY/B-'%+XFELY;V/^Q5:)
M3;;2GECS@R\KQES\I(.XX<..EK]!O5MKJ:WAFWCM_P!J7QPL<DQ$NCV,S"25
MY &+/G;N)VC@?*,#VKF/B RZO\;=2T_QMH.F:GX4TGPRVHM#-J$H,$7GG?=1
MJL/RW&$V@!AQTD&2*]"T/P-XATWXIZEXZU/Q1I]X=1LX;*>S@TIX !'DJRN;
MA\<DD@@\<<=:JZQ\+]2U_P"(>J^(M3\06,NCZII#:'<:8NFNLGV5F+G$WG\2
M;F/S;,8_ASS4ZJWS#35][&9:_%;4]+_X1R#4O \UO9>(+%IM$^S:FMQ+,R1>
M8D$WF*@B=DP<[W&>K=:J:-\;M8U3PWH^OOX >V@\0R)::,/[5C;[5<M(Z&.3
MY 8E58RY?#<< 9X.O!\+M96/0X]2\66VH#PQ;O%HN[2BGE.8_*66XQ-^^*IP
M GE#.2?:K8?!FZL_A;X?\&MXMQJGAN^%_I6KP6'E^4X9B!)$TC"0?.X(#+D$
M=,9-/K\A6V]/Q%U+XS7&AI%IWB/PW:^'M?FO)[6*/5M66UT^:.)58SI=O&"R
M$.H7$>2Q(P,$CI? _P 1K/QM\,7\:6.FW!:%9EEL+=A<2&6+.Z.-EXDS@;2.
MN15;5O ?B?5=0T;Q(WC"VMO%&D/((;F'2S]C:&0 20M;F8N0VU3GS<@J",=*
MZ&\T#4]4\%ZEH=]X@E&H:C;RPOJ%I%Y/DLZ[<Q)N)4+V!8GU8GFI?PON/JCS
M1?CIJ%O#X@CU+P,%U'2-%37&L[/58YG2(MAHI]Z1F&5.K)ACUQDX!LQ_'*/3
M6$WBSPP='M)O#Z^(+5X+T7,DJ%E7R678H5RSKC#,#D9(.0,L_ 77([6YM[/Q
MII5F+KPZ?#<RP^'BB>3NW&556Y&)#DY)+ DDX[";5/@+J'B*;3HO$'C"TFL+
M30AH#16NDM#(\8*LLH=KAPKAT0_=(X(QSD4!4TFZUV\_:MTJ\\0:!_8]S<^%
MYI%A34GO$V^;'C@JJQN,895!&>=S=:V_'OQUTOP5KFJZ>MMIUY_8GDF_BN-6
MCM;I_, ;%M RDSE5(8\H.P).<7M'^&OBB'XAZ+XTU_QX-2NM+TYM,\JUTI+8
M749(;,A:23DD DKMS@8V\@Z\O@G6[/QQJOB7PKXHBTN'6EC_ +1LKK3S=*\B
M*$$T3"5/+?8 .0ZG )4TNB\K_F);MOR/+]7M=2^(?QEU?3]0\+:+KVE1:':W
M6G0WNLW%L(4DE=EN(V2W9HYFVJ&VX*@ !V!Q7/?#_P 3:1X7\)>%?&&MZ/HL
M7B[7DNUM]6OO$#V8O(EE8RM>2/'@$'8J#$IZ8* ''L47@'Q?9_$/5?&%EXRT
MS??6,>G)#<Z-)*8XXRQC9G%TNY\OEC@!NP6L;0?@YKWAW1/#-OI_CBU&K^&'
MF2QO1I3".2WF.Z6&>(W!\S)P0RLA&!]:%HK+0;U;OKL.T'XUQ^,--T./PCX=
M74/$&II<R26,]^(8+5;=@LC&=4?<"S*$*H=V[)VC-4=#^(7CSQ!\:_#^ES>'
M1HVG3Z#+>W&FW]V\4\1^T)&[NHB(9E*'8O 97+;ESM'5ZI\/-:OM=T7Q=:>+
M$M_%.F+-%)<OI_F6ES#+C="8!*K*@*@KB7(.22V:>_P_UA_B7I?CH^*_]-M]
M/?3KN(6"[)XVF$N(_G_=@$;>=YV_Q;OFH6Z^=_T$]G;RL>DGI7SR/&OB.W^-
M&C^++K4I1X$U^]G\-VEJ7(A22/'E7.#QF2595!Q]T+R>*]9U72?%NH>![G28
M_$UG8:[<1M$=5M]-?RX@2?F2%IR0P7@$R'GG':N USX!>'=1^'%GX=TNS\.:
M)KT'DYU^UT%1.#&00Z8E#AR57):1\_-D'/ OBN^@WM8Q]>TNW;]H/QI;F6[6
M.[\#F:0+=RJ5;SBOR$-F,81>$P.#ZG._\.]>F\,_LL:'XBBTR;5I+#1EN&M8
MI4C>0*"6.YR ,#)/? X!. 5_X5?XWF\77_BB\\?Z5<7][HO]B/CP_(B^7N+"
M3 N_O[B2>WL*V--^'>L:7\$6^&Z^(K26<63Z?%J/]FL%6%AM.8O.^9]I;G>!
MG!QQ@K51:6X/5IG*)\<KR+2M%N]8\+:=H+>(+=+K2I=5\10P6TT7EAY3)*4)
MC*ED4#8Q?<.F&QSGB+XA:A\3-#^'DND:'I]QI&J:XUI?:=?:DWESSQ1RDP2%
M(75X.%</\V[Y<IW'H=O\+]6L?#W@M-.\61V_B'PE ;.WU$:<6@N;<J$:.6W,
MV3E43)$@.Y<C&<5+XD\ >+O$.I>&M0_X373HKG0[LZA^]T5Y$EG*,F !<KLB
M"MPN6;/)<YJK*XD<1H'QA\'>#[K2O"6@Z7I\>A'57T>*&WUT7%Y!.78%OLSC
M<(#)E58N.,'8H(K1M_CUJ7]C:CKVJ> 'TS1]/U";2)KB?6( R7:NB*C# 4*6
M?EPQ"A6/(YKL-!\!Z_X9NKVQT;Q9'%X<N+R2]2PFT\O/;N[F1TCG\T#RV<DX
M*%@"0&!YK$TWX-WT/@G7_#NJ^+([BXU+6#KUK?V6GFV>QNS()-P5I9 ZAE7
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M2&PN"36%HG[0=CX@O-/TNPTS3(M2GN[FTF:[UI8[+=#LX@N%B83LXD4H-JY
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MJ&N:W/JU@D*W>F:[I\-K=6CMO)?,*(DB/QM(!&$ZG=3 ]0[T>M?.B_$+QO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/!X?''C#_A$?"GC73]6%E::YK-M8:1X7AM8GCDLC(4_>2,IE,GEJ9-RLJK@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
J**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>scwo_10qimg24.jpg
<TEXT>
begin 644 scwo_10qimg24.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  F /8# 2(  A$! Q$!_\0
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M77B6WU9;VS^S".*V:(H=X;.2Q]*0'MC>(M 5BK:YIX(Z@W29'ZTO_"2>'_\
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MZ;RDIQP?N*<^_O7WCKFM:?X=\/W^N:I,(;&QA:XFD/95&3^-,D\$_:J^*/\
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1SD<\'/8\?0E%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>scwo_ex101img2.jpg
<TEXT>
begin 644 scwo_ex101img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" 2D Y8# 2(  A$! Q$!_\0
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M_P ) OAP[;73Y=9V?ZG[0\=ON)Z>9L9L =]G)'1<\ 'E?A;QOXDO_"5QX?\
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MBBB@ HHHH *Q-1\-^']8OK:^U;0=.U"[M<&">ZM8Y9(<'(VLP)7GGCO6W10
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !7FWQG\S_A5ETT,:2RK?Z>8U=MH+?;(<9.#CZX/TKTFN=\1>$]%\
M76<5EKT=S/;1R"58X;R:W!8$$$^4Z[L$ C.<$9&* /+]:;6A\;O"=WXFL[;P
MX]U:7=C87>CS?;&GG=/NRO)&F @ 9 8V7=U.*TO#>K>*M0^S>$]1\57@\1Z?
MK%Q'J4Z6]J#):1KO1@GE85'$D ! W N>>,5V%GX%\.:5K*>((;"\U#5;6)D@
MFO=0GO98P1RL9N)&"$].".O)Q4>@:,TOBS5?&%YHKZ3>7\$%FL,SQO,(X]Q+
M/Y;,@+%\<,?EC3H>  =):6LUK&Z3:A/?,TK.'F6,% 3D(-BJ-HZ#()]23S6A
M6;:V2Z?;S) ;B7?(\Q$UP\S;F.2 9&.!Z*"%'0 "L;_A*M=_Z)KXD_[_ .G?
M_)= '"?#/PGILVM>/I_$7A^VGU(>*[N>%[VU5W6%@C1.A8<*<D@BMWXW0ZM=
M?!'Q+:Z'!/->/ @\N!27:/S$\P #K\F[(],UO?\ "5:[_P!$V\1_]_\ 3O\
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MQ C&R+E54$[<*<YQ7L'_  E6NX_Y)MXC_P"_^G?_ "71_P )5KN/^2;>(_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6M6O/_A[YG]L^/O-"B3_ (2 [@O(S]CMLXKT"@ HHHH **** "BBB@ HHHH
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M<0+I\DV;R&^>:XNYIIGFA8-$S2NY=MI P"Q';&":ZN@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2<XP220 H'"@  \H\67/B*U_:LO[CPKI]M?:LOAIFAAN)C&"<'D85MS=,*<
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M>\!O)YH]W]X)([*&X&2 "<#TKKZ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO._$'B7QIH^L.
M&T?3(=$+83499I&$8S@&15'R_7D4 >B45QT=KX^NOWC>(=$MX7&5^S6+R''L
M6DP?RI)/"?B*Z<-=?$#54'=+6""('\=A/ZT =E17)1^!X0/WWB7Q!<'N6U!E
MS_WR!7.Z'H^GZIX@U_2+IM7B;2YT57&K7!\U60,"?GP.X_"@#T^BN1D\#V6S
M_1=;UVS?'#QZC(Y'_?9856C\/^-=)3_B5^,!J8!R8M6ME8D>@>/:1]2#0!V]
M%<7I_C+RM2BT?Q5I[:%J4IVP[F\R"X/^Q(.,GT.#P:[2@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]+N=95%"Q+91;+=%''^L;"_J:[::&&XC,<\*RH>JNH(/YT]56-0J*%4<  8
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M.%1%P!^%6** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !B:%X0CT#7=:U>'6M1O)-9G%Q<177D[%<*%!39&I&%55Y)X'KS67)\/IO\
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M2.K(V),8&Y2IP!GOFU8^ ;>QUJ?6(_$>M-J%Q:P6<MP\D(+K"Y=&P(@ >=I
M 5AG()))AC^*W@N9=.:&XU:8:FK-9&/0[YOM(4$MY>(?FP 2<=N>E=)H/B31
M?$U@;[0[_P"V0*[1/\K(\;CJCHP#(P]& - '.1_#/1XX7D_M+43K#:A_:8U@
M-$MRMQL$>X!8Q%@H-I7R]I&<@GFH[KX8V-S/973>(M8CO;?4!JDMTIMS)=W*
MIY:/)F$C"I\H50J@'IGFO0J* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">374WATER INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000933972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,682,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-27866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">88-0271109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">100 Southcenter Court<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line 2</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Morrisville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">NC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">27560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">601-9677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCWO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 6,883,845<span></span>
</td>
<td class="nump">$ 10,651,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance</a></td>
<td class="nump">94,103<span></span>
</td>
<td class="nump">269,733<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled accounts receivable</a></td>
<td class="nump">2,163,417<span></span>
</td>
<td class="nump">1,653,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other accounts receivable</a></td>
<td class="nump">29,246<span></span>
</td>
<td class="nump">43,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,876,554<span></span>
</td>
<td class="nump">1,701,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets</a></td>
<td class="nump">197,043<span></span>
</td>
<td class="nump">136,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">338,315<span></span>
</td>
<td class="nump">431,412<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">11,582,523<span></span>
</td>
<td class="nump">14,887,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-Term Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, and equipment, net</a></td>
<td class="nump">2,719,232<span></span>
</td>
<td class="nump">2,567,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible asset, net</a></td>
<td class="nump">998,251<span></span>
</td>
<td class="nump">1,016,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, net</a></td>
<td class="nump">662,310<span></span>
</td>
<td class="nump">691,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">15,847<span></span>
</td>
<td class="nump">20,847<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Long-Term Assets</a></td>
<td class="nump">4,395,640<span></span>
</td>
<td class="nump">4,296,026<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">15,978,163<span></span>
</td>
<td class="nump">19,183,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">819,528<span></span>
</td>
<td class="nump">906,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued bonuses</a></td>
<td class="nump">380,000<span></span>
</td>
<td class="nump">570,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForLossOnContracts', window );">Accrued contract loss provision</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SettlementLiabilitiesCurrent', window );">Accrued legal settlement</a></td>
<td class="nump">335,000<span></span>
</td>
<td class="nump">335,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue</a></td>
<td class="nump">170,000<span></span>
</td>
<td class="nump">197,683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">105,697<span></span>
</td>
<td class="nump">101,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">37,998<span></span>
</td>
<td class="nump">17,279<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">2,848,223<span></span>
</td>
<td class="nump">3,127,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Unearned revenue, less current portion</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, less current portion</a></td>
<td class="nump">523,210<span></span>
</td>
<td class="nump">551,376<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">3,401,433<span></span>
</td>
<td class="nump">3,709,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock: 50,000,000 shares authorized, par value $0.0001 per share, nil issued and outstanding at March 31, 2025 and December 31, 2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: 200,000,000 authorized, par value $0.0001 per share, 144,682,963 and 144,301,977 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively</a></td>
<td class="nump">14,467<span></span>
</td>
<td class="nump">14,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">44,645,824<span></span>
</td>
<td class="nump">43,845,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(32,086,032)<span></span>
</td>
<td class="num">(28,387,618)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">2,471<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">12,576,730<span></span>
</td>
<td class="nump">15,474,781<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 15,978,163<span></span>
</td>
<td class="nump">$ 19,183,833<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLossOnContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative provision for contract losses not offset against related costs accumulated on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 605<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481187/605-35-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLossOnContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SettlementLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SettlementLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Condensed Consolidated Balance Sheets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares issued</a></td>
<td class="nump">144,682,963<span></span>
</td>
<td class="nump">144,301,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">144,682,963<span></span>
</td>
<td class="nump">144,301,977<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Condensed Consolidated Statements of Operations (Unaudited)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 543,100<span></span>
</td>
<td class="nump">$ 315,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenues</a></td>
<td class="nump">404,817<span></span>
</td>
<td class="nump">617,298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin (deficit)</a></td>
<td class="nump">138,283<span></span>
</td>
<td class="num">(302,020)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">533,587<span></span>
</td>
<td class="nump">535,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Compensation and related expenses</a></td>
<td class="nump">1,675,865<span></span>
</td>
<td class="nump">790,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="nump">771,901<span></span>
</td>
<td class="nump">252,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">942,440<span></span>
</td>
<td class="nump">321,141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">3,923,793<span></span>
</td>
<td class="nump">1,899,183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from Operations</a></td>
<td class="num">(3,785,510)<span></span>
</td>
<td class="num">(2,201,203)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">89,710<span></span>
</td>
<td class="nump">104,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="num">(2,614)<span></span>
</td>
<td class="nump">72,118<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income, net</a></td>
<td class="nump">87,096<span></span>
</td>
<td class="nump">176,738<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net Loss before Income Taxes</a></td>
<td class="num">(3,698,414)<span></span>
</td>
<td class="num">(2,024,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="num">$ (3,698,414)<span></span>
</td>
<td class="num">$ (2,024,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net Loss per Share - Basic and Diluted</a></td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.02)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Common Shares Outstanding - Basic and Diluted</a></td>
<td class="nump">144,607,438<span></span>
</td>
<td class="nump">132,668,777<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Changes in Stockholders Equity (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,667,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2023</a></td>
<td class="nump">$ 14,747,176<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,266<span></span>
</td>
<td class="nump">$ 30,684,943<span></span>
</td>
<td class="num">$ (15,953,504)<span></span>
</td>
<td class="nump">$ 2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares for services, amount</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">183,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">183,200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,024,465)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,024,465)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,670,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2024</a></td>
<td class="nump">12,910,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 13,266<span></span>
</td>
<td class="nump">30,872,643<span></span>
</td>
<td class="num">(17,977,969)<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,667,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2023</a></td>
<td class="nump">14,747,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 13,266<span></span>
</td>
<td class="nump">30,684,943<span></span>
</td>
<td class="num">(15,953,504)<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,301,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Dec. 31, 2024</a></td>
<td class="nump">15,474,781<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 14,429<span></span>
</td>
<td class="nump">43,845,499<span></span>
</td>
<td class="num">(28,387,618)<span></span>
</td>
<td class="nump">2,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares for services, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of shares for services, amount</a></td>
<td class="nump">66,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">66,882<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,698,414)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,698,414)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AccretionOfStockBasedCompensationOptionsAmount', window );">Accretion of stock-based compensation - options</a></td>
<td class="nump">460,512<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">460,512<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AccretionOfStockBasedCompensationRestrictedStockAmount', window );">Accretion of stock-based compensation - restricted stock</a></td>
<td class="nump">248,951<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">248,951<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of shares of common stock for option exercise, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of shares of common stock for option exercise, amount</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">23,980<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance, shares at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,682,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance, amount at Mar. 31, 2025</a></td>
<td class="nump">$ 12,576,730<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14,467<span></span>
</td>
<td class="nump">$ 44,645,824<span></span>
</td>
<td class="num">$ (32,086,032)<span></span>
</td>
<td class="nump">$ 2,471<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AccretionOfStockBasedCompensationOptionsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AccretionOfStockBasedCompensationOptionsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AccretionOfStockBasedCompensationRestrictedStockAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AccretionOfStockBasedCompensationRestrictedStockAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (3,698,414)<span></span>
</td>
<td class="num">$ (2,024,465)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">164,004<span></span>
</td>
<td class="nump">24,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Non-cash lease expense</a></td>
<td class="nump">28,704<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of common stock for services</a></td>
<td class="nump">66,900<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">709,463<span></span>
</td>
<td class="nump">183,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_InventoryReserveIncreased', window );">Increase in inventory reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">175,630<span></span>
</td>
<td class="num">(19,532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInUnbilledReceivables', window );">Unbilled accounts receivable</a></td>
<td class="nump">14,640<span></span>
</td>
<td class="num">(277,056)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="num">(510,410)<span></span>
</td>
<td class="nump">5,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(175,080)<span></span>
</td>
<td class="num">(374,981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Contract assets</a></td>
<td class="num">(60,392)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">93,097<span></span>
</td>
<td class="num">(340,280)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(86,866)<span></span>
</td>
<td class="nump">183,424<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued bonus</a></td>
<td class="num">(190,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_IncreaseDecreaseInProvisionForLossOnContracts', window );">Accrued contract loss provision</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Unearned revenue</a></td>
<td class="num">(27,683)<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">20,719<span></span>
</td>
<td class="num">(26,379)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(23,789)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used In Operating Activities</a></td>
<td class="num">(3,494,477)<span></span>
</td>
<td class="num">(2,508,653)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(297,322)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Increase in intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(590)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used In Investing Activities</a></td>
<td class="num">(297,322)<span></span>
</td>
<td class="num">(590)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Decrease in Cash and Cash Equivalents</a></td>
<td class="num">(3,767,799)<span></span>
</td>
<td class="num">(2,509,243)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, Beginning of the Period</a></td>
<td class="nump">10,651,644<span></span>
</td>
<td class="nump">10,445,404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, End of the Period</a></td>
<td class="nump">6,883,845<span></span>
</td>
<td class="nump">7,936,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL CASHFLOW DISCLOSURES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IncreaseDecreaseInProvisionForLossOnContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IncreaseDecreaseInProvisionForLossOnContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_InventoryReserveIncreased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_InventoryReserveIncreased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInUnbilledReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInUnbilledReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non Rule 10b5-1 Arragement Adopted [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non Rule 10b5-1 Arragement Terminated [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Business and Presentation of Financial Statements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Nature of Business and Presentation of Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of Business and Presentation of Financial Statements</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note</strong><strong> </strong><strong>1</strong><strong> </strong><strong>&#8211;</strong><strong> </strong><strong>Nature</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Business</strong><strong> </strong><strong>and</strong><strong> </strong><strong>Presentation</strong><strong> </strong><strong>of</strong><strong> </strong><strong>Financial</strong><strong> </strong><strong>Statements</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Description of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">the</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Company</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">374Water Inc. (the &#8220;Company&#8221;, &#8220;374Water&#8221;, &#8220;We&#8221;, or &#8220;Our&#8221;) is a global industrial technology and services company providing innovative solutions addressing global organic waste destruction/treatment and waste management issues within the Municipal, Federal, and Industrial markets.&#160; 374Water offers our proprietary AirSCWO system, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy.&#160; Importantly, our AirSCWO system eliminates recalcitrant organic wastes without creating waste byproducts. Our AirSCWO system effectively converts solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., &#8220;per-and polyfluoroalkyl substances&#8221; or &#8220;PFAS&#8221;) into recoverable resources including water, minerals, and heat energy, by focusing on waste as a valuable resource.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">In the first quarter of fiscal year 2025, 374Water continued to build on the strategic plan implemented in 2024.&#160; &#160; During the first quarter, we continued to execute our plan towards reaching critical business milestones. Our first quarter 2025 achievements to date include (i) continuing ruggedizing and optimizing our AirSCWO system to effectively and continuously process a variety of organic waste streams; (ii) preparing our first commercial scale AirSCWO system at the City of Orlando for the Iron Bridge Water Reclamation Facility bio-sludge test; (iii) completing various federal&#160; waste destruction demonstrations; (iv) secured a waste destruction services contract for aqueous film forming firefighting form (&#8220;AFFF&#8221;) with the University of North Carolina at Chapel Hill Collaboratory; and (v) strengthening our leadership team and organization.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Presentation</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Financial</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial information. It is management&#8217;s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2024 filed with the SEC on March 28, 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, currently inactive, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 2 &#8211; Summary of Significant Accounting Policies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Use</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Estimates</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of inventory reserve, equity-based compensation, revenue recognition, and accrued loss provisions on onerous contracts, useful lives of long-lived assets, and valuation allowance against deferred tax assets.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Receivables</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Accounts</em><em> </em><em>Receivable, Net </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivable consist of balances due from equipment and service revenues. The Company monitors accounts receivable and provides allowances when considered necessary based on historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future economic conditions to form adjustments to historical loss patterns. At March 31, 2025 and December 31, 2024, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant at March 31, 2025 and December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Unbilled Accounts Receivable</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Unbilled accounts receivable consist of balances due from&#160;revenues earned but not yet billed related to one customer contract for an equipment sale and one customer contract for a full-scale demonstration completed in January 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Inventory, Net</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress. Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question. We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used, we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required. Once inventory has been written down, it creates a new cost basis for inventory. Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 at both March 31, 2025 and December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Property</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Equipmen</span>t</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and the estimated useful life of the asset. Expenses for maintenance and repairs are charged to expense as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt">The following table presents property and equipment at March 31, 2025 and December 31, 2024:</span></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">578,352</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">366,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment &#8211; Demo System</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,356,041</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,298,666</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">87,300</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">59,306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,041,670</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,744,349</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(322,438</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(176,778</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,719,232</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,567,571</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We completed the manufacturing and fabrication of one of our AirSCWO systems that we will be using for full-scale wastewater treatment demonstration purposes (&#8220;Demo System&#8221;). We have capitalized the material and labor costs incurred to develop this Demo System, and had previously classified these costs within inventory. In the first quarter of 2024, we executed a contract with the City of Orlando, Florida to deploy&#160;the Demo System as part of a full-scale demonstration. We began the set up and commissioning process of this Demo System in the third quarter of 2024 which was completed in October 2024.&#160; We began depreciating the Demo System over an estimated life of five years during the last calendar quarter of 2024.&#160; We expect to continue to develop and enhance this unit as we perform our demonstrations and continue progressing towards commercialization. Upgrades and enhancements that will improve the operational efficiency of the unit itself will be capitalized. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense for the three months ended March 31, 2025 and 2024 was $145,661 and $156,002, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense is presented as follows on the unaudited condensed consolidated statement of operations:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.1pt; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40,327</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,334</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total depreciation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">145,661</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Concentrations</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">of</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Credit</span><span style="text-decoration:underline"> Risk</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company&#8217;s revenues, purchases, accounts receivable and accounts payable. Two customers made up approximately 94% of total revenues for the three months ended March 31, 2025 and one customer made up&#160;94% of total revenues for the three months ended March 31, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers comprised 91% and three customers accounted for 89% of our outstanding accounts receivable, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers and one customer comprised our unbilled receivables. These customers comprise the majority of our revenue. The loss of a significant customer could adversely affect the results of our operations. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (&#8220;Merrell Bros.&#8221;) (see Note 7).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 8 for a license agreement we have with Duke University for the SCWO technology used in our systems.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Revenue Recognition</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the revenue standards of Codification (ASC) Topic 606: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of full-scale demonstrations and treatability studies. In the case of equipment revenues, the Company&#8217;s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Services revenues related to treatability studies are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In late 2024, we deployed our Demo System to the City of Orlando&#8217;s Iron Bridge Regional Water Reclamation Facility pursuant to a contract executed in March 2024 as part of a full-scale demonstration (the &#8220;Demo Contract&#8221;). Pursuant to the Demo Contract, the Company is responsible for system design, installation, commissioning and the start-up of the AirSCWO unit at the facility. Further, the Company will operate and maintain the AirSCWO unit for a period of approximately three months and is required to treat no less than 193 metric tons of wastewater during the three month period. Lastly, the Company will decommission, disassemble and demobilize the AirSCWO unit after the contract period. The Company will receive $812,000 as consideration for the full-scale demonstration. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASC 606-10-25-21, we have concluded that the Demo Contract includes one performance obligation the full-scale demonstration. The system design, site preparation, installation, commissioning and decommissioning represent fulfillment activities versus separate performance obligations. At March 31, 2025 and December 31, 2024, we have accounted for such costs as contract costs under ASC 340-40 (see below). We will recognize revenue on this Demo Contract over the three-month period of operations and maintenance which is the point in time that the City of Orlando receives the benefit simultaneously to the Company&#8217;s performance, which will commence in 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We&#160;plan to&#160;invoice the City of Orlando in accordance with the contract terms. Invoices are due within thirty days of receipt. At March 31, 2025, we have invoiced and collected $170,000 which is included in unearned revenue. The City of Orlando has the right to cancel the Demo Contract for convenience with a twenty-day written notice but is responsible for paying the Company all amounts owed and outstanding for work performed prior to the effective termination date and costs and expenses incurred by the Company to uninstall, remove, relocate and deliver the AirSCWO&#160;system up to a limit of&#160;$68,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we completed a full-scale demonstration for another customer. The contract with this customer included three performance obligations: i) treatability studies, ii) full-scale demonstration and iii) a technical report summarizing the results of the full-scale demonstration.&#160; We have allocated the transaction price of approximately $498,000 among the performance obligations using stand-alone selling price (&#8220;SASP&#8221;) for the treatability study, cost-plus-margin for the technical report and the residual approach in the case of the full-scale demonstration. Under the residual approach, the stand-alone selling price is estimated after subtracting the sum of the observable SASP allocated to the other performance obligations within the contract. We do not have a history of selling full-scale demonstrations and a technical report separately to our customers. &#160;At March 31, 2025, the delivery of the technical report is the only remaining performance obligation which approximately $72,000 of the contract transaction price has been allocated. We anticipate this performance obligation to be completed in the second quarter of 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we recognized as revenue approximately $25,000 and $376,000 for the completion of a treatability study and the full-scale demonstration, respectively. We have not yet billed for the full-scale demonstration and therefore, our unbilled receivables include the $376,000 at March 31, 2025.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred. At March 31, 2025, we have capitalized an aggregate of $197,043 of costs incurred to date related to the following: (i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, contract costs were comprised of the $136,651&#160;fulfillment related activities for the Demo Contract with the City of Orlando.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See further revenue related disclosures in Note 5.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Accrued</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Contract</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Loss</span><span style="text-decoration:underline"> Provision and Onerous Contracts</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. U.S. GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition&#8212;Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a total accrued loss provision of $1,000,000 at March 31, 2025 and December 31, 2024, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets.&#160; Any changes to the estimated loss provision are reflected within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Research</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">and</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Development</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Costs</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $533,587 and $535,147 for the three months ended March 31, 2025 and 2024, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Loss</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Per</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Share</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss per share is computed in accordance with ASC Topic 260, &#8220;Earnings per Share.&#8221; Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2025 and 2024 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive. At March 31, 2025 and March 31, 2024, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 16,409,062 and 10,740,250 shares of common stock, 14,675,244 and 1,235,000&#160;&#160;of outstanding common stock warrants and unvested restricted stock units of 5,931,576 and 0, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Reclassifications</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have made certain reclassifications to prior period amounts presented on our consolidated statements of operations to conform to the current period presentation with no impact to net loss or loss per share. These reclassifications consisted of reclassifying $138,586 of stock-based compensation expense from general and administrative expenses to compensation and related expenses. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Recent </span><span style="text-decoration:underline">Accounting</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Pronouncements</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">-</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Not</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Yet</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">Adopted</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): </em><em>Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Effective January 1, 2025, we adopted ASU 2023-09 on a prospective basis. The adoption of ASU 2023-09 did not &#160;have a material impact on these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU 2024-03,&#160;<em>Disaggregation of Income Statement Expenses (&#8220;<strong>DISE</strong>&#8221;)</em>. In November 2024, the FASB issued a new accounting standard to improve the disclosures about an entity&#8217;s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity Capital Resources and Going Concern<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Liquidity Capital Resources and Going Concern</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Liquidity, Capital Resources and Going Concern</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 3 &#8211; Liquidity, Capital Resources and Going Concern</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASU No. 2014-15 <em>Presentation of Financial Statements &#8211; Going Concern</em> (subtopic 205-40), the Company&#8217;s management evaluates whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the financial statements are issued. At March 31, 2025, the Company had working capital of $8,734,300 and an accumulated deficit of $32,086,032. For the three months ended March 31, 2025, the Company incurred a net loss of $3,698,414 and used $3,494,477 of net cash in operations for the period. These conditions raise substantial doubt regarding our ability to continue as a going concern.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Presently, the Company will need additional debt or equity financing or a combination of both to continue its operations and meet its financial obligations for at least the next twelve months from the date these unaudited condensed interim consolidated financial statements were issued and beyond. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. We expect to incur continuing losses and negative cash flows from operations for the foreseeable future.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100&#160;million of common stock, subject to applicable law. &#160; At March 31, 2025,&#160;approximately $86,154,000 remains available to be sold in the Company&#8217;s at-the-market offerings, subject to various limitations. During the three months ended March 31, 2025 and 2024, we did not use the ATM to raise capital. &#160;The Company is evaluating strategies to obtain the required additional funding for future operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2024, we closed on an offering of shares of common stock and common stock warrants resulting in net proceeds of approximately $11,393,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Any additional debt or equity financing that the Company obtains may substantially dilute the ownership held by our existing stockholders. The economic dilution to our shareholders will be significant if our stock price does not materially increase, or if the effective price of any sale is below the price paid by a particular investor. The Company may be unable to access further equity or debt financing when needed or obtain additional financing under acceptable terms, if at all.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We may decide to raise additional capital through a variety of sources in the short-term and in the long-term, including but not limited to:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:8%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">the public equity markets;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">private equity financings;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">collaborative arrangements;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">asset sales; and/or</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#9744;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">public or private debt.</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If the Company is unable to raise additional capital, there is a risk that the Company could be required to discontinue or significantly reduce the scope of its operations. These unaudited condensed interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory, Net</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 4 &#8211; Inventory, Net</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory, net consists of:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,926,554</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,751,474</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work-in-process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: inventory reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,876,554</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,701,474</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueDisclosureTextBlock', window );">Revenue</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 5 &#8211; Revenue</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our revenues by type for the three months ended March 31, 2025 and March 31, 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">134,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">25</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">94</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">408,690</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">75</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,182</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">6</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>543,100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>315,278</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned</strong><strong> </strong><strong>Revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unearned revenue activity for the three months ended March 31, 2025 and year ended December 31, 2024:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance </strong><strong>at </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unearned revenue at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">227,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Billings deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">197,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Refundable deposit returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(100,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recognition of prior unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(27,683</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned revenue at end of period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>200,000</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>227,683</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025 , we anticipate recognizing approximately $170,000 of the unearned revenue in 2025 which has been presented as a current liability at March 31, 2025.&#160; The remaining balance of $30,000&#160;has been classified as a long-term liability as the timing of revenue recognition is unknown.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Unbilled Accounts Receivable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following is a summary of our unbilled accounts receivable activity for the three months ended March 31, 2025 and the year ended December 31, 2024:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unbilled accounts receivable at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,007</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,494,553</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services performed but not yet billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">510,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">217,666</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(59,212</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unbilled accounts receivable at end of the period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>2,163,417</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,653,007</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Pursuant to contractual terms with our customers, we anticipate billing the unbilled accounts receivable during our 2025 fiscal year. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholder Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholder' Equity</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 6 &#8211; Stockholder&#8217; Equity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Issuance of Stock for Services</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we issued 180,986 fully vested shares of common stock to service providers with a fair value of $66,900 based on the market price of our common stock on date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, we issued 3,339 fully vested shares of common stock to a service provider with a fair value of $4,500 based on the market price of our common stock on date of grant.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Common Stock for Stock Option Exercises</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we issued an aggregate of 200,000 shares of common stock for stock option exercises that resulted in cash proceeds of $24,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Stock-based</span><span style="text-decoration:underline"> </span><span style="text-decoration:underline">compensation</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>2021 Plan</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has reserved 24,000,000 shares of common stock or common stock equivalents to be issued under our 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) to the Company&#8217;s employees and non-employee services providers. &#160;At March 31, 2025, the Company has issued a total of&#160;&#160;18,114,133 stock options and restricted stock units under the 2021 Plan with&#160;5,885,867&#160;reserved shares remaining for issuance.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, and 2024, the Company recorded stock-based compensation of $460,512 and $183,200, respectively, related to granted options to employees and various consultants expected to vest. During the three months ended March 31, 2025, $428,678 was charged as&#160;compensation and related expenses and $31,834 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations. During the three months ended March 31, 2024, $138,586 was charged as&#160;compensation and&#160;related expenses and $44,614 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Stock</strong><strong> </strong><strong>Options</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Stock option activity for the three months ended March 31, 2025 is summarized as follows:&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>December 31, </strong><strong>2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,843,116</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.94</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,324,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.95</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">908,659</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(200,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(142,713</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">16,409,062</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.92</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,274,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.98</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>Exercisable </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,150,185</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,274,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.74</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">*At March 31, 2025 and December 31, 2024, the options outstanding and exercisable include 5,700,00 and 5,900,000 granted in connection with a merger that occurred in 2021, respectively, which were not granted under the 2021 Plan &#160;and include 275,000 of options granted in 2024 pursuant to a legal settlement and were not granted under the 2021 Plan. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, the options granted were primarily to our Chief Financial Officer and key employees. The weighted average grant-date fair value of the granted options was $0.33.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Of the total&#160;options outstanding at March 31, 2025,&#160;3,708,288&#160;of the options include performance conditions. The performance-based options vest as follows:&#160;50% vest upon the achievement of operating profit, as defined in the employment agreements, and&#160;50% upon the achievement of a revenue target of $100&#160;million by the end of fiscal year 2028. The performance-based options with the revenue target begin vesting once the Company achieves $15&#160;million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of options that vest is based on the proportionate percentage of each fiscal year&#8217;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20&#160;million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, total unrecognized compensation expense for service based and performance-based options was $3,315,257&#160;and $2,821,770, respectively. The unrecognized service-based expense will be recognized over a weighted-average period of&#160;2.89&#160;years. The unrecognized expense associated with the performance-based options will be expensed when it becomes probable that the performance obligations will be met.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, intrinsic value is computed based on the difference between options exercise price and the market price of our common stock at March 31, 2025 of $0.34 per share multiplied by the total common stock options outstanding or exercisable whose market price exceeds the exercise price.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, 200,000 stock options issued outside of the 2021 Plan were exercised with an exercise price of $0.12 for total proceeds to the Company of $24,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">67.81 &#8211; 69.25%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26.36 &#8211; 26.38%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term (years)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6.25 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6.25 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free rate</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.14 - 4.51%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.09 &#8211; 4.31%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Restricted Stock Units</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, the Company granted an aggregate of&#160;2,382,284&#160;unvested restricted stock units under the 2021 Plan as follows:&#160;617,284 to&#160;our Chief Financial Officer (&#8220;CFO&#8221;) pursuant to an employment agreement and 1,765,000&#160;to non-executive key employees of the Company. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The unvested restricted stock units granted to our CFO consist of&#160;308,642 units with time-based vesting provisions and&#160;308,642 units with performance-based vesting provisions. The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year&#8217;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027. The 1,765,000 restricted stock units granted to non-executive key employees are all time-based vesting and vest as follows: 50% on the one-year grant-date anniversary with the remaining vesting ratably over a period of thirty-six months. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The grant-date fair value of the restricted stock units was determined using the market price of our common stock on the date of grant which ranged from $0.62&#160;to $0.63.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A summary of our outstanding nonvested restricted stock units is as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,549,292</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,382,284</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, end of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5,931,576</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.98</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, we have $2,524,952 of unrecognized stock-based compensation associated with the restricted stock units with a performance condition which will be recognized when the performance conditions are probable of being met. At March 31, 2025, the Company had $2,749,402&#160;of unrecognized stock-based compensation associated with the time vesting restricted stock units which will be recognized over a weighted-average period of approximately&#160;3.43&#160;years. During the three months ended March 31, 2025, our stock based compensation associated with the time-based restricted stock units totaled $248,951, of which $216,982 was charged as compensation and related expenses, and $31,969 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Stock</strong><strong> Warrants</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, there were 14,675,244 warrants outstanding which relate to and offering completed in November 2024, where investors were offered one and a half warrants for every one common share purchased in the offering at an exercise price of $1.125 per share.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025 and 2024, no warrants were issued or exercised. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A summary of warrant activity for the three months &#160;ended &#160;March 31, 2025, is as follows:</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exercise</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Intrinsic</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Contractual</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,675,244</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.13</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.88</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">14,675,244</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1.13</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">4.63</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 7 - Related Party Transactions</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On July 7, 2021, we entered into a manufacturing and services agreement (the &#8220;M&amp;S Agreement&#8221;) to fabricate and manufacture the AirSCWO systems with Merrell Bros. Fabrication, LLC (&#8220;Merrell Bros.&#8221;). As part of the agreement, the Company appointed Terry Merrell, one of the owners of Merrell Bros., to its board of directors. On December 18, 2024, Mr. Merrell notified the Company of his intention to resign from the Company's Board of Directors effective December 31, 2024, to allow him to focus more on his core business responsibilities at Merrell Bros. &#160;The M&amp;S Agreement terminated on its original expiration date of July 7, 2024.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 27, 2024, we executed a supplemental manufacturing and services agreement (the &#8220;Supplemental M&amp;S Agreement&#8221;) with Merrell Bros. as Merrell Bros. indicated to us their intent to not renew the Original M&amp;S Agreement and we indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations (see Note 9). The Supplemental M&amp;S Agreement became effective on July 7, 2024 and replaced the Original M&amp;S Agreement. Under the Supplemental M&amp;S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders. The term of the Supplemental M&amp;S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension. Either party may terminate this Supplement M&amp;S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.&#160;The Supplemental M&amp;S Agreement terminated during the year ended December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025 and 2024, the Company incurred $0 and $130,321, respectively,&#160;in related party expenses related to the manufacturing of our AirSCWO systems.&#160;At March 31, 2025 and December 31, 2024, we did not have any outstanding obligations owed to Merrell Bros. for these services. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies (Note 9)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note</strong><strong> </strong><strong>8</strong><strong> </strong><strong>&#8211;</strong><strong> </strong><strong>Commitments and Contingencies</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>License Agreement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The patented technology underlying 374Water&#8217;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#8220;Duke&#8221;), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#8220;License Agreement&#8221;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. At March 31, 2025, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#8217; written notice.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><em>Legal Settlement</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 4, 2024, our former Chief Executive Officer and Chairman of the Board filed a complaint against the Company alleging unpaid wages and a bonus. Management and the board of directors, in consultation with its attorneys, have estimated a potential loss associated with this complaint of approximately $335,000.&#160; At December 31, 2024, we established an accrual for legal settlement of this amount as presented on the consolidated balance sheet.&#160; This legal matter was officially settled on April 2, 2025 for the amount accrued. We have agreed to pay $110,000 of the settlement within ten calendar days of certain conditions being met by the plaintiff, as defined in the settlement agreement, with the remaining settlement being paid in equal statements through December 31, 2025. As of the date of this filling, we have paid the agreed upon $110,000 as all plaintiff conditions were met.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable. We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above. However, there is inherent uncertainty regarding such matters.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Note 9 - &#160;&#160;Segment Reporting</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Operating segments are defined as components of an entity for which separate financial information is available and that is regularly provided to the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#8217;s Chief Executive Officer, Chief Operating Officer and Chief Financial Officer comprise the Company&#8217;s CODMs. The CODMs review financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.&#160; The CODMs use consolidated net income (loss) to assess performance, evaluate cost optimization, and allocate resources, including personnel-related and financial or capital resources, in the annual budget and forecasting process, as well as budget-to-actual variances on a monthly basis. As such, the Company has determined that it operates as&#160;one&#160;operating and reportable segment.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The significant expenses regularly reviewed by the CODMs are consistent with those reported on the Company's unaudited condensed consolidated statement of operations and expenses are not regularly reviewed on a more disaggregated basis for assessing segment performance and deciding how to allocate resources. The CODMs do not regularly review total assets for our single reportable segment as total assets are not used to assess performance or allocate resources.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;<strong>Note 10 - Subsequent Events </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">On April 13, 2025, the Company appointed Stephen Jones to the Company&#8217;s Board of Directors, effective April 14, 2025. Mr. Jones, age 63, is being appointed to the Board of Directors to fill the vacancy on the Board of Directors. From March 2015 through October 2020, Mr. Jones was President, Chief Executive Officer and a director of Covanta Holding Corporation (formerly NYSE: CVA, now owned by private equity) (&#8220;Covanta&#8221;), a leading global provider of sustainable waste and energy solutions. Prior to joining Covanta in January 2015, Mr. Jones was employed from 1992 through September 2014 by Air Products and Chemicals, Inc. (&#8220;Air Products&#8221;), a global supplier of industrial gases and equipment. Mr. Jones held a variety of senior-level management positions at Air Products including in the company&#8217;s tonnage gases, equipment, energy and industrial chemicals businesses, culminating with his role as Air Products&#8217; China president based at the company&#8217;s office in Shanghai. Mr. Jones is a director of Tronox Holdings plc, an industrial and chemical company (NYSE: TROX), and chairman of the board of directors of Badger Infrastructure Solutions Ltd., a Canadian infrastructure solutions company specializing in nondestructive excavation services (TSE: BDGI). Mr. Jones also serves as a special advisor to the supervisory board of Hitachi Zosen Inova AG, a global cleantech company. Prior to joining Air Products in 1992, Mr. Jones practiced corporate law at Dechert LLP in Philadelphia, PA, primarily in the area of mergers and acquisitions.</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">Pursuant to an employment agreement executed with our Chief Technology Officer on March 31, 2025, our board of directors approved the following equity compensation grant under our 2021 Plan on April 30, 2025: </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">1,515,152 restricted stock units and 1,515,152 stock options vesting as follows: (a) with respect to 757,576 restricted stock and 757,576 shares subject to stock options, 25% vest on the first anniversary of the CTO&#8217;s employment agreement, and the remaining 75% vest in equal increments on the last day of every month thereafter over the following 36 months, subject to the CTO&#8217;s continued employment with the Company on each vesting date: and (b) with respect to the remaining 757,576 restricted stock and 757,576 stock options, each vest in accordance with a performance based milestone set forth by the Company and defined in the CTO&#8217;s employment agreement. See Note 6 for further disclosures on the performance-related milestones. The stock options have an exercise price of $0.33 and a ten-year contractual term. </p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of inventory reserve, equity-based compensation, revenue recognition, and accrued loss provisions on onerous contracts, useful lives of long-lived assets, and valuation allowance against deferred tax assets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Accounts</em><em> </em><em>Receivable, Net </em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounts receivable consist of balances due from equipment and service revenues. The Company monitors accounts receivable and provides allowances when considered necessary based on historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future economic conditions to form adjustments to historical loss patterns. At March 31, 2025 and December 31, 2024, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant at March 31, 2025 and December 31, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>Unbilled Accounts Receivable</em></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Unbilled accounts receivable consist of balances due from&#160;revenues earned but not yet billed related to one customer contract for an equipment sale and one customer contract for a full-scale demonstration completed in January 2025.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory, Net</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress. Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question. We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used, we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required. Once inventory has been written down, it creates a new cost basis for inventory. Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 at both March 31, 2025 and December 31, 2024.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and the estimated useful life of the asset. Expenses for maintenance and repairs are charged to expense as incurred.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"><span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt">The following table presents property and equipment at March 31, 2025 and December 31, 2024:</span></span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">578,352</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">366,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment &#8211; Demo System</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,356,041</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,298,666</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">87,300</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">59,306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,041,670</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,744,349</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(322,438</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(176,778</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,719,232</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,567,571</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We completed the manufacturing and fabrication of one of our AirSCWO systems that we will be using for full-scale wastewater treatment demonstration purposes (&#8220;Demo System&#8221;). We have capitalized the material and labor costs incurred to develop this Demo System, and had previously classified these costs within inventory. In the first quarter of 2024, we executed a contract with the City of Orlando, Florida to deploy&#160;the Demo System as part of a full-scale demonstration. We began the set up and commissioning process of this Demo System in the third quarter of 2024 which was completed in October 2024.&#160; We began depreciating the Demo System over an estimated life of five years during the last calendar quarter of 2024.&#160; We expect to continue to develop and enhance this unit as we perform our demonstrations and continue progressing towards commercialization. Upgrades and enhancements that will improve the operational efficiency of the unit itself will be capitalized. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense for the three months ended March 31, 2025 and 2024 was $145,661 and $156,002, respectively. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Depreciation expense is presented as follows on the unaudited condensed consolidated statement of operations:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.1pt; text-align:justify;">&#160;</p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40,327</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,334</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total depreciation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">145,661</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company&#8217;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant customers and suppliers are those that account for greater than 10% of the Company&#8217;s revenues, purchases, accounts receivable and accounts payable. Two customers made up approximately 94% of total revenues for the three months ended March 31, 2025 and one customer made up&#160;94% of total revenues for the three months ended March 31, 2024. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers comprised 91% and three customers accounted for 89% of our outstanding accounts receivable, respectively.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, two customers and one customer comprised our unbilled receivables. These customers comprise the majority of our revenue. The loss of a significant customer could adversely affect the results of our operations. &#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2024, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (&#8220;Merrell Bros.&#8221;) (see Note 7).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Refer to Note 8 for a license agreement we have with Duke University for the SCWO technology used in our systems.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the revenue standards of Codification (ASC) Topic 606: &#8220;Revenue from Contracts with Customers (Topic 606).&#8221; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of full-scale demonstrations and treatability studies. In the case of equipment revenues, the Company&#8217;s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Services revenues related to treatability studies are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In late 2024, we deployed our Demo System to the City of Orlando&#8217;s Iron Bridge Regional Water Reclamation Facility pursuant to a contract executed in March 2024 as part of a full-scale demonstration (the &#8220;Demo Contract&#8221;). Pursuant to the Demo Contract, the Company is responsible for system design, installation, commissioning and the start-up of the AirSCWO unit at the facility. Further, the Company will operate and maintain the AirSCWO unit for a period of approximately three months and is required to treat no less than 193 metric tons of wastewater during the three month period. Lastly, the Company will decommission, disassemble and demobilize the AirSCWO unit after the contract period. The Company will receive $812,000 as consideration for the full-scale demonstration. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASC 606-10-25-21, we have concluded that the Demo Contract includes one performance obligation the full-scale demonstration. The system design, site preparation, installation, commissioning and decommissioning represent fulfillment activities versus separate performance obligations. At March 31, 2025 and December 31, 2024, we have accounted for such costs as contract costs under ASC 340-40 (see below). We will recognize revenue on this Demo Contract over the three-month period of operations and maintenance which is the point in time that the City of Orlando receives the benefit simultaneously to the Company&#8217;s performance, which will commence in 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We&#160;plan to&#160;invoice the City of Orlando in accordance with the contract terms. Invoices are due within thirty days of receipt. At March 31, 2025, we have invoiced and collected $170,000 which is included in unearned revenue. The City of Orlando has the right to cancel the Demo Contract for convenience with a twenty-day written notice but is responsible for paying the Company all amounts owed and outstanding for work performed prior to the effective termination date and costs and expenses incurred by the Company to uninstall, remove, relocate and deliver the AirSCWO&#160;system up to a limit of&#160;$68,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we completed a full-scale demonstration for another customer. The contract with this customer included three performance obligations: i) treatability studies, ii) full-scale demonstration and iii) a technical report summarizing the results of the full-scale demonstration.&#160; We have allocated the transaction price of approximately $498,000 among the performance obligations using stand-alone selling price (&#8220;SASP&#8221;) for the treatability study, cost-plus-margin for the technical report and the residual approach in the case of the full-scale demonstration. Under the residual approach, the stand-alone selling price is estimated after subtracting the sum of the observable SASP allocated to the other performance obligations within the contract. We do not have a history of selling full-scale demonstrations and a technical report separately to our customers. &#160;At March 31, 2025, the delivery of the technical report is the only remaining performance obligation which approximately $72,000 of the contract transaction price has been allocated. We anticipate this performance obligation to be completed in the second quarter of 2025. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended March 31, 2025, we recognized as revenue approximately $25,000 and $376,000 for the completion of a treatability study and the full-scale demonstration, respectively. We have not yet billed for the full-scale demonstration and therefore, our unbilled receivables include the $376,000 at March 31, 2025.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred. At March 31, 2025, we have capitalized an aggregate of $197,043 of costs incurred to date related to the following: (i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At December 31, 2024, contract costs were comprised of the $136,651&#160;fulfillment related activities for the Demo Contract with the City of Orlando.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">See further revenue related disclosures in Note 5.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock', window );">Accrued Contract Loss Provision and Onerous Contracts</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. U.S. GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, <em>Revenue Recognition&#8212;Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). </em>ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">At March 31, 2025, and December 31, 2024, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a total accrued loss provision of $1,000,000 at March 31, 2025 and December 31, 2024, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets.&#160; Any changes to the estimated loss provision are reflected within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research And Development Costs</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company&#8217;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $533,587 and $535,147 for the three months ended March 31, 2025 and 2024, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Loss per share is computed in accordance with ASC Topic 260, &#8220;Earnings per Share.&#8221; Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2025 and 2024 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive. At March 31, 2025 and March 31, 2024, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 16,409,062 and 10,740,250 shares of common stock, 14,675,244 and 1,235,000&#160;&#160;of outstanding common stock warrants and unvested restricted stock units of 5,931,576 and 0, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have made certain reclassifications to prior period amounts presented on our consolidated statements of operations to conform to the current period presentation with no impact to net loss or loss per share. These reclassifications consisted of reclassifying $138,586 of stock-based compensation expense from general and administrative expenses to compensation and related expenses. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements - Not Yet Adopted</a></td>
<td class="text"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In December 2023 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (ASU) 2023-09, <em>Income Taxes (Topic 740): </em><em>Improvements to Income Tax Disclosures </em>(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Effective January 1, 2025, we adopted ASU 2023-09 on a prospective basis. The adoption of ASU 2023-09 did not &#160;have a material impact on these unaudited condensed consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ASU 2024-03,&#160;<em>Disaggregation of Income Statement Expenses (&#8220;<strong>DISE</strong>&#8221;)</em>. In November 2024, the FASB issued a new accounting standard to improve the disclosures about an entity&#8217;s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on our consolidated financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Computers</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">19,977</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">578,352</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">366,400</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment &#8211; Demo System</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,356,041</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,298,666</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Vehicles</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">87,300</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">59,306</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,041,670</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2,744,349</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: accumulated depreciation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(322,438</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(176,778</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,719,232</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,567,571</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ScheduleOfDepreciationExpenseTableTextBlock', window );">Schedule of depreciation expense</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cost of revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40,327</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">General and administrative</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">105,334</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px">Total depreciation expense</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">145,661</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">156,002</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ScheduleOfDepreciationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ScheduleOfDepreciationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule Of Inventory</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance </strong><strong>at</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,926,554</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,751,474</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work-in-process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: inventory reserves</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(50,000</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,876,554</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,701,474</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ScheduleOfRevenueByTypeTableTextBlock', window );">Schedule Of revenue by type</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>%</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Equipment revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">134,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">25</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">296,096</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">94</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Service revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">408,690</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">75</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,182</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">6</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Total</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>543,100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>315,278</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>100</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>%</strong></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned</strong><strong> </strong><strong>Revenue</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock', window );">Schedule Of unearned revenue activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance </strong><strong>at </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>March 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Balance at </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unearned revenue at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">227,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">130,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Billings deferred</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">197,683</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Refundable deposit returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(100,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Recognition of prior unearned revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(27,683</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unearned revenue at end of period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>200,000</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>227,683</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock', window );">Schedule Of unbilled accounts receivable</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance</strong><strong> </strong><strong>at</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March </strong><strong>31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December </strong><strong>31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2024</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Unbilled accounts receivable at beginning of the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,653,007</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,494,553</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services performed but not yet billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">510,410</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">217,666</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Services billed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(59,212</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Unbilled accounts receivable at end of the period</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>2,163,417</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>1,653,007</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ScheduleOfRevenueByTypeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ScheduleOfRevenueByTypeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholder Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Intrinsic</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>December 31, </strong><strong>2024</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,843,116</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.94</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,324,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.95</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">908,659</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.66</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(200,000</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.12</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expired/forfeit</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">(142,713</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.96</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>outstanding </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">16,409,062</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.92</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,274,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">5.98</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Options </strong><strong>Exercisable </strong><strong>at </strong><strong>March </strong><strong>31, </strong><strong>2025</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">8,150,185</td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">*</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">0.60</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,274,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">2.74</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of stock option assumtion</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2025</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">67.81 &#8211; 69.25%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">26.36 &#8211; 26.38%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term (years)</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6.25 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">6.25 Years</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free rate</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.14 - 4.51%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4.09 &#8211; 4.31%</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">0.00%</p></td><td style="width:1%;white-space: nowrap;"></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of outstanding nonvested restricted stock</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted-</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Average </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Grant Date </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Amount</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Fair Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, beginning of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,549,292</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.23</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,382,284</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.62</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Forfeited</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Nonvested, end of the year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">5,931,576</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">0.98</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of warrant activity</a></td>
<td class="text"><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Shares</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exercise</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Aggregate</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Intrinsic</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Value</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Contractual</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Life (Years)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at December 31, 2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,675,244</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.13</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4.88</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Exercised</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding and exercisable at March 31, 2025</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">14,675,244</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">1.13</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">4.63</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateAccumulatedDepreciation', window );">Less: accumulated depreciations</a></td>
<td class="num">$ (322,438)<span></span>
</td>
<td class="num">$ (176,778)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">2,719,232<span></span>
</td>
<td class="nump">2,567,571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total Property Plant And Equipment</a></td>
<td class="nump">3,041,670<span></span>
</td>
<td class="nump">2,744,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">19,977<span></span>
</td>
<td class="nump">19,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">87,300<span></span>
</td>
<td class="nump">59,306<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">578,352<span></span>
</td>
<td class="nump">366,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_EquipmentDemoSystemMember', window );">Equipment - Demo System [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">$ 2,356,041<span></span>
</td>
<td class="nump">$ 2,298,666<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 970<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-28(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478979/970-360-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_EquipmentDemoSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_EquipmentDemoSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_CostOfRevenues', window );">Cost of revenues</a></td>
<td class="nump">$ 40,327<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_GeneralAndAdministrative', window );">General and administrative</a></td>
<td class="nump">105,334<span></span>
</td>
<td class="nump">156,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 145,661<span></span>
</td>
<td class="nump">$ 156,002<span></span>
</td>
<td class="nump">$ 156,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_CostOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_CostOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_GeneralAndAdministrative">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_GeneralAndAdministrative</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and Development Cost</a></td>
<td class="nump">$ 533,587<span></span>
</td>
<td class="nump">$ 535,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_OtherStockBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">138,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">145,661<span></span>
</td>
<td class="nump">156,002<span></span>
</td>
<td class="nump">$ 156,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueReceiveAsConsideration', window );">Revenue receive as consideration</a></td>
<td class="nump">812,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnearnedPremiums', window );">Unearned revenue</a></td>
<td class="nump">170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Costs and expenses</a></td>
<td class="nump">68,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AllocatedTransactionPriceDuringCustomerContract', window );">Allocated transaction price</a></td>
<td class="nump">498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_DuringCustomerContractRemainingPerformanceObligation', window );">Remaining performance obligation</a></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized costs</a></td>
<td class="nump">$ 197,043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_DescriptionOfCapitalizedCost', window );">Capitalized cost description</a></td>
<td class="text">(i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ContractCostsOnDemoContract', window );">Contract costs</a></td>
<td class="nump">$ 136,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRecallExpense', window );">Inventory allowance</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">543,100<span></span>
</td>
<td class="nump">$ 315,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">2,163,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,653,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Contract loss provision</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=scwo_TreatabilityStudyServicesMember', window );">Treatability study services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_FullScaleDemonstrationMember', window );">Full-scale demonstration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="nump">$ 376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_UnvestedRestrictedStockMember', window );">Unvested Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">5,931,576<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">14,675,244<span></span>
</td>
<td class="nump">1,235,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">16,409,062<span></span>
</td>
<td class="nump">10,740,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=scwo_TwoCustomerMember', window );">Two Customer [Member] | Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ConcentrationsOfCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="nump">94.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=scwo_TwoCustomerMember', window );">Two Customer [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ConcentrationsOfCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="nump">91.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=scwo_OneCustomerMember', window );">One Customer [Member] | Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ConcentrationsOfCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=scwo_ThreeCustomerMember', window );">Three Customer [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ConcentrationsOfCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AllocatedTransactionPriceDuringCustomerContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AllocatedTransactionPriceDuringCustomerContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ConcentrationsOfCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ConcentrationsOfCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ContractCostsOnDemoContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ContractCostsOnDemoContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_DescriptionOfCapitalizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_DescriptionOfCapitalizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_DuringCustomerContractRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_DuringCustomerContractRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_OtherStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_OtherStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueReceiveAsConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueReceiveAsConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRecallExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRecallExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnearnedPremiums">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(2))<br> -SubTopic 210<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnearnedPremiums</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=scwo_TreatabilityStudyServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=scwo_TreatabilityStudyServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_FullScaleDemonstrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_FullScaleDemonstrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_UnvestedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_UnvestedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=scwo_TwoCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=scwo_TwoCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=scwo_RevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=scwo_RevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=scwo_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=scwo_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=scwo_ThreeCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=scwo_ThreeCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">$ (32,086,032)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,387,618)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,698,414)<span></span>
</td>
<td class="num">$ (2,024,465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInContinuingOperations', window );">Net Cash Used In Operations</a></td>
<td class="nump">3,494,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Capital', window );">Working Capital</a></td>
<td class="nump">8,734,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ProceedFromAtTheMarketOffering', window );">Net proceeds from ATM</a></td>
<td class="nump">$ 86,154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ProceedsFromCommonStockAndWarrantsShares', window );">Net proceeds from common stock and warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,393,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares issued</a></td>
<td class="nump">144,682,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,301,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=scwo_ATMMember', window );">ATM [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares issued</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ProceedFromAtTheMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ProceedFromAtTheMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ProceedsFromCommonStockAndWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ProceedsFromCommonStockAndWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477270/942-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_ATMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_ATMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory, Net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 1,926,554<span></span>
</td>
<td class="nump">$ 1,751,474<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Less: inventory reserves</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">(50,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 1,876,554<span></span>
</td>
<td class="nump">$ 1,701,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 543,100<span></span>
</td>
<td class="nump">$ 315,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_PremiumsRevenuePercentage', window );">Revenue percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_EquipmentRevenuesMember', window );">Equipment revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 134,410<span></span>
</td>
<td class="nump">$ 296,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenuePercentage', window );">Revenue percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_ServiceRevenueMember', window );">Service revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 408,690<span></span>
</td>
<td class="nump">$ 19,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenuePercentage', window );">Revenue percentage</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PremiumsRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PremiumsRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_EquipmentRevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_EquipmentRevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_ServiceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis=scwo_ServiceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details 1) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_UnearnedRevenue', window );">Unearned revenue at beginning of the period</a></td>
<td class="nump">$ 227,683<span></span>
</td>
<td class="nump">$ 130,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_BillingsDeferredUnearnedRevenue', window );">Billings deferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">197,683<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RefundableDepositReturned', window );">Refundable deposit returned</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecognitionOfDeferredRevenue', window );">Recognition of prior unearned revenue</a></td>
<td class="num">(27,683)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_UnearnedRevenue', window );">Unearned revenue at end of period</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 227,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_BillingsDeferredUnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_BillingsDeferredUnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RefundableDepositReturned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RefundableDepositReturned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_UnearnedRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_UnearnedRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecognitionOfDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecognitionOfDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Unbilled accounts receivable at beginning of year</a></td>
<td class="nump">$ 1,653,007<span></span>
</td>
<td class="nump">$ 1,494,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ServicesPerformedButUnbilled', window );">Services performed but unbilled</a></td>
<td class="nump">510,410<span></span>
</td>
<td class="nump">217,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ServicesBilled', window );">Services billed</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(59,212)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Unbilled accounts receivable at end of year</a></td>
<td class="nump">$ 2,163,417<span></span>
</td>
<td class="nump">$ 1,653,007<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ServicesBilled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ServicesBilled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ServicesPerformedButUnbilled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ServicesPerformedButUnbilled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liability</a></td>
<td class="nump">$ 2,848,223<span></span>
</td>
<td class="nump">$ 3,127,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardDateAxis=scwo_TwentyTwentyFiveMember', window );">2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long term liability</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liability</a></td>
<td class="nump">$ 170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=scwo_TwentyTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=scwo_TwentyTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">2,382,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, beginning balance | $ / shares</a></td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_OptionsMember', window );">Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, beginning balance | shares</a></td>
<td class="nump">15,843,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted | shares</a></td>
<td class="nump">908,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised | shares</a></td>
<td class="num">(200,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Expired/forfeited | shares</a></td>
<td class="num">(142,713)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, ending balance | shares</a></td>
<td class="nump">16,409,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Option Exercisable, ending balance | shares</a></td>
<td class="nump">8,150,185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, beginning balance | $ / shares</a></td>
<td class="nump">$ 0.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted | $ / shares</a></td>
<td class="nump">0.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="nump">0.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired/forfeit | $ / shares</a></td>
<td class="nump">2.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, ending balance | $ / shares</a></td>
<td class="nump">0.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable, ending balance | $ / shares</a></td>
<td class="nump">$ 0.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, beginning balance | $</a></td>
<td class="nump">$ 3,324,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised | $</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, ending balance | $</a></td>
<td class="nump">1,274,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable, ending balance | $</a></td>
<td class="nump">$ 1,274,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (years) Beginning</a></td>
<td class="text">5 years 11 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance', window );">Weighted Average Remaining Contractual Life (years) Ending</a></td>
<td class="text">5 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (years), Exercisable at June 30, 2024</a></td>
<td class="text">2 years 8 months 26 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 1) - Options [Member]<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember', window );">Bottom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">67.81%<span></span>
</td>
<td class="nump">26.36%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free Interest Rate</a></td>
<td class="nump">4.14%<span></span>
</td>
<td class="nump">4.09%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember', window );">Top [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected Volatility</a></td>
<td class="nump">69.25%<span></span>
</td>
<td class="nump">26.38%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free Interest Rate</a></td>
<td class="nump">4.51%<span></span>
</td>
<td class="nump">4.31%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=scwo_OptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=scwo_OptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 2)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Stockholder Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, beginning of the period | shares</a></td>
<td class="nump">3,549,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Granted | shares</a></td>
<td class="nump">2,382,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested,end of the period | shares</a></td>
<td class="nump">5,931,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, beginning balance | $ / shares</a></td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price granted | $ / shares</a></td>
<td class="nump">0.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Exercise Price, ending balance | $ / shares</a></td>
<td class="nump">$ 0.98<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details 3)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, beginning of the period | shares</a></td>
<td class="nump">3,549,292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, beginning balance | $ / shares</a></td>
<td class="nump">$ 1.23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested, beginning of the period | shares</a></td>
<td class="nump">14,675,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, ending balance | shares</a></td>
<td class="nump">14,675,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, beginning balance | $ / shares</a></td>
<td class="nump">$ 1.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, ending balance | $ / shares</a></td>
<td class="nump">$ 1.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, beginning balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, ending balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Warrants Weighted Average Remaining Contractual Life (years) Beginning</a></td>
<td class="text">4 years 10 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance', window );">Warrants Weighted Average Remaining Contractual Life (years) Ending</a></td>
<td class="text">4 years 7 months 17 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 3,315,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Restricted stock units granted</a></td>
<td class="nump">2,382,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="nump">$ 533,587<span></span>
</td>
<td class="nump">$ 535,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants outstanding</a></td>
<td class="nump">5,931,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,549,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 709,463<span></span>
</td>
<td class="nump">183,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">942,440<span></span>
</td>
<td class="nump">321,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 533,587<span></span>
</td>
<td class="nump">535,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=scwo_TwoZeroTwoOnePlanMember', window );">2021 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_OptionsGranted', window );">Options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options exercised</a></td>
<td class="nump">18,114,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_IssuanceOfShares', window );">Issuance of common shares</a></td>
<td class="nump">24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceIncrease', window );">Exercise price</a></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable', window );">Options outstanding and exercisable</a></td>
<td class="nump">570,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_StockOptionsIssued', window );">Issuance of stock options</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_CommonSharesForIssuanceRemaining', window );">Remaining common shares for issuance</a></td>
<td class="nump">5,885,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 460,512<span></span>
</td>
<td class="nump">183,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">428,678<span></span>
</td>
<td class="nump">138,586<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">31,834<span></span>
</td>
<td class="nump">$ 44,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Gross proceeds</a></td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_MarketPriceAndExercisePriceDifference', window );">Difference in market price and exercise price</a></td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AverageGrantDateFairValue', window );">Average grant-date fair value</a></td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_NumberOfOptionIncludePerformanceConditions', window );">Number of option include performance conditions</a></td>
<td class="nump">3,708,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Vest Upon Achievement Of 50% Target [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock Option [Member] | Vest Upon Achievement Of 50% Revenue Target [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RevenueTarget', window );">Revenue Target</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AchiveRevenueTarget', window );">Achive revenue target</a></td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_AnnualRevenueAchiveForFiscalYear2026', window );">Annual revenue achive for fiscal year 2026</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">2,524,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_OtherLaborAndRelatedExpense', window );">Compensation and related expenses</a></td>
<td class="nump">216,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation</a></td>
<td class="nump">248,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="nump">$ 31,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member] | Bottom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_GrantDateFairValueOfRestrictedStock', window );">Grant-date fair value of the restricted stock</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=scwo_RestrictedStockUnitsMember', window );">Restricted Stock Units [Member] | Top [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_GrantDateFairValueOfRestrictedStock', window );">Grant-date fair value of the restricted stock</a></td>
<td class="nump">$ 0.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_keyEmployeeMember', window );">key employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_OptionsGranted', window );">Options granted</a></td>
<td class="nump">1,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=scwo_FinancialOfficerMember', window );">Financial Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_OptionsGranted', window );">Options granted</a></td>
<td class="nump">617,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants outstanding</a></td>
<td class="nump">14,675,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,675,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceIncrease', window );">Exercise price</a></td>
<td class="nump">$ 1.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services</a></td>
<td class="nump">180,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued', window );">Fair value of common share</a></td>
<td class="nump">$ 66,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Member | Former employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued', window );">Fair value of common share</a></td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units RSU Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 2,749,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Restricted stock units granted</a></td>
<td class="nump">2,382,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU', window );">Unvested restricted stock units</a></td>
<td class="nump">308,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_PerformanceBasedRestrictedStockUnits', window );">Performance based restricted stock units</a></td>
<td class="nump">308,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_VestingRestrictedStockUnitsRecognizedPeriod', window );">Vesting restricted stock units recognized period</a></td>
<td class="text">3 years 5 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription', window );">Performance-based vesting conditions for restricted stock units</a></td>
<td class="text">The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year&#8217;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027. The 1,765,000 restricted stock units granted to non-executive key employees are all time-based vesting and vest as follows: 50% on the one-year grant-date anniversary with the remaining vesting ratably over a period of thirty-six months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_ServiceBasedOptionsMember', window );">Service Based Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period</a></td>
<td class="text">2 years 10 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=scwo_PerformanceBasedOptionMember', window );">Performance Based Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 2,821,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AchiveRevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AchiveRevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AnnualRevenueAchiveForFiscalYear2026">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AnnualRevenueAchiveForFiscalYear2026</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_AverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_AverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_CommonSharesForIssuanceRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_CommonSharesForIssuanceRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_GrantDateFairValueOfRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_GrantDateFairValueOfRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_IssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_IssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_MarketPriceAndExercisePriceDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_MarketPriceAndExercisePriceDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_NumberOfOptionIncludePerformanceConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_NumberOfOptionIncludePerformanceConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_OptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_OptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_OtherLaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_OtherLaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PerformanceBasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PerformanceBasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_StockOptionsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_StockOptionsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_VestingRestrictedStockUnitsRecognizedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_VestingRestrictedStockUnitsRecognizedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total fair value of shares issued during the period under a deferred compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_TwoZeroTwoOnePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_TwoZeroTwoOnePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=scwo_VestUponAchievementOfFifityPercentTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=scwo_VestUponAchievementOfFifityPercentTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=scwo_VestUponAchievementOfFifityPercentRevenueTargetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=scwo_VestUponAchievementOfFifityPercentRevenueTargetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=scwo_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=scwo_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_BottomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_BottomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=scwo_TopMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=scwo_TopMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_keyEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_keyEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=scwo_FinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=scwo_FinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_FormerEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=scwo_FormerEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_ServiceBasedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_ServiceBasedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=scwo_PerformanceBasedOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=scwo_PerformanceBasedOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_AirSCWOMember', window );">AirSCWO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty', window );">Expenses from Transactions with Related Party</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 130,321<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_AirSCWOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=scwo_AirSCWOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - Legal Settlement [Member]<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_PaymentOfLegalSettlementAmount', window );">Legal settlement amount</a></td>
<td class="nump">$ 110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_PotentialLossesAssociatedWithComplaints', window );">Potential loss</a></td>
<td class="nump">335,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for Legal Settlements</a></td>
<td class="nump">$ 110,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PaymentOfLegalSettlementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PaymentOfLegalSettlementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_PotentialLossesAssociatedWithComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_PotentialLossesAssociatedWithComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_CommitmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_CommitmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - Subsequent Events [Member]<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price | $ / shares</a></td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_DescriptionOfBoardOfDirectorsEquityCompensation', window );">Board of directors equity compensation description</a></td>
<td class="text">(a) with respect to 757,576 restricted stock and 757,576 shares subject to stock options, 25% vest on the first anniversary of the CTO&#8217;s employment agreement, and the remaining 75% vest in equal increments on the last day of every month thereafter over the following 36 months, subject to the CTO&#8217;s continued employment with the Company on each vesting date: and (b) with respect to the remaining 757,576 restricted stock and 757,576 stock options, each vest in accordance with a performance based milestone set forth by the Company and defined in the CTO&#8217;s employment agreement. See Note 6 for further disclosures on the performance-related milestones<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Stock options granted</a></td>
<td class="nump">1,515,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_scwo_ShareBasedRestrictedStockUnitsGranted', window );">Restricted stock units granted</a></td>
<td class="nump">1,515,152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_DescriptionOfBoardOfDirectorsEquityCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_DescriptionOfBoardOfDirectorsEquityCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_scwo_ShareBasedRestrictedStockUnitsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">scwo_ShareBasedRestrictedStockUnitsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>scwo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -& KUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( -& KUK>\M=*\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
M"J5,7K5::0##.'W)$Q+#W(*+"$MX%,O67.!;&B\CUNJTV]U6A&ELH1A'9&!]
M7BQH0-!445IO7R"TY1\S^!7+5(UEHP$35T$FN8BT\OELQ?S:WCYES^DZ'3*!
M;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'T=)(@(+)?90%NDGVH],5"#(-.SJ=
M6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+<!P$X%&[GL*=]&R_I$$)M*-IT&38
M]MJND::JC5-/T_=]W^N;:)P*C5M/TVMWW=..B<:MT'@-OO%/A\.NB<:KT'3K
M:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8<';6S-(#EEXI^G64&MD=N]U!7/!8
M[CF)$?[&Q036:=(9EC1&<IV0!0X -\313%!\KT&VBN#"DM)<D-;/*;50&@B:
MR('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_::L!I^V[F\^3_'/HY)^GD]=-0LYP
MO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR
M([O=]EA]]D]';B/7J<"S(M>41B1%G\@MNN01.+5)#3(3/PB=AIAJ4!P"I DQ
MEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7H5A)VH3X$$8:XIQSYG/1;/L'I4;1
M]E6\W*.76!4!EQC?-*HU+,76>)7 \:V</!T3$LV4"P9!AI<D)A*I.7Y-2!/^
M*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S&L%&KQMUAVC2/'K^!?F<-0H<D1L=
M F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV&G*U%H&V<:F$8%H2QM%X3M*T$?Q9
MK#63/F#([,V1=<[6D0X1DEXW0CYBSHN0$;\>ACA*FNVB<5@$_9Y>PTG!Z(++
M9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'HYI9";V$5FJ?JH<T/J@>,@H%\;D>
M/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y?RY]SZ7ON?0]H=*W-R-]9\'3BUO>
M1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@YG\#L_6@^GO'M^MDDA*^:62TC%I!+
M@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2GD(;;NE3]4J5U^6ON2BX/%ODZ:^A
M=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*]+',<$X>RPP[9SR2';9WH!TU^_9=
M=N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*TU*0;\/YZ<5X&N(YV02Y?9A7;>?8
MT='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#AWE[7YAGE<90-!1M;*PD+$:W8+C7
M\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B?$R,1>APYY=<7^/1DN/;IF6U;J\I
M=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*POFH]M!5.S_Y9K<B?#!%.%@L22&.4
M%Z9*HO,94[[G*TG$53B_13.V$I<8O./FQW%.4[@2=K8/ C*YNSFI>F4Q9Z;R
MWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=WP6#R_7#)1P_E.^=?]%U#KG[VW>/Z
M;I,[2$R<><41 71% B.5' 86%S+D4.Z2D 83 <V4R43P H)DIAR F/H+O?(,
MN2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7<N/O[Y-J=XS7^BR!;814,F35%\I#
MB<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@2\-Z;ITM)__;7M0]M!<]1O.CF> >
MLX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[
MM'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ
M#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1.
M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( -& KUHD*&V1UP4  )8?   8
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MKWSL'.4K^C2(LK1UC4=03HQ)(BH9L2B9X-C+'SM'_I"4C7)%>KK8CYE52B-
M3ED41A,*R'H%9-&9E?0I>6%.*?WA?9AGLC9TN]=4YFX8Q]$YAP" #)@>WMM&
MU7HJ#]H=(L="]A1L2+S71>;6Q<F(_0$/;.6#YHU9%2R&"RB?6G.\5TA^3JMY
M(C8XHI$^E,]\'!L8,/(2+YAHB7FODMS=9=YJE7Y=JR*3=?,+^0-Z+CPQ\F=M
M-)_+VM#I7F3YJ493KB2LH8PTQOU+$GAS6+?FES1K 8\D8JO7JL[_E=D<RK.:
M[$2QE>2%]Q(PE, "W0.AA<H+DC>-T6Q3OJFM;J ES,SJ%9J\%W6Z[K:B6\0;
MF<KR#@S@.\R'Z;8E>[QTG9#AQ!QMWI[8O55EJ:JG66%>/RUGSP?U_7D8LWD2
M\M9=<\\].D^BZ&EN_]]TS2&?-1O9'L44^%I%2@G?#\<:CL/8A#SRON#@)W:5
MLRPW>0GBWVR(7>052<4FAWR DK4K">#J!S$;[RMB2+-9[B=3E/NJ@[NK#J@Z
MM^6V:(]A,KG*TQPM.+E=4%Q S1.'GK7E@D$9M(I12.,)MGW]P=WUQS%;U=9+
MJ2HA4:S-2=].DKR">[08Y4@QXD?C/9A3J"'MO@SAYS3B9R=<I-EF 91#W$H$
M6 /O1SZT\!.4^Q*"NTL(2\7:D#S;A=@^M\%W%C DOK.P.#IV-&>^D#'N\ZJ!
MPF %0[V7$4Q#O3]&W=]HM6E/(N^4UJIL+]=2 '4#@.]72NFG&W.XV1UF+_\#
M4$L#!!0    ( -& KUJR"3E SP(  .0)   8    >&PO=V]R:W-H965T<R]S
M:&5E=#,N>&ULK59=;]HP%/TK5C9-F]21+Y) !Y%:JFE[F(:*UCV[R858=6)F
M.]#MU^\Z"1FT(85J/!#;N>?XG)OKC\E6R >5 6CRF/-"3:U,Z_6E;:LD@YRJ
M@5A#@6^60N948U>N;+660-,*E'/;<YS0SBDKK'A2C<UE/!&EYJR N22JS',J
M?U\#%]NIY5J[@5NVRK09L./)FJY@ ?K'>BZQ9[<L*<NA4$P41,)R:EVYES/7
M,8 JXH[!5NVUB;%R+\2#Z7Q-IY9C% &'1!L*BH\-S(!SPX0Z?C6D5CNG >ZW
M=^R?*_-HYIXJF G^DZ4ZFUHCBZ2PI"77MV+[!1I#@>%+!%?5/]G6L4%DD:14
M6N0-&!7DK*B?]+%)Q![ '1X!> W .Q7@-P"_,EHKJVS=4$WCB11;(DTTLIE&
ME9L*C6Y883[C0DM\RQ"GXYDHE. LI1I2<DTY+1(@"T.GR/LYE5#H##1+*/]
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M-F0;'[+Z(WW^0-H+<CA?0K.J^1\\'[&>.P')H:IIW@:S,\C3XO@W_M8*<18
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MX'F!*ZS6D8R\?.\#K9/OM(S["CWEM<UEE&W5LHVQ%D83AT;9(E-L_:HXVXV
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M'E^-.GZHZ;YY,^<SK6N:-X<[$F](R0'L]RVE]<L'_K)/]X+:XC]02P,$%
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MA%*Q-_D3='IK;O=\2$<?-I0&WS^(*I/Z#WB40RY=K2JQLM-"_O=\P'W" (C
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MP:&3PP?@_E*IVIW@!.TG8[?_ U!+ P04    " #1@*]:ZJ3%,68%  !O#0
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M$;$3 WP72>U>Q,'V-];B7U!+ P04    " #1@*]:WSO-R*\&   +#P  &0
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MFKVLWM:U6_V*C]J&.P>>K9,IUW%3K?.89GQ18(=8%@ L.[@;#F'.S?:P3+X
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M62L;&:STV[ASHSX5)$*8MT>3VA_[>'A6F[S>*)U6!28@1A*->RTRRQO)6>C
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MJ:N0-Y&24G=C\/-<^L06OG>BQ(.I$YN#?$3M2PP2;#-G$0IM.<W&DU#.*?'
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MCO7H+J**OCP96;?766D<-<X[D$+E+6@Y89D_NW 2V6:7!Y(^);OFDKAKX.>
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M=MVVFVC1V Z7"8W]T@Y+_$ !:0QP?RN$/DY,@.&39_T+4$L#!!0    ( -&
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M965T,C,N>&ULM5AMK]HV%/XK5E9-K=1[$^?-< >16EBU2:N$2MM]F/;!-QS
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M1[MZ;!1:**V$9$4#5C,H"*U_\;?&B#V XND'> W .P0$)P!^ _ / :>F%#2
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M@RI8X9:J![[[!KV?V/"5G$K[1+LN-O8<5+92\;H':P4U8=T;/_=Y. !HGG%
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MDA(6 LD]8U@\W0+E=>KXSG%B27:%,A-NEE1X!RM0]]5":,OM6#:$02D)+Y&
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M@# .>GW+N3H:INUT?YGL)U!+ P04    " #1@*]:CGINZD,$  !X$0  &0
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MDM>C]#NGN808_=MILF0M+?B%!1WNNSEQ0T)";VKO.J2]6MHS2G\K0D=I7^^
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M_N1EFU]>2+8I6NL%DZI1+T[70%4OK5]0SY>,R<.%%J@_MLS_ U!+ P04
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MI=/IJ]>$ESU%.9&L,&5Y9EXU,TQ5'P9<&ZCO<\;D;J(WJ#N[Z ]02P,$%
M  @ T8"O6@][M*&\ @  J@<  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&ULI95M3]LP$,>_BI5-TR:A)G6:M&%M) J,[0531;7QVDVNC45B!]MM0=J'
MGQ_:D(T0@7@3/]W][^=S?)[NN;B3!8!"#U7)Y,PKE*I/?5]F!51$#G@-3*^L
MN:B(TD.Q\64M@.36J2I]' 2Q7Q'*O'1JYQ8BG?*M*BF#A4!R6U5$/,ZAY/N9
M-_2.$S=T4R@SX:?3FFQ@">I7O1!ZY#<J.:V 2<H9$K">>6?#TWEB[*W!;PI[
MV>HCLY,5YW=F\".?>8$!@A(R912(;G9P#F5IA#3&_4'3:T(:QW;_J/[-[EWO
M944DG//REN:JF'D3#^6P)MM2W?#]=SCL)S)Z&2^E_:*]LXU''LJV4O'JX*P)
M*LI<2QX.>6@YA/@%!WQPP);;!;*4%T21="KX'@ECK=5,QV[5>FLXRLRA+)70
MJU3[J72I>'97\#('@2[OMU0]HL\7H @M)<)?IK[2,8REGQWTYDX/OZ 7HFO.
M5"'1)<LA_]??UVP-(#X"SG&OX#41 Q0.3Q .<(0^(A_)@@B0AZ8G0MBD(+01
MPE>GH&O;3F/4K6&NSJFL208S3]\-"6('7OKIPS .OO80CAK"49]Z^I.S'4@%
M^0E:P88R1MD&\352!: :!.4Y^M.9#X?NQ",K;B[I+@VC48(3//5W'5110Q7U
M4BW=.5P)PC1:+T'TC "'$XPGHVZ"N"&(7YD78/D;$A(_PXF2<!B-XVZ<<8,S
M[L6YM25 I^)L!T)7-'3Y "*C$M!"T S:A[<B)6$9:,JG/[J+U 6<M$B' QQV
M8TX:S,E[,-&F.=!^-A=E&+3@@D'\PD^5-'#)^W*H3_HM"4R>)3 8))/_&/U6
M_:Q ;.PK(5'&MTRY4MK,-@_1F:N_3^;N%=/E2I^Q1"6LM6LP&.N_3+B7P0T4
MKVTU7G&E:[OM%OHQ!6$,]/J:<W4<F #-\YS^!5!+ P04    " #1@*]:79P/
M_$4#  "Q"@  &0   'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6R]EFU/VS 0
M@/_**9LFD!!Y:?K&VDH4F(8T!@)M?)CVP4VNB45B9[;3@K0?/]MITTRD$1O:
MOM0O\=T]=^?Z;K+FXD&FB H>\XS)J9,J59RXKHQ2S(D\Y@4R_67)14Z47HK$
ME85 $ENA/',#SQNX.:',F4WLWHV837BI,LKP1H L\YR(ISEF?#UU?&>[<4N3
M5)D-=S8I2()WJ+X4-T*OW%I+3'-DDG(& I=3Y]0_F?L](V!/?*6XEHTY&%<6
MG#^8Q64\=3Q#A!E&RJ@@>ECA&6:9T:0Y?FR4.K5-(]B<;[5_L,YK9Q9$XAG/
M[FFLTJDS<B#&)2DS=<O7'W'C4-_HBW@F[2^LJ[-#;3$JI>+Y1EBO<\JJD3QN
M M$0"+T] L%&(+#<E2%+>4X4F4T$7X,PI[4V,[&N6FD-1YG)RIT2^BO5<FIV
MIWCTD/(L1@$7/TJJGN#@'!6AF83>X<15VH8YZ48;??-*7[!'7P^N.%.IA L6
M8_R[O*O9:L!@"S@/.A5>$7$,/?\( B_HPY>[<SAX>PAOP069$H%R,W18ZM6A
MZ%E+X1Y+GSE;H508'\$"$\H890GP):@4H4!!>0P_6ZU5;E3*^U:Y^2^L9KU^
M. [&P<1=M5"%-578275O[Q7&<+I"H?\G</&((J(2X4;0")NL"Y(1%J&FW(6G
MC;0R.&J0^L=!KQVS7V/VNS&)$(0I"=^N,%^@^-YFN%.%>7].9$$BG#KZ@9$H
M5NC,WKWQ!][[CNP.:L#!O\SNX%EV_7 P[ =AV!ZW88TU[,2Z+LSC).&Z5%(1
M%FNJ(T [-O*YGVOXAURCFFOTOZ_=J.7:^7NNW;C&'+\.\UDHNQG'?\#H>[LW
MUNND/$T2@0E1")=,":I+6@1?25;N"V/KLUN9&#30O#U<C;??_UNNYW%KA?)?
M#!7LH(*7O23/<GN+ILTP6&>ZQ@A=T$N2P2>Z1#AX0B+D(<RWX6RE[38<@E4"
MO@=Y5</\(<3DJ:NV^+OBXG=7EU>Y=6&ST>I3M]6M3\,7N.0VNH@<16)[)0D1
M+YFJ&HIZM^['3JLN9'>\:N9TT=9YD)#A4HMZQT/]0(FJ/ZH6BA>V)UEPI3L<
M.TUU3XG"'-#?EYRK[<(8J+O4V2]02P,$%     @ T8"O6H4[[<8%#   (%(
M !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULM5Q=;^,V%OTKA#LM6B")
M1>K#=IH$2*R9;A>83I"9M ^+?6!D.A9&EEQ*SL=B?_R2DFR*$GUM>>D^=&Q'
M/)?WZ)(\E[S2U6O&O^<+Q@KTMDS2_'JP*(K5Y7"81PNVI/E%MF*I^,L\XTM:
MB*_\>9BO.*.SLM$R&1+'"89+&J>#FZORMWM^<Y6MBR1.V3U'^7JYI/S]CB79
MZ_4 #S8_/,3/BT+^,+RY6M%G]I45CZM[+KX-MRBS>,G2/,Y2Q-G\>G"++\/
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M%_3<7$4@X W,)K/SR6S*1YZ<]Y@!567Z"$)GW>4QWO7FGU:MD3&!B*/,3'Z
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MX6!&Z+:9;LW&FRI,E(WQ-)_"LJ _!&A9@.YS0]EN-PS0_<58_@=02P,$%
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ T8"O6I 1=CR- P  )!H   \
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MR'=2'?MW_>/SM^5]$W$>W7!V<%F_^@502P,$%     @ T8"O6O]Y:I*? 0
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M9'W9_XI'QR!]]?M1.^V,LC.]P_%^:KOLYN%8MUQ_QM]G?-2_,(< R2%!<MR
MY+@%R3$&R7$'DN,>),<#2 X^0@F"0E2.@E2.PE2. E6.0E6.@E6.PE6. E:.
M0E:!0E:!0E:!0E:!0E:!0E:!0E:!0E:!0E:!0E:!0E:)0E:)0E:)0E:)0E:)
M0E:)0E:)0E:)0E:)0E;YGV3]T'KYUQ^LVS6I5=D<_%GW5V#V!5!+ 0(4 Q0
M   ( -& KUI&QTU(E0   ,T    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ T8"O6M[RUTKR    *P(  !$
M     ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ T8"O6IE<
MG",0!@  G"<  !,              ( !Y $  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    " #1@*]:)"AMD=<%  "6'P  &               @($E
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ T8"O6N^?
MA1\*!P  V!X  !@              ("!,@X  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( -& KUJR"3E SP(  .0)   8
M  " @7(5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " #1
M@*]:Z63[D=X$  !^$@  &               @(%W&   >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ T8"O6JA@KTA!!@  K"8  !@
M         ("!BQT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( -& KUJTOV 6_08  * >   8              " @0(D  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " #1@*]:(F0\/D@"  "H!@
M&               @($U*P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ T8"O6AXV9#SS!P  :!,  !@              ("!LRT  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -& KUIK:QGPE!D
M .A*   8              " @=PU  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " #1@*]:JE:SCWX&  !G#P  &0              @(&F
M3P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -& KUIM
M8."\9@(  (@%   9              " @5M6  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ T8"O6G;)D Y$!   \0H  !D
M     ("!^%@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -& KUI]LM*KFP8    /   9              "
M@3%Z  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ T8"O
M6K'+*:U &@  24\  !D              ("! X$  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " #1@*]:+H_^XAP#  !@!P  &0
M        @(%ZFP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( -& KUJ$OH:L8 (  %D%   9              " @<V>  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ T8"O6K]!_"5H P  _@@
M !D              ("!9*$  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " #1@*]:_C8B<#D$   J"P  &0              @($#I0
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( -& KUJBDVMB
MHP,  %D1   9              " @7.I  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ T8"O6HF#>!K  @  P@@  !D
M ("!3:T  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #1
M@*]:Q!V,N+X'  !0+0  &0              @(%$L   >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( -& KUIZ#KFRN ,  ) .   9
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M970S,"YX;6Q02P$"% ,4    " #1@*]:9U'/VT<"  !Q!@  &0
M    @(&XQP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M -& KUJ.>F[J0P0  '@1   9              " @3;*  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ T8"O6CZ!("KT @  Y0D  !D
M             ("!L,X  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " #1@*]:#WNTH;P"  "J!P  &0              @(';T0  >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( -& KUI=G _\10,
M +$*   9              " @<[4  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ T8"O6H4[[<8%#   (%(  !D              ("!
M2M@  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " #1@*]:
M] 1$IUH"  "O!0  &0              @(&&Y   >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( -& KUK -/\.$@(  ),$   9
M      " @1?G  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ T8"O6H5GRI:# P  ;@@  !D              ("!8.D  'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " #1@*]:0B!Q+3P#  #R$P
M#0              @ $:[0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( -&
MKUJ7BKL<P    !,"   +              "  8'P  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( -& KUJ0$78\C0,  "0:   /              "  6KQ  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #1@*]:0+O#+8<!  "\%P  &@
M            @ $D]0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #1@*]:_WEJDI\!   =&   $P              @ 'C]@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     +P O , ,  "S^      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>99</ContextCount>
  <ElementCount>248</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>41</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>110200 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>110201 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited</Role>
      <ShortName>Condensed Consolidated Changes in Stockholders Equity (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995446 - Disclosure - Nature of Business and Presentation of Financial Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements</Role>
      <ShortName>Nature of Business and Presentation of Financial Statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995448 - Disclosure - Liquidity Capital Resources and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern</Role>
      <ShortName>Liquidity Capital Resources and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995449 - Disclosure - Inventory, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/InventoryNet</Role>
      <ShortName>Inventory, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995450 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995451 - Disclosure - Stockholder Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquity</Role>
      <ShortName>Stockholder Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995452 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995453 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995454 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995456 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://scwo.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995457 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://scwo.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995458 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://scwo.com/role/InventoryNet</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995459 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://scwo.com/role/Revenue</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995460 - Disclosure - Stockholder Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityTables</Role>
      <ShortName>Stockholder Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquity</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995461 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1</Role>
      <ShortName>Summary of Significant Accounting Policies (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative</Role>
      <ShortName>Liquidity Capital Resources and Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/InventoryTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995466 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/RevenueTables</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995467 - Disclosure - Revenue (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RevenueDetails1</Role>
      <ShortName>Revenue (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/RevenueTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995468 - Disclosure - Revenue (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RevenueDetails2</Role>
      <ShortName>Revenue (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/RevenueTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995469 - Disclosure - Revenue (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RevenueDetailsNarrative</Role>
      <ShortName>Revenue (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/RevenueTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995470 - Disclosure - Stockholder Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityDetails</Role>
      <ShortName>Stockholder Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquityTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995471 - Disclosure - Stockholder Equity (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityDetails1</Role>
      <ShortName>Stockholder Equity (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquityTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995472 - Disclosure - Stockholder Equity (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityDetails2</Role>
      <ShortName>Stockholder Equity (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquityTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995473 - Disclosure - Stockholder Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityDetails3</Role>
      <ShortName>Stockholder Equity (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquityTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995474 - Disclosure - Stockholder Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/StockholderEquityDetailsNarrative</Role>
      <ShortName>Stockholder Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/StockholderEquityTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995476 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="scwo_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995477 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scwo.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://scwo.com/role/SubsequentEvents</ParentRole>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>scwo-20250331.xsd</File>
    <File>scwo-20250331_cal.xml</File>
    <File>scwo-20250331_def.xml</File>
    <File>scwo-20250331_lab.xml</File>
    <File>scwo-20250331_pre.xml</File>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="scwo_10q.htm">scwo_10q.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>scwo_10qimg24.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="397">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "scwo_10q.htm": {
   "nsprefix": "scwo",
   "nsuri": "http://scwo.com/20250331",
   "dts": {
    "schema": {
     "local": [
      "scwo-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "scwo-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "scwo-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "scwo-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "scwo-20250331_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "scwo_10q.htm"
     ]
    }
   },
   "keyStandard": 196,
   "keyCustom": 52,
   "axisStandard": 15,
   "axisCustom": 0,
   "memberStandard": 15,
   "memberCustom": 26,
   "hidden": {
    "total": 23,
    "http://fasb.org/us-gaap/2024": 12,
    "http://xbrl.sec.gov/ecd/2024": 4,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://scwo.com/20250331": 2
   },
   "contextCount": 99,
   "entityCount": 1,
   "segmentCount": 41,
   "elementCount": 356,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 397,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://scwo.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "110200 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "110201 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
     "longName": "124100 - Statement - Condensed Consolidated Statements of Operations (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Operations (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfRevenueByTypeTableTextBlock",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
     "longName": "148600 - Statement - Condensed Consolidated Changes in Stockholders Equity (Unaudited)",
     "shortName": "Condensed Consolidated Changes in Stockholders Equity (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-31_us-gaap_CommonStockMember",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-03-31_us-gaap_CommonStockMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "longName": "170000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements",
     "longName": "995446 - Disclosure - Nature of Business and Presentation of Financial Statements",
     "shortName": "Nature of Business and Presentation of Financial Statements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "995447 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern",
     "longName": "995448 - Disclosure - Liquidity Capital Resources and Going Concern",
     "shortName": "Liquidity Capital Resources and Going Concern",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://scwo.com/role/InventoryNet",
     "longName": "995449 - Disclosure - Inventory, Net",
     "shortName": "Inventory, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://scwo.com/role/Revenue",
     "longName": "995450 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:RevenueDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:RevenueDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://scwo.com/role/StockholderEquity",
     "longName": "995451 - Disclosure - Stockholder Equity",
     "shortName": "Stockholder Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://scwo.com/role/RelatedPartyTransactions",
     "longName": "995452 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://scwo.com/role/CommitmentsAndContingencies",
     "longName": "995453 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://scwo.com/role/SegmentReporting",
     "longName": "995454 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://scwo.com/role/SubsequentEvents",
     "longName": "995455 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995456 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:UseOfEstimates",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "995457 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://scwo.com/role/InventoryTables",
     "longName": "995458 - Disclosure - Inventory (Tables)",
     "shortName": "Inventory (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://scwo.com/role/RevenueTables",
     "longName": "995459 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:ScheduleOfRevenueByTypeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:ScheduleOfRevenueByTypeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://scwo.com/role/StockholderEquityTables",
     "longName": "995460 - Disclosure - Stockholder Equity (Tables)",
     "shortName": "Stockholder Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails",
     "longName": "995461 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "23",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:RealEstateAccumulatedDepreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:RealEstateAccumulatedDepreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
     "longName": "995462 - Disclosure - Summary of Significant Accounting Policies (Details 1)",
     "shortName": "Summary of Significant Accounting Policies (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:CostOfRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfDepreciationExpenseTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:CostOfRevenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfDepreciationExpenseTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "995463 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:OtherResearchAndDevelopmentExpense",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:ResearchAndDevelopmentExpensePolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:OtherStockBasedCompensation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R26": {
     "role": "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
     "longName": "995464 - Disclosure - Liquidity Capital Resources and Going Concern (Details Narrative)",
     "shortName": "Liquidity Capital Resources and Going Concern (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:NetCashProvidedByUsedInContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R27": {
     "role": "http://scwo.com/role/InventoryDetails",
     "longName": "995465 - Disclosure - Inventory (Details)",
     "shortName": "Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://scwo.com/role/RevenueDetails",
     "longName": "995466 - Disclosure - Revenue (Details)",
     "shortName": "Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:Revenues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfRevenueByTypeTableTextBlock",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "scwo:PremiumsRevenuePercentage",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfRevenueByTypeTableTextBlock",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R29": {
     "role": "http://scwo.com/role/RevenueDetails1",
     "longName": "995467 - Disclosure - Revenue (Details 1)",
     "shortName": "Revenue (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "scwo:UnearnedRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "scwo:UnearnedRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://scwo.com/role/RevenueDetails2",
     "longName": "995468 - Disclosure - Revenue (Details 2)",
     "shortName": "Revenue (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-31",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://scwo.com/role/RevenueDetailsNarrative",
     "longName": "995469 - Disclosure - Revenue (Details Narrative)",
     "shortName": "Revenue (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:LiabilitiesCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "strong",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31_scwo_TwentyTwentyFiveMember",
      "name": "us-gaap:LiabilitiesNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "scwo:RevenueDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://scwo.com/role/StockholderEquityDetails",
     "longName": "995470 - Disclosure - Stockholder Equity (Details)",
     "shortName": "Stockholder Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_scwo_OptionsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://scwo.com/role/StockholderEquityDetails1",
     "longName": "995471 - Disclosure - Stockholder Equity (Details 1)",
     "shortName": "Stockholder Equity (Details 1)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_scwo_OptionsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_scwo_OptionsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://scwo.com/role/StockholderEquityDetails2",
     "longName": "995472 - Disclosure - Stockholder Equity (Details 2)",
     "shortName": "Stockholder Equity (Details 2)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://scwo.com/role/StockholderEquityDetails3",
     "longName": "995473 - Disclosure - Stockholder Equity (Details 3)",
     "shortName": "Stockholder Equity (Details 3)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31_scwo_WarrantsMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://scwo.com/role/StockholderEquityDetailsNarrative",
     "longName": "995474 - Disclosure - Stockholder Equity (Details Narrative)",
     "shortName": "Stockholder Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-31",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "995475 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_scwo_AirSCWOMember",
      "name": "scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2025-01-01to2025-03-31_scwo_AirSCWOMember",
      "name": "scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "longName": "995476 - Disclosure - Commitments and Contingencies (Details Narrative)",
     "shortName": "Commitments and Contingencies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-11-01to2024-11-04_us-gaap_CommitmentsMember",
      "name": "scwo:PaymentOfLegalSettlementAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-11-01to2024-11-04_us-gaap_CommitmentsMember",
      "name": "scwo:PaymentOfLegalSettlementAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://scwo.com/role/SubsequentEventsDetailsNarrative",
     "longName": "995477 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-30_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-30_us-gaap_SubsequentEventMember",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "scwo_10q.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "scwo_ATMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ATMMember",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ATM [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsAndOtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsAndOtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other accounts receivable",
        "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Notes Loans And Financing Receivables By Billing Status Type Axis",
        "documentation": "Information by billing status of receivables."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r50"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unbilled accounts receivable at beginning of year",
        "label": "[Accounts Receivable, after Allowance for Credit Loss]",
        "periodEndLabel": "Unbilled accounts receivable at end of year",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r449",
      "r494",
      "r541",
      "r644",
      "r645"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net of allowance",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "scwo_AccretionOfStockBasedCompensationOptionsAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AccretionOfStockBasedCompensationOptionsAmount",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of stock-based compensation - options"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_AccretionOfStockBasedCompensationRestrictedStockAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AccretionOfStockBasedCompensationRestrictedStockAmount",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion of stock-based compensation - restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedBonusesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedBonusesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonuses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "scwo_AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Contract Loss Provision and Onerous Contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r54",
      "r113",
      "r399",
      "r422",
      "r423"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7",
      "r15",
      "r316",
      "r319",
      "r347",
      "r418",
      "r419",
      "r570",
      "r571",
      "r572",
      "r577",
      "r578",
      "r579",
      "r580"
     ]
    },
    "scwo_AchiveRevenueTarget": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AchiveRevenueTarget",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Achive revenue target"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r529",
      "r676"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-In Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r577",
      "r578",
      "r579",
      "r580",
      "r631",
      "r679"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-based compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r265"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_AirSCWOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AirSCWOMember",
     "presentation": [
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AirSCWO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "[Share-Based Payment Arrangement, Expense]",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294"
     ]
    },
    "scwo_AllocatedTransactionPriceDuringCustomerContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AllocatedTransactionPriceDuringCustomerContract",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocated transaction price"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "scwo_AnnualRevenueAchiveForFiscalYear2026": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AnnualRevenueAchiveForFiscalYear2026",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual revenue achive for fiscal year 2026"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "[Assets]",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r93",
      "r112",
      "r133",
      "r157",
      "r163",
      "r171",
      "r174",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r311",
      "r313",
      "r334",
      "r395",
      "r454",
      "r511",
      "r512",
      "r529",
      "r547",
      "r600",
      "r601",
      "r641"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "[Assets, Current]",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r117",
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r311",
      "r313",
      "r334",
      "r529",
      "r600",
      "r601",
      "r641"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Long-Term Assets",
        "label": "[Assets, Noncurrent]",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r311",
      "r313",
      "r334",
      "r600",
      "r601",
      "r641"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_AverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "AverageGrantDateFairValue",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average grant-date fair value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateAxis",
     "presentation": [
      "http://scwo.com/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Date [Axis]",
        "documentation": "Information by date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "us-gaap_AwardDateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardDateDomain",
     "presentation": [
      "http://scwo.com/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291"
     ]
    },
    "scwo_BillingsDeferredUnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "BillingsDeferredUnearnedRevenue",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Billings deferred"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_BottomMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "BottomMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom [Member]",
        "verboseLabel": "Bottom [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Capital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Capital",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working Capital",
        "documentation": "Amount of total capital as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r393"
     ]
    },
    "us-gaap_CapitalizedContractCostNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostNet",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized costs",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r232"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents, Beginning of the Period",
        "periodEndLabel": "Cash and cash equivalents, End of the Period",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r66",
      "r130"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Decrease in Cash and Cash Equivalents",
        "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect]",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r66"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and contingencies (Note 9)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments Disclosure [Text Block]",
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_CommitmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsMember",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Settlement [Member]",
        "documentation": "This element represents significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r84"
     ]
    },
    "scwo_CommonSharesForIssuanceRemaining": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "CommonSharesForIssuanceRemaining",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining common shares for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r542",
      "r543",
      "r544",
      "r545",
      "r577",
      "r578",
      "r580",
      "r631",
      "r675",
      "r679"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par Value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r441"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares issued",
        "verboseLabel": "Common Stock, Shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43",
      "r441",
      "r460",
      "r679",
      "r680"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock: 200,000,000 authorized, par value $0.0001 per share, 144,682,963 and 144,301,977 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r398",
      "r529"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r30",
      "r31",
      "r180",
      "r495"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r21",
      "r30",
      "r31",
      "r180",
      "r424",
      "r495"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations of Credit Risk",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r98"
     ]
    },
    "scwo_ConcentrationsOfCreditRisk": {
     "xbrltype": "percentItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ConcentrationsOfCreditRisk",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Concentrations of Credit Risk",
        "label": "[Concentrations of Credit Risk]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ContractCostsOnDemoContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ContractCostsOnDemoContract",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract assets",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r262",
      "r263"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenues",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r388"
     ]
    },
    "scwo_CostOfRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "CostOfRevenues",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of revenues",
        "label": "[Cost of revenues]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of common share",
        "documentation": "The total fair value of shares issued during the period under a deferred compensation arrangement."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue, less current portion",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "verboseLabel": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r25"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization expense",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r25"
     ]
    },
    "scwo_DescriptionOfBoardOfDirectorsEquityCompensation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "DescriptionOfBoardOfDirectorsEquityCompensation",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of directors equity compensation description"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_DescriptionOfCapitalizedCost": {
     "xbrltype": "stringItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "DescriptionOfCapitalizedCost",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized cost description"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DescriptionOfEffectOnPreviouslyReportedSegmentInformationForChangeInCompositionOfReportableSegments",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting",
        "documentation": "Description of recasting of previously reported segment information. Includes, but is not limited to, reason, timing, or why information has not been recast."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r551"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "scwo_DuringCustomerContractRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "DuringCustomerContractRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Remaining performance obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Loss per Share - Basic and Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r149",
      "r151",
      "r152",
      "r153",
      "r156",
      "r307",
      "r310",
      "r324",
      "r325",
      "r390",
      "r409",
      "r505"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Share",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r155"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted-average period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized compensation expense",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 2",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "scwo_EquipmentDemoSystemMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "EquipmentDemoSystemMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment - Demo System [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_EquipmentRevenuesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "EquipmentRevenuesMember",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r105",
      "r120",
      "r121",
      "r122",
      "r134",
      "r135",
      "r136",
      "r138",
      "r143",
      "r145",
      "r147",
      "r158",
      "r217",
      "r218",
      "r233",
      "r259",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r347",
      "r407",
      "r418",
      "r419",
      "r420",
      "r432",
      "r482"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r243",
      "r256",
      "r321",
      "r333",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r408",
      "r516",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r591",
      "r592",
      "r593",
      "r594",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ]
    },
    "scwo_FinancialOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "FinancialOfficerMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Officer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible asset, net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r596"
     ]
    },
    "scwo_FormerEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "FormerEmployeesMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_FullScaleDemonstrationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "FullScaleDemonstrationMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Full-scale demonstration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_GeneralAndAdministrative": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "GeneralAndAdministrative",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "[General and administrative]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "verboseLabel": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r464"
     ]
    },
    "scwo_GrantDateFairValueOfRestrictedStock": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "GrantDateFairValueOfRestrictedStock",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant-date fair value of the restricted stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross margin (deficit)",
        "label": "[Gross Profit]",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r59",
      "r92",
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r334",
      "r507",
      "r511",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r600"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss before Income Taxes",
        "label": "[Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest]",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r86",
      "r92",
      "r391",
      "r405",
      "r507",
      "r511",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Operations (Unaudited)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for Income Taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r103",
      "r146",
      "r147",
      "r157",
      "r166",
      "r174",
      "r297",
      "r298",
      "r303",
      "r410",
      "r519"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r129",
      "r299",
      "r300"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued expenses",
        "label": "[Increase (Decrease) in Accounts Payable and Accrued Liabilities]",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "[Increase (Decrease) in Accounts Receivable]",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Contract assets",
        "label": "[Increase (Decrease) in Contract with Customer, Asset]",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r575"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "label": "[Increase (Decrease) in Deferred Revenue]",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued bonus",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "[Increase (Decrease) in Inventories]",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating lease liability",
        "label": "[Increase (Decrease) in Operating Lease Liability]",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r575"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "[Increase (Decrease) in Other Operating Assets]",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "[Increase (Decrease) in Other Operating Liabilities]",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other receivables",
        "label": "[Increase (Decrease) in Other Receivables]",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "[Increase (Decrease) in Prepaid Expense]",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "scwo_IncreaseDecreaseInProvisionForLossOnContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "IncreaseDecreaseInProvisionForLossOnContracts",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued contract loss provision",
        "label": "[Accrued contract loss provision]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInUnbilledReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInUnbilledReceivables",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Unbilled accounts receivable",
        "label": "[Increase (Decrease) in Unbilled Receivables]",
        "documentation": "The increase (decrease) during the reporting period of the amount of revenue for work performed for which billing has not occurred, net of uncollectible accounts."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127",
      "r128"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/InventoryNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory, Net",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r227"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/InventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, net",
        "verboseLabel": "Total",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r501",
      "r529"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Inventory, Net",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r109",
      "r114",
      "r227",
      "r228",
      "r229",
      "r387",
      "r503"
     ]
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/InventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Raw materials",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "us-gaap_InventoryRecallExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRecallExpense",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory allowance",
        "documentation": "Reflects the amount charged against earnings comprised of the costs to announce and effect a recall of defective merchandise."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "scwo_InventoryReserveIncreased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "InventoryReserveIncreased",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in inventory reserve"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryValuationReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryValuationReserves",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/InventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: inventory reserves",
        "label": "[Inventory Valuation Reserves]",
        "documentation": "Amount of valuation reserve for inventory."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r569"
     ]
    },
    "us-gaap_InventoryWorkInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcess",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/InventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Work-in-process",
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "scwo_IssuanceOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "IssuanceOfShares",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock for services",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation and related expenses",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "[Liabilities]",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r312",
      "r313",
      "r314",
      "r334",
      "r440",
      "r506",
      "r547",
      "r600",
      "r641",
      "r642"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders' Equity",
        "label": "[Liabilities and Equity]",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r85",
      "r401",
      "r529",
      "r576",
      "r595",
      "r638"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "[Liabilities, Current]",
        "verboseLabel": "Current liability",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r108",
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r312",
      "r313",
      "r314",
      "r334",
      "r529",
      "r600",
      "r641",
      "r642"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long term liability",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r38",
      "r39",
      "r40",
      "r41",
      "r133",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r312",
      "r313",
      "r314",
      "r334",
      "r600",
      "r641",
      "r642"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyAccrualProvision",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract loss provision",
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges."
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r518",
      "r532",
      "r535",
      "r602",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ]
    },
    "scwo_MarketPriceAndExercisePriceDifference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "MarketPriceAndExercisePriceDifference",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Difference in market price and exercise price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r180",
      "r518",
      "r532",
      "r535",
      "r602",
      "r646",
      "r647",
      "r648",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInContinuingOperations",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Used In Operations",
        "documentation": "The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label."
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Provided by Financing Activities",
        "label": "[Net Cash Provided by (Used in) Financing Activities]",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used In Investing Activities",
        "label": "[Net Cash Provided by (Used in) Investing Activities]",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Cash Used In Operating Activities",
        "label": "[Net Cash Provided by (Used in) Operating Activities]",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss",
        "label": "[Net Income (Loss) Attributable to Parent]",
        "verboseLabel": "Net loss",
        "terseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r68",
      "r87",
      "r106",
      "r118",
      "r119",
      "r122",
      "r133",
      "r137",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r146",
      "r147",
      "r150",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r307",
      "r310",
      "r325",
      "r334",
      "r406",
      "r462",
      "r480",
      "r481",
      "r546",
      "r600"
     ]
    },
    "scwo_NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recent Accounting Pronouncements - Not Yet Adopted"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Income, net",
        "label": "[Nonoperating Income (Expense)]",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_NumberOfOptionIncludePerformanceConditions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "NumberOfOptionIncludePerformanceConditions",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of option include performance conditions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "scwo_OneCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "OneCustomerMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "[Operating Expenses]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from Operations",
        "label": "[Operating Income (Loss)]",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r507",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating lease liability, less current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use asset, net",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_OptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options [Member]",
        "label": "Options Held [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific commodity, or financial or equity instrument, at a specified price during a specified period (an American option) or at a specified date (a European option) which were purchased or otherwise acquired, excluding options written (for which a premium was received)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r450",
      "r455",
      "r470",
      "r476",
      "r490",
      "r491",
      "r492",
      "r538",
      "r539"
     ]
    },
    "scwo_OptionsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "OptionsGranted",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options granted"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_OptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "OptionsMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Business and Presentation of Financial Statements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/NatureOfBusinessAndPresentationOfFinancialStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Nature of Business and Presentation of Financial Statements",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r80",
      "r425",
      "r426"
     ]
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r111",
      "r394",
      "r512",
      "r547"
     ]
    },
    "scwo_OtherLaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "OtherLaborAndRelatedExpense",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Compensation and related expenses",
        "label": "[Compensation and related expenses]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r529"
     ]
    },
    "us-gaap_OtherNoncashExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashExpense",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash lease expense",
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income (expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Cost",
        "verboseLabel": "Research and Development Expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "scwo_OtherStockBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "OtherStockBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_PaymentOfLegalSettlementAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PaymentOfLegalSettlementAmount",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal settlement amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLegalSettlements",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Legal Settlements",
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Increase in intangible assets",
        "label": "[Payments to Acquire Intangible Assets]",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "[Payments to Acquire Property, Plant, and Equipment]",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "scwo_PerformanceBasedOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PerformanceBasedOptionMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Based Option [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_PerformanceBasedRestrictedStockUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PerformanceBasedRestrictedStockUnits",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance based restricted stock units"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance-based vesting conditions for restricted stock units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "scwo_PotentialLossesAssociatedWithComplaints": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PotentialLossesAssociatedWithComplaints",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potential loss"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r539",
      "r542",
      "r543",
      "r544",
      "r545",
      "r675",
      "r679"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par Value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r245"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r441"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r245"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://scwo.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r441",
      "r460",
      "r679",
      "r680"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock: 50,000,000 shares authorized, par value $0.0001 per share, nil issued and outstanding at March 31, 2025 and December 31, 2024",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r397",
      "r529"
     ]
    },
    "scwo_PremiumsRevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "PremiumsRevenuePercentage",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue percentage",
        "label": "[Revenue percentage]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r230",
      "r231",
      "r502"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassifications",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "scwo_ProceedFromAtTheMarketOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ProceedFromAtTheMarketOffering",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from ATM"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ProceedsFromCommonStockAndWarrantsShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ProceedsFromCommonStockAndWarrantsShares",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net proceeds from common stock and warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from the exercise of stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r11"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r177",
      "r388",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r500",
      "r517",
      "r531",
      "r533",
      "r534",
      "r536",
      "r537",
      "r598",
      "r599",
      "r602",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "auth_ref": [
      "r177",
      "r388",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r500",
      "r517",
      "r531",
      "r533",
      "r534",
      "r536",
      "r537",
      "r598",
      "r599",
      "r602",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r546",
      "r677",
      "r678"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property Plant And Equipment By Type Axis",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r346"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Property Plant And Equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r110",
      "r404"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, and equipment, net",
        "verboseLabel": "Total property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r346",
      "r392",
      "r404",
      "r529"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r99",
      "r102",
      "r403"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of property and equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r346"
     ]
    },
    "us-gaap_ProvisionForLossOnContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForLossOnContracts",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued contract loss provision",
        "documentation": "Cumulative provision for contract losses not offset against related costs accumulated on the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r260"
     ]
    },
    "us-gaap_RealEstateAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstateAccumulatedDepreciation",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciations",
        "label": "[SEC Schedule, 12-28, Real Estate Companies, Investment in Real Estate, Accumulated Depreciation]",
        "documentation": "Amount of accumulated depreciation pertaining to real estate investments for entities with a substantial portion of business acquiring and holding investment real estate."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_ReceivablesBillingStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesBillingStatusDomain",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r183",
      "r184",
      "r185",
      "r590"
     ]
    },
    "us-gaap_RecognitionOfDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecognitionOfDeferredRevenue",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognition of prior unearned revenue",
        "label": "[Recognition of Deferred Revenue]",
        "documentation": "The amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. For cash flows, this element primarily pertains to amortization of deferred credits on long-term arrangements. As a noncash item, it is deducted from net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "scwo_RefundableDepositReturned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RefundableDepositReturned",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Refundable deposit returned"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r264",
      "r351",
      "r352",
      "r396",
      "r402",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r459",
      "r461",
      "r489"
     ]
    },
    "scwo_RelatedPartyTransactionExpensesFromTransactionWithRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RelatedPartyTransactionExpensesFromTransactionWithRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expenses from Transactions with Related Party"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r264",
      "r351",
      "r352",
      "r396",
      "r402",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r459",
      "r461",
      "r489",
      "r640"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r352",
      "r353",
      "r429",
      "r430",
      "r431",
      "r465",
      "r466",
      "r467",
      "r486",
      "r488"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development",
        "verboseLabel": "Research and development expenses",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r497",
      "r511",
      "r643"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research And Development Costs",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Member",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "scwo_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock Units RSU Member",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "verboseLabel": "Accumulated Deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r75",
      "r400",
      "r421",
      "r423",
      "r428",
      "r442",
      "r529"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Deficit",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r134",
      "r135",
      "r136",
      "r138",
      "r143",
      "r145",
      "r147",
      "r217",
      "r218",
      "r233",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r315",
      "r317",
      "r318",
      "r320",
      "r323",
      "r342",
      "r343",
      "r418",
      "r420",
      "r432",
      "r679"
     ]
    },
    "scwo_RevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_RevenueDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenueDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "[Revenue]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_RevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenueMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_RevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenuePercentage",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue percentage"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_RevenueReceiveAsConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenueReceiveAsConsideration",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue receive as consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r463",
      "r499",
      "r504"
     ]
    },
    "scwo_RevenueTarget": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "RevenueTarget",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Target"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited",
      "http://scwo.com/role/RevenueDetails",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "verboseLabel": "Revenues",
        "terseLabel": "Revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91",
      "r123",
      "r133",
      "r157",
      "r164",
      "r165",
      "r170",
      "r174",
      "r177",
      "r179",
      "r180",
      "r216",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r334",
      "r391",
      "r511",
      "r600"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity Capital Resources and Going Concern"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arragement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "scwo_ScheduleOfDepreciationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ScheduleOfDepreciationExpenseTableTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of depreciation expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://scwo.com/role/InventoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inventory",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r51",
      "r52",
      "r53"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://scwo.com/role/StockholderEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of outstanding nonvested restricted stock",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "scwo_ScheduleOfRevenueByTypeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ScheduleOfRevenueByTypeTableTextBlock",
     "presentation": [
      "http://scwo.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of revenue by type"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://scwo.com/role/StockholderEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r10",
      "r76"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://scwo.com/role/StockholderEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of stock option assumtion",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://scwo.com/role/StockholderEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of warrant activity",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "scwo_ScheduleOfUnbilledAccountsReceivableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ScheduleOfUnbilledAccountsReceivableTableTextBlock",
     "presentation": [
      "http://scwo.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of unbilled accounts receivable"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ScheduleOfUnearnedRevenueActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ScheduleOfUnearnedRevenueActivityTableTextBlock",
     "presentation": [
      "http://scwo.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of unearned revenue activity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r157",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r180",
      "r508",
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515"
     ]
    },
    "scwo_ServiceBasedOptionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ServiceBasedOptionsMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service Based Options [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ServiceRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ServiceRevenueMember",
     "presentation": [
      "http://scwo.com/role/RevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Service revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ServicesBilled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ServicesBilled",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services billed"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ServicesPerformedButUnbilled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ServicesPerformedButUnbilled",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Services performed but unbilled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SettlementLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SettlementLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued legal settlement",
        "documentation": "Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock-based compensation",
        "label": "[Share-Based Payment Arrangement, Noncash Expense]",
        "terseLabel": "Stock-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price granted",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r280"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails2",
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested, beginning of the period",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number]",
        "periodEndLabel": "Nonvested,end of the period",
        "verboseLabel": "Warrants outstanding",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r281"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercise price",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price]",
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected Volatility",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Option Exercisable, ending balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number]",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable, ending balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r271"
     ]
    },
    "scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Exercised",
        "label": "[Exercised]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r284"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options exercised",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expired/forfeited",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period]",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Expired/forfeit",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeited",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r275"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options granted",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails2",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted",
        "verboseLabel": "Shares Granted",
        "terseLabel": "Restricted stock units granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options outstanding and exercisable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Aggregate Intrinsic Value, beginning balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value]",
        "periodEndLabel": "Aggregate Intrinsic Value, ending balance",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Options Outstanding, beginning balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]",
        "periodEndLabel": "Options Outstanding, ending balance",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails2",
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, beginning balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]",
        "periodEndLabel": "Weighted Average Exercise Price, ending balance",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "scwo_ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested restricted stock units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r274"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r273"
     ]
    },
    "scwo_ShareBasedRestrictedStockUnitsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ShareBasedRestrictedStockUnitsGranted",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted stock units granted",
        "label": "[Restricted stock units granted]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vested percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected Life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Exercisable, ending balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value]",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (years), Exercisable at June 30, 2024",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, ending balance",
        "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price]",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (years) Beginning",
        "verboseLabel": "Warrants Weighted Average Remaining Contractual Life (years) Beginning",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "scwo_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance": {
     "xbrltype": "durationItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (years) Ending",
        "verboseLabel": "Warrants Weighted Average Remaining Contractual Life (years) Ending"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "label": "[Shares, Issued]",
        "periodEndLabel": "Balance, shares",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r131"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43",
      "r47",
      "r48",
      "r105",
      "r120",
      "r121",
      "r122",
      "r134",
      "r135",
      "r136",
      "r138",
      "r143",
      "r145",
      "r147",
      "r158",
      "r217",
      "r218",
      "r233",
      "r259",
      "r301",
      "r302",
      "r304",
      "r305",
      "r306",
      "r308",
      "r309",
      "r310",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r342",
      "r343",
      "r347",
      "r407",
      "r418",
      "r419",
      "r420",
      "r432",
      "r482"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://scwo.com/role/RevenueDetails",
      "http://scwo.com/role/RevenueDetailsNarrative",
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SubsequentEventsDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r158",
      "r343",
      "r388",
      "r427",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r463",
      "r464",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r482",
      "r541"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Statements of Cash Flows (Unaudited)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Balance Sheets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Consolidated Changes in Stockholders Equity (Unaudited)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://scwo.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcernDetailsNarrative",
      "http://scwo.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://scwo.com/role/RevenueDetails",
      "http://scwo.com/role/RevenueDetailsNarrative",
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SubsequentEventsDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r158",
      "r181",
      "r343",
      "r388",
      "r427",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r463",
      "r464",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r482",
      "r541"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for services, shares",
        "verboseLabel": "Common stock issued for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited",
      "http://scwo.com/role/StockholderEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares of common stock for option exercise, shares",
        "negatedLabel": "Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r42",
      "r43",
      "r75",
      "r274"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares for services, amount",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares of common stock for option exercise, amount",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r43",
      "r47",
      "r48",
      "r75"
     ]
    },
    "us-gaap_StockOptionExercisePriceIncrease": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionExercisePriceIncrease",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price",
        "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r258"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "scwo_StockOptionsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "StockOptionsIssued",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of stock options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/CondensedConsolidatedChangesInStockholdersEquityUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders' Equity",
        "label": "[Equity, Attributable to Parent]",
        "periodStartLabel": "Balance, amount",
        "periodEndLabel": "Balance, amount",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r47",
      "r48",
      "r70",
      "r443",
      "r460",
      "r483",
      "r484",
      "r529",
      "r547",
      "r576",
      "r595",
      "r638",
      "r679"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://scwo.com/role/StockholderEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r132",
      "r244",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r257",
      "r259",
      "r322",
      "r485",
      "r487",
      "r493"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r355"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type Axis",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r355"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://scwo.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r355"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://scwo.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r354",
      "r356"
     ]
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://scwo.com/role/LiquidityCapitalResourcesAndGoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liquidity, Capital Resources and Going Concern",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SUPPLEMENTAL CASHFLOW DISCLOSURES:"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_ThreeCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "ThreeCustomerMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Three Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r588",
      "r639"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "auth_ref": []
    },
    "scwo_TopMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "TopMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top [Member]",
        "verboseLabel": "Top [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://scwo.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails",
      "http://scwo.com/role/StockholderEquityDetails1",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r243",
      "r256",
      "r321",
      "r333",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r408",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r591",
      "r592",
      "r593",
      "r594",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637"
     ]
    },
    "scwo_TreatabilityStudyServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "TreatabilityStudyServicesMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treatability study services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_TwentyTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "TwentyTwentyFiveMember",
     "presentation": [
      "http://scwo.com/role/RevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_TwoCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "TwoCustomerMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_TwoZeroTwoOnePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "TwoZeroTwoOnePlanMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2021 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnbilledReceivablesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedBalanceSheets",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unbilled accounts receivable",
        "verboseLabel": "Unbilled receivables",
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnearnedPremiums": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnearnedPremiums",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Unearned revenue",
        "label": "[Unearned Premiums]",
        "documentation": "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "scwo_UnearnedRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "UnearnedRevenue",
     "crdr": "credit",
     "presentation": [
      "http://scwo.com/role/RevenueDetails1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unearned revenue at beginning of the period",
        "label": "[Unearned revenue at beginning of the period]",
        "periodEndLabel": "Unearned revenue at end of period"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_UnvestedRestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "UnvestedRestrictedStockMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unvested Restricted Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use Of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r96",
      "r97",
      "r100",
      "r101"
     ]
    },
    "us-gaap_VehiclesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VehiclesMember",
     "presentation": [
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vehicles [Member]",
        "documentation": "Equipment used primarily for road transportation."
       }
      }
     },
     "auth_ref": []
    },
    "scwo_VestUponAchievementOfFifityPercentRevenueTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "VestUponAchievementOfFifityPercentRevenueTargetMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vest Upon Achievement Of 50% Revenue Target [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_VestUponAchievementOfFifityPercentTargetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "VestUponAchievementOfFifityPercentTargetMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vest Upon Achievement Of 50% Target [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingAxis",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VestingDomain",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628"
     ]
    },
    "scwo_VestingRestrictedStockUnitsRecognizedPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "VestingRestrictedStockUnitsRecognizedPeriod",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting restricted stock units recognized period"
       }
      }
     },
     "auth_ref": []
    },
    "scwo_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "WarrantsMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetails3",
      "http://scwo.com/role/StockholderEquityDetailsNarrative",
      "http://scwo.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://scwo.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Common Shares Outstanding - Basic and Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r153"
     ]
    },
    "scwo_keyEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://scwo.com/20250331",
     "localname": "keyEmployeeMember",
     "presentation": [
      "http://scwo.com/role/StockholderEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "key employee [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "83",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480647/815-10-15-83"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(2))",
   "SubTopic": "210",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "605",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481187/605-35-45-2"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477270/942-505-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r585": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r586": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r587": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-35"
  },
  "r588": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r589": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r592": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r599": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r601": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r602": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r633": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r637": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r639": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r642": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r643": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r647": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r648": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r649": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r650": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r651": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r652": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r653": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r654": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0001654954-25-005746-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001654954-25-005746-xbrl.zip
M4$L#!!0    ( -& KUH:O6Q.7 \  ,"7   1    <V-W;RTR,#(U,#,S,2YX
M<V3M7=USVS82?[^9^Q]X>KETIK(L.TYJ3]*.;,<9SSB6QW*:]EXZ$ E)F%"
M"H"V=7_]+<!O@M_VE;PY]B&5@-W%[OX [BX(0Q]^>=ZZUB/F@C#Z<30].!Q9
MF-K,(73]<>2),1(V(2-+2$0=Y#**/X[V6(Q^^?GO?_OPC_'XM_/[&^N2V=X6
M4VE=<(PD=JPG(C>6ZOJ"A,1\/ ZH?_7'.;..#HX/#G^*VL^1 "Y&-0]T3J.>
M2Y!GL95E*\F:]?!D,CV9'!T>G41$"[:23XAC"W%[0R2VI<>1:SE8D#6U0''+
M-^C,FOW3MBXWB&_1CN,MHLHH:_8H#R)9%VRWYV2]D=8;^P=+#6-=CV\_/5CG
MGB 4"V$MF.LI5<2/UC6U#ZR9ZUKWBD-8]UA@_HB=0)RP-S"(!1ZFXNS9_3C:
M2+D[FTR>GIX.GI?</6!\#98<'D]^NR'T^RB@Y'A52/IN KTAH>UQ#F#M(VI-
M*;!]L&:/D[!7^>IMR *(KA':C9&4$=<*B:66'W1.H).3I2<!YX!-$#M_$.A(
MR<?/]B:?4O6D2 E]Q$+F$_M]0#X]'A].Q\?3D(GBM9IAA?XYG7#FXDE %G$A
M8HO\D717UD5RO\,BUS^Z)T4NY(X7^ 9ZDJ0II9^.0Y6GD]^^W"ST5!E%<P6F
M0Q[Y]/3T=*)[0U*#,CVQ5/<25E<D&7I)"3VA:J7;*7HG U) ?#+Q.U.D))?T
MG4]*HHG+/"IYT;SU.].82%X".?1&:'!9A%[4E9+L2)YA2,F'[HGJ5CR':BH>
M39-#J<E6,)3N2@^%2;[%T)$BI-ZV0AN@P)S8$0.C-7@8'6?X0,]<Y?,>&<6/
MB]3ZMYV"Y6\[Z65C/[&(4GTYL-E6/]8/C]5RCYY!5XQO+_$*>2[HZM$_/>22
M%5%K&[M819T40:);(K[&\A9ML=@A&Y<,!L]JR_J *&52!QG]7;7L=H2N6/ 5
M&M1J.E/ /H!#+?7AZ_VU*5@_@BX81-611< ?_L=(3"C(P2M"B1[P4/TWM<9Q
M*!U;FNO#)$N:E>)!Z)S3G_5G"&H"F+41*J($W %)&:>-7-MS6S#&FA7S!:VA
MX]KZDSJ8@F#X()A+'/6 /T>N>EHM-AA+$3J[DJX,B>D4%OHAN'\!;L01%(%,
M*RG4"J1:OM@!J@14^9Z_@R2-R@V6!(R(X*I#6PG9U(2L""CK34KV#P-PI6LL
M\JJ8K^8[S+4!XBM%GD-TCE6XZJHX2T$]>CNMNP[C<52I$(]DO8G&&D N!_EB
M@^@:BVNZD,S^OF&N Z7:IS\](O=UD*[%7@KWVY_>U84[&,PBU$H.9_GC#:"W
M6MD72&RN7/;4>&'G,)8"_5ZE.FW6M1K(TB,-$.=!?$T%@77PP)':ZYAQCM:^
M\WP@B[O+X#H]/7G[]D0EID38+A,>Q_ ED&4%PJR$M &/$(];),%;\U6X<32C
MSEW"W/GJBE#(2@ARXWGN0]6*LQ+%=UD4_6'4THKVMM1>67(HU1D-EEB/ \HA
MR@MONT5\/U\MR)I"Y6DC*F>VWL. E7$'SS*;X #7FK252+[/(AD(5F@E1%NQ
M;"L4/@ 7 G=#(%V &+*_0#LBD7N/!?.XC=5J^\S 9Q"*;,RI#UUMZDKP?LJ"
M%XFV ME6)%RO1RW>"N0/^,7A[A%,8WQ_BV48X1(ME3B<FD$M8/_1 @&#HT-'
MWV/PBX=]'X=?JMQ[<IAU;\ Y^#6*'''MXE<N09 PFBM]/37B02PCJ(H&M\?3
MV57%Q1WB<@_Y*Q7(UIL%X?PNZ*T$X<B<\%J4I65926$#&'%9NMT2J5-*"*00
MXU2R@FF<,I415$)RG(4D(4V'UI2\ 97HR837RD?W>,>X\D_P8,JV5OK_K?%<
M\D58D8S!YW$=L13X3P_,^_085X)&:Z7/C5H]%F'Y,@:?-ZO=VM1PM6NY$Z,J
MKU_+66_"3\,N6$-,']#2;89HP%&)YPMJ<^N-/\B IEGD)0'+-E9B8I3<D83!
MY47E7M+AZ:9*=QN5=< _.+NZ!DP]F HZJP!X9]3>9CTX8-$R<EQBB8C;*'2$
M+)6XF75\@]@1C#( V@[0:0M$I]60&KL"+2"UI@.H[4"]15P=!7G$+<"->2M!
M-O89VH <C3> W?@=33[<K;DK 3<V-AJ]PQDPKY7RIR*MT5J)4<ZAA2CI'V)E
M0=:?\GFFK=+CQE9&E/</_B[W]S3/X36R"V.S(>OQ(74H]/E1GL^/JGUN;"88
M/C\:?%[@\TR +NJLQ*!XAV&(K TV&]*U;%%O%1KO:VTW#"&@+AS3<CRJP\+[
M&N<!A@C1!)*C<DBJH\9[<Q^@!)(A@%1#<EP.R7$U)&;57@+)\0!))239W99*
MLDJ(S ,$)1 -(;_^8:>B?*PF=25P1O%=?!AJ +#E :E\#)LP5,)H5/2E!Z@&
M))L<\"G:HJZ@JL0LYP!"Y@#0_RE.ZA]U%<8]7EGZ"HTS=2W"QY$@VYVK+KS0
M;1M]^XJ";AS>#_ 'F'OPO'5#$B6_Y H-C7;60\' H0C$;4.*<<4'"&$[S"4L
MK4FH_,B:O)I9+EHV-0M8L-M7>V!N-;4G,QW[:!5,_*96I=?*ZQOU89*\&0.^
MI6_.^  V,2XM:ER]47;?C']9T@VSM: 2%O5M'/*-5=-X>C0^GAX\"R?4L8D*
ML7W-5 CY&JN0?XE.S<%#!C7J28/Q\F_7R1M4E+&$7]3\?-MF^/2E5/7&3_)$
MW]IJ$%^V4VOPD%Q]:#!DC2MXZ@">Y+SU&17PIVJZ3=^]2)5V:K34H>@FL%H0
M1/3Z4UL0]$U1P<-OLH+B8XR?=RZB2+T2O(+O]5SA<IZ2\BD6\C)D<BXOJZM/
MDNOUE&C@D)#C9?,B>15;K8D1,_@?VSX2XDOL:@T;DJL/#88LO!VL=%#C6JX)
M=J6(9;15('D36EL%M(P7/Q23-ZL5:5+%J;^+-M#'=_35PSZDUY_:.-\3+<!/
M7K7F^S\4TU*%YO#GJM!T!N1<,M=V\K6S.W%AW0O,UE=HMGS8Q!?AU0M^ ;GZ
M8 X97(&GMPY4V?#'S+8Y5N+F*[U7JF]6O6#;':;"OSQBIW?=9EN5QXVTLA]'
MC;F(ZZKCPQ]'DJN_#-:W2IXM_5NV/HY F$-DV QU!&'.@RYW',^_FFED^>6/
M3[%E$#L0WU]+O%5TX!IO*221^I[5SYQYNY"4 ,D+K+_'0D+^HJ^P@?Z&7BCB
M[JDWH@-/P;6TUU3=HBM49N$;7$90;I.#EQV9Y&MXB?W_7],[SAZ)NE3XBO$;
M)L2<JCU)#IF9B,ULQM1/T\/#$M'6W@-^EN<NS,/0SE**7*/*U/?O%#V3H8Q7
M69R>OD=*>UKY/<)A1ITYQ2!+1$#H$[)[P\@72^G>$;?X*7'JF#,*'VW_7IU;
M)G_'<N:PG7H/HW4O\,-+A73O!G7EL>.Y>+ZZQ#N.;:*'@WI*W02F_SK%,+H9
M2Y],#-;F^5[)JS*NG+A/9GVE&'&*G4#CF2W)8_B'2B4&UF7KEZE+4 <[P:H3
M]]C&Y%%K7&EM;<[N#;Y@0D8S, JA1FL_8^1G#(]_Y$(<F#E;0@FD:\&[-=^,
MDOY^&C27&\SSD]'0IG*2?IH53"1_(>"9"M?Z0L&4855$/<VZ9ZZK*CKL) XY
MW$'5@"\]KO[FQ!.2;3$/,Y0HKVG,UD]H\]6]AT(7UAMD*IBO&-\J'>=+EZQ3
MB+?D;3L1_'=(\K_E""QL3G9^/1G\51#YMUJ@(@*]@J9Q-/ I5)%*UZ\0"7S_
M*V6@0KK$6Y:=M.4D_9R@^H^PJ RNB :WZ_EQ3\3WA%7%%,TC-(1GZ%<27ZP[
MY/DVQLX59]N9?-C@+XA_QQ"85YCK:WI\_2NI^@E,H+90>JMS1LR_3!J"]3=U
M3 42I\4&\3@G:4#?3X.# '?G3PZTQIG(E^KH>-[A+?&VHE#C,H).-<]4&J&^
M9G,_@\@YJ 5K5EQB6+R@0X$YU60]39;N\<JCCM(,"GHFX"F+I:<TCY=",4%/
M;5I@_@AYFPC2%>R<>S(L :/BL)RFYY:=Y]IRWG?M53189FLD=74Y]>\N/]_'
M)'=HKYIF3X@[P<N/N2?UK^#!0ON&U>^]047_B-7%YU&&&B8_'G(?,-\>?=+4
MP:^/1/[J7H^6B678^CI0&.6JZ8+S A=\>H;P0*#OFMYIK5.^?67!;;-PG7QT
MYZJO^B?T( 8LOK[8.VE9W3HD405J/3,OY;Y2$K_YJ4G;K4&_@E*P.O-TN\<V
M6U-5$::G>3.6KE>[WJ&Z04O&(3</_A DV+-/;6(5DO0S??^L:@SU^Z17B/!?
MD>OIG?L4(M&^8RW22IPRN6:0)^LE^^K+*IABZI=9]$EB<<5XWGQ+;&$4K;IV
MHKK=_ CB@08N3G6,UFZ?'-=">'HW;)6NC'/:_T>#F)GRP/,A"-+*GM>*^V4#
M-%V6K^LYM3H")16LB;0[KZ=;F(-=&"T,UG@X#:.T--Y@JZ3KU.G^AIG>?8]G
M _9WXXG:1L.)=+XN<=MMD-=YO <5@AF(HO</)03=JG[K;9>8JU\0U-D(M5W/
MP8D8$\>5Z&Q$$XYNETQTM:KZK=K,_E_4V-.">F9OR"/.M2"_JZ]V4.JIV^&"
MLPA*<W@J71%A(_=WC/C1X=&[R+!ZM#VUM. /O(-,6^^D)YJ_$;E)<L33\X52
M^IG/!VG!?'6#U\A=8"E]BO0AT4JJGD)_QR1\)\A5)^:PF G!U/$I["A\5-+D
M0NQ-5,ZUR?L)9NK-ZCE3F=[JDG!L2Q;^,&G>88KF;-V6*7%2FU=09:J7NL2]
MB(BSI4B]:C:;,VJBH.>O1<)7[N&)A:<6OF"5>XQB>W+Z6A_S<IC*D%^F:^!(
M0\],>Z<Z!F6-H6.FO5,=HSW1]%HR=*Z@Z];/%!?.VYR^3G6=/7PQ=$RT=:J;
MB@P[_\>1_!.2AJ:%%)WJ';RZ*WHDY'=WJO&5Y[H+R+6Q.FM$17!(Q]"\G*Q;
M"\*?TYVO5N!<<^$5$72J]7>\_P1)']MC<YKD]'4<X<SL)B?<%1-U.S_4>0 >
M.M14O*"_4YTAQ_D7Y@S^!U'C#E+_O"PHGZ(?SVWUF%CL(4QOBY_<)DVW/M]P
M7!R]<WN[C=^$+RZ^S<T8GF[OUJ<<(XF6Q(4Z;R$]9Q^>;3']6T79\7J$SWO_
MWROR:#ZRBP@ZU3H\MFEHF^WH5,MS)F%1&3JFF[M%G^U,P..V3G53[X*_[AA5
M6Z>05OI;:5=D!<LH.#3J[Q8;!C1E[+F5J:WQ%L;F\O>AEM#[2T7U>PE-I[IG
M3RSXNAGJEY/]E19\F/B71_S\'U!+ P04    " #1@*]:]*><6>,.  #5L0
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MVLH&C(]>P="O]X5@<SF@9V(V\CM.AY<93^D(,:6538>Q(K9!Z-3O.,+>!N$
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M3#V^W-+O62%;)'0:AH/!5T2$*HG<PQ6/,,$\S<_5UW:16D*_9X5L$;+4/QS
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MK $Z];K>/)=*_N_T#YJ#\_?_!U!+ P04    " #1@*]:^MPVPE9-  #J(00
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MJVV:$G!AYL'HKPBF>#](W"8\,T4H:LBF4T"MS#N!G -D4$#K&'U,'#!Y0!0
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M>$&Z+6KZ_6@^U.[KT4TYMDP@\C*S;<>'%D+QR]&IB<S,14(M9?9MOIPA2LA
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M:W#H"UZ'M4";D95P_8)7$@!<)F U.=6E95^:VNJGDUAJ3F_LGT0&J:/7>(@
M3 8&U-  "@?/%3#>A6?69I13SKQL^7DQ?S*;^J;"A37.4@>O9YNQM+3L5/(;
M[CV _T*'RE /!?7^_!]A">(WJ9D5J/EM]H Q&OG^2>]]#JIU>UPSV5,=S]TD
M;.;>^#JI4:INJ('R S98.//&WNJD+4#="K:'V4?UVWHNTN;T]A>;R62T@$9]
M"T-=!3ZL_F+/ CGZ_7_#I2!-^TU_O(8YJGR)QCNP-[X36&F&ZA0S4TI/<,RV
M&OGSD2EWIAV+\J!FZ9F2$3RI]I@NQE6TI^3]>6WDZZR'5N.9L1L#1E(8[-L
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M%$'AAE&M9B55B[0*@LPM7!UFIB\GBXT+L3[]T(J>) "O1,>MV)UN:F.\:RH
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M9U;70*S_PR?\)_R/Y3_A_R.1Z/_R?P%02P,$%     @ T8"O6G=[W\" /0
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M<6)[ZA9 <Z)(4V2[[",EPX-R@$3V7;X@N\3/688JDR'.7^(0%_=9PKWUL?H
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M+Y YIW>AB0X!PB",?$4"=<8LNL% )>?9%WOLM_?JS8V0C51[J-F^(G5KZEU
M=L]5AAF/GW$>9_2!5EY*-"$?F2$J,F&HBNMX,#?9<'8O6F;+T[647JYR<B3<
MKJ?5D-[/65X_Y>GAM_ X(-*-P%4D]&.4+ R'*C?1!6/2U1OQX]G</0PP3%^]
M-,/'<;D'J=PG-Q?HOU?%.K7U0\;0RBLQ#6#E<EA2;W/%ASM,-K4B+O$&T1KL
M'0ZSQ[0:I2<M[JF_##P?F:I<D8:*TMF((_?1T*@P 2] 6JA(F,!0OG8CV3T)
M&J8/O. \R H\7A>@GD7*%5LS3;WB#/U)59034T)NG#4?#H7LYKF*1+I8TG*C
M'7RCHPP;!%AN@#U%(J>%N7H$SJ->'(WEVQTNRCP.RXWQ\CC^=0X&=!MJ>&XJ
M^P1XY;X_XBJ8U2\W4OCI.\[#N.#>IP>/!5S/U_2Y,?UXN+NW30KQO#K?IV$Y
M>RC@ACB,5(LMF$!/YZ-M/'J:B3TLU'7?5^3U^U'VL!I(X]'1&./)IQ3)-IV,
M-X<%V/>Q(O;G"<QA-9S&4Z4I6*I03JR/L'CZG&3?V"FQ7$T;EQ*+#KVHQE8H
M_&Z+=U#47:L7T(W(:#M:SG8GI1.J*KD3,?CP^I5PXBK=OJ:\",OX99WSO?_!
MZ."Q@&\CTU,DI%:(1ZQ[[EC@<O-SC;)(Z)'G.JHI0V-XUH%IK*^B)/O\$9:)
M:0V;U/R5AG&"]S ^9),M]%-\#6BA:9BJ&3 'B]5)22/70W*)"3/">,V*%%TL
ML[R,_UG]DRTJG$[ "3Q/E032)^5;IZ2(4$:NMZ1^O1T2V,)/V1N-@67J+E(D
MQN[\#.911*XC@EXR:56:C>V/2-]O,,\A(4W#97>3?TQ@S(OO'S0,@$ZDC(/J
M_,(PCE9RLZ=5%HF68;C'%--J#SS?,BU%GA*<G_$]1-DY1M1PAEVE+X0X6?Y*
MLS#F5:!<3LNW=UG@: =F>V '1*=6Q'%Y1K:+$46N_Z2>SR5>_[>!<^-M%\KT
M+3@& >WH[0JY;UX2QA-*KJ>E/>&+,*3>OX+0"\<O_%>9(KV![MF&*N[O$?P1
MY#,'^/!\<OYZWT_Q(S6/RLU*<H#S:QK$28+1#B=/:13I#DP38W6*I8XU!@S#
M.MS7H[!,5)>?D0)QV!<8D8T"1=Z43"D-3*##?40*BT*M#<7#I*#1#2#?0%"U
M=PX3"$ 7QD8RO/GSGF;THH3Y+2Z?/A+%BZA8^451X$&*)7,0H'DFLE6+GYY
M+OH1#\_!I["4W.;X&<;]6?3[>@('VH:A7FG7H^6! 7-X9CN%A: Z#'>W+"KM
MP[6&@_Y -T//>X,;!!=L(QO>_,6BOD3=PE>J(U%/21CF*S++73GZ,;=1WGC
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MR'(M18)9QEZ4Q5'N3-2"+TW]M2DIQ8]T3!5?FG*K /)Z =,WL:/(UCN6]4(
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M+4=MAQR#$C5K)#W?NB/RDL<T/73EJNHKQ=+9'(0>"BQ%CHDS<E6()C5_)WV
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MW:U;C1=8C81T-]&'C#YECR[C'(=D@&*=*JCGU2P=9N HP-60H:NBTXH*R3%
M)==3F#1=^PFVE<[O -<(3-@Z.A67DM.2XM#$,&W>D:Z,E?SL6D)] 3F9 V=N
MC!P.;VSE@JZ]G6T[VOR&_D&?*?W[_P=02P,$%     @ T8"O6A"0+U0,.0$
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M/FH+J!(F#C B7^I5K!^<UIK-=K?>:S<V/;KL-&[PT36JM5ZGDW%T=Z!",!
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MXMT.KLP!V%:@..CPIQS'(W6?F+^P "L)WIGJK8OS/YHU\KC@!A0R[_03.I;
M@D;W%71"N$_J&-T!L$#F:(RD$Y\-N6L%)U()3>O#'Y[!C=RY=_(_/2=P^5_<
M574LEY />844")LS;G*&?YD&_CTPF4OX4%FBG_#\^G]GS<OYAT_#CV;?/N8V
M5/@7 -CUT: [G0XQ?&[Z731,(]:TP>VXV6_"O\-.CF:68_7J-&.KTZPTJE.
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M)BG:WO&]/45#T&%9FG8SJ.$S-ICNB'R(L+7 !F*9-FY+Z\*.F,&E4+$/R "
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M\$HUNP>G;7BZU^YT7A.H15+CP]12_J^?NO5:YR0-+_C,8F.<*+$#$5'VZB/
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M!T1-LY2NS8/PS4OC$4PU#;E=[I.(:"H91_0N>^5N.N;CT[I@ YKR)"L8ISI
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M]X?N=#RK58P936+NW*!O@?H1.ST@CY=_/%:N;RXN;Q[%2B11M)6JRQ@EQL#
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M3'EC6\0A$O:#N;KI,440O_V\5MK\VTV_%;*R^(O;_#MY3G,I.=4H=_3M[;D
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MW'SR_,:Q*US7M!CU6"G BV.AY!SL*00XORP!=$.R70IZY6:=KM8IY;8J/1<
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M BQ/Q/=3R;8S,BV:9!*D5PDW,;I0EA%&7?2"(;@1-Q,FY @'E\4% ? #J/
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M#&/9BV$SW^&J!PV^G_54J\>3D):T/I:<:G6\:N+3RYQJ)0=,.?H:[WK(U+<
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MK($3CY"5#81PXT<8UYQ!H-N$\7/R-)"(95"O*\N>J;+LI*XL>T)E&9O[)8Z
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M5J._17#>#GO_500B<OSSP#UWQ\ )@&$Z" U@VP#TM3L8==NG]O'):9&:'D#
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M4MUV-N\3";A6B Z&Z,MK(YZ%Z#>3']RRVR?+Y0?7)%ZK+7,RCI>>@+K@AO!
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M=4?.V 8+*P*E_,*)@ D&CG;2X//*'%5]!3]$#6,9;%^&MLP0MA)&TD)#,6E
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M<G-%ME.>-\60;5B_H\>:XB=Y4F G]P.(RE@A&'A48"M<RL\P=WGV,R"+V8_
MQ/*PF" 1L]_(')?9CU4V9^'S'Z@'SWY*]>;N[*>3*$0J4Y]28;P'6@,6J_Y
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M5@CP&;A![0Y(QB&!1XH)F/=>/\J\$%\\82L>(Q2@D</A &5PZ(.@4ZE,N&(
M5D;&5 V(*)5<R23'NG<B3Y#8L)3"H;Q662@'N8+\U =SDCZD8(:?$F/M@W&"
M-.1[8X_=BV^KXI8Q?NV+8;(]-TTN?>5T)X,!NX4DC-D\RBW _>RDVRW=TZZW
M0LPF!<U^H%@$JT/Q4@,-9[U5&T?1"\8,B(![-)QF!62-F>?>RB#TP;P,90H"
MJ7;LS:I1\]Q;<6*,UJ ^%;]#@?O7,*I1\LQ\C*5+B&%BYFBH@39FT+*=],5M
MQ[4NAWF?:6PHX//41EMZN#T*0'OQ]Z+%,PA3M&$,.QP3T+PX"^U%ID7BRU G
M6T+PU(3#WCFOGO*X/LT#YX:DHK+2*LAX<5R$!W\]$QG'Y#4@-^6S);,8XW"T
M;^6-Q(<BM#[X[CIC#)W'<Q[V/7X9N2P0;&.\PPBJ0*"]@V%?4+D1?"9 <Y;1
M\G[CI[.!3=7B8 CO KU8G]"+)<-TI6&I#>YY&Z952<!@)E@ V'#01F8D#Y>-
M7LSDBMB]YJE]W.OH!5(F],6K4$)F/ G9TR63#>!'Z G*)0!PUES//FUWV0XW
M4P,>7^_!B8NI"V6Y)+G0BRXQ6)"6$  AX_(S>77']FFK)2U08X6\AS1,DZ)C
M&C>.%Y-OI'G_:$L Y--CT]-8=GATYN:/#,=%?V(NZH#^?<S7BNGDL_$OR0J)
MSVSOFFZ/Y-MG)W:GW38)GCTY&R%X8*("W@"O^JEWUBP0?>;#>2K1M\^P9UE[
M$='WIT\]6?%Z.!D S44G*?S.D60^B9":I)S1V=%STLCQ+#U.,,R]!$0A:/,>
MB@HF^T/Q:3&%$"5V51HLQT7PLB\DD!5Y;Y/?.\&V%R[3PP;ICS=_BQE<^@ND
M%SJ&]J;KT^H@I/B!R4_\%D<Z;T,*1*V4IC:;*K6!ZIH=);W\+9Y@U)/SH)S$
MN=/U4*!93GQG^A8 BB4.KRS/_?NKRPZHMZ#V69V&]3\INMP3:>_"[8(/?/7O
M#Z"7@HA*,1#"&1:_<4#M*^BV<'MPV7G*RG[>IB^@ 6>AO(-@$.L225<2"6A!
MF$<6A3[K"==X$5VDB89!(/.>>18BV0E<C1"-+>,G9*-A=9IL"H2@H#PL<L52
MG =S$:3!LSA]R@P?H-)T,?+$T/JH$]:OAF \8<P&UN#OLF0N^9W-X7"5A^7F
MXU14C">WX0JT.<W0^OPMXE_:S7=NAOJ!B?J)1CT]V'IGO79BRF *6&'YFH(
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M"<'RP@^OZ6)%*=TUO"EP34LV0'"PG# 'BX%J&<JGU[4&54EA-!II)5E+D[)
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MT5K/Z,$<=7XI..IT+-D1)< JVDDU+<D::!-(RBEI>:C<-&8.+F_]RDX<$Z1
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MKBZ6^#/7@YJB.-E*WPG^M*("*@=OK7:#L70%Q?D\A'7SNFAT>_?H$(X%DLE
M1<N&9EE0!2I:*)6H<9!8,_UN7TF?B+@ :4M:R]%5CN,<GM!'6%5;+N&EU27I
M(1(-]A(.<>NN) SY=@][)!QRN"='CSF>=MA[P^2E2^K L\*!=4?H27;-$54T
M@,BIDS2/*GS8UG_9IGT]X?R_+E<^HE+(*P'-C<=(G]T_KS4+L#_.YN+D+&IY
MR(&.M@':4.9 CIY!22GW*84A42V'FAVKT5I92WE[\5=K'N"BVV&1GI'%208E
M1JNJ#N:B9,8_P7:PS8\9";$/'HYC=R,3DY>2IVR-[3EXB!"K\.@ =@4N</N\
M=NB"*95R L)H*^V-NL15TMZYAO8B^-LL7%^]"9T@*"V1>Q=S%1]2X<NM4IE5
M?EFQ3@_15.9-,/Z6+J#$W$#:9/#YGLA:SZZ,T@MK;9"HFXZCOG,'V'@.9N@O
M"B<35Y5GOX8.Z[,[>'U08B6C;[<$1'1Q0E08G?G%^;X%.%!J7A-E?SG8^B(N
M-H2;O^FXFTQW&U-[203/"2M0 E2D_ '/&O$!66('FC)6P0XK!T_$%7.V<D>,
MYV28K\)J.!?V#^):W1 0_@+M;!( V44I%[%+_R9-GXS=^IZ"GL%;RKXF.)2P
M3!O"F1,C ]:XD"8Y?H/S</]"2\+\X+:]RWL(DL:D F("+,YEN,.JO!#A, Z0
MMG7-6-9XMS4QMJXM<<77UPX@>W<>J'6Q$]S-(GF.PU@:CL63CZ$^FT9!460M
M2 D2KY"ICTT!=4JS6A"^LF@ Y*/3X5F?T\>+(=Q0.A'&'*F'LRG2H: +,= %
M\R]:-4D'UH,K-"*3T44XU5H/%7:FZ',4KV2#3!@D 3FK*]_H-SF01<8A86P7
M* ='^9,3)D] BSR<9[=];*IAWXG:0$)0&2G7]"P\1.(XO@*+V9G3!I8S?HMT
MR(0<;VAPN,7T.XB!^S;RI0X[C@>.QYB\7L'$>9$@*&7,:0I(]2J:@Z(,81=(
M!D+E<X>?YXYJRM^TC,VHA-Z_*'?+/NSBRCR=1T:F6N,5'%:O2NMR9>RM9X(8
M,;(VDK9VH:?M/5:.U1[@-FEVII3_CH]0MN1G;<5A^P='7ME*HL  /0N0*TJ]
M"6=K;YL@C-):N9MU)>96S!"Y(F-GH*",AQAT)GII@T,3!V?/#8B\OH".Z2S)
M(%43!ZZR :AG[,QU2$5.]FS4]1P"RHJAH(3]=!/'#0S:>:YEH5N2GQY3Y!\G
M1?[XF"+_6&$)QIQ/87K$4CXY8^FL:!72J8;\YIBXI 4?&?=Y&JV(WW)[83(-
M<5Y%K@1MSI(/;'A=<LJ:[PNZ@%C$57)H.CBR1V %*4FDZ65E*^/8M17W>#L%
MCW<%E1Y, /5\9I[CP$@=Q5E+3IAJWLS@SI478'X^Q#)N9Q78,J4!V&:-^]9K
MTA#ED"(-F(?'Q9?GO)O3KVW7%./)KWE2K6Y?7\/FY BUTA4@3ZA*;.?#SV6_
MQ<2N99-;O.2^>6C56.&*X$!RN,T=<&2?#G8?E2;XKY0UO>85&NUS3D;,C2H/
M6:NM>=>,&ZKL=='&+D E1FJ)\SC""08/_.$&\A"6,+GS'R0['>(T.M,+#Y[H
M\N4=B2C6Z&&5A;0L]K64015-?@LVEVLZ(6/ =CB^D7).['%4;H&H1Q3N70V'
M/&9,-MS&<4Z^*IP'F,:LJ?)U3?]J^RH$ F3&E#R1DTU8B>?_ZO/7T*S^VZ.O
M*#UU0E7?#ODIGK9XAU5Y66Z#/X-X T?@1/<)P21QMB!D5*I8^ <DN3AS2_J5
M=5.V@#_N*$:F$Y*#2*FD(J6]!AA!XGWL*W,$#;/R=::N*"]@]6W)Q^D5+XO1
MVU3]:AM&@!@A<>AH25J#UG^Y:BGEW+<]:SZS/>N:Q_$.JI,G)J9YC17?RG@9
M]930I+!706V0G"M3D9]SGR0UO;C&"R<NF\5TI6-H:H;*J /I2F=?\53O8+#N
MI]ZRJU[J;P9>)C(>GJXX8<*MX669\6V%8AA")J'GH8HF&BR8F:KA;TO0-S&T
MB87(=I,8D1\HA3UOH"EIK%( 4:+JR^?Y(NI'BJ9VJ\E<P#J4!Z1Q!_>8N1RW
M*?]<@>[]96?*)\1&R$T^8A?*Q8\%RKHJ8A_1*]R^O;S7L;'7$Q8DX\AW.)-A
M[M4"<@-WQ.V5ZS2^@2WIE1,2,%]Y48T3ND*D?CF8S3"=VF!Y:P>@B?NB&ISL
MA32Z3UGUU;(8LC<..251;)1NW V_5O"?Y6;3\@\<BW3AV5"]33[!7'&3(O(W
MU)/^&*>1;XMET]-F].#>@\?9XL?PQM@3%J^:?G?!#&($0BU6O>C*KCG<J<(&
M"&;J]JHH+C!5/.*+NO)>KSP#;%:+@$_SL"_GV>+[XDVYXH;AI\&YYZ>+9Z:Q
M9L_T*)/'0CW'KKG!5PJX'[H\H3KSW: 1V6=![]_[DSP=\9:&W:WJ(CYD^&[2
MEF=/\ST8V1_=^! XG-SB$3(J4;5JV_)8R!Z'+SVX]Z?3Q2_GY9:(2=M.<]YN
M:#%P>77"0T>C68:?Y!GL\2+I \A%PQ2&<"6$,$\NFO"_#W1<-;VHUP?WXC:X
MP+53Z-3S2R/0%)<B-!U5O8"R,6M/K]Z=N.$(1D&'J12%S)/@'V" 9[+NPG7?
MI1[%EGCJ+NP+],G^(NR.@Z2X&\T0015<+\BW1 O:[Q@*: .IA^T4F\R;<K"E
MU3GV.][+B/F8;/P\''R;0O2EHWI ?$J:_6UQHL@6WI#<)X5Y!DBF5H[O*7TZ
M6 !C-90C'5*^/0QHRO/4!#H3^C(*33LC40R\,_?B;9$Q*E829X>6K\.'B?@_
M"J)Y(0.7E59=:ZZM3.\NSAA#=)2S]J6!9):%?P:&A^+8X%,NH^!(%">5IX@=
M)EKS=67JTQ FC/?&\/H/'O_)&_9_/+RW6))\#H6EP4I *DQJQ"-74>ZX\0%*
MO'&I0Z%HFW,OM9 UI6N5.V+CLG*#%)>F!8T43$D+&/,=JX*>NIE*2-C\%.H@
MS?FY4]X\9'3:V@V-!.-Q1/S+;Z@W+%4"1=C"< !J#=EQI8L;\/CP$[FRH>IL
M5#TJQG0("T_X]J43'7._O*[6EC!+H(I'M04/.<!8I4%A%ADEH$8/6*,0,0R"
M-SA;\WQ23/+-UP!=*=&_XC;#*P.;B1BE6,^$C"E.IH ZM=$5X8&I1:5'-U\N
MO[G*FQC1I\P;? 2,FL03=ZU% K+2 ZQ874SP0B=#1VD:FZMPQ#28E:8S9)BV
M!%)O):I>B+*D@WY,?$C70J87ZE2\7!4NZ>POYL^J7BT["IQ=,>YTI'T7X-8U
M7!*OTN @!;,,3AHI)[0WV4D!2[K5FMN<[/%<%ZK_BG4ST'=_^O^"8_[J&W$5
MHT^!K4I#!;F=9 /"HY>S0BJ0I5^=%SFA(L)&PD9RJ53";1:SX*D\IM19)7I
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MX0Y%L-S[+SJP#-7;E)!))8CY_==))L)2DV>PN9%$*3NIB:T-Y1&Z@27OT'.
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MDG&0<'0N2EJ\C<:^+=U@B<]G78H.MC;S?U/8UB-J@3G A;6M^K+8\$WBDL#
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MXRFI.(9#5$ZGYI1A)YE@0V>'("&L=^S\5./>EM+XY&B'6)K/>V8^Y&)KR2$
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MRRQ'-8U2^)%366'4N+7C1W8_!\=3_0)\H)2K*Z0I N -U(2V)>0V$\U)<L.
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MBIM?H_Z;S:(;.1?N2_/W.X051XY4Q3RE03"WJ&Q'V'5(R$GW-F_I^TQ#- $
M05XM7Q.>G6@KG)PW^B37JH2%ZFX4XI8&^L@Z%KZ@\R1S[6*&8/%%B4 .F[3:
MF9/%H@"NXF[^*]F-Z2NB+I,+,$E?(B%'#$Y^[F4/Q[O^<MOYM=-92_(L964T
MI3_U8=KN/UB>/-#E_NR->((GJTY<Y[S9W&PO<M6;S&;N%DHZ/FQF']]0B"O&
M]\'AIT8S$KW_G?+N&#,/;<_E'GK0II;2 A4.B@0RP_]X\/C>8D?M:W12"*>N
MGGCN)0NSI1R)=8:N\[VS]QH-7_1DU( ;SM0-#MIW2GF2G-'$\,1],;CI_7OQ
MIFON)T(H2PP"M!K 0\9]L] 2Y?N04*]1]+W]F_[UWOMZT]/%U^CLE2_3I+#P
MXQR$//SCO_JJ6#R\I\&"-EP+L<@UYAAN@=,#M>2$,R2+/BV@!K%)1B9<^/$I
MK]#%*SXG"X-KN-G8M+CAD=A O&5YDC$C#<$&65)*#*?G3:W= '4CNC3Y=B\D
M6$_CVD3 ?ZMV02&NZELE*B=F-A(FCOP0B5<\%#W*6S@B:?#:E9VDK;QH$#N&
MDR4=_J?G4%O.7SY[*C3YK0RP--HP;S,!&5("HJ&D^<SE([:A> ,R^TNG%RM)
M$02G.#Z'">2W;)6P[,T^#&Y8K#L6[#;!C2VWNY-QK>L+MOG88L\V=$M72WQ'
MX7P-DD.0[G$#S+4#'[W[:' G!G3 DP^?XS?\?$DQHJ(#:>$M"[ 7Q#<@#[6)
M@IJ':.S/-\YKD!)6J>V9B2_'Z(6C!X31J#4YGG-,2%3/&$X1>F:VXM+!CCEO
M):K[KI+O\AS\#)IZ<ZF]R0ZUZ0PT'R&T>^A(,_.1*GX/CQ6_CR55)7VV4&59
MJSXY]/W"SZUR""0AD=8 D(<O6$I$9(P.Z203:77CX$AW,=*JHLJ4-Q5V$BI,
M("PJI$D=O?_6I5Z\"<ZJ=2WJGK9%/!A3"$S.R"IOS]]]6I"W8-Z=C#)^V[R1
MI+)D&YG)9J^Z.?)N\7ZT38_2BJA$4; AN6_RW6& W#M^79/*?/CA&TTG,=O9
M^/?*ZQ?3D3$\X5+!_,/A8:+,&C@UK$TSU?:>Y,75*<RL14!XSW:>>22AV5G5
MER1B!(:%MEXY+<MUL>S22-Q1T&W#.Z57SU2XAXB*:&<-^U59,599RLT7V$Y7
M7BM6*]!<E)P<T/ @Q<Y( )2;C:I9I$L[R\]&MI;;V X4R.HF:47&9ZN]^[22
M7X!@EZXMVK,V5P<1#9'GO 7$6!D,*"!L$9 S'6,,*2.Y0-W8YQ11$,/MJ<\/
MHA5?9!08!9>+:+&'[QR.8X8GFX[I$F\8XK?,.05FQ- 90/V*1Q?6?]-4ZMR,
MI\)KX8GJ]3XFK"^9Z!L\:WPI<&K4%>/-*;:4?)3=RE3^5OBV*!NLZZOJ#$RL
M-O-XU&U]Q;<@?FW!K&OZ Q\:FPHG+H5<0,UC^JG:&Y^+:I#!FTG6!T<T_#WF
MP"R-2C !X^L@ET?,(7%Q\&R$Q^^9Z<91&A#U_#*ILD8WSB8PH.OF9//PQ6E[
M3)<(:$%T?7S^2R-ELDW.1 U8.H9[54]EK+!JD 'C<ZMEK*@X?4;Y,E<6-V,(
M4[O+?PT#NFSJUSS;FY(4#YG8RKZ@-7NNQDAA1)MYO:'PD^1R(FRH4@!^+KG!
MR;H(1T318P?8!9.KR!!+O-?$F61 BROCT4+M*>Q!_^:\!!?P(59>\%:UEKYB
MIAV<KMJ]0JVM9>4:J?R82[&7$;L-L59G9V:K\V@&8@@,<.6)8)!"/K@M0YBP
M!G3I![]?RQY^5EX6 A$B- S6$?$(#6:$=O4LW<>)_[%R:WE0!N%='O2WD)9'
M&I6$XW5TVZAK( L1OQ.VL>(\WVX.8CV!=9 CGY;1XXTCZFX54#[:>A0*PC9I
M2+)YSY3XH0/9IYDZ*AQ[RA:F/2B[I2L@TC!MF:(I+3]K&3QCTKQ\$3X8#+SJ
M4<8W3'_&E;D9OL81+G,J;(AI3&H-ZT["ET[D2Q2T=W$1D+-H^]R)K*EXJ/26
M]1><7U_D9V=TENG@-9+Z"7.>NG'P I.)QF>4-VJ*2_#07/]P,,[@NZWIP6&%
M^,AW>],U<=6+HH' BR(3I<*%>_"@ Q^9);9^&SCLH6W$;\5-E F083^@>1JL
MBI3T:=2@,A)XH)V)$9*E!8Q$PD?;[Z;LA%;NFH?DK]!3.L1'#!G7%MTR'KL+
M9]Q+RI=6W7D[_4X*["ZX&QN7&<I@?UV$"X5][;_RJ@][#D\7XW0>X*(3Z)UQ
M(>^B4 <[^U(@,UQKX1Z@35J>CT[_]FAQ)WST2;C2=O$0]WAX5R1?*6@('[IW
M^I>_XD/Q8:0Z>!<.Q"2!<#RO+!06:*QE:E1->NM'8^(DXR:I;#V8UF-QA$(5
M]]SD2J+1"G W&R;CN71*;C3VOLQO:<L]4&HD;)'>U,&*TGA?G<]R+QB9F6]A
MDOHA](8-J)OGDQ_B;J((N;>XHCK+&4/$GX=7/ 0/PV3;HE0=@K 0T.?[=B1Z
M)"HO,5B&$:7,AH.";L2(BDMQ'0ZLH$ ,AM.$H5+ZP:O$>I'CW*92MH';I+-C
MXCJB#&#!9<H,J>!P3=:EV.T[*J!5A55P63>1AS32D-[E\^X@"@MV%IVL/!A(
MU7%&XIVLHQ4#8VVGT,+I,?0:J*Z'V@I!Z[O#;1<ORVHUFN78!:.GWN"6@@/[
MC_NG(00Q#VF5:KRJ"T!(5J5-I1JEM8=O4B@NI_2V&$PD'._&#R,2Y90\)]-<
M#"7-W>7UMC1BX=SQ49.&?^RRVZ-CV>UCE=U8'<!(FI,RN>'R\8<44QC#/T=>
MHV T*2RL>?E>UA 6BIZ'GI9YG:_\^BNKDEB>@S,Z(&+Z)V[HIM$Y/ ,^+$%U
M)@-6I:\ZU:C@K8OZ2:I61&Y":-,L\^![3UZ\V883YY.5< ^34EN:$S5M"J5X
M+@A^(NV00"-3_Z)PBZ9EIVJ$)?'5+,OY6(41@HH%5R"I'TJ5J3RF8K374["E
M)2W%<I]19,_7T=J3U.TFE32,.DEBL"(QP'SB[*G21Q+&ML6<.3HQ2OX<C[!L
M)KVPJ?-]J7<J1.RC"1V]L]TI[L2X0,22.^EJ9,/I64^H.->;<@E]=[L?\(I?
M%:9_$,_'TX_LL7D1H:X*"E4+4#&TD!U+IF9%?%(D;)>Y)<<E1$YBJX%?8'9V
M'&4NPMZPVG.N,I8U*7=X$#$R>=H?$^%:D)!3MI>:-<+K_E0 P+9>/"7: 3(:
M3M(\KW0Q:/CU]9Y(I&3<P[$O_$0Q$V5FF)_2Q$ZYDX'2/I&F;G T2J-$3?AR
M?"FAVFS:X' \],OB$@PL3EM8B?+?=HHR/S^CR2'W%RX+C9V)/A.N<^!PX&:,
M#YG#O@Z#OMG1 OL!%)=!LLQ=KZHM@I6%99?YUZ1K']F8CVS,GP0#RHM*4NY+
MA9#$W#LD:Q%;XF^7^8HVT:(]LB%][K/^(["U$EUPO2*<&:O7B]5Y@3-[L2D:
MBAB.7'<'-.FRYR7;&I([)$B!E$L(7H&J* HZ_QP7^F<_Y]_3H9#;E"ZVI/9,
M!X5P,/,)-JN$CK> HP%\[@;P35VT@B=&A$I'$^K*D9J+1<MT0#^A_#S*>N&7
MQZG_W*?^)U%O3OQ]A#]I1RQ:"U<XL6BFWF6,DIR49^$!EU8X^5@=B53&"4M&
M)S2'W^AP&.:64NKC2;>8(Y?BP9C;=\"\#50O45L@_%L=#655[Y9D)CAG>[X&
M5MO4QOX1$<+O3,+X0?$BK8?W_[XI$9V ;G_!:(!DCB+;%7)<G2SKG)"CQ+T%
M(A2?^FJFF3SZ))O=5U2H6G&V1#<AJH#N+@C<6S#4$<A429/I$S&=%N&>8LW1
M?%WX: UF#VB!<&EY"(J9@CL(4 ;N<%D+SPJ-3XZVT90XZA"2<5*5TEJ\5&JG
MBK0*KUA;G7;8+/-JC@3R<'*73UH#XFWW4E]B4@'TEG+CF,BQT6^_)0G++T_^
M2=D4_IS@FQ;W'P,X]#A+L/)"*[*F5ARP#!45)>H+8O49E>._DWGX/V$ILCO
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M\+??VP_]6>YYWNVV__A_4$L#!!0    ( -& KUH>K#!8W1$  (82   1
M<V-W;U\Q,'%I;6<R-"YJ<&>=EF=4T\^7QK\Q0D!1!.DM=!"DB!3IH-)4#+U#
MD/)#B(A8($H)14!Z$U! $!"0+KV(A!Y0E-ZE)*#42$() 4*R^#];7NR^V-UG
MSIDW]YXY\[G/S)VA3=$6@0NW](WT 1 (!#B?#( V"]P Z$Z?"/QWIJ>CHV<X
MQ\  @3!<.,O$>.[B!;:+K!=86=DX^;G9./@X6%EY1'CX!*!"0D)LW*(2HH+B
M_()"@G\7 ='1TS- &)@9&)@%V5G9!?_/HK4#+ R .$ "@X2!4RP@, N(U@U
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M ^EJ$?6C@M\8_K$6#%B<[.5!;=XK@Z_Y90R3M[]S_&9[<ZGZ2>/C\$3TEHV
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MQY08%;NU^8QW^,)MJX;D9?<4,_^^GN'GO0:HUOOY;Z!6UJHX&G#.DZI \*O
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MB<:_]C4YQOOH-4M_>9%?4$L#!!0    ( -& KUJ8X%-Y_B4  %W"   .
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M&FD)]P/=1WF.[J,1OAB?Q3[_Y@9UI\E>;:!NFE3."M"BT,9"W;<0VQO?]?N
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MG8(RFK,/)LY/[-%XTV).R$59^4X'K<0$%/02?1&#UBB(*8,^' X\.R[,9D.
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M=#%^A,LKD$VA]<@9>VU#R[U $/1QLBM7"MA Y,'.0;2\59E0TN)PX[M5YVK
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M]]V, ),0%GK5EN4$<,!GX*)U'(/ ^.'*YI#<,UA^:*,23[8Y3-;QB5YJ"(4
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M,1YT(4U[)HS<C:FL&4-M7-S.S?)--]Y$43VK(R!6/SC+DP;T"NJYPAZ>5,^
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MOW4XGQWZD&^[R\2)X@#,JR(E/CS\X?G3L)G^P!T--GRER*:YF++VWIN5L"-
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M?6>=,/^XJ3;/[U8+?S$JTL7>_P-02P,$%     @ T8"O6HJGU%ER!P  2S$
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MB5UZ/?^T8;?-NOO>'XPC0][8M1?;V+89_V[O/6'WMP[M?P!02P,$%     @
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M,#(U,#,S,5]D968N>&UL4$L! A0#%     @ T8"O6OK<-L)630  ZB$$ !4
M             ( !7CP  '-C=V\M,C R-3 S,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( -& KUIW>]_ @#T  "YQ P 5              "  >>)  !S8W=O+3(P
M,C4P,S,Q7W!R92YX;6Q02P$"% ,4    " #1@*]:$) O5 PY 0#0>@P #
M            @ &:QP  <V-W;U\Q,'$N:'1M4$L! A0#%     @ T8"O6AZL
M,%C=$0  AA(  !$              ( !T  " '-C=V]?,3!Q:6UG,C0N:G!G
M4$L! A0#%     @ T8"O6OJ\ \+2 0  ' <   X              ( !W!("
M '-C=V]?97@Q,#$N:'1M4$L! A0#%     @ T8"O6IC@4WG^)0  7<(   X
M             ( !VA0" '-C=V]?97@Q,#(N:'1M4$L! A0#%     @ T8"O
M6HJGU%ER!P  2S$   X              ( !!#L" '-C=V]?97@S,3$N:'1M
M4$L! A0#%     @ T8"O6KLBNB59!P  ;#    X              ( !HD("
M '-C=V]?97@S,3(N:'1M4$L! A0#%     @ T8"O6A^T.76T!   BQ$   X
M             ( !)TH" '-C=V]?97@S,C$N:'1M4$L! A0#%     @ T8"O
M6D1#78RQ!   UA$   X              ( !!T\" '-C=V]?97@S,C(N:'1M
64$L%!@     -  T + ,  .13 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>scwo_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:scwo="http://scwo.com/20250331"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="scwo-20250331.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:CommitmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_AirSCWOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:AirSCWOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_AirSCWOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:AirSCWOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_PerformanceBasedOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:PerformanceBasedOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">scwo:VestUponAchievementOfFifityPercentRevenueTargetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentTargetMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">scwo:VestUponAchievementOfFifityPercentTargetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31_scwo_TwoZeroTwoOnePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_scwo_TwoZeroTwoOnePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TwoZeroTwoOnePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_keyEmployeeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:keyEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_FinancialOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">scwo:FinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">scwo:FormerEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_ServiceBasedOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:ServiceBasedOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:TopMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:BottomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_TwentyTwentyFiveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">scwo:TwentyTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:ServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:EquipmentRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis">scwo:EquipmentRevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_ATMMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">scwo:ATMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_UnvestedRestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:UnvestedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">scwo:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_OptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">scwo:OptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_FullScaleDemonstrationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:FullScaleDemonstrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31_scwo_ThreeCustomerMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:ThreeCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_scwo_OneCustomerMember_scwo_RevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">scwo:RevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_scwo_RevenueMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:TwoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">scwo:RevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_TreatabilityStudyServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">scwo:TreatabilityStudyServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_FullScaleDemonstrationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:FullScaleDemonstrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">scwo:TwoCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_scwo_EquipmentDemoSystemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:EquipmentDemoSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_scwo_EquipmentDemoSystemMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">scwo:EquipmentDemoSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-01to2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000933972</identifier>
        </entity>
        <period>
            <instant>2025-05-15</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-03-31" id="ixv-8655">0000933972</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-03-31" id="ixv-8656">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-03-31" id="ixv-8657">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-03-31" id="ixv-8658">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-03-31" id="ixv-8659">2025</dei:DocumentFiscalYearFocus>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8660"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-8661"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-8662"
      unitRef="Shares">144682963</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8663"
      unitRef="Shares">144301977</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="ixv-8664"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8665"
      unitRef="Shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8666"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="ixv-8667"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-8668"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="ixv-8669"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-03-31" id="ixv-8670">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-03-31" id="ixv-8671">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-03-31" id="ixv-8672">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-03-31" id="ixv-8673">false</ecd:NonRule10b51ArrTrmntdFlag>
    <us-gaap:InventoryRecallExpense
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="ixv-8674"
      unitRef="USD">50000</us-gaap:InventoryRecallExpense>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="ixv-8675"
      unitRef="USD">1000000</us-gaap:LossContingencyAccrualProvision>
    <scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable
      contextRef="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="ixv-8676"
      unitRef="Shares">570000</scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable>
    <scwo:AnnualRevenueAchiveForFiscalYear2026
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember"
      decimals="0"
      id="ixv-8677"
      unitRef="USD">20000000</scwo:AnnualRevenueAchiveForFiscalYear2026>
    <dei:DocumentType contextRef="From2025-01-01to2025-03-31" id="ixv-9434">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-03-31" id="ixv-9435">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentQuarterlyReport contextRef="From2025-01-01to2025-03-31" id="ixv-9436">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-03-31" id="ixv-9437">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-03-31" id="ixv-9438">000-27866</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-03-31" id="ixv-9439">374WATER INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-03-31" id="ixv-9440">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-01-01to2025-03-31" id="ixv-9441">88-0271109</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-03-31" id="ixv-9442">100 Southcenter Court</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-03-31" id="ixv-9443">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-03-31" id="ixv-9444">Morrisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-01-01to2025-03-31" id="ixv-9445">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-03-31" id="ixv-9446">27560</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-01-01to2025-03-31" id="ixv-9447">440</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-01-01to2025-03-31" id="ixv-9448">601-9677</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2025-01-01to2025-03-31" id="ixv-9449">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2025-01-01to2025-03-31" id="ixv-9450">SCWO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2025-01-01to2025-03-31" id="ixv-9451">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-03-31" id="ixv-9452">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-03-31" id="ixv-9453">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-03-31" id="ixv-9454">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-01-01to2025-03-31" id="ixv-9455">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-03-31" id="ixv-9456">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-03-31" id="ixv-9457">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-05-15"
      decimals="INF"
      id="ixv-9458"
      unitRef="Shares">144682963</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1012"
      unitRef="USD">6883845</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1013"
      unitRef="USD">10651644</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1014"
      unitRef="USD">94103</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1015"
      unitRef="USD">269733</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1016"
      unitRef="USD">2163417</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1017"
      unitRef="USD">1653007</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1018"
      unitRef="USD">29246</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1019"
      unitRef="USD">43886</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1020"
      unitRef="USD">1876554</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1021"
      unitRef="USD">1701474</us-gaap:InventoryNet>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1022"
      unitRef="USD">197043</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1023"
      unitRef="USD">136651</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1024"
      unitRef="USD">338315</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1025"
      unitRef="USD">431412</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1026"
      unitRef="USD">11582523</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1027"
      unitRef="USD">14887807</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1028"
      unitRef="USD">2719232</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1029"
      unitRef="USD">2567571</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1030"
      unitRef="USD">998251</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1031"
      unitRef="USD">1016594</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1032"
      unitRef="USD">662310</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1033"
      unitRef="USD">691014</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1034"
      unitRef="USD">15847</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1035"
      unitRef="USD">20847</us-gaap:OtherAssets>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1036"
      unitRef="USD">4395640</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1037"
      unitRef="USD">4296026</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1038"
      unitRef="USD">15978163</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1039"
      unitRef="USD">19183833</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1042"
      unitRef="USD">819528</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1043"
      unitRef="USD">906394</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1044"
      unitRef="USD">380000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1045"
      unitRef="USD">570000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:ProvisionForLossOnContracts
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1046"
      unitRef="USD">1000000</us-gaap:ProvisionForLossOnContracts>
    <us-gaap:ProvisionForLossOnContracts
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1047"
      unitRef="USD">1000000</us-gaap:ProvisionForLossOnContracts>
    <us-gaap:SettlementLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1048"
      unitRef="USD">335000</us-gaap:SettlementLiabilitiesCurrent>
    <us-gaap:SettlementLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1049"
      unitRef="USD">335000</us-gaap:SettlementLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1050"
      unitRef="USD">170000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1051"
      unitRef="USD">197683</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1052"
      unitRef="USD">105697</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1053"
      unitRef="USD">101320</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1054"
      unitRef="USD">37998</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1055"
      unitRef="USD">17279</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1056"
      unitRef="USD">2848223</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1057"
      unitRef="USD">3127676</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1058"
      unitRef="USD">30000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1059"
      unitRef="USD">30000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1060"
      unitRef="USD">523210</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1061"
      unitRef="USD">551376</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1064"
      unitRef="USD">3401433</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1065"
      unitRef="USD">3709052</us-gaap:Liabilities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_363"
      unitRef="Shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_91"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1068"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1069"
      unitRef="USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_71"
      unitRef="Shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_73"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_76"
      unitRef="Shares">144682963</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_75"
      unitRef="Shares">144301977</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1070"
      unitRef="USD">14467</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1071"
      unitRef="USD">14429</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1072"
      unitRef="USD">44645824</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1073"
      unitRef="USD">43845499</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1074"
      unitRef="USD">-32086032</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1075"
      unitRef="USD">-28387618</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1076"
      unitRef="USD">2471</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1077"
      unitRef="USD">2471</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1078"
      unitRef="USD">12576730</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1079"
      unitRef="USD">15474781</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1080"
      unitRef="USD">15978163</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1081"
      unitRef="USD">19183833</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1082"
      unitRef="USD">543100</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1083"
      unitRef="USD">315278</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1084"
      unitRef="USD">404817</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1085"
      unitRef="USD">617298</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1086"
      unitRef="USD">138283</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1087"
      unitRef="USD">-302020</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1089"
      unitRef="USD">533587</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1090"
      unitRef="USD">535147</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1091"
      unitRef="USD">1675865</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1092"
      unitRef="USD">790190</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1093"
      unitRef="USD">771901</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1094"
      unitRef="USD">252705</us-gaap:ProfessionalFees>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1095"
      unitRef="USD">942440</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1096"
      unitRef="USD">321141</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1097"
      unitRef="USD">3923793</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1098"
      unitRef="USD">1899183</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1099"
      unitRef="USD">-3785510</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1100"
      unitRef="USD">-2201203</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeOther
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1102"
      unitRef="USD">89710</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1103"
      unitRef="USD">104620</us-gaap:InterestIncomeOther>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1104"
      unitRef="USD">-2614</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1105"
      unitRef="USD">72118</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1106"
      unitRef="USD">87096</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1107"
      unitRef="USD">176738</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1108"
      unitRef="USD">-3698414</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1109"
      unitRef="USD">-2024465</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1110"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1111"
      unitRef="USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1112"
      unitRef="USD">-3698414</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1113"
      unitRef="USD">-2024465</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_1114"
      unitRef="USDPShares">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_1115"
      unitRef="USDPShares">-0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1116"
      unitRef="Shares">144607438</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1117"
      unitRef="Shares">132668777</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1185"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1184"
      unitRef="Shares">144301977</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1186"
      unitRef="USD">14429</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1187"
      unitRef="USD">43845499</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1188"
      unitRef="USD">-28387618</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1189"
      unitRef="USD">2471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1190"
      unitRef="USD">15474781</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1193"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1192"
      unitRef="Shares">180986</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1194"
      unitRef="USD">18</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1195"
      unitRef="USD">66882</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1196"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1197"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1198"
      unitRef="USD">66900</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1199"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1200"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1201"
      unitRef="USD">460512</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1202"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1203"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationOptionsAmount
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1204"
      unitRef="USD">460512</scwo:AccretionOfStockBasedCompensationOptionsAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1205"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1206"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1207"
      unitRef="USD">248951</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1208"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1209"
      unitRef="USD">0</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <scwo:AccretionOfStockBasedCompensationRestrictedStockAmount
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1210"
      unitRef="USD">248951</scwo:AccretionOfStockBasedCompensationRestrictedStockAmount>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1213"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1212"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1214"
      unitRef="USD">20</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1215"
      unitRef="USD">23980</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1216"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1217"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1218"
      unitRef="USD">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1219"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1220"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1221"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1222"
      unitRef="USD">-3698414</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1223"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1224"
      unitRef="USD">-3698414</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1227"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1226"
      unitRef="Shares">144682963</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1228"
      unitRef="USD">14467</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1229"
      unitRef="USD">44645824</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1230"
      unitRef="USD">-32086032</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1231"
      unitRef="USD">2471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1232"
      unitRef="USD">12576730</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1235"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1234"
      unitRef="Shares">132667107</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1236"
      unitRef="USD">13266</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1237"
      unitRef="USD">30684943</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1238"
      unitRef="USD">-15953504</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1239"
      unitRef="USD">2471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1240"
      unitRef="USD">14747176</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1243"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1242"
      unitRef="Shares">3339</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1244"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1245"
      unitRef="USD">4500</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1246"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1247"
      unitRef="USD">0</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1248"
      unitRef="USD">4500</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1249"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1250"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1251"
      unitRef="USD">183200</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1252"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1253"
      unitRef="USD">0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1254"
      unitRef="USD">183200</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1255"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1256"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1257"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1258"
      unitRef="USD">-2024465</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1259"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1260"
      unitRef="USD">-2024465</us-gaap:NetIncomeLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="fid_1263"
      unitRef="USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1262"
      unitRef="Shares">132670446</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="fid_1264"
      unitRef="USD">13266</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="fid_1265"
      unitRef="USD">30872643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="fid_1266"
      unitRef="USD">-17977969</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="fid_1267"
      unitRef="USD">2471</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1268"
      unitRef="USD">12910411</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1118"
      unitRef="USD">-3698414</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1119"
      unitRef="USD">-2024465</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1121"
      unitRef="USD">164004</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1122"
      unitRef="USD">24560</us-gaap:DepreciationAndAmortization>
    <us-gaap:OtherNoncashExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1123"
      unitRef="USD">28704</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1124"
      unitRef="USD">0</us-gaap:OtherNoncashExpense>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1125"
      unitRef="USD">66900</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1126"
      unitRef="USD">4500</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1127"
      unitRef="USD">709463</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1128"
      unitRef="USD">183200</us-gaap:ShareBasedCompensation>
    <scwo:InventoryReserveIncreased
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1129"
      unitRef="USD">0</scwo:InventoryReserveIncreased>
    <scwo:InventoryReserveIncreased
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1130"
      unitRef="USD">50000</scwo:InventoryReserveIncreased>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1132"
      unitRef="USD">-175630</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1133"
      unitRef="USD">19532</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInUnbilledReceivables
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1134"
      unitRef="USD">-14640</us-gaap:IncreaseDecreaseInUnbilledReceivables>
    <us-gaap:IncreaseDecreaseInUnbilledReceivables
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1135"
      unitRef="USD">277056</us-gaap:IncreaseDecreaseInUnbilledReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1136"
      unitRef="USD">510410</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1137"
      unitRef="USD">-5588</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1138"
      unitRef="USD">175080</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1139"
      unitRef="USD">374981</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1140"
      unitRef="USD">60392</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1141"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1142"
      unitRef="USD">-93097</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1143"
      unitRef="USD">340280</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1144"
      unitRef="USD">-5000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1145"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1146"
      unitRef="USD">-86866</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1147"
      unitRef="USD">183424</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1148"
      unitRef="USD">-190000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1149"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <scwo:IncreaseDecreaseInProvisionForLossOnContracts
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1150"
      unitRef="USD">0</scwo:IncreaseDecreaseInProvisionForLossOnContracts>
    <scwo:IncreaseDecreaseInProvisionForLossOnContracts
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1151"
      unitRef="USD">100000</scwo:IncreaseDecreaseInProvisionForLossOnContracts>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1152"
      unitRef="USD">-27683</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1153"
      unitRef="USD">2768</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1154"
      unitRef="USD">20719</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1155"
      unitRef="USD">-26379</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1156"
      unitRef="USD">-23789</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1157"
      unitRef="USD">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1158"
      unitRef="USD">-3494477</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1159"
      unitRef="USD">-2508653</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1161"
      unitRef="USD">297322</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1162"
      unitRef="USD">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1163"
      unitRef="USD">0</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1164"
      unitRef="USD">590</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1165"
      unitRef="USD">-297322</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1166"
      unitRef="USD">-590</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1168"
      unitRef="USD">24000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1169"
      unitRef="USD">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1170"
      unitRef="USD">24000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1171"
      unitRef="USD">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1172"
      unitRef="USD">-3767799</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1173"
      unitRef="USD">-2509243</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1174"
      unitRef="USD">10651644</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1175"
      unitRef="USD">10445404</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1176"
      unitRef="USD">6883845</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="fid_1177"
      unitRef="USD">7936161</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1179"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1180"
      unitRef="USD">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1181"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1182"
      unitRef="USD">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_366">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;1&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;&#x2013;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Nature&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;of&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Business&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;and&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Presentation&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;of&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Financial&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Statements&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Description of&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;the&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Company&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;374Water Inc. (the &#x201c;Company&#x201d;, &#x201c;374Water&#x201d;, &#x201c;We&#x201d;, or &#x201c;Our&#x201d;) is a global industrial technology and services company providing innovative solutions addressing global organic waste destruction/treatment and waste management issues within the Municipal, Federal, and Industrial markets.&#160; 374Water offers our proprietary AirSCWO system, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy.&#160; Importantly, our AirSCWO system eliminates recalcitrant organic wastes without creating waste byproducts. Our AirSCWO system effectively converts solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., &#x201c;per-and polyfluoroalkyl substances&#x201d; or &#x201c;PFAS&#x201d;) into recoverable resources including water, minerals, and heat energy, by focusing on waste as a valuable resource.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;In the first quarter of fiscal year 2025, 374Water continued to build on the strategic plan implemented in 2024.&#160; &#160; During the first quarter, we continued to execute our plan towards reaching critical business milestones. Our first quarter 2025 achievements to date include (i) continuing ruggedizing and optimizing our AirSCWO system to effectively and continuously process a variety of organic waste streams; (ii) preparing our first commercial scale AirSCWO system at the City of Orlando for the Iron Bridge Water Reclamation Facility bio-sludge test; (iii) completing various federal&#160; waste destruction demonstrations; (iv) secured a waste destruction services contract for aqueous film forming firefighting form (&#x201c;AFFF&#x201d;) with the University of North Carolina at Chapel Hill Collaboratory; and (v) strengthening our leadership team and organization.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Presentation&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;of&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Financial&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial information. It is management&#x2019;s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. as of and for the year ended December 31, 2024 filed with the SEC on March 28, 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The results of operations for the three months ended March 31, 2025, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, currently inactive, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_367">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Use&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;of&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of inventory reserve, equity-based compensation, revenue recognition, and accrued loss provisions on onerous contracts, useful lives of long-lived assets, and valuation allowance against deferred tax assets.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;Accounts&lt;/em&gt;&lt;em&gt; &lt;/em&gt;&lt;em&gt;Receivable, Net &lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts receivable consist of balances due from equipment and service revenues. The Company monitors accounts receivable and provides allowances when considered necessary based on historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future economic conditions to form adjustments to historical loss patterns. At March 31, 2025 and December 31, 2024, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant at March 31, 2025 and December 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;Unbilled Accounts Receivable&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Unbilled accounts receivable consist of balances due from&#160;revenues earned but not yet billed related to one customer contract for an equipment sale and one customer contract for a full-scale demonstration completed in January 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Inventory, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress. Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question. We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used, we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required. Once inventory has been written down, it creates a new cost basis for inventory. Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 at both March 31, 2025 and December 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Property&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;and&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Equipmen&lt;/span&gt;t&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and the estimated useful life of the asset. Expenses for maintenance and repairs are charged to expense as incurred.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"&gt;&lt;span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"&gt;The following table presents property and equipment at March 31, 2025 and December 31, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Computers&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;578,352&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;366,400&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment &#x2013; Demo System&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,356,041&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,298,666&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vehicles&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;87,300&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;59,306&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3,041,670&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,744,349&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less: accumulated depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(322,438&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(176,778&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment, net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,719,232&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,567,571&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We completed the manufacturing and fabrication of one of our AirSCWO systems that we will be using for full-scale wastewater treatment demonstration purposes (&#x201c;Demo System&#x201d;). We have capitalized the material and labor costs incurred to develop this Demo System, and had previously classified these costs within inventory. In the first quarter of 2024, we executed a contract with the City of Orlando, Florida to deploy&#160;the Demo System as part of a full-scale demonstration. We began the set up and commissioning process of this Demo System in the third quarter of 2024 which was completed in October 2024.&#160; We began depreciating the Demo System over an estimated life of five years during the last calendar quarter of 2024.&#160; We expect to continue to develop and enhance this unit as we perform our demonstrations and continue progressing towards commercialization. Upgrades and enhancements that will improve the operational efficiency of the unit itself will be capitalized. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Depreciation expense for the three months ended March 31, 2025 and 2024 was $145,661 and $156,002, respectively. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Depreciation expense is presented as follows on the unaudited condensed consolidated statement of operations:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.1pt; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cost of revenues&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40,327&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;105,334&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total depreciation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;145,661&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Concentrations&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;of&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Credit&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company&#x2019;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Significant customers and suppliers are those that account for greater than 10% of the Company&#x2019;s revenues, purchases, accounts receivable and accounts payable. Two customers made up approximately 94% of total revenues for the three months ended March 31, 2025 and one customer made up&#160;94% of total revenues for the three months ended March 31, 2024. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, two customers comprised 91% and three customers accounted for 89% of our outstanding accounts receivable, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, two customers and one customer comprised our unbilled receivables. These customers comprise the majority of our revenue. The loss of a significant customer could adversely affect the results of our operations. &#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2024, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (&#x201c;Merrell Bros.&#x201d;) (see Note 7).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Refer to Note 8 for a license agreement we have with Duke University for the SCWO technology used in our systems.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company follows the revenue standards of Codification (ASC) Topic 606: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of full-scale demonstrations and treatability studies. In the case of equipment revenues, the Company&#x2019;s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Services revenues related to treatability studies are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In late 2024, we deployed our Demo System to the City of Orlando&#x2019;s Iron Bridge Regional Water Reclamation Facility pursuant to a contract executed in March 2024 as part of a full-scale demonstration (the &#x201c;Demo Contract&#x201d;). Pursuant to the Demo Contract, the Company is responsible for system design, installation, commissioning and the start-up of the AirSCWO unit at the facility. Further, the Company will operate and maintain the AirSCWO unit for a period of approximately three months and is required to treat no less than 193 metric tons of wastewater during the three month period. Lastly, the Company will decommission, disassemble and demobilize the AirSCWO unit after the contract period. The Company will receive $812,000 as consideration for the full-scale demonstration. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In accordance with ASC 606-10-25-21, we have concluded that the Demo Contract includes one performance obligation the full-scale demonstration. The system design, site preparation, installation, commissioning and decommissioning represent fulfillment activities versus separate performance obligations. At March 31, 2025 and December 31, 2024, we have accounted for such costs as contract costs under ASC 340-40 (see below). We will recognize revenue on this Demo Contract over the three-month period of operations and maintenance which is the point in time that the City of Orlando receives the benefit simultaneously to the Company&#x2019;s performance, which will commence in 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We&#160;plan to&#160;invoice the City of Orlando in accordance with the contract terms. Invoices are due within thirty days of receipt. At March 31, 2025, we have invoiced and collected $170,000 which is included in unearned revenue. The City of Orlando has the right to cancel the Demo Contract for convenience with a twenty-day written notice but is responsible for paying the Company all amounts owed and outstanding for work performed prior to the effective termination date and costs and expenses incurred by the Company to uninstall, remove, relocate and deliver the AirSCWO&#160;system up to a limit of&#160;$68,000.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we completed a full-scale demonstration for another customer. The contract with this customer included three performance obligations: i) treatability studies, ii) full-scale demonstration and iii) a technical report summarizing the results of the full-scale demonstration.&#160; We have allocated the transaction price of approximately $498,000 among the performance obligations using stand-alone selling price (&#x201c;SASP&#x201d;) for the treatability study, cost-plus-margin for the technical report and the residual approach in the case of the full-scale demonstration. Under the residual approach, the stand-alone selling price is estimated after subtracting the sum of the observable SASP allocated to the other performance obligations within the contract. We do not have a history of selling full-scale demonstrations and a technical report separately to our customers. &#160;At March 31, 2025, the delivery of the technical report is the only remaining performance obligation which approximately $72,000 of the contract transaction price has been allocated. We anticipate this performance obligation to be completed in the second quarter of 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we recognized as revenue approximately $25,000 and $376,000 for the completion of a treatability study and the full-scale demonstration, respectively. We have not yet billed for the full-scale demonstration and therefore, our unbilled receivables include the $376,000 at March 31, 2025.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred. At March 31, 2025, we have capitalized an aggregate of $197,043 of costs incurred to date related to the following: (i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2024, contract costs were comprised of the $136,651&#160;fulfillment related activities for the Demo Contract with the City of Orlando.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;See further revenue related disclosures in Note 5.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Accrued&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Contract&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Loss&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; Provision and Onerous Contracts&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. U.S. GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, &lt;em&gt;Revenue Recognition&#x2014;Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). &lt;/em&gt;ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a total accrued loss provision of $1,000,000 at March 31, 2025 and December 31, 2024, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets.&#160; Any changes to the estimated loss provision are reflected within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Research&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;and&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Development&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $533,587 and $535,147 for the three months ended March 31, 2025 and 2024, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Loss&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Per&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Share&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Loss per share is computed in accordance with ASC Topic 260, &#x201c;Earnings per Share.&#x201d; Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2025 and 2024 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive. At March 31, 2025 and March 31, 2024, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 16,409,062 and 10,740,250 shares of common stock, 14,675,244 and 1,235,000&#160;&#160;of outstanding common stock warrants and unvested restricted stock units of 5,931,576 and 0, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Reclassifications&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We have made certain reclassifications to prior period amounts presented on our consolidated statements of operations to conform to the current period presentation with no impact to net loss or loss per share. These reclassifications consisted of reclassifying $138,586 of stock-based compensation expense from general and administrative expenses to compensation and related expenses. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Recent &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Accounting&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Pronouncements&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;-&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Not&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Yet&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In December 2023 the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (ASU) 2023-09, &lt;em&gt;Income Taxes (Topic 740): &lt;/em&gt;&lt;em&gt;Improvements to Income Tax Disclosures &lt;/em&gt;(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Effective January 1, 2025, we adopted ASU 2023-09 on a prospective basis. The adoption of ASU 2023-09 did not &#160;have a material impact on these unaudited condensed consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;ASU 2024-03,&#160;&lt;em&gt;Disaggregation of Income Statement Expenses (&#x201c;&lt;strong&gt;DISE&lt;/strong&gt;&#x201d;)&lt;/em&gt;. In November 2024, the FASB issued a new accounting standard to improve the disclosures about an entity&#x2019;s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on our consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-01-01to2025-03-31" id="fid_394">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of inventory reserve, equity-based compensation, revenue recognition, and accrued loss provisions on onerous contracts, useful lives of long-lived assets, and valuation allowance against deferred tax assets.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_377">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;Accounts&lt;/em&gt;&lt;em&gt; &lt;/em&gt;&lt;em&gt;Receivable, Net &lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Accounts receivable consist of balances due from equipment and service revenues. The Company monitors accounts receivable and provides allowances when considered necessary based on historical loss patterns, the number of days that billings are past due, an evaluation of the potential risk of loss associated with delinquent accounts, current market conditions and reasonable and supportable forecasts of future economic conditions to form adjustments to historical loss patterns. At March 31, 2025 and December 31, 2024, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for credit losses based on a reserve of current and aged receivables which was not significant at March 31, 2025 and December 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;em&gt;Unbilled Accounts Receivable&lt;/em&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Unbilled accounts receivable consist of balances due from&#160;revenues earned but not yet billed related to one customer contract for an equipment sale and one customer contract for a full-scale demonstration completed in January 2025.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_379">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress. Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question. We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. Further, as we continue to hence and develop are AirSCWO systems we may replace materials and parts with upgrades to enhance the units. If it is not probable that the replacement part will be used, we establish a reserve against the material or part or dispose of it. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required. Once inventory has been written down, it creates a new cost basis for inventory. Inventories are classified as current assets in accordance with recognized industry practice. Based on our evaluation we estimated an inventory allowance of $50,000 at both March 31, 2025 and December 31, 2024.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryRecallExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1301"
      unitRef="USD">50000</us-gaap:InventoryRecallExpense>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_380">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and the estimated useful life of the asset. Expenses for maintenance and repairs are charged to expense as incurred.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"&gt;&lt;span style="white-space:normal;word-spacing:0px;text-transform:none;float:none;font-weight:400;color:rgb(0,0,0);font-style:normal;text-align:left;orphans:2;widows:2;display:inline !important;text-indent:0px;font-variant-ligatures:normal;font-variant-caps:normal;-webkit-text-stroke-width:0px;text-decoration-thickness:initial;text-decoration-style:initial;text-decoration-color:initial;font-size:14pt"&gt;The following table presents property and equipment at March 31, 2025 and December 31, 2024:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Computers&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;578,352&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;366,400&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment &#x2013; Demo System&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,356,041&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,298,666&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vehicles&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;87,300&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;59,306&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3,041,670&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,744,349&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less: accumulated depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(322,438&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(176,778&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment, net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,719,232&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,567,571&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We completed the manufacturing and fabrication of one of our AirSCWO systems that we will be using for full-scale wastewater treatment demonstration purposes (&#x201c;Demo System&#x201d;). We have capitalized the material and labor costs incurred to develop this Demo System, and had previously classified these costs within inventory. In the first quarter of 2024, we executed a contract with the City of Orlando, Florida to deploy&#160;the Demo System as part of a full-scale demonstration. We began the set up and commissioning process of this Demo System in the third quarter of 2024 which was completed in October 2024.&#160; We began depreciating the Demo System over an estimated life of five years during the last calendar quarter of 2024.&#160; We expect to continue to develop and enhance this unit as we perform our demonstrations and continue progressing towards commercialization. Upgrades and enhancements that will improve the operational efficiency of the unit itself will be capitalized. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Depreciation expense for the three months ended March 31, 2025 and 2024 was $145,661 and $156,002, respectively. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Depreciation expense is presented as follows on the unaudited condensed consolidated statement of operations:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 8.1pt; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cost of revenues&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40,327&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;105,334&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total depreciation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;145,661&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_396">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Computers&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;19,977&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;578,352&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;366,400&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment &#x2013; Demo System&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,356,041&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,298,666&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Vehicles&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;87,300&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;59,306&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;3,041,670&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2,744,349&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less: accumulated depreciation&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(322,438&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(176,778&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total property and equipment, net&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,719,232&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;2,567,571&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="fid_1288"
      unitRef="USD">19977</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="fid_1283"
      unitRef="USD">19977</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="fid_1287"
      unitRef="USD">578352</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="fid_1286"
      unitRef="USD">366400</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_scwo_EquipmentDemoSystemMember"
      decimals="0"
      id="fid_1291"
      unitRef="USD">2356041</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_scwo_EquipmentDemoSystemMember"
      decimals="0"
      id="fid_1290"
      unitRef="USD">2298666</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_us-gaap_VehiclesMember"
      decimals="0"
      id="fid_1285"
      unitRef="USD">87300</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31_us-gaap_VehiclesMember"
      decimals="0"
      id="fid_1284"
      unitRef="USD">59306</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1278"
      unitRef="USD">3041670</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1289"
      unitRef="USD">2744349</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:RealEstateAccumulatedDepreciation
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1280"
      unitRef="USD">322438</us-gaap:RealEstateAccumulatedDepreciation>
    <us-gaap:RealEstateAccumulatedDepreciation
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1279"
      unitRef="USD">176778</us-gaap:RealEstateAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1282"
      unitRef="USD">2719232</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1281"
      unitRef="USD">2567571</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1305"
      unitRef="USD">145661</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1304"
      unitRef="USD">156002</us-gaap:Depreciation>
    <scwo:ScheduleOfDepreciationExpenseTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_415">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Cost of revenues&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;40,327&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;General and administrative&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;105,334&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 15px"&gt;Total depreciation expense&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;145,661&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;156,002&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</scwo:ScheduleOfDepreciationExpenseTableTextBlock>
    <scwo:CostOfRevenues
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1293"
      unitRef="USD">40327</scwo:CostOfRevenues>
    <scwo:CostOfRevenues
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1292"
      unitRef="USD">0</scwo:CostOfRevenues>
    <scwo:GeneralAndAdministrative
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1295"
      unitRef="USD">105334</scwo:GeneralAndAdministrative>
    <scwo:GeneralAndAdministrative
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1294"
      unitRef="USD">156002</scwo:GeneralAndAdministrative>
    <us-gaap:Depreciation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1296"
      unitRef="USD">145661</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1297"
      unitRef="USD">156002</us-gaap:Depreciation>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-01-01to2025-03-31" id="fid_384">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company&#x2019;s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Significant customers and suppliers are those that account for greater than 10% of the Company&#x2019;s revenues, purchases, accounts receivable and accounts payable. Two customers made up approximately 94% of total revenues for the three months ended March 31, 2025 and one customer made up&#160;94% of total revenues for the three months ended March 31, 2024. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, two customers comprised 91% and three customers accounted for 89% of our outstanding accounts receivable, respectively.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, two customers and one customer comprised our unbilled receivables. These customers comprise the majority of our revenue. The loss of a significant customer could adversely affect the results of our operations. &#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2024, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC (&#x201c;Merrell Bros.&#x201d;) (see Note 7).&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Refer to Note 8 for a license agreement we have with Duke University for the SCWO technology used in our systems.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <scwo:ConcentrationsOfCreditRisk
      contextRef="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_scwo_RevenueMember"
      decimals="INF"
      id="fid_1312"
      unitRef="Pure">0.94</scwo:ConcentrationsOfCreditRisk>
    <scwo:ConcentrationsOfCreditRisk
      contextRef="From2024-01-01to2024-03-31_scwo_OneCustomerMember_scwo_RevenueMember"
      decimals="INF"
      id="fid_1314"
      unitRef="Pure">0.94</scwo:ConcentrationsOfCreditRisk>
    <scwo:ConcentrationsOfCreditRisk
      contextRef="From2025-01-01to2025-03-31_scwo_TwoCustomerMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="fid_1306"
      unitRef="Pure">0.91</scwo:ConcentrationsOfCreditRisk>
    <scwo:ConcentrationsOfCreditRisk
      contextRef="From2024-01-01to2024-12-31_scwo_ThreeCustomerMember_us-gaap_AccountsReceivableMember"
      decimals="INF"
      id="fid_1315"
      unitRef="Pure">0.89</scwo:ConcentrationsOfCreditRisk>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_385">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company follows the revenue standards of Codification (ASC) Topic 606: &#x201c;Revenue from Contracts with Customers (Topic 606).&#x201d; The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company generates revenue from the sale of equipment (AirSCWO units) and services, specifically the completion of full-scale demonstrations and treatability studies. In the case of equipment revenues, the Company&#x2019;s performance obligations are satisfied over time over the life of the contract which are typically long-term fixed price contracts. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Equipment sale related contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Changes in our overall expected cost estimates are recognized as a cumulative adjustment for the inception-to-date effective of such change. If these changes in estimates result in a possible loss being incurred on the contract, we accrue for such a loss in the period such an outcome becomes probable.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Services revenues related to treatability studies are recognized when all five revenue recognition criteria have been completed which is generally when we deliver a completed treatability study report to the customer.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In late 2024, we deployed our Demo System to the City of Orlando&#x2019;s Iron Bridge Regional Water Reclamation Facility pursuant to a contract executed in March 2024 as part of a full-scale demonstration (the &#x201c;Demo Contract&#x201d;). Pursuant to the Demo Contract, the Company is responsible for system design, installation, commissioning and the start-up of the AirSCWO unit at the facility. Further, the Company will operate and maintain the AirSCWO unit for a period of approximately three months and is required to treat no less than 193 metric tons of wastewater during the three month period. Lastly, the Company will decommission, disassemble and demobilize the AirSCWO unit after the contract period. The Company will receive $812,000 as consideration for the full-scale demonstration. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In accordance with ASC 606-10-25-21, we have concluded that the Demo Contract includes one performance obligation the full-scale demonstration. The system design, site preparation, installation, commissioning and decommissioning represent fulfillment activities versus separate performance obligations. At March 31, 2025 and December 31, 2024, we have accounted for such costs as contract costs under ASC 340-40 (see below). We will recognize revenue on this Demo Contract over the three-month period of operations and maintenance which is the point in time that the City of Orlando receives the benefit simultaneously to the Company&#x2019;s performance, which will commence in 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We&#160;plan to&#160;invoice the City of Orlando in accordance with the contract terms. Invoices are due within thirty days of receipt. At March 31, 2025, we have invoiced and collected $170,000 which is included in unearned revenue. The City of Orlando has the right to cancel the Demo Contract for convenience with a twenty-day written notice but is responsible for paying the Company all amounts owed and outstanding for work performed prior to the effective termination date and costs and expenses incurred by the Company to uninstall, remove, relocate and deliver the AirSCWO&#160;system up to a limit of&#160;$68,000.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we completed a full-scale demonstration for another customer. The contract with this customer included three performance obligations: i) treatability studies, ii) full-scale demonstration and iii) a technical report summarizing the results of the full-scale demonstration.&#160; We have allocated the transaction price of approximately $498,000 among the performance obligations using stand-alone selling price (&#x201c;SASP&#x201d;) for the treatability study, cost-plus-margin for the technical report and the residual approach in the case of the full-scale demonstration. Under the residual approach, the stand-alone selling price is estimated after subtracting the sum of the observable SASP allocated to the other performance obligations within the contract. We do not have a history of selling full-scale demonstrations and a technical report separately to our customers. &#160;At March 31, 2025, the delivery of the technical report is the only remaining performance obligation which approximately $72,000 of the contract transaction price has been allocated. We anticipate this performance obligation to be completed in the second quarter of 2025. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we recognized as revenue approximately $25,000 and $376,000 for the completion of a treatability study and the full-scale demonstration, respectively. We have not yet billed for the full-scale demonstration and therefore, our unbilled receivables include the $376,000 at March 31, 2025.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Contract costs include all direct material, labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expenses as incurred. At March 31, 2025, we have capitalized an aggregate of $197,043 of costs incurred to date related to the following: (i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At December 31, 2024, contract costs were comprised of the $136,651&#160;fulfillment related activities for the Demo Contract with the City of Orlando.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;See further revenue related disclosures in Note 5.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <scwo:RevenueReceiveAsConsideration
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1316"
      unitRef="USD">812000</scwo:RevenueReceiveAsConsideration>
    <us-gaap:UnearnedPremiums
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1317"
      unitRef="USD">170000</us-gaap:UnearnedPremiums>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1318"
      unitRef="USD">68000</us-gaap:OperatingCostsAndExpenses>
    <scwo:AllocatedTransactionPriceDuringCustomerContract
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1319"
      unitRef="USD">498000</scwo:AllocatedTransactionPriceDuringCustomerContract>
    <scwo:DuringCustomerContractRemainingPerformanceObligation
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1320"
      unitRef="USD">72000</scwo:DuringCustomerContractRemainingPerformanceObligation>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31_scwo_TreatabilityStudyServicesMember"
      decimals="0"
      id="fid_1311"
      unitRef="USD">25000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31_scwo_FullScaleDemonstrationMember"
      decimals="0"
      id="fid_1310"
      unitRef="USD">376000</us-gaap:Revenues>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="AsOf2025-03-31_scwo_FullScaleDemonstrationMember"
      decimals="0"
      id="fid_1321"
      unitRef="USD">376000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:CapitalizedContractCostNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1322"
      unitRef="USD">197043</us-gaap:CapitalizedContractCostNet>
    <scwo:DescriptionOfCapitalizedCost contextRef="From2025-01-01to2025-03-31" id="fid_1323">(i) third-party costs totaling $60,393 related to the technical report to be delivered on the contract discussed above in the second quarter of 2025, which will be expensed at that time, and (ii) $136,651 of fulfillment related activities for the Demo Contract with the City of Orlando which will be expensed over the three month demonstration period expected to begin in the second quarter of 2025</scwo:DescriptionOfCapitalizedCost>
    <scwo:ContractCostsOnDemoContract
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1324"
      unitRef="USD">136651</scwo:ContractCostsOnDemoContract>
    <scwo:AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_386">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Onerous contracts are those where the costs to fulfill a contract exceed the consideration expected to be received under the contract. The revenue standard does not provide guidance on the accounting for onerous contracts or onerous performance obligations. U.S. GAAP contains other applicable guidance on the accounting for onerous contracts, and those requirements should be used to identify and measure onerous contracts.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Our outstanding equipment manufacturing contract is a fixed price contract. Due to the nature of the contract, including customer specific equipment design, we applied ASC 605-35, &lt;em&gt;Revenue Recognition&#x2014;Provision for Losses on Construction-Type and Production-Type Contract (ASC 605-35). &lt;/em&gt;ASC 605-35 requires the recognition of a liability for anticipated losses on contracts prior to those losses being incurred when a loss is probable and can be estimated.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, and December 31, 2024, we evaluated the total costs incurred on this contract to date and the estimated costs we anticipate incurring to complete the contract. Based on this analysis, we accrued a total accrued loss provision of $1,000,000 at March 31, 2025 and December 31, 2024, respectively, which has been presented on the accompanying unaudited condensed consolidated balance sheets.&#160; Any changes to the estimated loss provision are reflected within cost of revenues on the accompanying unaudited condensed consolidated statements of operations.&lt;/p&gt;</scwo:AccruedContractLossProvisionAndOnerousContractsPolicyTextBlock>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1303"
      unitRef="USD">1000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2025-01-01to2025-03-31" id="fid_391">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company&#x2019;s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $533,587 and $535,147 for the three months ended March 31, 2025 and 2024, respectively.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1307"
      unitRef="USD">533587</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1313"
      unitRef="USD">535147</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_392">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Loss per share is computed in accordance with ASC Topic 260, &#x201c;Earnings per Share.&#x201d; Basic weighted-average number of shares of common stock outstanding for the three- months ended March 31, 2025 and 2024 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares of common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive. At March 31, 2025 and March 31, 2024, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 16,409,062 and 10,740,250 shares of common stock, 14,675,244 and 1,235,000&#160;&#160;of outstanding common stock warrants and unvested restricted stock units of 5,931,576 and 0, respectively.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1308"
      unitRef="Shares">16409062</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1326"
      unitRef="Shares">10740250</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1309"
      unitRef="Shares">14675244</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-03-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1327"
      unitRef="Shares">1235000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2025-01-01to2025-03-31_scwo_UnvestedRestrictedStockMember"
      decimals="0"
      id="fid_1328"
      unitRef="Shares">5931576</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-01-01to2024-03-31_scwo_UnvestedRestrictedStockMember"
      decimals="0"
      id="fid_1329"
      unitRef="Shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2025-01-01to2025-03-31" id="fid_1277">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We have made certain reclassifications to prior period amounts presented on our consolidated statements of operations to conform to the current period presentation with no impact to net loss or loss per share. These reclassifications consisted of reclassifying $138,586 of stock-based compensation expense from general and administrative expenses to compensation and related expenses. &lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <scwo:OtherStockBasedCompensation
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1486"
      unitRef="USD">138586</scwo:OtherStockBasedCompensation>
    <scwo:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_395">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In December 2023 the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (ASU) 2023-09, &lt;em&gt;Income Taxes (Topic 740): &lt;/em&gt;&lt;em&gt;Improvements to Income Tax Disclosures &lt;/em&gt;(ASU 2023-09). The ASU focuses on income tax disclosures around effective tax rates and cash income taxes paid. ASU 2023-09 requires public business entities to disclose, on an annual basis, a rate reconciliation presented in both dollars and percentages. The guidance requires the rate reconciliation to include specific categories and provides further guidance on disaggregation of those categories based on a quantitative threshold equal to 5% or more of the amount determined by multiplying pretax income (loss) from continuing operations by the applicable statutory rate. For entities reconciling to the US statutory rate of 21%, this would generally require disclosing any reconciling items that impact the rate by 1.05% or more. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024 (generally, calendar year 2025) and effective for all other business entities one year later. Effective January 1, 2025, we adopted ASU 2023-09 on a prospective basis. The adoption of ASU 2023-09 did not &#160;have a material impact on these unaudited condensed consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;ASU 2024-03,&#160;&lt;em&gt;Disaggregation of Income Statement Expenses (&#x201c;&lt;strong&gt;DISE&lt;/strong&gt;&#x201d;)&lt;/em&gt;. In November 2024, the FASB issued a new accounting standard to improve the disclosures about an entity&#x2019;s expenses and address requests from investors for more detailed information about the types of expenses included in commonly presented expense captions. The new standard is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with retrospective application permitted. The Company is evaluating the disclosure requirements related to the new standard and its impact on our consolidated financial statements.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.&lt;/p&gt;</scwo:NewAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_368">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 3 &#x2013; Liquidity, Capital Resources and Going Concern&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;In accordance with ASU No. 2014-15 &lt;em&gt;Presentation of Financial Statements &#x2013; Going Concern&lt;/em&gt; (subtopic 205-40), the Company&#x2019;s management evaluates whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that the financial statements are issued. At March 31, 2025, the Company had working capital of $8,734,300 and an accumulated deficit of $32,086,032. For the three months ended March 31, 2025, the Company incurred a net loss of $3,698,414 and used $3,494,477 of net cash in operations for the period. These conditions raise substantial doubt regarding our ability to continue as a going concern.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Presently, the Company will need additional debt or equity financing or a combination of both to continue its operations and meet its financial obligations for at least the next twelve months from the date these unaudited condensed interim consolidated financial statements were issued and beyond. We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding. We expect to incur continuing losses and negative cash flows from operations for the foreseeable future.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Since inception, we have financed our operations principally through the sale of debt and equity securities and operating cash flows. We have an at-the-market (ATM) equity offering under which we may issue up to $100&#160;million of common stock, subject to applicable law. &#160; At March 31, 2025,&#160;approximately $86,154,000 remains available to be sold in the Company&#x2019;s at-the-market offerings, subject to various limitations. During the three months ended March 31, 2025 and 2024, we did not use the ATM to raise capital. &#160;The Company is evaluating strategies to obtain the required additional funding for future operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During 2024, we closed on an offering of shares of common stock and common stock warrants resulting in net proceeds of approximately $11,393,000.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Any additional debt or equity financing that the Company obtains may substantially dilute the ownership held by our existing stockholders. The economic dilution to our shareholders will be significant if our stock price does not materially increase, or if the effective price of any sale is below the price paid by a particular investor. The Company may be unable to access further equity or debt financing when needed or obtain additional financing under acceptable terms, if at all.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We may decide to raise additional capital through a variety of sources in the short-term and in the long-term, including but not limited to:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="width:8%;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:4%;vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x2610;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;the public equity markets;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x2610;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;private equity financings;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x2610;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;collaborative arrangements;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x2610;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;asset sales; and/or&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#x2610;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;public or private debt.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;If the Company is unable to raise additional capital, there is a risk that the Company could be required to discontinue or significantly reduce the scope of its operations. These unaudited condensed interim consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:Capital
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1333"
      unitRef="USD">8734300</us-gaap:Capital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1330"
      unitRef="USD">-32086032</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1331"
      unitRef="USD">-3698414</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInContinuingOperations
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1332"
      unitRef="USD">3494477</us-gaap:NetCashProvidedByUsedInContinuingOperations>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31_scwo_ATMMember"
      decimals="-6"
      id="fid_1335"
      unitRef="Shares">100000000</us-gaap:CommonStockSharesIssued>
    <scwo:ProceedFromAtTheMarketOffering
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1334"
      unitRef="USD">86154000</scwo:ProceedFromAtTheMarketOffering>
    <scwo:ProceedsFromCommonStockAndWarrantsShares
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1336"
      unitRef="USD">11393000</scwo:ProceedsFromCommonStockAndWarrantsShares>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_369">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 4 &#x2013; Inventory, Net&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Inventory, net consists of:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,926,554&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,751,474&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less: inventory reserves&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(50,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(50,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,876,554&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,701,474&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_397">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Raw materials&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,926,554&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,751,474&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Work-in-process&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Less: inventory reserves&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(50,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(50,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,876,554&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,701,474&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1338"
      unitRef="USD">1926554</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1337"
      unitRef="USD">1751474</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1340"
      unitRef="USD">0</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1339"
      unitRef="USD">0</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryValuationReserves
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1342"
      unitRef="USD">50000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1341"
      unitRef="USD">50000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1344"
      unitRef="USD">1876554</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1343"
      unitRef="USD">1701474</us-gaap:InventoryNet>
    <scwo:RevenueDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_371">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 5 &#x2013; Revenue&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following is a summary of our revenues by type for the three months ended March 31, 2025 and March 31, 2024:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;134,410&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;25&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;296,096&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;94&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Service revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;408,690&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;75&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;19,182&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;543,100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;315,278&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unearned&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Revenue&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following is a summary of our unearned revenue activity for the three months ended March 31, 2025 and year ended December 31, 2024:&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Unearned revenue at beginning of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;227,683&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;130,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Billings deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;197,683&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Refundable deposit returned&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(100,000&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Recognition of prior unearned revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(27,683&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unearned revenue at end of period&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;200,000&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;227,683&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025 , we anticipate recognizing approximately $170,000 of the unearned revenue in 2025 which has been presented as a current liability at March 31, 2025.&#160; The remaining balance of $30,000&#160;has been classified as a long-term liability as the timing of revenue recognition is unknown.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Unbilled Accounts Receivable&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The following is a summary of our unbilled accounts receivable activity for the three months ended March 31, 2025 and the year ended December 31, 2024:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;December &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Unbilled accounts receivable at beginning of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,653,007&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,494,553&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Services performed but not yet billed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;510,410&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;217,666&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Services billed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(59,212&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unbilled accounts receivable at end of the period&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;2,163,417&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,653,007&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Pursuant to contractual terms with our customers, we anticipate billing the unbilled accounts receivable during our 2025 fiscal year. &lt;/p&gt;</scwo:RevenueDisclosureTextBlock>
    <scwo:ScheduleOfRevenueByTypeTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_400">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Equipment revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;134,410&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;25&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;296,096&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;94&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Service revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;408,690&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;75&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;19,182&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;6&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Total&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;543,100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;315,278&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;100&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;%&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unearned&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Revenue&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</scwo:ScheduleOfRevenueByTypeTableTextBlock>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember"
      decimals="0"
      id="fid_1348"
      unitRef="USD">134410</us-gaap:Revenues>
    <scwo:RevenuePercentage
      contextRef="From2025-01-01to2025-03-31_scwo_EquipmentRevenuesMember"
      decimals="INF"
      id="fid_1352"
      unitRef="Pure">0.25</scwo:RevenuePercentage>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember"
      decimals="0"
      id="fid_1347"
      unitRef="USD">296096</us-gaap:Revenues>
    <scwo:RevenuePercentage
      contextRef="From2024-01-01to2024-03-31_scwo_EquipmentRevenuesMember"
      decimals="INF"
      id="fid_1351"
      unitRef="Pure">0.94</scwo:RevenuePercentage>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember"
      decimals="0"
      id="fid_1350"
      unitRef="USD">408690</us-gaap:Revenues>
    <scwo:RevenuePercentage
      contextRef="From2025-01-01to2025-03-31_scwo_ServiceRevenueMember"
      decimals="INF"
      id="fid_1354"
      unitRef="Pure">0.75</scwo:RevenuePercentage>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember"
      decimals="0"
      id="fid_1349"
      unitRef="USD">19182</us-gaap:Revenues>
    <scwo:RevenuePercentage
      contextRef="From2024-01-01to2024-03-31_scwo_ServiceRevenueMember"
      decimals="INF"
      id="fid_1353"
      unitRef="Pure">0.06</scwo:RevenuePercentage>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1346"
      unitRef="USD">543100</us-gaap:Revenues>
    <scwo:PremiumsRevenuePercentage
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_1355"
      unitRef="Pure">1</scwo:PremiumsRevenuePercentage>
    <us-gaap:Revenues
      contextRef="From2024-01-01to2024-03-31"
      decimals="0"
      id="fid_1345"
      unitRef="USD">315278</us-gaap:Revenues>
    <scwo:PremiumsRevenuePercentage
      contextRef="From2024-01-01to2024-03-31"
      decimals="INF"
      id="fid_1356"
      unitRef="Pure">1</scwo:PremiumsRevenuePercentage>
    <scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_401">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Balance at &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;December 31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Unearned revenue at beginning of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;227,683&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;130,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Billings deferred&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;197,683&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Refundable deposit returned&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(100,000&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Recognition of prior unearned revenue&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(27,683&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unearned revenue at end of period&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;200,000&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;227,683&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</scwo:ScheduleOfUnearnedRevenueActivityTableTextBlock>
    <scwo:UnearnedRevenue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1358"
      unitRef="USD">227683</scwo:UnearnedRevenue>
    <scwo:UnearnedRevenue
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1357"
      unitRef="USD">130000</scwo:UnearnedRevenue>
    <scwo:BillingsDeferredUnearnedRevenue
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1360"
      unitRef="USD">0</scwo:BillingsDeferredUnearnedRevenue>
    <scwo:BillingsDeferredUnearnedRevenue
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1359"
      unitRef="USD">197683</scwo:BillingsDeferredUnearnedRevenue>
    <scwo:RefundableDepositReturned
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1366"
      unitRef="USD">0</scwo:RefundableDepositReturned>
    <scwo:RefundableDepositReturned
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1365"
      unitRef="USD">-100000</scwo:RefundableDepositReturned>
    <us-gaap:RecognitionOfDeferredRevenue
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1362"
      unitRef="USD">27683</us-gaap:RecognitionOfDeferredRevenue>
    <us-gaap:RecognitionOfDeferredRevenue
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1361"
      unitRef="USD">0</us-gaap:RecognitionOfDeferredRevenue>
    <scwo:UnearnedRevenue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1363"
      unitRef="USD">200000</scwo:UnearnedRevenue>
    <scwo:UnearnedRevenue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1364"
      unitRef="USD">227683</scwo:UnearnedRevenue>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-03-31_scwo_TwentyTwentyFiveMember"
      decimals="0"
      id="fid_1376"
      unitRef="USD">170000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2025-03-31_scwo_TwentyTwentyFiveMember"
      decimals="0"
      id="fid_1375"
      unitRef="USD">30000</us-gaap:LiabilitiesNoncurrent>
    <scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_402">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Balance&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;at&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Name&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;December &lt;/strong&gt;&lt;strong&gt;31,&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Unbilled accounts receivable at beginning of the period&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,653,007&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1,494,553&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Services performed but not yet billed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;510,410&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;217,666&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Services billed&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(59,212&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Unbilled accounts receivable at end of the period&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;2,163,417&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;strong&gt;$&lt;/strong&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;strong&gt;1,653,007&lt;/strong&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</scwo:ScheduleOfUnbilledAccountsReceivableTableTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1368"
      unitRef="USD">1653007</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="fid_1367"
      unitRef="USD">1494553</us-gaap:AccountsReceivableNet>
    <scwo:ServicesPerformedButUnbilled
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1370"
      unitRef="USD">510410</scwo:ServicesPerformedButUnbilled>
    <scwo:ServicesPerformedButUnbilled
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1369"
      unitRef="USD">217666</scwo:ServicesPerformedButUnbilled>
    <scwo:ServicesBilled
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1372"
      unitRef="USD">0</scwo:ServicesBilled>
    <scwo:ServicesBilled
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="fid_1371"
      unitRef="USD">-59212</scwo:ServicesBilled>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1373"
      unitRef="USD">2163417</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1374"
      unitRef="USD">1653007</us-gaap:AccountsReceivableNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_372">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 6 &#x2013; Stockholder&#x2019; Equity&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Issuance of Stock for Services&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we issued 180,986 fully vested shares of common stock to service providers with a fair value of $66,900 based on the market price of our common stock on date of grant.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2024, we issued 3,339 fully vested shares of common stock to a service provider with a fair value of $4,500 based on the market price of our common stock on date of grant.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Common Stock for Stock Option Exercises&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, we issued an aggregate of 200,000 shares of common stock for stock option exercises that resulted in cash proceeds of $24,000.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;span style="text-decoration:underline"&gt;Stock-based&lt;/span&gt;&lt;span style="text-decoration:underline"&gt; &lt;/span&gt;&lt;span style="text-decoration:underline"&gt;compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;2021 Plan&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The Company has reserved 24,000,000 shares of common stock or common stock equivalents to be issued under our 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;) to the Company&#x2019;s employees and non-employee services providers. &#160;At March 31, 2025, the Company has issued a total of&#160;&#160;18,114,133 stock options and restricted stock units under the 2021 Plan with&#160;5,885,867&#160;reserved shares remaining for issuance.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, and 2024, the Company recorded stock-based compensation of $460,512 and $183,200, respectively, related to granted options to employees and various consultants expected to vest. During the three months ended March 31, 2025, $428,678 was charged as&#160;compensation and related expenses and $31,834 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations. During the three months ended March 31, 2024, $138,586 was charged as&#160;compensation and&#160;related expenses and $44,614 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Stock&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Options&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Stock option activity for the three months ended March 31, 2025 is summarized as follows:&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;outstanding &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;December 31, &lt;/strong&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;15,843,116&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.94&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,324,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.95&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;908,659&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.66&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(200,000&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.12&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(142,713&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;outstanding &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31, &lt;/strong&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;16,409,062&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.92&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,274,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.98&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;Exercisable &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31, &lt;/strong&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;8,150,185&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.60&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,274,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.74&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;*At March 31, 2025 and December 31, 2024, the options outstanding and exercisable include 5,700,00 and 5,900,000 granted in connection with a merger that occurred in 2021, respectively, which were not granted under the 2021 Plan &#160;and include 275,000 of options granted in 2024 pursuant to a legal settlement and were not granted under the 2021 Plan. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, the options granted were primarily to our Chief Financial Officer and key employees. The weighted average grant-date fair value of the granted options was $0.33.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Of the total&#160;options outstanding at March 31, 2025,&#160;3,708,288&#160;of the options include performance conditions. The performance-based options vest as follows:&#160;50% vest upon the achievement of operating profit, as defined in the employment agreements, and&#160;50% upon the achievement of a revenue target of $100&#160;million by the end of fiscal year 2028. The performance-based options with the revenue target begin vesting once the Company achieves $15&#160;million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of options that vest is based on the proportionate percentage of each fiscal year&#x2019;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20&#160;million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, total unrecognized compensation expense for service based and performance-based options was $3,315,257&#160;and $2,821,770, respectively. The unrecognized service-based expense will be recognized over a weighted-average period of&#160;2.89&#160;years. The unrecognized expense associated with the performance-based options will be expensed when it becomes probable that the performance obligations will be met.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, intrinsic value is computed based on the difference between options exercise price and the market price of our common stock at March 31, 2025 of $0.34 per share multiplied by the total common stock options outstanding or exercisable whose market price exceeds the exercise price.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, 200,000 stock options issued outside of the 2021 Plan were exercised with an exercise price of $0.12 for total proceeds to the Company of $24,000.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31, &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;67.81 &#x2013; 69.25%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;26.36 &#x2013; 26.38%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;4.14 - 4.51%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;4.09 &#x2013; 4.31%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Dividend rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Restricted Stock Units&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025, the Company granted an aggregate of&#160;2,382,284&#160;unvested restricted stock units under the 2021 Plan as follows:&#160;617,284 to&#160;our Chief Financial Officer (&#x201c;CFO&#x201d;) pursuant to an employment agreement and 1,765,000&#160;to non-executive key employees of the Company. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The unvested restricted stock units granted to our CFO consist of&#160;308,642 units with time-based vesting provisions and&#160;308,642 units with performance-based vesting provisions. The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year&#x2019;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027. The 1,765,000 restricted stock units granted to non-executive key employees are all time-based vesting and vest as follows: 50% on the one-year grant-date anniversary with the remaining vesting ratably over a period of thirty-six months. &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The grant-date fair value of the restricted stock units was determined using the market price of our common stock on the date of grant which ranged from $0.62&#160;to $0.63.&#160; &lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;A summary of our outstanding nonvested restricted stock units is as follows:&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Amount&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Nonvested, beginning of the year&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,549,292&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.23&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,382,284&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Nonvested, end of the year&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;5,931,576&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.98&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, we have $2,524,952 of unrecognized stock-based compensation associated with the restricted stock units with a performance condition which will be recognized when the performance conditions are probable of being met. At March 31, 2025, the Company had $2,749,402&#160;of unrecognized stock-based compensation associated with the time vesting restricted stock units which will be recognized over a weighted-average period of approximately&#160;3.43&#160;years. During the three months ended March 31, 2025, our stock based compensation associated with the time-based restricted stock units totaled $248,951, of which $216,982 was charged as compensation and related expenses, and $31,969 as research and development expenses in the accompanying unaudited condensed consolidated statements of operations.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Stock&lt;/strong&gt;&lt;strong&gt; Warrants&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;At March 31, 2025, there were 14,675,244 warrants outstanding which relate to and offering completed in November 2024, where investors were offered one and a half warrants for every one common share purchased in the offering at an exercise price of $1.125 per share.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025 and 2024, no warrants were issued or exercised. &#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;A summary of warrant activity for the three months &#160;ended &#160;March 31, 2025, is as follows:&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160; &lt;/p&gt;&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding and exercisable at December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,675,244&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.13&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.88&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding and exercisable at March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;14,675,244&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.13&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;4.63&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember"
      decimals="0"
      id="fid_1430"
      unitRef="Shares">180986</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember"
      decimals="0"
      id="fid_1438"
      unitRef="USD">66900</us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember"
      decimals="0"
      id="fid_1453"
      unitRef="Shares">3339</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
      contextRef="From2024-01-01to2024-12-31_us-gaap_RestrictedStockMember"
      decimals="0"
      id="fid_1452"
      unitRef="USD">4500</us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember"
      decimals="0"
      id="fid_1444"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockMember_scwo_FormerEmployeesMember"
      decimals="0"
      id="fid_1445"
      unitRef="USD">24000</us-gaap:DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued>
    <scwo:IssuanceOfShares
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1447"
      unitRef="Shares">24000000</scwo:IssuanceOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1446"
      unitRef="Shares">18114133</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <scwo:CommonSharesForIssuanceRemaining
      contextRef="AsOf2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1463"
      unitRef="Shares">5885867</scwo:CommonSharesForIssuanceRemaining>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1464"
      unitRef="USD">460512</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1465"
      unitRef="USD">183200</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1466"
      unitRef="USD">428678</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1467"
      unitRef="USD">31834</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1468"
      unitRef="USD">138586</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-01to2024-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1469"
      unitRef="USD">44614</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_403">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;outstanding &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;December 31, &lt;/strong&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;15,843,116&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.94&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,324,000&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;5.95&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;908,659&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.66&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;(200,000&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.12&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expired/forfeit&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;(142,713&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;)&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.96&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;outstanding &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31, &lt;/strong&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;16,409,062&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.92&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,274,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;5.98&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Options &lt;/strong&gt;&lt;strong&gt;Exercisable &lt;/strong&gt;&lt;strong&gt;at &lt;/strong&gt;&lt;strong&gt;March &lt;/strong&gt;&lt;strong&gt;31, &lt;/strong&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;8,150,185&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;*&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;0.60&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;1,274,000&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;2.74&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1379"
      unitRef="Shares">15843116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1377"
      unitRef="USDPShares">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-12-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1395"
      unitRef="USD">3324000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      id="fid_1391">P5Y11M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1378"
      unitRef="Shares">908659</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1384"
      unitRef="USDPShares">0.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1380"
      unitRef="Shares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1385"
      unitRef="USDPShares">0.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1394"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1381"
      unitRef="Shares">142713</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1387"
      unitRef="USDPShares">2.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1382"
      unitRef="Shares">16409062</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1386"
      unitRef="USDPShares">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1389"
      unitRef="USD">1274000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      id="fid_1392">P5Y11M23D</scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1383"
      unitRef="Shares">8150185</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1388"
      unitRef="USDPShares">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2025-03-31_scwo_OptionsMember"
      decimals="0"
      id="fid_1390"
      unitRef="USD">1274000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      id="fid_1393">P2Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable
      contextRef="AsOf2024-12-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1471"
      unitRef="Shares">5900000</scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisable>
    <scwo:OptionsGranted
      contextRef="From2024-01-01to2024-12-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1472"
      unitRef="Shares">275000</scwo:OptionsGranted>
    <scwo:AverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="fid_1454"
      unitRef="USDPShares">0.33</scwo:AverageGrantDateFairValue>
    <scwo:NumberOfOptionIncludePerformanceConditions
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember"
      decimals="0"
      id="fid_1455"
      unitRef="Shares">3708288</scwo:NumberOfOptionIncludePerformanceConditions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentTargetMember"
      decimals="INF"
      id="fid_1456"
      unitRef="Pure">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember"
      decimals="INF"
      id="fid_1457"
      unitRef="Pure">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <scwo:RevenueTarget
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember"
      decimals="-6"
      id="fid_1458"
      unitRef="USD">100000000</scwo:RevenueTarget>
    <scwo:AchiveRevenueTarget
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember_scwo_VestUponAchievementOfFifityPercentRevenueTargetMember"
      decimals="-6"
      id="fid_1459"
      unitRef="USD">15000000</scwo:AchiveRevenueTarget>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1462"
      unitRef="USD">3315257</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_scwo_PerformanceBasedOptionMember"
      decimals="0"
      id="fid_1450"
      unitRef="USD">2821770</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2025-01-01to2025-03-31_scwo_ServiceBasedOptionsMember"
      id="fid_1461">P2Y10M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <scwo:MarketPriceAndExercisePriceDifference
      contextRef="From2025-01-01to2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="fid_1494"
      unitRef="USDPShares">0.34</scwo:MarketPriceAndExercisePriceDifference>
    <scwo:StockOptionsIssued
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1473"
      unitRef="Shares">200000</scwo:StockOptionsIssued>
    <us-gaap:StockOptionExercisePriceIncrease
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="INF"
      id="fid_1448"
      unitRef="USDPShares">0.12</us-gaap:StockOptionExercisePriceIncrease>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-01-01to2025-03-31_scwo_TwoZeroTwoOnePlanMember"
      decimals="0"
      id="fid_1449"
      unitRef="USD">24000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_404">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31, &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;March 31,&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2025&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;2024&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expected volatility&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;67.81 &#x2013; 69.25%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;26.36 &#x2013; 26.38%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Expected term (years)&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;6.25 Years&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:bottom;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Risk-free rate&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;4.14 - 4.51%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td class="hdcell" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;4.09 &#x2013; 4.31%&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Dividend rate&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;0.00%&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember"
      decimals="INF"
      id="fid_1400"
      unitRef="Pure">0.6781</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember"
      decimals="INF"
      id="fid_1401"
      unitRef="Pure">0.6925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember"
      decimals="INF"
      id="fid_1398"
      unitRef="Pure">0.2636</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember"
      decimals="INF"
      id="fid_1399"
      unitRef="Pure">0.2638</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      id="fid_1407">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember"
      id="fid_1406">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_BottomMember"
      decimals="INF"
      id="fid_1404"
      unitRef="Pure">0.0414</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2025-01-01to2025-03-31_us-gaap_OptionMember_scwo_TopMember"
      decimals="INF"
      id="fid_1405"
      unitRef="Pure">0.0451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_BottomMember"
      decimals="INF"
      id="fid_1402"
      unitRef="Pure">0.0409</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-01-01to2024-03-31_us-gaap_OptionMember_scwo_TopMember"
      decimals="INF"
      id="fid_1403"
      unitRef="Pure">0.0431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2025-01-01to2025-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1397"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-01-01to2024-03-31_scwo_OptionsMember"
      decimals="INF"
      id="fid_1396"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="fid_1433"
      unitRef="Shares">2382284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <scwo:OptionsGranted
      contextRef="From2025-01-01to2025-03-31_scwo_FinancialOfficerMember"
      decimals="0"
      id="fid_1431"
      unitRef="Shares">617284</scwo:OptionsGranted>
    <scwo:OptionsGranted
      contextRef="From2025-01-01to2025-03-31_scwo_keyEmployeeMember"
      decimals="0"
      id="fid_1432"
      unitRef="Shares">1765000</scwo:OptionsGranted>
    <scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="fid_1439"
      unitRef="Shares">308642</scwo:ShareBasedCompensationArrangementByShareBasedPaymentAwardUnvestedRSU>
    <scwo:PerformanceBasedRestrictedStockUnits
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="fid_1440"
      unitRef="Shares">308642</scwo:PerformanceBasedRestrictedStockUnits>
    <scwo:PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="fid_1441">The performance-based units vest as follows: 50% vest upon the achievement of Operating Profit, as defined in the employment agreements, and 50% upon the achievement of revenue targets between $15 and $100 million by the end of fiscal year 2028. The restricted stock units with the revenue target begin vesting once the Company achieves $15.0 million in revenue for a fiscal year. Vesting will occur on January 31 of each year through January 31, 2029. The number of restricted stock units that vest is based on the proportionate percentage of each fiscal year&#x2019;s revenue to the $100 million target. For example, if our annual revenue for fiscal year 2026 is $20 million, 20% of the restricted stock units with the revenue performance condition will vest on January 31, 2027. The 1,765,000 restricted stock units granted to non-executive key employees are all time-based vesting and vest as follows: 50% on the one-year grant-date anniversary with the remaining vesting ratably over a period of thirty-six months</scwo:PerformanceBasedVestingConditionsForRestrictedStockUnitsDescription>
    <scwo:GrantDateFairValueOfRestrictedStock
      contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_BottomMember"
      decimals="INF"
      id="fid_1436"
      unitRef="USDPShares">0.62</scwo:GrantDateFairValueOfRestrictedStock>
    <scwo:GrantDateFairValueOfRestrictedStock
      contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember_scwo_TopMember"
      decimals="INF"
      id="fid_1437"
      unitRef="USDPShares">0.63</scwo:GrantDateFairValueOfRestrictedStock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_414">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Weighted-&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Average &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Grant Date &lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Amount&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"&gt;&lt;strong&gt;Fair Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Nonvested, beginning of the year&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;3,549,292&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.23&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Granted&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;2,382,284&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;0.62&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Vested&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt"&gt;Forfeited&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Nonvested, end of the year&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;5,931,576&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;0.98&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="fid_1408"
      unitRef="Shares">3549292</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="fid_1412"
      unitRef="USDPShares">1.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-01-01to2025-03-31"
      decimals="0"
      id="fid_1409"
      unitRef="Shares">2382284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2025-01-01to2025-03-31"
      decimals="INF"
      id="fid_1410"
      unitRef="USDPShares">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="fid_1411"
      unitRef="Shares">5931576</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="fid_1413"
      unitRef="USDPShares">0.98</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_scwo_RestrictedStockUnitsMember"
      decimals="0"
      id="fid_1435"
      unitRef="USD">2524952</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="fid_1434"
      unitRef="USD">2749402</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <scwo:VestingRestrictedStockUnitsRecognizedPeriod
      contextRef="From2025-01-01to2025-03-31_us-gaap_RestrictedStockUnitsRSUMember"
      id="fid_1442">P3Y5M4D</scwo:VestingRestrictedStockUnitsRecognizedPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember"
      decimals="0"
      id="fid_1474"
      unitRef="USD">248951</us-gaap:AllocatedShareBasedCompensationExpense>
    <scwo:OtherLaborAndRelatedExpense
      contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember"
      decimals="0"
      id="fid_1487"
      unitRef="USD">216982</scwo:OtherLaborAndRelatedExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-03-31_scwo_RestrictedStockUnitsMember"
      decimals="0"
      id="fid_1488"
      unitRef="USD">31969</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2025-03-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1476"
      unitRef="Shares">14675244</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:StockOptionExercisePriceIncrease
      contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember"
      decimals="INF"
      id="fid_1475"
      unitRef="USDPShares">1.125</us-gaap:StockOptionExercisePriceIncrease>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_405">&lt;table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"&gt;&lt;tbody&gt;&lt;tr style="height:15px"&gt;&lt;td&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Shares&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Exercise&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Price&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Aggregate&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Intrinsic&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Value&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Weighted&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Average&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Remaining&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Contractual&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&lt;strong&gt;Life (Years)&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding and exercisable at December 31, 2024&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;14,675,244&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;1.13&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;4.88&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Issued&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#cceeff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Exercised&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15px;background-color:#ffffff"&gt;&lt;td style="vertical-align:top;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Outstanding and exercisable at March 31, 2025&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;14,675,244&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;1.13&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"&gt;$&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;-&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;"&gt;4.63&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="AsOf2024-12-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1414"
      unitRef="Shares">14675244</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-12-31_scwo_WarrantsMember"
      decimals="INF"
      id="fid_1422"
      unitRef="USDPShares">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-12-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1423"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember"
      id="fid_1416">P4Y10M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1419"
      unitRef="Shares">14675244</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_scwo_WarrantsMember"
      decimals="INF"
      id="fid_1418"
      unitRef="USDPShares">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-03-31_scwo_WarrantsMember"
      decimals="0"
      id="fid_1417"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance
      contextRef="From2025-01-01to2025-03-31_scwo_WarrantsMember"
      id="fid_1415">P4Y7M17D</scwo:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2EndingBalance>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_373">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 7 - Related Party Transactions&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On July 7, 2021, we entered into a manufacturing and services agreement (the &#x201c;M&amp;amp;S Agreement&#x201d;) to fabricate and manufacture the AirSCWO systems with Merrell Bros. Fabrication, LLC (&#x201c;Merrell Bros.&#x201d;). As part of the agreement, the Company appointed Terry Merrell, one of the owners of Merrell Bros., to its board of directors. On December 18, 2024, Mr. Merrell notified the Company of his intention to resign from the Company's Board of Directors effective December 31, 2024, to allow him to focus more on his core business responsibilities at Merrell Bros. &#160;The M&amp;amp;S Agreement terminated on its original expiration date of July 7, 2024.&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On March 27, 2024, we executed a supplemental manufacturing and services agreement (the &#x201c;Supplemental M&amp;amp;S Agreement&#x201d;) with Merrell Bros. as Merrell Bros. indicated to us their intent to not renew the Original M&amp;amp;S Agreement and we indicated our desire to relocate to a larger manufacturer facility with more square footage dedicated to expanding our manufacturing operations (see Note 9). The Supplemental M&amp;amp;S Agreement became effective on July 7, 2024 and replaced the Original M&amp;amp;S Agreement. Under the Supplemental M&amp;amp;S Agreement, our relationship and the manufacturing services provided by Merrell Bros. will continue an as needed basis based on statements of work to be agreed upon by both parties to fulfill future and current manufacturing orders. The term of the Supplemental M&amp;amp;S Agreement is one year from July 7, 2024 with a one-year renewal upon a mutually executed written extension. Either party may terminate this Supplement M&amp;amp;S Agreement upon written notice of such a termination, specifying the extent to which performance of work is terminated and the effective date of termination.&#160;The Supplemental M&amp;amp;S Agreement terminated during the year ended December 31, 2024.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;During the three months ended March 31, 2025 and 2024, the Company incurred $0 and $130,321, respectively,&#160;in related party expenses related to the manufacturing of our AirSCWO systems.&#160;At March 31, 2025 and December 31, 2024, we did not have any outstanding obligations owed to Merrell Bros. for these services. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty
      contextRef="From2025-01-01to2025-03-31_scwo_AirSCWOMember"
      decimals="0"
      id="fid_1479"
      unitRef="USD">0</scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty>
    <scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty
      contextRef="From2024-01-01to2024-03-31_scwo_AirSCWOMember"
      decimals="0"
      id="fid_1478"
      unitRef="USD">130321</scwo:RelatedPartyTransactionExpensesFromTransactionWithRelatedParty>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_374">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;8&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;&#x2013;&lt;/strong&gt;&lt;strong&gt; &lt;/strong&gt;&lt;strong&gt;Commitments and Contingencies&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;License Agreement&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The patented technology underlying 374Water&#x2019;s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (&#x201c;Duke&#x201d;), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the &#x201c;License Agreement&#x201d;). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Note 5). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. At March 31, 2025, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days&#x2019; written notice.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;&lt;em&gt;Legal Settlement&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;On November 4, 2024, our former Chief Executive Officer and Chairman of the Board filed a complaint against the Company alleging unpaid wages and a bonus. Management and the board of directors, in consultation with its attorneys, have estimated a potential loss associated with this complaint of approximately $335,000.&#160; At December 31, 2024, we established an accrual for legal settlement of this amount as presented on the consolidated balance sheet.&#160; This legal matter was officially settled on April 2, 2025 for the amount accrued. We have agreed to pay $110,000 of the settlement within ten calendar days of certain conditions being met by the plaintiff, as defined in the settlement agreement, with the remaining settlement being paid in equal statements through December 31, 2025. As of the date of this filling, we have paid the agreed upon $110,000 as all plaintiff conditions were met.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;We note that in the ordinary course of business we may be the subject of, or party to, various pending or threatened legal actions which could result in a material adverse outcome for which the related damages may not be estimable. We do not believe any legal action would have a significant impact on the financials other than the matter disclosed above. However, there is inherent uncertainty regarding such matters.&lt;/p&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <scwo:PotentialLossesAssociatedWithComplaints
      contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember"
      decimals="0"
      id="fid_1480"
      unitRef="USD">335000</scwo:PotentialLossesAssociatedWithComplaints>
    <scwo:PaymentOfLegalSettlementAmount
      contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember"
      decimals="0"
      id="fid_1481"
      unitRef="USD">110000</scwo:PaymentOfLegalSettlementAmount>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="From2024-11-01to2024-11-04_us-gaap_CommitmentsMember"
      decimals="0"
      id="fid_1498"
      unitRef="USD">110000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_407">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&lt;strong&gt;Note 9 - &#160;&#160;Segment Reporting&lt;/strong&gt;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;Operating segments are defined as components of an entity for which separate financial information is available and that is regularly provided to the Chief Operating Decision Maker (CODM) in deciding how to allocate resources to an individual segment and in assessing performance. The Company&#x2019;s Chief Executive Officer, Chief Operating Officer and Chief Financial Officer comprise the Company&#x2019;s CODMs. The CODMs review financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance.&#160; The CODMs use consolidated net income (loss) to assess performance, evaluate cost optimization, and allocate resources, including personnel-related and financial or capital resources, in the annual budget and forecasting process, as well as budget-to-actual variances on a monthly basis. As such, the Company has determined that it operates as&#160;one&#160;operating and reportable segment.&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;The significant expenses regularly reviewed by the CODMs are consistent with those reported on the Company's unaudited condensed consolidated statement of operations and expenses are not regularly reviewed on a more disaggregated basis for assessing segment performance and deciding how to allocate resources. The CODMs do not regularly review total assets for our single reportable segment as total assets are not used to assess performance or allocate resources.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-01to2025-03-31" id="fid_375">&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;strong&gt;Note 10 - Subsequent Events &lt;/strong&gt;&lt;/p&gt;&lt;p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;On April 13, 2025, the Company appointed Stephen Jones to the Company&#x2019;s Board of Directors, effective April 14, 2025. Mr. Jones, age 63, is being appointed to the Board of Directors to fill the vacancy on the Board of Directors. From March 2015 through October 2020, Mr. Jones was President, Chief Executive Officer and a director of Covanta Holding Corporation (formerly NYSE: CVA, now owned by private equity) (&#x201c;Covanta&#x201d;), a leading global provider of sustainable waste and energy solutions. Prior to joining Covanta in January 2015, Mr. Jones was employed from 1992 through September 2014 by Air Products and Chemicals, Inc. (&#x201c;Air Products&#x201d;), a global supplier of industrial gases and equipment. Mr. Jones held a variety of senior-level management positions at Air Products including in the company&#x2019;s tonnage gases, equipment, energy and industrial chemicals businesses, culminating with his role as Air Products&#x2019; China president based at the company&#x2019;s office in Shanghai. Mr. Jones is a director of Tronox Holdings plc, an industrial and chemical company (NYSE: TROX), and chairman of the board of directors of Badger Infrastructure Solutions Ltd., a Canadian infrastructure solutions company specializing in nondestructive excavation services (TSE: BDGI). Mr. Jones also serves as a special advisor to the supervisory board of Hitachi Zosen Inova AG, a global cleantech company. Prior to joining Air Products in 1992, Mr. Jones practiced corporate law at Dechert LLP in Philadelphia, PA, primarily in the area of mergers and acquisitions.&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;Pursuant to an employment agreement executed with our Chief Technology Officer on March 31, 2025, our board of directors approved the following equity compensation grant under our 2021 Plan on April 30, 2025: &lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;1,515,152 restricted stock units and 1,515,152 stock options vesting as follows: (a) with respect to 757,576 restricted stock and 757,576 shares subject to stock options, 25% vest on the first anniversary of the CTO&#x2019;s employment agreement, and the remaining 75% vest in equal increments on the last day of every month thereafter over the following 36 months, subject to the CTO&#x2019;s continued employment with the Company on each vesting date: and (b) with respect to the remaining 757,576 restricted stock and 757,576 stock options, each vest in accordance with a performance based milestone set forth by the Company and defined in the CTO&#x2019;s employment agreement. See Note 6 for further disclosures on the performance-related milestones. The stock options have an exercise price of $0.33 and a ten-year contractual term. &lt;/p&gt;&lt;p style="font-size:10pt;font-family:times new roman;margin:0px"&gt;&#160;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <scwo:ShareBasedRestrictedStockUnitsGranted
      contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_1483"
      unitRef="Shares">1515152</scwo:ShareBasedRestrictedStockUnitsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember"
      decimals="0"
      id="fid_1482"
      unitRef="Shares">1515152</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <scwo:DescriptionOfBoardOfDirectorsEquityCompensation
      contextRef="From2025-04-01to2025-04-30_us-gaap_SubsequentEventMember"
      id="fid_1484">(a) with respect to 757,576 restricted stock and 757,576 shares subject to stock options, 25% vest on the first anniversary of the CTO&#x2019;s employment agreement, and the remaining 75% vest in equal increments on the last day of every month thereafter over the following 36 months, subject to the CTO&#x2019;s continued employment with the Company on each vesting date: and (b) with respect to the remaining 757,576 restricted stock and 757,576 stock options, each vest in accordance with a performance based milestone set forth by the Company and defined in the CTO&#x2019;s employment agreement. See Note 6 for further disclosures on the performance-related milestones</scwo:DescriptionOfBoardOfDirectorsEquityCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2025-04-30_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="fid_1485"
      unitRef="USDPShares">0.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
